{ "disclosure": "AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team.", "corrections": "https://phage.directory/tips", "method": "AI-assisted source collection and extraction; registry identity, source/status and duplicate checks. Linked protocol years are not clinic operating dates. Public intake may be unconfirmed for case-by-case programs. Coverage and source access are incomplete; failed retrieval is not evidence of closure.", "checked": "2026-10-05", "records": [ { "id": "therapyRoutes/argentina-inlain", "name": "INLAIN UNL-CONICET phage research", "countries": [ "AR" ], "uuid": "88eeaf4c7d035f17aeef0c3fee8ba8c9", "permalink": "/items/inlain-unl-conicet-phage-research-88eeaf4c7d035f17aeef0c3fee8ba8c9", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://santafe.conicet.gov.ar/superbacterias/" ], "checked": "2026-10-03", "location": "Santa Fe; Argentina", "detail": "Institutional account of KPC-producing Klebsiella phage/meropenem laboratory research and intended future clinical collaborations.", "searchTerms": [ "Institutional account of KPC-producing Klebsiella phage/meropenem laboratory research and intended future clinical collaborations.", "Santa Fe; Argentina" ] }, { "id": "trial-site/96437e12f250b474", "name": "Monash Health — Clayton", "countries": [ "AU" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Clayton", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "Monash Health", "Clayton", "", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "therapyRoutes/au-monash-foundry", "name": "Monash University Phage Foundry", "countries": [ "AU" ], "uuid": "dc72420544b95cbe99cc1b03f9eaf2c7", "permalink": "/items/monash-university-phage-foundry-dc72420544b95cbe99cc1b03f9eaf2c7", "kind": "Supplier", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.monash.edu/impact-amr/phage-therapy", "https://www.monash.edu/news/articles/scientists-develop-a-virus-cocktail-to-combat-superbugs" ], "checked": "2026-10-03", "location": "Melbourne; Australia", "accessMode": "clinician-support", "detail": "Manufacture and matching of therapeutic phages, including Enterobacter cocktail Entelli02 for compassionate-use supply.", "searchTerms": [ "Manufacture and matching of therapeutic phages, including Enterobacter cocktail Entelli02 for compassionate-use supply.", "Melbourne; Australia" ] }, { "id": "therapyRoutes/au-phage-australia", "name": "Phage Australia", "countries": [ "AU" ], "uuid": "dd8ee65eadae5715bde672927bf40a2d", "permalink": "/items/phage-australia-dd8ee65eadae5715bde672927bf40a2d", "kind": "Network", "status": "Case-by-case; Official referral/inquiry route", "activity": "current", "sources": [ "https://www.phageaustralia.org/patient-information", "https://www.phageaustralia.org/our-approach", "https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382817&isReview=true" ], "checked": "2026-10-03", "trialIds": [ "actrn12621001526864" ], "location": "Westmead; Australia", "accessMode": "case-by-case", "detail": "Personalized therapy for difficult infections after established approaches are optimized; adults and children; multisite treatment network.", "searchTerms": [ "Personalized therapy for difficult infections after established approaches are optimized; adults and children; multisite treatment network.", "Westmead; Australia" ] }, { "id": "therapyRoutes/au-phage-wa", "name": "Phage WA / Wal-yan Respiratory Research Centre, The Kids Research Institute Australia", "countries": [ "AU" ], "uuid": "7459f355ce2b57748d0e3a6ef2fd2b09", "permalink": "/items/phage-wa-wal-yan-respiratory-research-centre-the-kids-research-institute-australia-7459f355ce2b57748d0e3a6ef2fd2b09", "kind": "Network", "status": "Official referral/inquiry route", "activity": "current", "sources": [ "https://walyanrespiratory.thekids.org.au/projects/phage-wa/", "https://walyanrespiratory.thekids.org.au/projects/phage-wa/phage-therapy-compassionate-use/", "https://walyanrespiratory.thekids.org.au/projects/phage-wa/get-involved/" ], "checked": "2026-10-03", "location": "Perth; Australia", "detail": "Resistant infections, particularly respiratory/CF research; phage bank/matching and manufacture supporting clinical partners.", "searchTerms": [ "Resistant infections, particularly respiratory/CF research; phage bank/matching and manufacture supporting clinical partners.", "Perth; Australia" ] }, { "id": "trial-site/3108c058b39ebd9c", "name": "Royal Adelaide Hospital — Adelaide", "countries": [ "AU" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Adelaide", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "Royal Adelaide Hospital", "Adelaide", "", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "trial-site/c78dd2536809e756", "name": "Royal Melbourne Hospital — Melbourne", "countries": [ "AU" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Melbourne", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "Royal Melbourne Hospital", "Melbourne", "", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "therapyRoutes/historical-special-phage-holdings", "name": "Special Phage Holdings Pty Ltd", "countries": [ "AU" ], "uuid": "3bcaf0f330a65e719b266c2b0e68a4c5", "permalink": "/items/special-phage-holdings-pty-ltd-3bcaf0f330a65e719b266c2b0e68a4c5", "kind": "Company", "status": "Acquired by AmpliPhi in 2012", "activity": "historical", "sources": [ "https://www.sec.gov/Archives/edgar/data/921114/000155837020002943/armp-20191231x10k.htm" ], "checked": "2026-10-03", "detail": "Historical phage-development company.", "searchTerms": [ "Historical phage-development company.", "" ] }, { "uuid": "d4644a200f9f5293bf0ab88d19f3ecdd", "permalink": "/items/stamp-d4644a200f9f5293bf0ab88d19f3ecdd", "id": "trials/actrn12621001526864", "name": "STAMP (ACTRN12621001526864)", "countries": [ "AU" ], "kind": "Trial", "status": "Recruiting", "activity": "current", "sources": [ "https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382817&isReview=true" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "actrn12621001526864", "start": { "date": "2022-04-01", "kind": "actual" }, "end": { "date": "2027-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382817&isReview=true" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-04-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382817&isReview=true" ], "candidates": [ { "date": "2022-04-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382817&isReview=true" ] }, { "date": "2022-04-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382817&isReview=true" ] } ] }, "end": { "value": { "date": "2027-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382817&isReview=true" ], "candidates": [ { "date": "2027-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382817&isReview=true" ] }, { "date": "2027-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382817&isReview=true" ] } ] } } } ], "searchTerms": [ "STAMP", "ACTRN12621001526864" ] }, { "id": "trial-site/66a0f3c56bb6106f", "name": "The Alfred Hospital — Melbourne", "countries": [ "AU" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Melbourne", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "The Alfred Hospital", "Melbourne", "", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "therapyRoutes/au-vicphage", "name": "VICPhage Service, The Alfred", "countries": [ "AU" ], "uuid": "2ba7d68c4616565eaee130ca655821d1", "permalink": "/items/vicphage-service-the-alfred-2ba7d68c4616565eaee130ca655821d1", "kind": "Center", "status": "Official referral/inquiry route", "activity": "current", "sources": [ "https://www.alfredhealth.org.au/the-alfred/services/hp/vicphage-service", "https://www.alfredhealth.org.au/images/resources/referral-forms/Referral_to_Infectious_Diseases_-_VICPhage.pdf" ], "checked": "2026-10-03", "trialIds": [ "actrn12621001526864" ], "location": "Melbourne; Australia", "detail": "Assessment for adjunctive phages in challenging bacterial infections; case selection and optimized conventional management precede treatment.", "searchTerms": [ "Assessment for adjunctive phages in challenging bacterial infections; case selection and optimized conventional management precede treatment.", "Melbourne; Australia" ] }, { "id": "trial-site/57faef2ca7a4e352", "name": "Westmead Hospital — Westmead", "countries": [ "AU" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Westmead", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "Westmead Hospital", "Westmead", "", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "therapyRoutes/au-westmead", "name": "Westmead Hospital / Westmead Institute for Medical Research phage team", "countries": [ "AU" ], "uuid": "2bfadb04d238566fb61b6387c1d886e0", "permalink": "/items/westmead-hospital-westmead-institute-for-medical-research-phage-team-2bfadb04d238566fb61b6387c1d886e0", "kind": "Center", "status": "Official referral/inquiry route", "activity": "current", "sources": [ "https://wimr.org.au/research-groups/phage-therapy-group/", "https://www.phageaustralia.org/patient-information", "https://www.phageaustralia.org/our-approach", "https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382817&isReview=true", "https://www.abc.net.au/news/2021-01-15/antibiotic-resistant-superbug-bacteriophage-therapy/12213010" ], "checked": "2026-10-03", "trialIds": [ "actrn12621001526864" ], "location": "Westmead; Australia", "detail": "Personalized phage therapy for difficult-to-treat bacterial infections, including clinical trials and compassionate-use cases. In October 2022, STAMP administered its first patient dose of locally produced phages at Westmead.", "searchTerms": [ "Personalized phage therapy for difficult-to-treat bacterial infections, including clinical trials and compassionate-use cases. In October 2022, STAMP administered its first patient dose of locally produced phages at Westmead.", "Westmead; Australia" ] }, { "uuid": "b865f812faac5582bec8fd5513490aa5", "permalink": "/items/study-evaluating-safety-tolerability-and-efficacy-of-intravenous-ap-sa02-in-subjects-with-b865f812faac5582bec8fd5513490aa5", "id": "trials/nct05184764", "name": "diSArm (NCT05184764)", "countries": [ "AU", "US" ], "kind": "Trial", "status": "Completed", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ], "detail": "Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus", "searchTerms": [ "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764", "Banner University Medical Center", "Tucson", "Arizona", "United States", "University of California, San Diego (UCSD) - Medical Center", "La Jolla", "California", "United States", "University of Southern California Keck School of Medicine", "Los Angeles", "California", "United States", "University of California, Los Angeles (UCLA) - Medical Center", "Los Angeles", "California", "United States", "Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center", "Torrance", "California", "United States", "Rocky Mountain Regional VA Medical Center", "Aurora", "Colorado", "United States", "University of Florida (UF) - Division of Infectious Disease", "Gainesville", "Florida", "United States", "University of Florida - Jacksonville", "Jacksonville", "Florida", "United States", "University of South Florida", "Tampa", "Florida", "United States", "Emory University Hospital Midtown", "Atlanta", "Georgia", "United States", "Johns Hopkins University", "Baltimore", "Maryland", "United States", "Tufts Medical Center", "Boston", "Massachusetts", "United States", "University of Michigan", "Ann Arbor", "Michigan", "United States", "Henry Ford Health System", "Detroit", "Michigan", "United States", "The Jamaica Hospital Medical Center", "Jamaica", "New York", "United States", "Icahn School of Medicine at Mount Sinai", "New York", "New York", "United States", "Montefiore Medical Center", "The Bronx", "New York", "United States", "University of North Carolina - Chapel Hill School of Medicine", "Chapel Hill", "North Carolina", "United States", "Wake Forest University Health Sciences", "Winston-Salem", "North Carolina", "United States", "Rhode Island Hospital", "Providence", "Rhode Island", "United States", "Regional One Healthcare", "Memphis", "Tennessee", "United States", "Methodist Hospital Research Institute - Houston", "Houston", "Texas", "United States", "Froedtert Hospital and the Medical College of Wisconsin", "Milwaukee", "Wisconsin", "United States", "Royal Adelaide Hospital", "Adelaide", "", "Australia", "Monash Health", "Clayton", "", "Australia", "Royal Melbourne Hospital", "Melbourne", "", "Australia", "The Alfred Hospital", "Melbourne", "", "Australia", "Westmead Hospital", "Westmead", "", "Australia" ] }, { "id": "therapyRoutes/eu-phagomed-biontech", "name": "Former PhagoMed / BioNTech R&D Austria", "countries": [ "AT" ], "uuid": "13006149511e524c94314c12c29bf5cd", "permalink": "/items/former-phagomed-biontech-r-d-austria-13006149511e524c94314c12c29bf5cd", "kind": "Company", "status": "Historical/inactive", "activity": "historical", "sources": [ "https://investors.biontech.de/system/files-encrypted/nasdaq_kms/assets/2021/11/10/4-05-39/BNTX_Q3%202021%20Presentation_11.09.2021_F.pdf", "https://www.biontech.com/content/dam/corporate/pdf/20-F%202023.pdf" ], "checked": "2026-10-03", "location": "Vienna; Austria", "detail": "Synthetic lysin antibacterial development; not established as a current live-phage clinic.", "searchTerms": [ "Synthetic lysin antibacterial development; not established as a current live-phage clinic.", "Vienna; Austria" ] }, { "uuid": "05e6365885b855c1994b21fa47f885d0", "permalink": "/items/antibacterial-treatment-against-diarrhea-in-oral-rehydration-solution-05e6365885b855c1994b21fa47f885d0", "id": "trials/nct00937274", "name": "Antibacterial Treatment Against Diarrhea in Oral Rehydration Solution (NCT00937274)", "countries": [ "BD" ], "kind": "Trial", "status": "Terminated", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT00937274" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct00937274", "start": { "date": "2009-08", "kind": "reported" }, "end": { "date": "2013-01", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00937274" ], "label": "2009–2013", "dateEvidence": { "start": { "value": { "date": "2009-08", "kind": "reported" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00937274" ], "candidates": [ { "date": "2009-08", "kind": "reported", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00937274" ] }, { "date": "2009-08", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00937274" ] } ] }, "end": { "value": { "date": "2013-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00937274" ], "candidates": [ { "date": "2013-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00937274" ] }, { "date": "2013-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00937274" ] } ] } } } ], "detail": "Diarrhea", "searchTerms": [ "Antibacterial Treatment Against Diarrhea in Oral Rehydration Solution", "Diarrhea", "NCT00937274", "Clinical Sciences Division, ICDDR,B, Mohakhali,", "Dhaka", "", "Bangladesh" ] }, { "id": "trial-site/3465c8690903a6ae", "name": "Clinical Sciences Division, ICDDR,B, Mohakhali, — Dhaka", "countries": [ "BD" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT00937274" ], "checked": "2026-10-03", "trialIds": [ "nct00937274" ], "location": "Dhaka", "detail": "Recorded study locations: Diarrhea. Not an offer of treatment.", "searchTerms": [ "Clinical Sciences Division, ICDDR,B, Mohakhali,", "Dhaka", "", "Antibacterial Treatment Against Diarrhea in Oral Rehydration Solution", "Diarrhea", "NCT00937274" ], "studyYears": [ { "trialId": "nct00937274", "start": { "date": "2009-08", "kind": "reported" }, "end": { "date": "2013-01", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00937274" ], "label": "2009–2013", "dateEvidence": { "start": { "value": { "date": "2009-08", "kind": "reported" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00937274" ], "candidates": [ { "date": "2009-08", "kind": "reported", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00937274" ] }, { "date": "2009-08", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00937274" ] } ] }, "end": { "value": { "date": "2013-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00937274" ], "candidates": [ { "date": "2013-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00937274" ] }, { "date": "2013-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00937274" ] } ] } } } ] }, { "id": "therapyRoutes/bd-icddrb", "name": "icddr,b", "countries": [ "BD" ], "uuid": "126e2a10128455618f2438d57e8018db", "permalink": "/items/icddr-b-126e2a10128455618f2438d57e8018db", "kind": "Research", "status": "Historical/inactive", "activity": "historical", "sources": [ "https://www.icddrb.org/storage/file/Document/icddr%2Cb%20Annual%20Report_2016_31May17.pdf" ], "checked": "2026-10-03", "location": "Dhaka; Bangladesh", "detail": "Past childhood E. coli diarrhea randomized clinical research; report states safe administration without demonstrated clinical benefit.", "searchTerms": [ "Past childhood E. coli diarrhea randomized clinical research; report states safe administration without demonstrated clinical benefit.", "Dhaka; Bangladesh" ] }, { "id": "trial-site/16ff1371f85fe656", "name": "CHU Sart-Tilman — Liège", "countries": [ "BE" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT02116010" ], "checked": "2026-10-04", "trialIds": [ "nct02116010" ], "location": "Liège", "detail": "Recorded study locations: Wound Infection. Not an offer of treatment.", "searchTerms": [ "CHU Sart-Tilman", "Liège", "", "Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients", "Wound Infection", "NCT02116010", "2014-000714-65" ], "studyYears": [ { "trialId": "nct02116010", "start": { "date": "2015-07-26", "kind": "actual" }, "end": { "date": "2017-01-16", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ], "label": "2015–2017", "dateEvidence": { "start": { "value": { "date": "2015-07-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ], "candidates": [ { "date": "2015-07-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] }, { "date": "2015-07", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02116010" ] }, { "date": "2015-07-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] } ] }, "end": { "value": { "date": "2017-01-16", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ], "candidates": [ { "date": "2017-01-16", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] }, { "date": "2017-01-16", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] }, { "date": "2017-01-16", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] } ] } } } ] }, { "uuid": "b10b9710e25b532db1e6cddece41d005", "permalink": "/items/establishing-personalized-phage-therapy-and-its-comparative-cost-in-difficult-to-treat-inf-b10b9710e25b532db1e6cddece41d005", "id": "trials/nct06368388", "name": "EPHICACI (NCT06368388)", "countries": [ "BE" ], "kind": "Observational study", "status": "Recruiting", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06368388" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct06368388", "start": { "date": "2021-06-01", "kind": "actual" }, "end": { "date": "2029-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06368388" ], "label": "2021–2029 (estimated)", "dateEvidence": { "start": { "value": { "date": "2021-06-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06368388" ], "candidates": [ { "date": "2021-06-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06368388" ] }, { "date": "2021-06-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06368388" ] } ] }, "end": { "value": { "date": "2029-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06368388" ], "candidates": [ { "date": "2029-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06368388" ] }, { "date": "2029-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06368388" ] } ] } } } ], "detail": "Musculoskeletal Infection; Chronic Rhinosinusitis (Diagnosis); Persistent Bacteremia; Pulmonary Infection; Hidradenitis Suppurativa", "searchTerms": [ "Establishing Personalized Phage Therapy and Its Comparative Cost in Difficult-to-treat Infections (EPHICACI)", "Musculoskeletal Infection", "Chronic Rhinosinusitis (Diagnosis)", "Persistent Bacteremia", "Pulmonary Infection", "Hidradenitis Suppurativa", "NCT06368388", "University Hospitals Leuven", "Leuven", "", "Belgium" ] }, { "id": "trial-site/3f506cfa3b372726", "name": "Hopital Militaire Reine Astrid — Brussels", "countries": [ "BE" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT02116010" ], "checked": "2026-10-04", "trialIds": [ "nct02116010" ], "location": "Brussels", "detail": "Recorded study locations: Wound Infection. Not an offer of treatment.", "searchTerms": [ "Hopital Militaire Reine Astrid", "Brussels", "", "Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients", "Wound Infection", "NCT02116010", "2014-000714-65" ], "studyYears": [ { "trialId": "nct02116010", "start": { "date": "2015-07-26", "kind": "actual" }, "end": { "date": "2017-01-16", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ], "label": "2015–2017", "dateEvidence": { "start": { "value": { "date": "2015-07-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ], "candidates": [ { "date": "2015-07-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] }, { "date": "2015-07", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02116010" ] }, { "date": "2015-07-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] } ] }, "end": { "value": { "date": "2017-01-16", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ], "candidates": [ { "date": "2017-01-16", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] }, { "date": "2017-01-16", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] }, { "date": "2017-01-16", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] } ] } } } ] }, { "id": "therapyRoutes/eu-queen-astrid-labmct", "name": "Queen Astrid Military Hospital LabMCT", "countries": [ "BE" ], "uuid": "d885ecb9e6f6583fac68112ba92c4ee3", "permalink": "/items/queen-astrid-military-hospital-labmct-d885ecb9e6f6583fac68112ba92c4ee3", "kind": "Supplier", "status": "Active program; intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.hopitalmilitaire.be/onderzoek_labmct_fr.php", "https://www.mil.be/fr/news/la-recherche-medicale-militaire-au-service-de-tous/", "https://researchportal.rma.ac.be/de/projects/research-in-support-of-personalized-bacteriophage-therapy-of-diff/" ], "checked": "2026-10-03", "location": "Brussels (Neder-over-Heembeek); Belgium", "accessMode": "clinician-support", "detail": "Phage research, characterization and clinical supply expertise associated with the military hospital.", "searchTerms": [ "Phage research, characterization and clinical supply expertise associated with the military hospital.", "Brussels (Neder-over-Heembeek); Belgium" ] }, { "id": "trial-site/87d760d03185e8f5", "name": "University Hospitals Leuven — Leuven", "countries": [ "BE" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06368388" ], "checked": "2026-10-03", "trialIds": [ "nct06368388" ], "location": "Leuven", "detail": "Recorded study locations: Musculoskeletal Infection; Chronic Rhinosinusitis (Diagnosis); Persistent Bacteremia; Pulmonary Infection; Hidradenitis Suppurativa. Not an offer of treatment.", "searchTerms": [ "University Hospitals Leuven", "Leuven", "", "Establishing Personalized Phage Therapy and Its Comparative Cost in Difficult-to-treat Infections (EPHICACI)", "Musculoskeletal Infection", "Chronic Rhinosinusitis (Diagnosis)", "Persistent Bacteremia", "Pulmonary Infection", "Hidradenitis Suppurativa", "NCT06368388" ], "studyYears": [ { "trialId": "nct06368388", "start": { "date": "2021-06-01", "kind": "actual" }, "end": { "date": "2029-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06368388" ], "label": "2021–2029 (estimated)", "dateEvidence": { "start": { "value": { "date": "2021-06-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06368388" ], "candidates": [ { "date": "2021-06-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06368388" ] }, { "date": "2021-06-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06368388" ] } ] }, "end": { "value": { "date": "2029-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06368388" ], "candidates": [ { "date": "2029-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06368388" ] }, { "date": "2029-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06368388" ] } ] } } } ] }, { "id": "therapyRoutes/eu-uz-leuven", "name": "UZ Leuven Center for Bacteriophage Therapy", "countries": [ "BE" ], "uuid": "f801bf91882d59dcb89312e630245938", "permalink": "/items/uz-leuven-center-for-bacteriophage-therapy-f801bf91882d59dcb89312e630245938", "kind": "Center", "status": "Official referral/inquiry route", "activity": "current", "sources": [ "https://www.uzleuven.be/en/bacteriophage-therapy", "https://clinicaltrials.gov/study/NCT06368388", "https://research.kuleuven.be/portal/en/project/3M250516" ], "checked": "2026-10-03", "trialIds": [ "nct06368388" ], "location": "Leuven; Belgium", "detail": "Selected severe bacterial infections after other options fail: chronic rhinosinusitis, bronchiectasis/CF respiratory infection, musculoskeletal infection and sepsis.", "searchTerms": [ "Selected severe bacterial infections after other options fail: chronic rhinosinusitis, bronchiectasis/CF respiratory infection, musculoskeletal infection and sepsis.", "Leuven; Belgium" ] }, { "uuid": "785d1db7e2395f5b8a10f80de329802e", "permalink": "/items/evaluation-of-phage-therapy-for-the-treatment-of-escherichia-coli-and-pseudomonas-aerugino-785d1db7e2395f5b8a10f80de329802e", "id": "trials/nct02116010", "name": "PHAGOBURN (NCT02116010)", "countries": [ "BE", "CH", "FR" ], "kind": "Trial", "status": "Ended", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT02116010", "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ], "checked": "2026-10-04", "studyYears": [ { "trialId": "nct02116010", "start": { "date": "2015-07-26", "kind": "actual" }, "end": { "date": "2017-01-16", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ], "label": "2015–2017", "dateEvidence": { "start": { "value": { "date": "2015-07-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ], "candidates": [ { "date": "2015-07-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] }, { "date": "2015-07", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02116010" ] }, { "date": "2015-07-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] } ] }, "end": { "value": { "date": "2017-01-16", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ], "candidates": [ { "date": "2017-01-16", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] }, { "date": "2017-01-16", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] }, { "date": "2017-01-16", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] } ] } } } ], "detail": "Wound Infection", "searchTerms": [ "Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients", "Wound Infection", "NCT02116010", "2014-000714-65", "Hopital Militaire Reine Astrid", "Brussels", "", "Belgium", "CHU Sart-Tilman", "Liège", "", "Belgium", "Hôpital d'instruction des armées Percy", "Clamart", "", "France", "Centre hospitalier ST Joseph et St Luc", "Lyon", "", "France", "Centre Hospitalier Universitaire Vaudois", "Lausanne", "", "Switzerland" ] }, { "id": "therapyRoutes/eu-phagoburn", "name": "PhagoBurn consortium", "countries": [ "BE", "CH", "FR" ], "uuid": "d91b6594c61850fdbb73f478c91a9d14", "permalink": "/items/phagoburn-consortium-d91b6594c61850fdbb73f478c91a9d14", "kind": "Research", "status": "Historical/inactive", "activity": "historical", "sources": [ "https://cordis.europa.eu/project/id/601857", "https://clinicaltrials.gov/study/NCT02116010" ], "checked": "2026-10-03", "trialIds": [ "nct02116010" ], "location": "France; Belgium; Switzerland", "detail": "P. aeruginosa/E. coli burn-wound phage development; multinational burn-unit study.", "searchTerms": [ "P. aeruginosa/E. coli burn-wound phage development; multinational burn-unit study.", "France; Belgium; Switzerland" ] }, { "uuid": "e9ccb59bee8752b29b2c57439bbfb424", "permalink": "/items/kidnap-unifesp-kpc-decolonization-e9ccb59bee8752b29b2c57439bbfb424", "id": "trials/rbr-9f3whw9", "name": "KIDNAP / UNIFESP KPC decolonization (RBR-9f3whw9)", "countries": [ "BR" ], "kind": "Trial", "status": "Not yet recruiting", "activity": "planned", "sources": [ "https://ensaiosclinicos.gov.br/rg/RBR-9f3whw9" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "rbr-9f3whw9", "start": { "date": "2025-09-01", "kind": "estimated" }, "sourceUrls": [ "https://ensaiosclinicos.gov.br/rg/RBR-9f3whw9" ], "label": "Started 2025 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-09-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://ensaiosclinicos.gov.br/rg/RBR-9f3whw9" ], "candidates": [ { "date": "2025-09-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://ensaiosclinicos.gov.br/rg/RBR-9f3whw9" ] }, { "date": "2025-09-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://ensaiosclinicos.gov.br/rg/RBR-9f3whw9" ] } ] } } } ], "searchTerms": [ "KIDNAP / UNIFESP KPC decolonization", "RBR-9f3whw9" ] }, { "id": "therapyRoutes/unifesp-kidnap", "name": "UNIFESP Escola Paulista de Medicina — KIDNAP", "countries": [ "BR" ], "uuid": "27a2dfcee3d55fc8a46aac538a25e347", "permalink": "/items/unifesp-escola-paulista-de-medicina-kidnap-27a2dfcee3d55fc8a46aac538a25e347", "kind": "Center", "status": "Research/development", "activity": "research", "sources": [ "https://ensaiosclinicos.gov.br/rg/RBR-9f3whw9" ], "checked": "2026-10-03", "trialIds": [ "rbr-9f3whw9" ], "location": "São Paulo; Brazil", "detail": "Feasibility/proof-of-concept oral phage trial targeting KPC-producing Klebsiella intestinal colonization in selected high-risk adults; active matching required.", "searchTerms": [ "Feasibility/proof-of-concept oral phage trial targeting KPC-producing Klebsiella intestinal colonization in selected high-risk adults; active matching required.", "São Paulo; Brazil" ] }, { "id": "therapyRoutes/usp-cepid-b3", "name": "University of São Paulo CEPID B3 phage research", "countries": [ "BR" ], "uuid": "e2427ba8e556550ca6e7f3c70bbfb92c", "permalink": "/items/university-of-sao-paulo-cepid-b3-phage-research-e2427ba8e556550ca6e7f3c70bbfb92c", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://jornal.usp.br/ciencias/virus-podera-ser-usado-em-tratamento-contra-bacteria-que-causa-infeccoes-hospitalares/" ], "checked": "2026-10-03", "location": "São Paulo; Brazil", "detail": "Institutional report of Pseudomonas phage research using in vitro and larvae models, with prospective therapeutic applications.", "searchTerms": [ "Institutional report of Pseudomonas phage research using in vitro and larvae models, with prospective therapeutic applications.", "São Paulo; Brazil" ] }, { "uuid": "bac9b81dd8ef5f8ca79cbf416a2184db", "permalink": "/items/bacteriophage-clinical-trial-for-periprosthetic-joint-infection-of-multidrug-resistant-pse-bac9b81dd8ef5f8ca79cbf416a2184db", "id": "trials/nct06798168", "name": "Bacteriophage Clinical Trial for Periprosthetic Joint Infection of Multidrug Resistant Pseudomonas Aeruginosa (NCT06798168)", "countries": [ "CA" ], "kind": "Individual-case protocol", "status": "Expanded access", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06798168" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct06798168", "sourceUrls": [], "label": "Not listed", "dateEvidence": { "start": { "conflict": false, "sourceUrls": [], "candidates": [] } } } ], "detail": "Joint Infection", "searchTerms": [ "Bacteriophage Clinical Trial for Periprosthetic Joint Infection of Multidrug Resistant Pseudomonas Aeruginosa", "Joint Infection", "NCT06798168", "The Ottawa Hospital", "Ottawa", "", "Canada" ] }, { "uuid": "98f2bb10c88657aba36c2ad46d0f8019", "permalink": "/items/bacteriophage-therapy-for-mycobacterium-abscessus-pulmonary-infection-98f2bb10c88657aba36c2ad46d0f8019", "id": "trials/nct07228702", "name": "Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection (NCT07228702)", "countries": [ "CA" ], "kind": "Individual-case protocol", "status": "Invitation only", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT07228702" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct07228702", "start": { "date": "2026-01-11", "kind": "actual" }, "end": { "date": "2027-10", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07228702" ], "label": "2026–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-01-11", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07228702" ], "candidates": [ { "date": "2026-01-11", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07228702" ] }, { "date": "2026-01-11", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07228702" ] } ] }, "end": { "value": { "date": "2027-10", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07228702" ], "candidates": [ { "date": "2027-10", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07228702" ] }, { "date": "2027-10", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07228702" ] } ] } } } ], "detail": "Non-Tuberculous Mycobacterial (NTM) Pneumonia; Mycobacterium Abscessus Infection", "searchTerms": [ "Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection", "Non-Tuberculous Mycobacterial (NTM) Pneumonia", "Mycobacterium Abscessus Infection", "NCT07228702", "Vancouver General Hospital Non-Tuberculous Mycobacterial Disease Clinic", "Vancouver", "British Columbia", "Canada" ] }, { "uuid": "7577f4e771075ae2862bf14741ffaef6", "permalink": "/items/bacteriophage-therapy-for-staphylococcus-lugdunensis-prosthetic-joint-infection-7577f4e771075ae2862bf14741ffaef6", "id": "trials/nct07461337", "name": "Bacteriophage Therapy for Staphylococcus Lugdunensis Prosthetic Joint Infection (NCT07461337)", "countries": [ "CA" ], "kind": "Individual-case protocol", "status": "Not yet recruiting", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07461337" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct07461337", "start": { "date": "2026-03", "kind": "estimated" }, "end": { "date": "2027-03", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07461337" ], "label": "2026 (estimated)–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07461337" ], "candidates": [ { "date": "2026-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07461337" ] }, { "date": "2026-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07461337" ] } ] }, "end": { "value": { "date": "2027-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07461337" ], "candidates": [ { "date": "2027-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07461337" ] }, { "date": "2027-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07461337" ] } ] } } } ], "detail": "Prosthetic Joint Infections of Hip; Bacteriophage Therapy", "searchTerms": [ "Bacteriophage Therapy for Staphylococcus Lugdunensis Prosthetic Joint Infection", "Prosthetic Joint Infections of Hip", "Bacteriophage Therapy", "NCT07461337", "Foothills Medical Centre, University of Calgary", "Calgary", "", "Canada" ] }, { "uuid": "fd162f73d13750ada1aee2926ca6cd08", "permalink": "/items/use-of-phage-therapy-for-treatment-of-a-periprosthetic-joint-infection-fd162f73d13750ada1aee2926ca6cd08", "id": "trials/nct06827041", "name": "BPhage (NCT06827041)", "countries": [ "CA" ], "kind": "Individual-case protocol", "status": "Active, not recruiting", "activity": "ongoing", "sources": [ "https://clinicaltrials.gov/study/NCT06827041" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct06827041", "start": { "date": "2024-02-22", "kind": "actual" }, "end": { "date": "2025-02", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06827041" ], "label": "2024–2025 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06827041" ], "candidates": [ { "date": "2024-02-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06827041" ] }, { "date": "2024-02-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06827041" ] } ] }, "end": { "value": { "date": "2025-02", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06827041" ], "candidates": [ { "date": "2025-02", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06827041" ] }, { "date": "2025-02", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06827041" ] } ] } } } ], "detail": "Periprosthetic Joint Infection", "searchTerms": [ "Use of Phage Therapy for Treatment of a Periprosthetic Joint Infection", "Periprosthetic Joint Infection", "NCT06827041", "Ottawa Hospital Research Institute", "Ottawa", "Ontario", "Canada" ] }, { "id": "trial-site/8305ce2386d452d6", "name": "Concordia Hospital — Winnipeg, Manitoba", "countries": [ "CA" ], "kind": "Trial site", "status": "Not yet recruiting (trial)", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT06942624" ], "checked": "2026-10-03", "trialIds": [ "nct06942624" ], "location": "Winnipeg, Manitoba", "detail": "Recorded study locations: Periprosthetic Joint Infection. Not an offer of treatment.", "searchTerms": [ "Concordia Hospital", "Winnipeg", "Manitoba", "Phage Therapy for the Treatment of a Chronic Enterococcus Faecium Periprosthetic Joint Infection", "Periprosthetic Joint Infection", "NCT06942624" ], "studyYears": [ { "trialId": "nct06942624", "start": { "date": "2025-05", "kind": "estimated" }, "end": { "date": "2026-06", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06942624" ], "label": "2025 (estimated)–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-05", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06942624" ], "candidates": [ { "date": "2025-05", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06942624" ] }, { "date": "2025-05", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06942624" ] } ] }, "end": { "value": { "date": "2026-06", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06942624" ], "candidates": [ { "date": "2026-06", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06942624" ] }, { "date": "2026-06", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06942624" ] } ] } } } ] }, { "id": "therapyRoutes/cytophage", "name": "Cytophage Technologies", "countries": [ "CA" ], "uuid": "7aec9606632a563db9566b6bf6c955a5", "permalink": "/items/cytophage-technologies-7aec9606632a563db9566b6bf6c955a5", "kind": "Company", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://cytophage.com/news/cytophage-identifies-two-new-patient-candidates-for-phage-therapy-for-prosthetic-joint-infections/" ], "checked": "2026-10-03", "location": "Winnipeg, Manitoba; Canada", "detail": "PJI phage supply: historical 2024 case and two S. aureus candidate patients announced September 2025, subject to ethics, Health Canada and Environment Canada approvals.", "searchTerms": [ "PJI phage supply: historical 2024 case and two S. aureus candidate patients announced September 2025, subject to ethics, Health Canada and Environment Canada approvals.", "Winnipeg, Manitoba; Canada" ] }, { "uuid": "a208da7825c0595bb7eecaae1ff82c07", "permalink": "/items/debridement-phage-antibiotics-for-pji-a208da7825c0595bb7eecaae1ff82c07", "id": "trials/nct07698002", "name": "DePHEAT-PJI (NCT07698002)", "countries": [ "CA" ], "kind": "Trial", "status": "Not yet recruiting", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07698002" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct07698002", "start": { "date": "2026-07-02", "kind": "estimated" }, "end": { "date": "2028-08-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07698002" ], "label": "2026 (estimated)–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-07-02", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07698002" ], "candidates": [ { "date": "2026-07-02", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07698002" ] }, { "date": "2026-07-02", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07698002" ] } ] }, "end": { "value": { "date": "2028-08-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07698002" ], "candidates": [ { "date": "2028-08-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07698002" ] }, { "date": "2028-08-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07698002" ] } ] } } } ], "detail": "Periprosthetic Infection", "searchTerms": [ "\"Debridement PhagE AnTibiotics for PJI\"", "Periprosthetic Infection", "NCT07698002", "Ottawa Hospital Research Institute", "Ottawa", "", "Canada" ] }, { "id": "trial-site/dd7bd04506017c46", "name": "Foothills Medical Centre, University of Calgary — Calgary", "countries": [ "CA" ], "kind": "Trial site", "status": "Mixed trial statuses", "activity": "ongoing", "sources": [ "https://clinicaltrials.gov/study/NCT06814756", "https://clinicaltrials.gov/study/NCT07461337" ], "checked": "2026-10-03", "trialIds": [ "nct06814756", "nct07461337" ], "location": "Calgary", "detail": "Recorded study locations: Prosthetic Joint Infections of Hip; Bacteriophage Therapy. Not an offer of treatment.", "searchTerms": [ "Foothills Medical Centre, University of Calgary", "Calgary", "", "Bacteriophage Therapy for Morganella Morganii Prosthetic Joint Infection", "Prosthetic Joint Infections of Hip", "NCT06814756", "Foothills Medical Centre, University of Calgary", "Calgary", "", "Bacteriophage Therapy for Staphylococcus Lugdunensis Prosthetic Joint Infection", "Prosthetic Joint Infections of Hip", "Bacteriophage Therapy", "NCT07461337" ], "studyYears": [ { "trialId": "nct06814756", "start": { "date": "2025-03-26", "kind": "actual" }, "end": { "date": "2026-03", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06814756" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-03-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06814756" ], "candidates": [ { "date": "2025-03-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06814756" ] }, { "date": "2025-03-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06814756" ] } ] }, "end": { "value": { "date": "2026-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06814756" ], "candidates": [ { "date": "2026-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06814756" ] }, { "date": "2026-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06814756" ] } ] } } }, { "trialId": "nct07461337", "start": { "date": "2026-03", "kind": "estimated" }, "end": { "date": "2027-03", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07461337" ], "label": "2026 (estimated)–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07461337" ], "candidates": [ { "date": "2026-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07461337" ] }, { "date": "2026-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07461337" ] } ] }, "end": { "value": { "date": "2027-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07461337" ], "candidates": [ { "date": "2027-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07461337" ] }, { "date": "2027-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07461337" ] } ] } } } ] }, { "id": "therapyRoutes/mcgill-phage", "name": "McGill University — Corinne Maurice phage research", "countries": [ "CA" ], "uuid": "d95370810907598ca350c223f24783a6", "permalink": "/items/mcgill-university-corinne-maurice-phage-research-d95370810907598ca350c223f24783a6", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://www.mcgill.ca/newsroom/corinne-maurice" ], "checked": "2026-10-03", "location": "Montréal, Québec; Canada", "detail": "Human gut microbiome and phage/IBD research expertise.", "searchTerms": [ "Human gut microbiome and phage/IBD research expertise.", "Montréal, Québec; Canada" ] }, { "id": "trial-site/50b9444687120ee0", "name": "Ottawa Hospital Research Institute — Ottawa", "countries": [ "CA" ], "kind": "Trial site", "status": "Not yet recruiting (trial)", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07698002" ], "checked": "2026-10-03", "trialIds": [ "nct07698002" ], "location": "Ottawa", "detail": "Recorded study locations: Periprosthetic Infection. Not an offer of treatment.", "searchTerms": [ "Ottawa Hospital Research Institute", "Ottawa", "", "\"Debridement PhagE AnTibiotics for PJI\"", "Periprosthetic Infection", "NCT07698002" ], "studyYears": [ { "trialId": "nct07698002", "start": { "date": "2026-07-02", "kind": "estimated" }, "end": { "date": "2028-08-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07698002" ], "label": "2026 (estimated)–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-07-02", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07698002" ], "candidates": [ { "date": "2026-07-02", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07698002" ] }, { "date": "2026-07-02", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07698002" ] } ] }, "end": { "value": { "date": "2028-08-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07698002" ], "candidates": [ { "date": "2028-08-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07698002" ] }, { "date": "2028-08-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07698002" ] } ] } } } ] }, { "id": "trial-site/249b4d4a98df573a", "name": "Ottawa Hospital Research Institute — Ottawa, Ontario", "countries": [ "CA" ], "kind": "Trial site", "status": "Active, not recruiting (trial)", "activity": "ongoing", "sources": [ "https://clinicaltrials.gov/study/NCT06827041" ], "checked": "2026-10-03", "trialIds": [ "nct06827041" ], "location": "Ottawa, Ontario", "detail": "Recorded study locations: Periprosthetic Joint Infection. Not an offer of treatment.", "searchTerms": [ "Ottawa Hospital Research Institute", "Ottawa", "Ontario", "Use of Phage Therapy for Treatment of a Periprosthetic Joint Infection", "Periprosthetic Joint Infection", "NCT06827041" ], "studyYears": [ { "trialId": "nct06827041", "start": { "date": "2024-02-22", "kind": "actual" }, "end": { "date": "2025-02", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06827041" ], "label": "2024–2025 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06827041" ], "candidates": [ { "date": "2024-02-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06827041" ] }, { "date": "2024-02-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06827041" ] } ] }, "end": { "value": { "date": "2025-02", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06827041" ], "candidates": [ { "date": "2025-02", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06827041" ] }, { "date": "2025-02", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06827041" ] } ] } } } ] }, { "id": "therapyRoutes/phagecanada", "name": "Phage Canada", "countries": [ "CA" ], "uuid": "0b22a17c5bcb5187b6e3f44df40b9461", "permalink": "/items/phage-canada-0b22a17c5bcb5187b6e3f44df40b9461", "kind": "Network", "status": "Provider-listed inquiry route", "activity": "current", "sources": [ "https://www.phagecanada.ca/en/frequently-asked-questions", "https://www.phagecanada.ca/en/contact-us" ], "checked": "2026-10-03", "location": "National network; referral clinic in Toronto; Canada", "detail": "Helps clinicians coordinate phage matching and single-patient research in Canada. Its FAQ describes fundraising for a proposed treatment center at the University of Toronto; the center is not listed as open for treatment.", "searchTerms": [ "Helps clinicians coordinate phage matching and single-patient research in Canada. Its FAQ describes fundraising for a proposed treatment center at the University of Toronto; the center is not listed as open for treatment.", "National network; referral clinic in Toronto; Canada" ] }, { "uuid": "fb80a9100c385f318b708a0f32f6744f", "permalink": "/items/phage-therapy-for-the-treatment-of-a-chronic-enterococcus-faecium-periprosthetic-joint-inf-fb80a9100c385f318b708a0f32f6744f", "id": "trials/nct06942624", "name": "Phage Therapy for the Treatment of a Chronic Enterococcus Faecium Periprosthetic Joint Infection (NCT06942624)", "countries": [ "CA" ], "kind": "Individual-case protocol", "status": "Not yet recruiting", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT06942624" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct06942624", "start": { "date": "2025-05", "kind": "estimated" }, "end": { "date": "2026-06", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06942624" ], "label": "2025 (estimated)–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-05", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06942624" ], "candidates": [ { "date": "2025-05", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06942624" ] }, { "date": "2025-05", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06942624" ] } ] }, "end": { "value": { "date": "2026-06", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06942624" ], "candidates": [ { "date": "2026-06", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06942624" ] }, { "date": "2026-06", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06942624" ] } ] } } } ], "detail": "Periprosthetic Joint Infection", "searchTerms": [ "Phage Therapy for the Treatment of a Chronic Enterococcus Faecium Periprosthetic Joint Infection", "Periprosthetic Joint Infection", "NCT06942624", "Concordia Hospital", "Winnipeg", "Manitoba", "Canada" ] }, { "uuid": "3431b1c66f9f574abaa0987b6db0c9ae", "permalink": "/items/phage-therapy-for-the-treatment-of-urinary-tract-infection-3431b1c66f9f574abaa0987b6db0c9ae", "id": "trials/nct05537519", "name": "Phage Therapy for the Treatment of Urinary Tract Infection (NCT05537519)", "countries": [ "CA" ], "kind": "Individual-case protocol", "status": "Status unconfirmed", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT05537519" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05537519", "start": { "date": "2023-05-01", "kind": "actual" }, "end": { "date": "2024-06-30", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05537519" ], "label": "2023–2024 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-05-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05537519" ], "candidates": [ { "date": "2023-05-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05537519" ] }, { "date": "2023-05-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05537519" ] } ] }, "end": { "value": { "date": "2024-06-30", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05537519" ], "candidates": [ { "date": "2024-06-30", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05537519" ] }, { "date": "2024-06-30", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05537519" ] } ] } } } ], "detail": "Recurrent Urinary Tract Infection", "searchTerms": [ "Phage Therapy for the Treatment of Urinary Tract Infection", "Recurrent Urinary Tract Infection", "NCT05537519", "St. Joseph's Health Centre", "Toronto", "Ontario", "Canada" ] }, { "uuid": "476efabaf5475ad4a8dbcd589b453f74", "permalink": "/items/bacteriophage-therapy-for-methicillin-sensitive-staphylococcus-aureus-prosthetic-joint-inf-476efabaf5475ad4a8dbcd589b453f74", "id": "trials/nct06456424", "name": "PHAGE-2024-01 (NCT06456424)", "countries": [ "CA" ], "kind": "Individual-case protocol", "status": "Active, not recruiting", "activity": "ongoing", "sources": [ "https://clinicaltrials.gov/study/NCT06456424" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct06456424", "start": { "date": "2024-11-20", "kind": "actual" }, "end": { "date": "2025-11", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06456424" ], "label": "2024–2025 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-11-20", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06456424" ], "candidates": [ { "date": "2024-11-20", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06456424" ] }, { "date": "2024-11-20", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06456424" ] } ] }, "end": { "value": { "date": "2025-11", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06456424" ], "candidates": [ { "date": "2025-11", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06456424" ] }, { "date": "2025-11", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06456424" ] } ] } } } ], "detail": "Prosthetic Joint Infections of Hip; Staphylococcus Aureus Infection", "searchTerms": [ "Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection", "Prosthetic Joint Infections of Hip", "Staphylococcus Aureus Infection", "NCT06456424", "South Health Campus", "Calgary", "Alberta", "Canada" ] }, { "uuid": "a4acacff7ecb5b84888564f4c39f079d", "permalink": "/items/bacteriophage-therapy-for-morganella-morganii-prosthetic-joint-infection-a4acacff7ecb5b84888564f4c39f079d", "id": "trials/nct06814756", "name": "PHAGE-MOM-001 (NCT06814756)", "countries": [ "CA" ], "kind": "Individual-case protocol", "status": "Active, not recruiting", "activity": "ongoing", "sources": [ "https://clinicaltrials.gov/study/NCT06814756" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct06814756", "start": { "date": "2025-03-26", "kind": "actual" }, "end": { "date": "2026-03", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06814756" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-03-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06814756" ], "candidates": [ { "date": "2025-03-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06814756" ] }, { "date": "2025-03-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06814756" ] } ] }, "end": { "value": { "date": "2026-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06814756" ], "candidates": [ { "date": "2026-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06814756" ] }, { "date": "2026-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06814756" ] } ] } } } ], "detail": "Prosthetic Joint Infections of Hip", "searchTerms": [ "Bacteriophage Therapy for Morganella Morganii Prosthetic Joint Infection", "Prosthetic Joint Infections of Hip", "NCT06814756", "Foothills Medical Centre, University of Calgary", "Calgary", "", "Canada" ] }, { "id": "therapyRoutes/phac-phagestar", "name": "Public Health Agency of Canada / NML PhageSTAR", "countries": [ "CA" ], "uuid": "b9f4b701dd025ca7958dba304403a4f2", "permalink": "/items/public-health-agency-of-canada-nml-phagestar-b9f4b701dd025ca7958dba304403a4f2", "kind": "Supplier", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.canada.ca/en/public-health/corporate/mandate/about-agency/access-information-privacy/info-source-federal-government-employee-information.html" ], "checked": "2026-10-03", "location": "Winnipeg, Manitoba; Canada", "accessMode": "clinician-support", "detail": "Phage susceptibility testing and library support for Canadian clinicians; not a treating clinic.", "searchTerms": [ "Phage susceptibility testing and library support for Canadian clinicians; not a treating clinic.", "Winnipeg, Manitoba; Canada" ] }, { "id": "therapyRoutes/qeen", "name": "Qeen Biotechnologies", "countries": [ "CA" ], "uuid": "2f92d4dae4ed5d4b84cae554b1084208", "permalink": "/items/qeen-biotechnologies-2f92d4dae4ed5d4b84cae554b1084208", "kind": "Supplier", "status": "Provider-listed inquiry route", "activity": "current", "sources": [ "https://qeen-bio.com/patient-access/", "https://qeen-bio.com/services/", "https://qeen-bio.com/", "https://unityhealth.to/2026/06/international-trial-using-viruses-to-treat-drug-resistant-infections/" ], "checked": "2026-10-04", "location": "Gatineau, Québec; Canada", "accessMode": "clinician-support", "detail": "Tailored phage development, manufacture, characterization, quality control and regulatory consultation. Institutional P-PEAKS announcement names Qeen as one of three manufacturers.", "searchTerms": [ "Tailored phage development, manufacture, characterization, quality control and regulatory consultation. Institutional P-PEAKS announcement names Qeen as one of three manufacturers.", "Gatineau, Québec; Canada" ] }, { "id": "trial-site/d2e36db4a04dd411", "name": "South Health Campus — Calgary, Alberta", "countries": [ "CA" ], "kind": "Trial site", "status": "Active, not recruiting (trial)", "activity": "ongoing", "sources": [ "https://clinicaltrials.gov/study/NCT06456424" ], "checked": "2026-10-03", "trialIds": [ "nct06456424" ], "location": "Calgary, Alberta", "detail": "Recorded study locations: Prosthetic Joint Infections of Hip; Staphylococcus Aureus Infection. Not an offer of treatment.", "searchTerms": [ "South Health Campus", "Calgary", "Alberta", "Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection", "Prosthetic Joint Infections of Hip", "Staphylococcus Aureus Infection", "NCT06456424" ], "studyYears": [ { "trialId": "nct06456424", "start": { "date": "2024-11-20", "kind": "actual" }, "end": { "date": "2025-11", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06456424" ], "label": "2024–2025 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-11-20", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06456424" ], "candidates": [ { "date": "2024-11-20", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06456424" ] }, { "date": "2024-11-20", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06456424" ] } ] }, "end": { "value": { "date": "2025-11", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06456424" ], "candidates": [ { "date": "2025-11", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06456424" ] }, { "date": "2025-11", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06456424" ] } ] } } } ] }, { "id": "trial-site/80f77683e4d2c3ed", "name": "St. Joseph's Health Centre — Toronto, Ontario", "countries": [ "CA" ], "kind": "Trial site", "status": "Status unconfirmed (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT05537519" ], "checked": "2026-10-03", "trialIds": [ "nct05537519" ], "location": "Toronto, Ontario", "detail": "Recorded study locations: Recurrent Urinary Tract Infection. Not an offer of treatment.", "searchTerms": [ "St. Joseph's Health Centre", "Toronto", "Ontario", "Phage Therapy for the Treatment of Urinary Tract Infection", "Recurrent Urinary Tract Infection", "NCT05537519" ], "studyYears": [ { "trialId": "nct05537519", "start": { "date": "2023-05-01", "kind": "actual" }, "end": { "date": "2024-06-30", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05537519" ], "label": "2023–2024 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-05-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05537519" ], "candidates": [ { "date": "2023-05-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05537519" ] }, { "date": "2023-05-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05537519" ] } ] }, "end": { "value": { "date": "2024-06-30", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05537519" ], "candidates": [ { "date": "2024-06-30", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05537519" ] }, { "date": "2024-06-30", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05537519" ] } ] } } } ] }, { "id": "trial-site/1fa2ee4f83ef58d3", "name": "The Ottawa Hospital — Ottawa", "countries": [ "CA" ], "kind": "Trial site", "status": "Expanded access (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06798168" ], "checked": "2026-10-03", "trialIds": [ "nct06798168" ], "location": "Ottawa", "detail": "Recorded study locations: Joint Infection. Not an offer of treatment.", "searchTerms": [ "The Ottawa Hospital", "Ottawa", "", "Bacteriophage Clinical Trial for Periprosthetic Joint Infection of Multidrug Resistant Pseudomonas Aeruginosa", "Joint Infection", "NCT06798168" ], "studyYears": [ { "trialId": "nct06798168", "sourceUrls": [], "label": "Not listed", "dateEvidence": { "start": { "conflict": false, "sourceUrls": [], "candidates": [] } } } ] }, { "id": "therapyRoutes/ottawa-phage", "name": "The Ottawa Hospital / OHRI implant infection phage research", "countries": [ "CA" ], "uuid": "b6f51a64c4a65524a7bd1fe3bc049379", "permalink": "/items/the-ottawa-hospital-ohri-implant-infection-phage-research-b6f51a64c4a65524a7bd1fe3bc049379", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://impact-program.ca/research", "https://clinicaltrials.gov/study/NCT06827041", "https://clinicaltrials.gov/study/NCT06798168", "https://clinicaltrials.gov/study/NCT07698002" ], "checked": "2026-10-03", "trialIds": [ "nct06798168", "nct06827041", "nct07698002" ], "location": "Ottawa, Ontario; Canada", "detail": "PJI single-patient phage cases and planned dEPAnt PJI debridement/phage/antibiotic research.", "searchTerms": [ "PJI single-patient phage cases and planned dEPAnt PJI debridement/phage/antibiotic research.", "Ottawa, Ontario; Canada" ] }, { "id": "therapyRoutes/unity-german", "name": "Unity Health Toronto / St. Joseph's — Greg German", "countries": [ "CA" ], "uuid": "9c571274d7275220aa280808ede9179c", "permalink": "/items/unity-health-toronto-st-joseph-s-greg-german-9c571274d7275220aa280808ede9179c", "kind": "Center", "status": "Provider-listed inquiry route", "activity": "current", "sources": [ "https://unityhealth.to/2026/02/meet-the-researchers-using-viruses-to-treat-patients/", "https://www.phagecanada.ca/en/frequently-asked-questions", "https://unityhealth.to/2026/06/international-trial-using-viruses-to-treat-drug-resistant-infections/" ], "checked": "2026-10-03", "trialIds": [ "nct05537519" ], "location": "Toronto, Ontario; Canada", "detail": "Selected difficult chronic bacterial infections; research leadership for P-PEAKS UTI trial and PHAGE4DAIR training.", "searchTerms": [ "Selected difficult chronic bacterial infections; research leadership for P-PEAKS UTI trial and PHAGE4DAIR training.", "Toronto, Ontario; Canada" ] }, { "id": "therapyRoutes/laval-phage-bank", "name": "Université Laval Félix d'Hérelle Reference Center for Bacterial Viruses", "countries": [ "CA" ], "uuid": "d216881c7bee5b4abd731d6a98261cb3", "permalink": "/items/universite-laval-felix-d-herelle-reference-center-for-bacterial-viruses-d216881c7bee5b4abd731d6a98261cb3", "kind": "Supplier", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.phage.ulaval.ca/", "https://greb.ulaval.ca/services/" ], "checked": "2026-10-03", "location": "Québec City, Québec; Canada", "accessMode": "clinician-support", "detail": "Phage strain collection, electron microscopy identification, genomic analysis and bacterial lysogeny screening; Phage Canada names Laval as a phage bank.", "searchTerms": [ "Phage strain collection, electron microscopy identification, genomic analysis and bacterial lysogeny screening; Phage Canada names Laval as a phage bank.", "Québec City, Québec; Canada" ] }, { "id": "therapyRoutes/calgary-phage", "name": "University of Calgary / Alberta Health Services phage research", "countries": [ "CA" ], "uuid": "adad97d950105b09b1799f6303124d02", "permalink": "/items/university-of-calgary-alberta-health-services-phage-research-adad97d950105b09b1799f6303124d02", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://engage.ucalgary.ca/Phage_Therapy", "https://clinicaltrials.gov/study/NCT06456424", "https://clinicaltrials.gov/study/NCT06814756", "https://clinicaltrials.gov/study/NCT07461337" ], "checked": "2026-10-03", "trialIds": [ "nct06456424", "nct06814756", "nct07461337" ], "location": "Calgary, Alberta; Canada", "detail": "Individual-patient PJI phage research at Calgary hospitals; registry includes MSSA, Morganella and Staphylococcus lugdunensis cases.", "searchTerms": [ "Individual-patient PJI phage research at Calgary hospitals; registry includes MSSA, Morganella and Staphylococcus lugdunensis cases.", "Calgary, Alberta; Canada" ] }, { "id": "therapyRoutes/utoronto-phage", "name": "University of Toronto bacteriophage therapy research initiative", "countries": [ "CA" ], "uuid": "8145719525e75869b648697ce78c779e", "permalink": "/items/university-of-toronto-bacteriophage-therapy-research-initiative-8145719525e75869b648697ce78c779e", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://lmp.utoronto.ca/bacteriophage-therapy-research", "https://www.phagecanada.ca/en/frequently-asked-questions" ], "checked": "2026-10-03", "location": "Toronto, Ontario; Canada", "detail": "Research support across phage biology, clinical translation and proposed Canadian center.", "searchTerms": [ "Research support across phage biology, clinical translation and proposed Canadian center.", "Toronto, Ontario; Canada" ] }, { "id": "trial-site/e09b9e0e284736b0", "name": "Vancouver General Hospital Non-Tuberculous Mycobacterial Disease Clinic — Vancouver, British Columbia", "countries": [ "CA" ], "kind": "Trial site", "status": "Invitation only (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT07228702" ], "checked": "2026-10-03", "trialIds": [ "nct07228702" ], "location": "Vancouver, British Columbia", "detail": "Recorded study locations: Non-Tuberculous Mycobacterial (NTM) Pneumonia; Mycobacterium Abscessus Infection. Not an offer of treatment.", "searchTerms": [ "Vancouver General Hospital Non-Tuberculous Mycobacterial Disease Clinic", "Vancouver", "British Columbia", "Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection", "Non-Tuberculous Mycobacterial (NTM) Pneumonia", "Mycobacterium Abscessus Infection", "NCT07228702" ], "studyYears": [ { "trialId": "nct07228702", "start": { "date": "2026-01-11", "kind": "actual" }, "end": { "date": "2027-10", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07228702" ], "label": "2026–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-01-11", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07228702" ], "candidates": [ { "date": "2026-01-11", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07228702" ] }, { "date": "2026-01-11", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07228702" ] } ] }, "end": { "value": { "date": "2027-10", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07228702" ], "candidates": [ { "date": "2027-10", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07228702" ] }, { "date": "2027-10", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07228702" ] } ] } } } ] }, { "id": "therapyRoutes/coaniquem-phage", "name": "COANIQUEM phage research/regulatory development", "countries": [ "CL" ], "uuid": "d202f194258f5de9a073f7aa4488b9a9", "permalink": "/items/coaniquem-phage-research-regulatory-development-d202f194258f5de9a073f7aa4488b9a9", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://www.leylobby.gob.cl/instituciones/AO005/audiencias/2026/799948/952096" ], "checked": "2026-10-03", "location": "Pudahuel, Santiago; Chile", "detail": "Official August 2026 regulator meeting describes earlier clinical research with Georgia and ongoing product/regulatory development; current commercial focus mentioned includes animal dermatologic infections.", "searchTerms": [ "Official August 2026 regulator meeting describes earlier clinical research with Georgia and ongoing product/regulatory development; current commercial focus mentioned includes animal dermatologic infections.", "Pudahuel, Santiago; Chile" ] }, { "id": "trial-site/3ab87adad0ca51d9", "name": "1st Medical Center of Chinese PLA General Hospital — Beijing", "countries": [ "CN" ], "kind": "Trial site", "status": "Not yet recruiting (trial)", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07612605" ], "checked": "2026-10-03", "trialIds": [ "nct07612605" ], "location": "Beijing", "detail": "Recorded study locations: Pneumonia. Not an offer of treatment.", "searchTerms": [ "1st Medical Center of Chinese PLA General Hospital", "Beijing", "", "Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia", "Pneumonia", "NCT07612605" ], "studyYears": [ { "trialId": "nct07612605", "start": { "date": "2026-06-01", "kind": "estimated" }, "end": { "date": "2029-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ], "label": "2026 (estimated)–2029 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-06-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ], "candidates": [ { "date": "2026-06-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ] }, { "date": "2026-06-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ] } ] }, "end": { "value": { "date": "2029-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ], "candidates": [ { "date": "2029-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ] }, { "date": "2029-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ] } ] } } } ] }, { "id": "trial-site/0b27b32c52f95b64", "name": "8th Medical Center of Chinese PLA General Hospital — Beijing", "countries": [ "CN" ], "kind": "Trial site", "status": "Not yet recruiting (trial)", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07612605" ], "checked": "2026-10-03", "trialIds": [ "nct07612605" ], "location": "Beijing", "detail": "Recorded study locations: Pneumonia. Not an offer of treatment.", "searchTerms": [ "8th Medical Center of Chinese PLA General Hospital", "Beijing", "", "Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia", "Pneumonia", "NCT07612605" ], "studyYears": [ { "trialId": "nct07612605", "start": { "date": "2026-06-01", "kind": "estimated" }, "end": { "date": "2029-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ], "label": "2026 (estimated)–2029 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-06-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ], "candidates": [ { "date": "2026-06-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ] }, { "date": "2026-06-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ] } ] }, "end": { "value": { "date": "2029-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ], "candidates": [ { "date": "2029-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ] }, { "date": "2029-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ] } ] } } } ] }, { "id": "therapyRoutes/cn-anhui-first-north", "name": "Anhui Medical University First Affiliated Hospital North District / Anhui Public Health Clinical Center", "countries": [ "CN" ], "uuid": "0db54d0257465802adc17075b1aa1762", "permalink": "/items/anhui-medical-university-first-affiliated-hospital-north-district-anhui-public-health-clin-0db54d0257465802adc17075b1aa1762", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.ahsphcc.cn/info/1134/1421.htm" ], "checked": "2026-10-04", "location": "Anhui; China", "detail": "Multidisciplinary respiratory and critical-care service describes experience with phages for multidrug-resistant lung infections.", "searchTerms": [ "Multidisciplinary respiratory and critical-care service describes experience with phages for multidrug-resistant lung infections.", "Anhui; China" ] }, { "uuid": "5f2aecf56bb95e9a8668ce661aaedfd8", "permalink": "/items/bacteriophage-therapy-for-orthopedic-implant-associated-infections-5f2aecf56bb95e9a8668ce661aaedfd8", "id": "trials/nct07533292", "name": "Bacteriophage Therapy for Orthopedic Implant-Associated Infections (NCT07533292)", "countries": [ "CN" ], "kind": "Trial", "status": "Not yet recruiting", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07533292" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct07533292", "start": { "date": "2026-04-05", "kind": "estimated" }, "end": { "date": "2030-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07533292" ], "label": "2026 (estimated)–2030 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-04-05", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07533292" ], "candidates": [ { "date": "2026-04-05", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07533292" ] }, { "date": "2026-04-05", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07533292" ] } ] }, "end": { "value": { "date": "2030-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07533292" ], "candidates": [ { "date": "2030-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07533292" ] }, { "date": "2030-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07533292" ] } ] } } } ], "detail": "Orthopedic; Implant Infection", "searchTerms": [ "Bacteriophage Therapy for Orthopedic Implant-Associated Infections", "Orthopedic", "Implant Infection", "NCT07533292", "the Second Affiliated Hospital of Zhejiang University School of Medicine", "Hangzhou", "Zhejiang", "China" ] }, { "id": "therapyRoutes/cn-fudan-childrens", "name": "Children’s Hospital of Fudan University / 复旦大学附属儿科医院", "countries": [ "CN" ], "uuid": "bee084c029e05478b76ce2a2983cf4d9", "permalink": "/items/children-s-hospital-of-fudan-university-bee084c029e05478b76ce2a2983cf4d9", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://ch.shmu.edu.cn/main/news/content/pid/19254.html", "https://ch.shmu.edu.cn/uploads/file/20250516/1747381309499556.pdf" ], "checked": "2026-10-03", "location": "Shanghai; China", "detail": "Pediatric difficult-to-treat infections. Hospital newsletter documents nebulized personalized phages for carbapenem-resistant A. baumannii in January 2025 and describes a pediatric clinical research team.", "searchTerms": [ "Pediatric difficult-to-treat infections. Hospital newsletter documents nebulized personalized phages for carbapenem-resistant A. baumannii in January 2025 and describes a pediatric clinical research team.", "Shanghai; China" ] }, { "id": "therapyRoutes/cn-pla-general", "name": "Chinese PLA General Hospital (First and Eighth Medical Centers)", "countries": [ "CN" ], "uuid": "fd97ffd594245376bd7e279042c97f7c", "permalink": "/items/chinese-pla-general-hospital-first-and-eighth-medical-centers-fd97ffd594245376bd7e279042c97f7c", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT07612605" ], "checked": "2026-10-03", "trialIds": [ "nct07612605" ], "location": "Beijing; China", "detail": "Multicenter severe multidrug-resistant Gram-negative pneumonia study combining phages with Yiqi Huoxue Jiedu traditional Chinese medicine formula.", "searchTerms": [ "Multicenter severe multidrug-resistant Gram-negative pneumonia study combining phages with Yiqi Huoxue Jiedu traditional Chinese medicine formula.", "Beijing; China" ] }, { "uuid": "666ac32d44f25026b20c59a8d2517170", "permalink": "/items/clinical-study-of-phage-therapy-for-chronic-constipation-efficacy-and-safety-666ac32d44f25026b20c59a8d2517170", "id": "trials/nct05973721", "name": "Clinical Study of Phage Therapy for Chronic Constipation Efficacy and Safety (NCT05973721)", "countries": [ "CN" ], "kind": "Trial", "status": "Status unconfirmed", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT05973721" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05973721", "start": { "date": "2023-07-01", "kind": "actual" }, "end": { "date": "2023-10-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05973721" ], "label": "2023–2023 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-07-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05973721" ], "candidates": [ { "date": "2023-07-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05973721" ] }, { "date": "2023-07-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05973721" ] } ] }, "end": { "value": { "date": "2023-10-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05973721" ], "candidates": [ { "date": "2023-10-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05973721" ] }, { "date": "2023-10-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05973721" ] } ] } } } ], "detail": "Pib Specific Phage; Intractable Constipation", "searchTerms": [ "Clinical Study of Phage Therapy for Chronic Constipation Efficacy and Safety", "Pib Specific Phage", "Intractable Constipation", "NCT05973721", "Shanghai Tenth People's Hospital", "Shanghai", "", "China" ] }, { "id": "therapyRoutes/cn-creatiphage", "name": "CreatiPhage / 创噬纪（上海）生物技术有限公司", "countries": [ "CN" ], "uuid": "7ef8ae889d6655988ba103791587f618", "permalink": "/items/creatiphage-7ef8ae889d6655988ba103791587f618", "kind": "Supplier", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.cphage.com/phage_therapy_application/", "https://www.cphage.com/", "https://www.cphage.com/en_pipelines/" ], "checked": "2026-10-03", "location": "Shanghai; China", "accessMode": "clinician-support", "detail": "Phage bank, matching, formulation and partner-hospital investigator-initiated studies; pipeline describes nebulized A. baumannii pneumonia and K. pneumoniae urinary-infection applications.", "searchTerms": [ "Phage bank, matching, formulation and partner-hospital investigator-initiated studies; pipeline describes nebulized A. baumannii pneumonia and K. pneumoniae urinary-infection applications.", "Shanghai; China" ] }, { "id": "therapyRoutes/cn-guangzhou-medical-first", "name": "First Affiliated Hospital of Guangzhou Medical University", "countries": [ "CN" ], "uuid": "c87daaa4a704589596df4139032fb3ca", "permalink": "/items/first-affiliated-hospital-of-guangzhou-medical-university-c87daaa4a704589596df4139032fb3ca", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT07612605" ], "checked": "2026-10-03", "trialIds": [ "nct07612605" ], "location": "Guangzhou; China", "detail": "Site in planned severe MDR Gram-negative pneumonia trial combining phages and traditional Chinese medicine.", "searchTerms": [ "Site in planned severe MDR Gram-negative pneumonia trial combining phages and traditional Chinese medicine.", "Guangzhou; China" ] }, { "id": "therapyRoutes/cn-guangzhou-tcm-first", "name": "First Affiliated Hospital of Guangzhou University of Chinese Medicine", "countries": [ "CN" ], "uuid": "634f5b21e72252c69e98e0d118c5e70e", "permalink": "/items/first-affiliated-hospital-of-guangzhou-university-of-chinese-medicine-634f5b21e72252c69e98e0d118c5e70e", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT07612605" ], "checked": "2026-10-03", "trialIds": [ "nct07612605" ], "location": "Guangzhou; China", "detail": "Site in planned combined phage/TCM trial for severe MDR Gram-negative pneumonia.", "searchTerms": [ "Site in planned combined phage/TCM trial for severe MDR Gram-negative pneumonia.", "Guangzhou; China" ] }, { "id": "therapyRoutes/cn-xian-first", "name": "First Affiliated Hospital of Xi’an Jiaotong University / 西安交通大学第一附属医院", "countries": [ "CN" ], "uuid": "abe2ae4a7bb2563e8e858ac5b08039b2", "permalink": "/items/first-affiliated-hospital-of-xi-an-jiaotong-university-abe2ae4a7bb2563e8e858ac5b08039b2", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT07619924", "https://www.cphage.com/media_creatiphage/248" ], "checked": "2026-10-03", "trialIds": [ "nct07619924" ], "location": "Xi’an; China", "detail": "Randomized personalized phage treatment study for multidrug-resistant bacterial skin infections; separate July 2026 company announcement describes a joint phage bank.", "searchTerms": [ "Randomized personalized phage treatment study for multidrug-resistant bacterial skin infections; separate July 2026 company announcement describes a joint phage bank.", "Xi’an; China" ] }, { "id": "therapyRoutes/cn-ningxia-general", "name": "General Hospital of Ningxia Medical University / 宁夏医科大学总医院", "countries": [ "CN" ], "uuid": "d3fa5fd8f2bc5d189bbecc6234031e61", "permalink": "/items/general-hospital-of-ningxia-medical-university-d3fa5fd8f2bc5d189bbecc6234031e61", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.nxmu.edu.cn/info/1197/9237.htm" ], "checked": "2026-10-03", "location": "Yinchuan; China", "detail": "MDR A. baumannii pulmonary infections; Shanghai partners matched/manufactured phages. Regional phage/bacterial-bank research continues.", "searchTerms": [ "MDR A. baumannii pulmonary infections; Shanghai partners matched/manufactured phages. Regional phage/bacterial-bank research continues.", "Yinchuan; China" ] }, { "id": "therapyRoutes/cn-hainan-peoples", "name": "Hainan Provincial People’s Hospital / 海南省人民医院", "countries": [ "CN" ], "uuid": "e8636c765e9b5026b1a297e4762e8ba6", "permalink": "/items/hainan-provincial-people-s-hospital-e8636c765e9b5026b1a297e4762e8ba6", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://www.phhp.com.cn/ppxk/tszk/grk.htm" ], "checked": "2026-10-03", "location": "Haikou; China", "detail": "Development of MDR infection phage technology and clinical strain resources.", "searchTerms": [ "Development of MDR infection phage technology and clinical strain resources.", "Haikou; China" ] }, { "id": "therapyRoutes/cn-jiangxia-lab", "name": "Hubei Jiangxia Laboratory / 湖北江夏实验室", "countries": [ "CN" ], "uuid": "c0c95f4157a4513ca0925ad38109ac9b", "permalink": "/items/hubei-jiangxia-laboratory-c0c95f4157a4513ca0925ad38109ac9b", "kind": "Research", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://wjw.hubei.gov.cn/bmdt/mtjj/mtgz/202605/t20260519_5938919.shtml" ], "checked": "2026-10-03", "location": "China", "detail": "MDR phage screening/engineering, clinical phage resource bank and nebulized formulations for resistant lung infection.", "searchTerms": [ "MDR phage screening/engineering, clinical phage resource bank and nebulized formulations for resistant lung infection.", "China" ] }, { "id": "therapyRoutes/cn-jiahui", "name": "Jiahui International Hospital / 上海嘉会国际医院", "countries": [ "CN" ], "uuid": "8057736f02285c74a7cfb1644085eedb", "permalink": "/items/jiahui-international-hospital-8057736f02285c74a7cfb1644085eedb", "kind": "Center", "status": "Status unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.jiahui.com/news/125", "https://www.cphage.com/76/190" ], "checked": "2026-10-03", "location": "Shanghai; China", "detail": "Personalized phage clinical research for difficult infections; historical program evidence only.", "searchTerms": [ "Personalized phage clinical research for difficult infections; historical program evidence only.", "Shanghai; China" ] }, { "uuid": "0ed5fd71ab6d5415bdf32dd4f4080c5c", "permalink": "/items/jiahui-international-hospital-phage-study-lead-0ed5fd71ab6d5415bdf32dd4f4080c5c", "id": "trials/chictr2300067705", "name": "Jiahui International Hospital phage study lead (ChiCTR2300067705)", "countries": [ "CN" ], "kind": "Trial lead", "status": "Unverified lead", "activity": "unconfirmed", "sources": [ "https://www.jiahui.com/news/125" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "chictr2300067705", "sourceUrls": [], "label": "Not listed", "dateEvidence": { "start": { "conflict": false, "sourceUrls": [], "candidates": [] } } } ], "searchTerms": [ "Jiahui International Hospital phage study lead", "ChiCTR2300067705" ] }, { "id": "therapyRoutes/cn-nanjing-drum-tower", "name": "Nanjing Drum Tower Hospital / 南京鼓楼医院", "countries": [ "CN" ], "uuid": "06b7cb76b0cf5c8db2bebc251eeaa10f", "permalink": "/items/nanjing-drum-tower-hospital-06b7cb76b0cf5c8db2bebc251eeaa10f", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.chictr.org.cn/hvshowproject.html?id=301261&v=1.0" ], "checked": "2026-10-03", "trialIds": [ "chictr2600124009" ], "location": "Nanjing; China", "detail": "Pilot six-person matched-phage study for drug-resistant infections, adults 18–75, non-IV routes; English objectives emphasize urinary infection while Chinese wording is broader.", "searchTerms": [ "Pilot six-person matched-phage study for drug-resistant infections, adults 18–75, non-IV routes; English objectives emphasize urinary infection while Chinese wording is broader.", "Nanjing; China" ] }, { "uuid": "9ca43bb4a5b1595ea2287b70bd4508e5", "permalink": "/items/nanjing-drum-tower-phage-pilot-9ca43bb4a5b1595ea2287b70bd4508e5", "id": "trials/chictr2600124009", "name": "Nanjing Drum Tower phage pilot (ChiCTR2600124009)", "countries": [ "CN" ], "kind": "Trial", "status": "Not yet recruiting", "activity": "planned", "sources": [ "https://www.chictr.org.cn/hvshowproject.html?id=301261&v=1.0" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "chictr2600124009", "sourceUrls": [], "label": "Not listed", "dateEvidence": { "start": { "conflict": false, "sourceUrls": [], "candidates": [] } } } ], "searchTerms": [ "Nanjing Drum Tower phage pilot", "ChiCTR2600124009" ] }, { "uuid": "bf124138fe7c588fbb0f0eceb40ed444", "permalink": "/items/randomized-controlled-study-on-the-safety-and-efficacy-of-phage-cocktail-in-the-treatment-bf124138fe7c588fbb0f0eceb40ed444", "id": "trials/nct07619924", "name": "Randomized Controlled Study on the Safety and Efficacy of Phage Cocktail in the Treatment of Multidrug-Resistant Bacterial Skin Infections (NCT07619924)", "countries": [ "CN" ], "kind": "Trial", "status": "Invitation only", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT07619924" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct07619924", "start": { "date": "2025-01-15", "kind": "actual" }, "end": { "date": "2028-05", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07619924" ], "label": "2025–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-01-15", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07619924" ], "candidates": [ { "date": "2025-01-15", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07619924" ] }, { "date": "2025-01-15", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07619924" ] } ] }, "end": { "value": { "date": "2028-05", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07619924" ], "candidates": [ { "date": "2028-05", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07619924" ] }, { "date": "2028-05", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07619924" ] } ] } } } ], "detail": "Phage Therapy; Bacteriophage Therapy; Skin and Soft Tissue Infections", "searchTerms": [ "Randomized Controlled Study on the Safety and Efficacy of Phage Cocktail in the Treatment of Multidrug-Resistant Bacterial Skin Infections", "Phage Therapy", "Bacteriophage Therapy", "Skin and Soft Tissue Infections", "NCT07619924", "The First Affiliated Hospital of Xi'an Jiaotong University", "Xi'an", "Shaanxi", "China" ] }, { "id": "therapyRoutes/cn-zhejiang-second", "name": "Second Affiliated Hospital, Zhejiang University School of Medicine", "countries": [ "CN" ], "uuid": "a2aee1902e6d53aaab13e10e1594545c", "permalink": "/items/second-affiliated-hospital-zhejiang-university-school-of-medicine-a2aee1902e6d53aaab13e10e1594545c", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT07533292" ], "checked": "2026-10-03", "trialIds": [ "nct07533292" ], "location": "Hangzhou; China", "detail": "Phage treatment research for orthopedic implant-associated infections.", "searchTerms": [ "Phage treatment research for orthopedic implant-associated infections.", "Hangzhou; China" ] }, { "id": "therapyRoutes/cn-shphc", "name": "Shanghai Public Health Clinical Center / 上海市公共卫生临床中心", "countries": [ "CN" ], "uuid": "29443d14c5c6558a9672a5c2988d3fb7", "permalink": "/items/shanghai-public-health-clinical-center-29443d14c5c6558a9672a5c2988d3fb7", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.chictr.org.cn/hvshowproject.html?id=276909&v=1.0", "https://www.shanghai.gov.cn/nw4411/20250823/ff84d819233a404dbaf2fb4f79737435.html" ], "checked": "2026-10-03", "trialIds": [ "chictr2500102677" ], "location": "Shanghai; China", "detail": "Single-arm difficult-to-treat bacterial infection study, planned 240 participants, matched phages, non-IV routes including nebulization, topical, local injection or perfusion.", "searchTerms": [ "Single-arm difficult-to-treat bacterial infection study, planned 240 participants, matched phages, non-IV routes including nebulization, topical, local injection or perfusion.", "Shanghai; China" ] }, { "uuid": "fd896b8fcebc559bacbfc5697d844888", "permalink": "/items/shanghai-public-health-clinical-center-personalized-phage-study-fd896b8fcebc559bacbfc5697d844888", "id": "trials/chictr2500102677", "name": "Shanghai Public Health Clinical Center personalized phage study (ChiCTR2500102677)", "countries": [ "CN" ], "kind": "Trial", "status": "Not yet recruiting", "activity": "planned", "sources": [ "https://www.chictr.org.cn/hvshowproject.html?id=276909&v=1.0" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "chictr2500102677", "sourceUrls": [], "label": "Not listed", "dateEvidence": { "start": { "conflict": false, "sourceUrls": [], "candidates": [] } } } ], "searchTerms": [ "Shanghai Public Health Clinical Center personalized phage study", "ChiCTR2500102677" ] }, { "id": "trial-site/36dcfe1d4b774727", "name": "Shanghai Tenth People's Hospital — Shanghai", "countries": [ "CN" ], "kind": "Trial site", "status": "Status unconfirmed (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT05973721" ], "checked": "2026-10-03", "trialIds": [ "nct05973721" ], "location": "Shanghai", "detail": "Recorded study locations: Pib Specific Phage; Intractable Constipation. Not an offer of treatment.", "searchTerms": [ "Shanghai Tenth People's Hospital", "Shanghai", "", "Clinical Study of Phage Therapy for Chronic Constipation Efficacy and Safety", "Pib Specific Phage", "Intractable Constipation", "NCT05973721" ], "studyYears": [ { "trialId": "nct05973721", "start": { "date": "2023-07-01", "kind": "actual" }, "end": { "date": "2023-10-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05973721" ], "label": "2023–2023 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-07-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05973721" ], "candidates": [ { "date": "2023-07-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05973721" ] }, { "date": "2023-07-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05973721" ] } ] }, "end": { "value": { "date": "2023-10-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05973721" ], "candidates": [ { "date": "2023-10-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05973721" ] }, { "date": "2023-10-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05973721" ] } ] } } } ] }, { "id": "therapyRoutes/cn-shenzhen-peoples", "name": "Shenzhen People’s Hospital / 深圳市人民医院", "countries": [ "CN" ], "uuid": "6d3ba7312ae456f2b4dc193b27a2e5f5", "permalink": "/items/shenzhen-people-s-hospital-6d3ba7312ae456f2b4dc193b27a2e5f5", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.chictr.org.cn/showproj.html?proj=275896" ], "checked": "2026-10-03", "trialIds": [ "chictr2500104137" ], "location": "Shenzhen; China", "detail": "ICU pneumonia caused by multidrug-resistant organisms; age 18–95 and bacteria susceptible to selected phages in the registry eligibility criteria.", "searchTerms": [ "ICU pneumonia caused by multidrug-resistant organisms; age 18–95 and bacteria susceptible to selected phages in the registry eligibility criteria.", "Shenzhen; China" ] }, { "uuid": "ceebdc91b4f1555ba8aae6de47369bfd", "permalink": "/items/shenzhen-people-s-hospital-icu-pneumonia-phage-study-ceebdc91b4f1555ba8aae6de47369bfd", "id": "trials/chictr2500104137", "name": "Shenzhen People's Hospital ICU pneumonia phage study (ChiCTR2500104137)", "countries": [ "CN" ], "kind": "Trial", "status": "Status unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.chictr.org.cn/showproj.html?proj=275896" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "chictr2500104137", "sourceUrls": [], "label": "Not listed", "dateEvidence": { "start": { "conflict": false, "sourceUrls": [], "candidates": [] } } } ], "searchTerms": [ "Shenzhen People's Hospital ICU pneumonia phage study", "ChiCTR2500104137" ] }, { "id": "trial-site/4750f0b1def0cfa0", "name": "The First Affiliated Hospital of Guangzhou Medical University — Guangdong, Guangzhou", "countries": [ "CN" ], "kind": "Trial site", "status": "Not yet recruiting (trial)", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07612605" ], "checked": "2026-10-03", "trialIds": [ "nct07612605" ], "location": "Guangdong, Guangzhou", "detail": "Recorded study locations: Pneumonia. Not an offer of treatment.", "searchTerms": [ "The First Affiliated Hospital of Guangzhou Medical University", "Guangdong", "Guangzhou", "Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia", "Pneumonia", "NCT07612605" ], "studyYears": [ { "trialId": "nct07612605", "start": { "date": "2026-06-01", "kind": "estimated" }, "end": { "date": "2029-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ], "label": "2026 (estimated)–2029 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-06-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ], "candidates": [ { "date": "2026-06-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ] }, { "date": "2026-06-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ] } ] }, "end": { "value": { "date": "2029-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ], "candidates": [ { "date": "2029-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ] }, { "date": "2029-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ] } ] } } } ] }, { "id": "trial-site/34c8df7f7120de54", "name": "The First Affiliated Hospital of Guangzhou University of Chinese Medicine — Guangdong, Guangzhou", "countries": [ "CN" ], "kind": "Trial site", "status": "Not yet recruiting (trial)", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07612605" ], "checked": "2026-10-03", "trialIds": [ "nct07612605" ], "location": "Guangdong, Guangzhou", "detail": "Recorded study locations: Pneumonia. Not an offer of treatment.", "searchTerms": [ "The First Affiliated Hospital of Guangzhou University of Chinese Medicine", "Guangdong", "Guangzhou", "Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia", "Pneumonia", "NCT07612605" ], "studyYears": [ { "trialId": "nct07612605", "start": { "date": "2026-06-01", "kind": "estimated" }, "end": { "date": "2029-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ], "label": "2026 (estimated)–2029 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-06-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ], "candidates": [ { "date": "2026-06-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ] }, { "date": "2026-06-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ] } ] }, "end": { "value": { "date": "2029-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ], "candidates": [ { "date": "2029-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ] }, { "date": "2029-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ] } ] } } } ] }, { "id": "trial-site/1c639497c882c734", "name": "The First Affiliated Hospital of Xi'an Jiaotong University — Xi'an, Shaanxi", "countries": [ "CN" ], "kind": "Trial site", "status": "Invitation only (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT07619924" ], "checked": "2026-10-03", "trialIds": [ "nct07619924" ], "location": "Xi'an, Shaanxi", "detail": "Recorded study locations: Phage Therapy; Bacteriophage Therapy; Skin and Soft Tissue Infections. Not an offer of treatment.", "searchTerms": [ "The First Affiliated Hospital of Xi'an Jiaotong University", "Xi'an", "Shaanxi", "Randomized Controlled Study on the Safety and Efficacy of Phage Cocktail in the Treatment of Multidrug-Resistant Bacterial Skin Infections", "Phage Therapy", "Bacteriophage Therapy", "Skin and Soft Tissue Infections", "NCT07619924" ], "studyYears": [ { "trialId": "nct07619924", "start": { "date": "2025-01-15", "kind": "actual" }, "end": { "date": "2028-05", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07619924" ], "label": "2025–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-01-15", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07619924" ], "candidates": [ { "date": "2025-01-15", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07619924" ] }, { "date": "2025-01-15", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07619924" ] } ] }, "end": { "value": { "date": "2028-05", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07619924" ], "candidates": [ { "date": "2028-05", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07619924" ] }, { "date": "2028-05", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07619924" ] } ] } } } ] }, { "id": "trial-site/6cacebf70bc321b5", "name": "the Second Affiliated Hospital of Zhejiang University School of Medicine — Hangzhou, Zhejiang", "countries": [ "CN" ], "kind": "Trial site", "status": "Not yet recruiting (trial)", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07533292" ], "checked": "2026-10-03", "trialIds": [ "nct07533292" ], "location": "Hangzhou, Zhejiang", "detail": "Recorded study locations: Orthopedic; Implant Infection. Not an offer of treatment.", "searchTerms": [ "the Second Affiliated Hospital of Zhejiang University School of Medicine", "Hangzhou", "Zhejiang", "Bacteriophage Therapy for Orthopedic Implant-Associated Infections", "Orthopedic", "Implant Infection", "NCT07533292" ], "studyYears": [ { "trialId": "nct07533292", "start": { "date": "2026-04-05", "kind": "estimated" }, "end": { "date": "2030-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07533292" ], "label": "2026 (estimated)–2030 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-04-05", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07533292" ], "candidates": [ { "date": "2026-04-05", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07533292" ] }, { "date": "2026-04-05", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07533292" ] } ] }, "end": { "value": { "date": "2030-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07533292" ], "candidates": [ { "date": "2030-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07533292" ] }, { "date": "2030-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07533292" ] } ] } } } ] }, { "uuid": "51c2abbbdeb8521698a1f85078c1e9af", "permalink": "/items/yiqi-huoxue-jiedu-formula-combined-with-bacteriophages-in-the-treatment-of-severe-pneumoni-51c2abbbdeb8521698a1f85078c1e9af", "id": "trials/nct07612605", "name": "Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia (NCT07612605)", "countries": [ "CN" ], "kind": "Trial", "status": "Not yet recruiting", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07612605" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct07612605", "start": { "date": "2026-06-01", "kind": "estimated" }, "end": { "date": "2029-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ], "label": "2026 (estimated)–2029 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-06-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ], "candidates": [ { "date": "2026-06-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ] }, { "date": "2026-06-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ] } ] }, "end": { "value": { "date": "2029-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ], "candidates": [ { "date": "2029-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ] }, { "date": "2029-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07612605" ] } ] } } } ], "detail": "Pneumonia", "searchTerms": [ "Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia", "Pneumonia", "NCT07612605", "The First Affiliated Hospital of Guangzhou Medical University", "Guangdong", "Guangzhou", "China", "The First Affiliated Hospital of Guangzhou University of Chinese Medicine", "Guangdong", "Guangzhou", "China", "1st Medical Center of Chinese PLA General Hospital", "Beijing", "", "China", "8th Medical Center of Chinese PLA General Hospital", "Beijing", "", "China" ] }, { "uuid": "9dc6063a7f8d58ee9524d6dfce6e6d96", "permalink": "/items/zhongshan-hospital-personalized-phage-pilot-9dc6063a7f8d58ee9524d6dfce6e6d96", "id": "trials/chictr2400082131", "name": "Zhongshan Hospital personalized phage pilot (ChiCTR2400082131)", "countries": [ "CN" ], "kind": "Trial", "status": "Not yet recruiting", "activity": "planned", "sources": [ "https://www.chictr.org.cn/showprojEN.html?proj=223337" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "chictr2400082131", "sourceUrls": [], "label": "Not listed", "dateEvidence": { "start": { "conflict": false, "sourceUrls": [], "candidates": [] } } } ], "searchTerms": [ "Zhongshan Hospital personalized phage pilot", "ChiCTR2400082131" ] }, { "id": "therapyRoutes/cn-zhongshan", "name": "Zhongshan Hospital, Fudan University / 复旦大学附属中山医院", "countries": [ "CN" ], "uuid": "09f8869bb9d35ce784001fa2d6ebdc4c", "permalink": "/items/zhongshan-hospital-fudan-university-09f8869bb9d35ce784001fa2d6ebdc4c", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.chictr.org.cn/showprojEN.html?proj=223337" ], "checked": "2026-10-03", "trialIds": [ "chictr2400082131" ], "location": "Shanghai; China", "detail": "Single-arm personalized phage study for difficult-to-treat bacterial infections; requires a matched lytic phage and a feasible non-intravenous route. Antibiotic-controlled infections and cases with IV as the only route are excluded.", "searchTerms": [ "Single-arm personalized phage study for difficult-to-treat bacterial infections; requires a matched lytic phage and a feasible non-intravenous route. Antibiotic-controlled infections and cases with IV as the only route are excluded.", "Shanghai; China" ] }, { "id": "therapyRoutes/javeriana-phage", "name": "Pontificia Universidad Javeriana phage research", "countries": [ "CO" ], "uuid": "248c3cee61945ae48f53f788af163b70", "permalink": "/items/pontificia-universidad-javeriana-phage-research-248c3cee61945ae48f53f788af163b70", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://www.javeriana.edu.co/pesquisa/helicobacter-pylori-colombia-tratamiento-antibiotico/" ], "checked": "2026-10-03", "location": "Bogotá; Colombia", "detail": "Institutional 2021 report on Helicobacter pylori phage research; candidate isolation work rather than a clinical treatment program.", "searchTerms": [ "Institutional 2021 report on Helicobacter pylori phage research; candidate isolation work rather than a clinical treatment program.", "Bogotá; Colombia" ] }, { "uuid": "3d3491b6745053b0ad32913fd4c5327c", "permalink": "/items/clinical-trial-to-demonstrate-the-safety-and-efficacy-of-duofag-3d3491b6745053b0ad32913fd4c5327c", "id": "trials/nct06319235", "name": "Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG® (NCT06319235)", "countries": [ "CZ" ], "kind": "Trial", "status": "Status unconfirmed", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT06319235" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct06319235", "start": { "date": "2023-10-27", "kind": "actual" }, "end": { "date": "2025-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06319235" ], "label": "2023–2025 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-10-27", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06319235" ], "candidates": [ { "date": "2023-10-27", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06319235" ] }, { "date": "2023-10-27", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06319235" ] } ] }, "end": { "value": { "date": "2025-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06319235" ], "candidates": [ { "date": "2025-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06319235" ] }, { "date": "2025-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06319235" ] } ] } } } ], "detail": "Surgical Site Infection; Staphylococcus Aureus Infection; Pseudomonas Aeruginosa Infection; Bacterial Infections; Surgical Wound Infection", "searchTerms": [ "Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG®", "Surgical Site Infection", "Staphylococcus Aureus Infection", "Pseudomonas Aeruginosa Infection", "Bacterial Infections", "Surgical Wound Infection", "NCT06319235", "St. Anne's University Hospital Brno", "Brno", "Czech Republic", "Czechia" ] }, { "id": "therapyRoutes/eu-mb-pharma-duofag", "name": "MB Pharma / DUOFAG", "countries": [ "CZ" ], "uuid": "e56da8a5218c5fb19c3540137b949482", "permalink": "/items/mb-pharma-duofag-e56da8a5218c5fb19c3540137b949482", "kind": "Company", "status": "Research/development", "activity": "research", "sources": [ "https://www.mbph.cz/duofag", "https://clinicaltrials.gov/study/NCT06319235" ], "checked": "2026-10-03", "trialIds": [ "nct06319235" ], "location": "Prague; Czech Republic", "detail": "DUOFAG topical phages for S. aureus and P. aeruginosa wounds/ulcers; official timeline reports Phase I completed July 2025, Phase IIA recruitment and Phase IIB approval February 2026.", "searchTerms": [ "DUOFAG topical phages for S. aureus and P. aeruginosa wounds/ulcers; official timeline reports Phase I completed July 2025, Phase IIA recruitment and Phase IIB approval February 2026.", "Prague; Czech Republic" ] }, { "id": "trial-site/aa6fb48e4fb08bfa", "name": "St. Anne's University Hospital Brno — Brno, Czech Republic", "countries": [ "CZ" ], "kind": "Trial site", "status": "Status unconfirmed (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT06319235" ], "checked": "2026-10-03", "trialIds": [ "nct06319235" ], "location": "Brno, Czech Republic", "detail": "Recorded study locations: Surgical Site Infection; Staphylococcus Aureus Infection; Pseudomonas Aeruginosa Infection; Bacterial Infections; Surgical Wound Infection. Not an offer of treatment.", "searchTerms": [ "St. Anne's University Hospital Brno", "Brno", "Czech Republic", "Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG®", "Surgical Site Infection", "Staphylococcus Aureus Infection", "Pseudomonas Aeruginosa Infection", "Bacterial Infections", "Surgical Wound Infection", "NCT06319235" ], "studyYears": [ { "trialId": "nct06319235", "start": { "date": "2023-10-27", "kind": "actual" }, "end": { "date": "2025-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06319235" ], "label": "2023–2025 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-10-27", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06319235" ], "candidates": [ { "date": "2023-10-27", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06319235" ] }, { "date": "2023-10-27", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06319235" ] } ] }, "end": { "value": { "date": "2025-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06319235" ], "candidates": [ { "date": "2025-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06319235" ] }, { "date": "2025-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06319235" ] } ] } } } ] }, { "id": "trial-site/4cb002cfc4605897", "name": "University Hospital in Motol — Prague", "countries": [ "CZ" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct05010577" ], "location": "Prague", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "University Hospital in Motol", "Prague", "", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "uuid": "3e1370bb949f5ec7a33ffea7e50d6487", "permalink": "/items/study-with-phage-for-cf-subjects-with-pseudomonas-lung-infection-3e1370bb949f5ec7a33ffea7e50d6487", "id": "trials/nct06998043", "name": "Study With Phage for CF Subjects With Pseudomonas Lung Infection (NCT06998043)", "countries": [ "CZ", "DE", "ES", "FR", "IE", "IT", "NL", "PL", "US" ], "kind": "Trial", "status": "Conflicting status", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT06998043", "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en", "https://www.sec.gov/Archives/edgar/data/1739174/000121390026078003/ea0298043-424b3_biomx.htm" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct06998043", "start": { "date": "2025-07-02", "kind": "actual" }, "end": { "date": "2026-09", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-07-02", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2025-07-02", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-07-02", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-08-18", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] }, "end": { "value": { "date": "2026-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2026-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2026-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-12-08", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] } } } ], "detail": "Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis (CF)", "searchTerms": [ "Study With Phage for CF Subjects With Pseudomonas Lung Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis (CF)", "NCT06998043", "2024-519856-94-00", "University of Alabama at Birmingham", "Birmingham", "Alabama", "United States", "Providence Alaska Medical Center", "Anchorage", "Alaska", "United States", "University of Arkansas for Medical Sciences", "Little Rock", "Arkansas", "United States", "Stanford University", "Palo Alto", "California", "United States", "University of California San Francisco", "San Francisco", "California", "United States", "National Jewish Health", "Denver", "Colorado", "United States", "Joe DiMaggio Children's Health", "Hollywood", "Florida", "United States", "Central Florida Pulmonary Group", "Orlando", "Florida", "United States", "Avanza Medical Center", "Pensacola", "Florida", "United States", "Rutgers, Robert Wood Johnson Medical School", "New Brunswick", "New Jersey", "United States", "New York Medical College", "Hawthorne", "New York", "United States", "Northwell Health", "New York", "New York", "United States", "Vanderbilt University Medical Center", "Nashville", "Tennessee", "United States", "University of Utah", "Salt Lake City", "Utah", "United States" ] }, { "uuid": "9a04949ae2e65f95a5a01fef55c15796", "permalink": "/items/nebulized-bacteriophage-therapy-in-cystic-fibrosis-patients-with-chronic-pseudomonas-aerug-9a04949ae2e65f95a5a01fef55c15796", "id": "trials/nct05010577", "name": "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection (NCT05010577)", "countries": [ "CZ", "ES", "IL", "NL", "US" ], "kind": "Trial", "status": "Completed", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ], "detail": "Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis", "searchTerms": [ "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577", "The University of Alabama at Birmingham", "Birmingham", "Alabama", "United States", "Providence Alaska Medical Center", "Anchorage", "Alaska", "United States", "University of Arkansas for Medical Sciences", "Little Rock", "Arkansas", "United States", "Yale University", "New Haven", "Connecticut", "United States", "Children's National Medical Center", "Washington D.C.", "District of Columbia", "United States", "University of Florida", "Gainesville", "Florida", "United States", "Joe DiMaggio Children's Hospital", "Hollywood", "Florida", "United States", "Central Florida Pulmonary Group", "Orlando", "Florida", "United States", "Boston Children's Hospital", "Boston", "Massachusetts", "United States", "New York Medical College", "Valhalla", "New York", "United States", "Cincinnati Children's Hospital", "Cincinnati", "Ohio", "United States", "University Hospitals Rainbow Babies and Children's Hospital", "Cleveland", "Ohio", "United States", "Nationwide Children's Hospital", "Columbus", "Ohio", "United States", "Penn State Health Milton S. Hershey Medical Center", "Hershey", "Pennsylvania", "United States", "Medical University of South Carolina", "Charleston", "South Carolina", "United States", "Baylor College of Medicine, Texas Children Clinic", "Houston", "Texas", "United States", "University of Utah", "Salt Lake City", "Utah", "United States", "Seattle Children's Hospital", "Seattle", "Washington", "United States", "University Hospital in Motol", "Prague", "", "Czechia", "Rambam Health Care Campus (RHCC) - Ruth Rappaport Children's Hospital", "Haifa", "", "Israel", "Carmel Medical Center", "Haifa", "", "Israel", "Hadassah University Medical Center", "Jerusalem", "", "Israel", "Schneider Children's Medical Center of Israel", "Petach Tikvah", "", "Israel", "The Chaim Sheba Medical Center", "Ramat Gan", "", "Israel", "Amsterdam Medical Center", "Amsterdam", "", "Netherlands", "University Medical Center Utrecht", "Utrecht", "", "Netherlands", "Hospital Clinico Universitario Virgen de la Arrixaca", "El Palmar", "Murcia", "Spain", "Vall d'Hebron Barcelona Hospital Campus", "Barcelona", "", "Spain" ] }, { "uuid": "10e6d0acef78540b9d554453e2b65dae", "permalink": "/items/prephage-faecal-bacteriophage-transfer-for-enhanced-gastrointestinal-tract-maturation-in-p-10e6d0acef78540b9d554453e2b65dae", "id": "trials/nct05272579", "name": "PrePhage - Faecal Bacteriophage Transfer for Enhanced Gastrointestinal Tract Maturation in Preterm Infants (NCT05272579)", "countries": [ "DK" ], "kind": "Adjacent product trial", "status": "Recruiting", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05272579" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05272579", "start": { "date": "2023-11-07", "kind": "actual" }, "end": { "date": "2025-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05272579" ], "label": "2023–2025 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-11-07", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05272579" ], "candidates": [ { "date": "2023-11-07", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05272579" ] }, { "date": "2023-11-07", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05272579" ] } ] }, "end": { "value": { "date": "2025-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05272579" ], "candidates": [ { "date": "2025-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05272579" ] }, { "date": "2025-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05272579" ] } ] } } } ], "detail": "Necrotizing Enterocolitis; Microbial Substitution", "searchTerms": [ "PrePhage - Faecal Bacteriophage Transfer for Enhanced Gastrointestinal Tract Maturation in Preterm Infants", "Necrotizing Enterocolitis", "Microbial Substitution", "NCT05272579", "Rigshospitalet", "Copenhagen", "", "Denmark" ] }, { "id": "trial-site/d03a6ff0809ccc87", "name": "Rigshospitalet — Copenhagen", "countries": [ "DK" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05272579" ], "checked": "2026-10-03", "trialIds": [ "nct05272579" ], "location": "Copenhagen", "detail": "Recorded study locations: Necrotizing Enterocolitis; Microbial Substitution. Not an offer of treatment.", "searchTerms": [ "Rigshospitalet", "Copenhagen", "", "PrePhage - Faecal Bacteriophage Transfer for Enhanced Gastrointestinal Tract Maturation in Preterm Infants", "Necrotizing Enterocolitis", "Microbial Substitution", "NCT05272579" ], "studyYears": [ { "trialId": "nct05272579", "start": { "date": "2023-11-07", "kind": "actual" }, "end": { "date": "2025-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05272579" ], "label": "2023–2025 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-11-07", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05272579" ], "candidates": [ { "date": "2023-11-07", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05272579" ] }, { "date": "2023-11-07", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05272579" ] } ] }, "end": { "value": { "date": "2025-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05272579" ], "candidates": [ { "date": "2025-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05272579" ] }, { "date": "2025-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05272579" ] } ] } } } ] }, { "id": "therapyRoutes/eu-snipr-biome", "name": "SNIPR Biome", "countries": [ "DK" ], "uuid": "f660ac748a965d4c9e1f9a0f7608737f", "permalink": "/items/snipr-biome-f660ac748a965d4c9e1f9a0f7608737f", "kind": "Company", "status": "Provider-listed inquiry route", "activity": "current", "sources": [ "https://www.sniprbiome.com/expandedaccess", "https://www.sniprbiome.com/", "https://clinicaltrials.gov/study/NCT06938867", "https://clinicaltrials.gov/study/NCT05277350" ], "checked": "2026-10-03", "trialIds": [ "nct05277350", "nct06938867" ], "location": "Copenhagen; Denmark", "detail": "Engineered CRISPR/phage programs; SNIPR001 targets E. coli, including hematologic malignancy/transplant infection-risk research.", "searchTerms": [ "Engineered CRISPR/phage programs; SNIPR001 targets E. coli, including hematologic malignancy/transplant infection-risk research.", "Copenhagen; Denmark" ] }, { "id": "therapyRoutes/eu-helsinki-hus", "name": "HUS / University of Helsinki phage therapy collaboration", "countries": [ "FI" ], "uuid": "e49c3906957b51e2862be8f171053ad0", "permalink": "/items/hus-university-of-helsinki-phage-therapy-collaboration-e49c3906957b51e2862be8f171053ad0", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.hus.fi/sv/aktuellt/bakteriofager-som-losning-pa-antibiotikaresistens", "https://www.helsinki.fi/en/researchgroups/phage-therapy", "https://www.helsinki.fi/en/researchgroups/phage-therapy/people" ], "checked": "2026-10-03", "location": "Helsinki; Finland", "detail": "Experimental individualized treatment after antibiotics/usual treatment fail; lab matching and manufacture.", "searchTerms": [ "Experimental individualized treatment after antibiotics/usual treatment fail; lab matching and manufacture.", "Helsinki; Finland" ] }, { "id": "therapyRoutes/eu-aphp-pyophaneb", "name": "AP-HP / PYOPHANEB multicenter study", "countries": [ "FR" ], "uuid": "966ba8b11197512bb2c89b0b10f36dd4", "permalink": "/items/ap-hp-pyophaneb-multicenter-study-966ba8b11197512bb2c89b0b10f36dd4", "kind": "Network", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT07804082" ], "checked": "2026-10-03", "trialIds": [ "nct07804082" ], "location": "Paris coordinating center; French ICU sites; France", "accessMode": "trial-inquiry", "detail": "Nebulized phages for P. aeruginosa ventilator-associated pneumonia; multicenter randomized study.", "searchTerms": [ "Nebulized phages for P. aeruginosa ventilator-associated pneumonia; multicenter randomized study.", "Paris coordinating center; French ICU sites; France" ] }, { "uuid": "73b2242d86be5e7c9c503f13607edd97", "permalink": "/items/avis-phageinlyon-clinic-73b2242d86be5e7c9c503f13607edd97", "id": "trials/nct05883995", "name": "Avis-PHAGEinLYON Clinic (NCT05883995)", "countries": [ "FR" ], "kind": "Observational study", "status": "Recruiting", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05883995" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05883995", "start": { "date": "2023-02-01", "kind": "actual" }, "end": { "date": "2029-02-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05883995" ], "label": "2023–2029 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-02-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05883995" ], "candidates": [ { "date": "2023-02-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05883995" ] }, { "date": "2023-02-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05883995" ] } ] }, "end": { "value": { "date": "2029-02-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05883995" ], "candidates": [ { "date": "2029-02-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05883995" ] }, { "date": "2029-02-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05883995" ] } ] } } } ], "detail": "Bone Infection", "searchTerms": [ "Avis-PHAGEinLYON Clinic", "Bone Infection", "NCT05883995", "Centre de Référence des Infections Ostéo-Articulaires complexes (CRIOAc) - Hôpital de la Croix-Rousse", "Lyon", "", "France" ] }, { "id": "trial-site/6181d5315a57193c", "name": "Centre de Référence des Infections Ostéo-Articulaires complexes (CRIOAc) - Hôpital de la Croix-Rousse — Lyon", "countries": [ "FR" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05883995" ], "checked": "2026-10-03", "trialIds": [ "nct05883995" ], "location": "Lyon", "detail": "Recorded study locations: Bone Infection. Not an offer of treatment.", "searchTerms": [ "Centre de Référence des Infections Ostéo-Articulaires complexes (CRIOAc) - Hôpital de la Croix-Rousse", "Lyon", "", "Avis-PHAGEinLYON Clinic", "Bone Infection", "NCT05883995" ], "studyYears": [ { "trialId": "nct05883995", "start": { "date": "2023-02-01", "kind": "actual" }, "end": { "date": "2029-02-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05883995" ], "label": "2023–2029 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-02-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05883995" ], "candidates": [ { "date": "2023-02-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05883995" ] }, { "date": "2023-02-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05883995" ] } ] }, "end": { "value": { "date": "2029-02-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05883995" ], "candidates": [ { "date": "2029-02-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05883995" ] }, { "date": "2029-02-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05883995" ] } ] } } } ] }, { "id": "trial-site/ac71302e37460b17", "name": "Centre hospitalier ST Joseph et St Luc — Lyon", "countries": [ "FR" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT02116010" ], "checked": "2026-10-04", "trialIds": [ "nct02116010" ], "location": "Lyon", "detail": "Recorded study locations: Wound Infection. Not an offer of treatment.", "searchTerms": [ "Centre hospitalier ST Joseph et St Luc", "Lyon", "", "Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients", "Wound Infection", "NCT02116010", "2014-000714-65" ], "studyYears": [ { "trialId": "nct02116010", "start": { "date": "2015-07-26", "kind": "actual" }, "end": { "date": "2017-01-16", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ], "label": "2015–2017", "dateEvidence": { "start": { "value": { "date": "2015-07-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ], "candidates": [ { "date": "2015-07-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] }, { "date": "2015-07", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02116010" ] }, { "date": "2015-07-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] } ] }, "end": { "value": { "date": "2017-01-16", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ], "candidates": [ { "date": "2017-01-16", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] }, { "date": "2017-01-16", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] }, { "date": "2017-01-16", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] } ] } } } ] }, { "id": "trial-site/9d95ee8b1bdcd35c", "name": "CH de Tourcoing — Tourcoing", "countries": [ "FR" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT02664740" ], "checked": "2026-10-03", "trialIds": [ "nct02664740" ], "location": "Tourcoing", "detail": "Recorded study locations: Diabetic Foot; Staphylococcal Infections. Not an offer of treatment.", "searchTerms": [ "CH de Tourcoing", "Tourcoing", "", "Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus", "Diabetic Foot", "Staphylococcal Infections", "NCT02664740", "2022-500541-24-00" ], "studyYears": [ { "trialId": "nct02664740", "start": { "date": "2026-09-01", "kind": "estimated" }, "end": { "date": "2028-11", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "label": "2026 (estimated)–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-09-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "candidates": [ { "date": "2026-09-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2026-09-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2024-07-02", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2022-500541-24-00?lang=en" ] } ] }, "end": { "value": { "date": "2028-11", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "candidates": [ { "date": "2028-11", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2028-11", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] } ] } } } ] }, { "id": "trial-site/d77a2b6e532ac555", "name": "CH Intercommunal de Villeneuve-Saint-Georges — Villeneuve-Saint-Georges", "countries": [ "FR" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT02664740" ], "checked": "2026-10-03", "trialIds": [ "nct02664740" ], "location": "Villeneuve-Saint-Georges", "detail": "Recorded study locations: Diabetic Foot; Staphylococcal Infections. Not an offer of treatment.", "searchTerms": [ "CH Intercommunal de Villeneuve-Saint-Georges", "Villeneuve-Saint-Georges", "", "Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus", "Diabetic Foot", "Staphylococcal Infections", "NCT02664740", "2022-500541-24-00" ], "studyYears": [ { "trialId": "nct02664740", "start": { "date": "2026-09-01", "kind": "estimated" }, "end": { "date": "2028-11", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "label": "2026 (estimated)–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-09-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "candidates": [ { "date": "2026-09-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2026-09-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2024-07-02", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2022-500541-24-00?lang=en" ] } ] }, "end": { "value": { "date": "2028-11", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "candidates": [ { "date": "2028-11", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2028-11", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] } ] } } } ] }, { "id": "trial-site/dbb4edd5939fe2ca", "name": "CH Nantes — Nantes", "countries": [ "FR" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT06370598" ], "checked": "2026-10-03", "trialIds": [ "nct06370598" ], "location": "Nantes", "detail": "Recorded study locations: Pneumonia, Ventilator-Associated. Not an offer of treatment.", "searchTerms": [ "CH Nantes", "Nantes", "", "Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia", "Pneumonia, Ventilator-Associated", "NCT06370598", "2023-508825-29-00" ], "studyYears": [ { "trialId": "nct06370598", "start": { "date": "2024-09", "kind": "estimated" }, "end": { "date": "2025-06", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06370598" ], "label": "2024 (estimated)–2025 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06370598" ], "candidates": [ { "date": "2024-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06370598" ] }, { "date": "2024-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06370598" ] } ] }, "end": { "value": { "date": "2025-06", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06370598" ], "candidates": [ { "date": "2025-06", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06370598" ] }, { "date": "2025-06", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06370598" ] } ] } } } ] }, { "id": "trial-site/da0cb1b784614a36", "name": "CHRU de Nîmes - Hôpital Universitaire de Réadaptation du Grau du Roi — Le Grau-du-Roi", "countries": [ "FR" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT02664740" ], "checked": "2026-10-03", "trialIds": [ "nct02664740" ], "location": "Le Grau-du-Roi", "detail": "Recorded study locations: Diabetic Foot; Staphylococcal Infections. Not an offer of treatment.", "searchTerms": [ "CHRU de Nîmes - Hôpital Universitaire de Réadaptation du Grau du Roi", "Le Grau-du-Roi", "", "Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus", "Diabetic Foot", "Staphylococcal Infections", "NCT02664740", "2022-500541-24-00" ], "studyYears": [ { "trialId": "nct02664740", "start": { "date": "2026-09-01", "kind": "estimated" }, "end": { "date": "2028-11", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "label": "2026 (estimated)–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-09-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "candidates": [ { "date": "2026-09-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2026-09-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2024-07-02", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2022-500541-24-00?lang=en" ] } ] }, "end": { "value": { "date": "2028-11", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "candidates": [ { "date": "2028-11", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2028-11", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] } ] } } } ] }, { "id": "trial-site/80ac24c11cfd1245", "name": "CHRU de Toulouse - Hôpital de Rangueil — Toulouse", "countries": [ "FR" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT02664740" ], "checked": "2026-10-03", "trialIds": [ "nct02664740" ], "location": "Toulouse", "detail": "Recorded study locations: Diabetic Foot; Staphylococcal Infections. Not an offer of treatment.", "searchTerms": [ "CHRU de Toulouse - Hôpital de Rangueil", "Toulouse", "", "Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus", "Diabetic Foot", "Staphylococcal Infections", "NCT02664740", "2022-500541-24-00" ], "studyYears": [ { "trialId": "nct02664740", "start": { "date": "2026-09-01", "kind": "estimated" }, "end": { "date": "2028-11", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "label": "2026 (estimated)–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-09-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "candidates": [ { "date": "2026-09-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2026-09-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2024-07-02", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2022-500541-24-00?lang=en" ] } ] }, "end": { "value": { "date": "2028-11", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "candidates": [ { "date": "2028-11", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2028-11", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] } ] } } } ] }, { "id": "trial-site/01325ce7410798e1", "name": "CHU Amiens — Amiens", "countries": [ "FR" ], "kind": "Trial site", "status": "Not yet recruiting (trial)", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07804082" ], "checked": "2026-10-03", "trialIds": [ "nct07804082" ], "location": "Amiens", "detail": "Recorded study locations: Ventilator Associated Bacterial Pneumonia; Pseudomonas Aeruginosa Infection. Not an offer of treatment.", "searchTerms": [ "CHU Amiens", "Amiens", "", "A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa", "Ventilator Associated Bacterial Pneumonia", "Pseudomonas Aeruginosa Infection", "NCT07804082", "CHU Amiens", "Amiens", "", "A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa", "Ventilator Associated Bacterial Pneumonia", "Pseudomonas Aeruginosa Infection", "NCT07804082" ], "studyYears": [ { "trialId": "nct07804082", "start": { "date": "2026-11-03", "kind": "estimated" }, "end": { "date": "2030-01-03", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "label": "2026 (estimated)–2030 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-11-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2026-11-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2026-11-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] }, "end": { "value": { "date": "2030-01-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2030-01-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2030-01-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] } } } ] }, { "id": "trial-site/a4ed6e33372aaff3", "name": "CHU Angers — Angers", "countries": [ "FR" ], "kind": "Trial site", "status": "Not yet recruiting (trial)", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07804082" ], "checked": "2026-10-03", "trialIds": [ "nct07804082" ], "location": "Angers", "detail": "Recorded study locations: Ventilator Associated Bacterial Pneumonia; Pseudomonas Aeruginosa Infection. Not an offer of treatment.", "searchTerms": [ "CHU Angers", "Angers", "", "A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa", "Ventilator Associated Bacterial Pneumonia", "Pseudomonas Aeruginosa Infection", "NCT07804082" ], "studyYears": [ { "trialId": "nct07804082", "start": { "date": "2026-11-03", "kind": "estimated" }, "end": { "date": "2030-01-03", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "label": "2026 (estimated)–2030 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-11-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2026-11-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2026-11-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] }, "end": { "value": { "date": "2030-01-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2030-01-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2030-01-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] } } } ] }, { "id": "trial-site/2e4fbd5780c7ed4b", "name": "CHU Clermont-Ferrand — Clermont-Ferrand", "countries": [ "FR" ], "kind": "Trial site", "status": "Not yet recruiting (trial)", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07804082" ], "checked": "2026-10-03", "trialIds": [ "nct07804082" ], "location": "Clermont-Ferrand", "detail": "Recorded study locations: Ventilator Associated Bacterial Pneumonia; Pseudomonas Aeruginosa Infection. Not an offer of treatment.", "searchTerms": [ "CHU Clermont-Ferrand", "Clermont-Ferrand", "", "A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa", "Ventilator Associated Bacterial Pneumonia", "Pseudomonas Aeruginosa Infection", "NCT07804082" ], "studyYears": [ { "trialId": "nct07804082", "start": { "date": "2026-11-03", "kind": "estimated" }, "end": { "date": "2030-01-03", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "label": "2026 (estimated)–2030 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-11-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2026-11-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2026-11-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] }, "end": { "value": { "date": "2030-01-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2030-01-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2030-01-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] } } } ] }, { "id": "trial-site/14dca6f157b8e961", "name": "CHU de Bordeaux - Hôpital Pellegrin — Bordeaux", "countries": [ "FR" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT02664740" ], "checked": "2026-10-03", "trialIds": [ "nct02664740" ], "location": "Bordeaux", "detail": "Recorded study locations: Diabetic Foot; Staphylococcal Infections. Not an offer of treatment.", "searchTerms": [ "CHU de Bordeaux - Hôpital Pellegrin", "Bordeaux", "", "Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus", "Diabetic Foot", "Staphylococcal Infections", "NCT02664740", "2022-500541-24-00" ], "studyYears": [ { "trialId": "nct02664740", "start": { "date": "2026-09-01", "kind": "estimated" }, "end": { "date": "2028-11", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "label": "2026 (estimated)–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-09-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "candidates": [ { "date": "2026-09-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2026-09-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2024-07-02", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2022-500541-24-00?lang=en" ] } ] }, "end": { "value": { "date": "2028-11", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "candidates": [ { "date": "2028-11", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2028-11", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] } ] } } } ] }, { "id": "trial-site/16face914d37310c", "name": "CHU Nice — Nice", "countries": [ "FR" ], "kind": "Trial site", "status": "Not yet recruiting (trial)", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07804082" ], "checked": "2026-10-03", "trialIds": [ "nct07804082" ], "location": "Nice", "detail": "Recorded study locations: Ventilator Associated Bacterial Pneumonia; Pseudomonas Aeruginosa Infection. Not an offer of treatment.", "searchTerms": [ "CHU Nice", "Nice", "", "A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa", "Ventilator Associated Bacterial Pneumonia", "Pseudomonas Aeruginosa Infection", "NCT07804082" ], "studyYears": [ { "trialId": "nct07804082", "start": { "date": "2026-11-03", "kind": "estimated" }, "end": { "date": "2030-01-03", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "label": "2026 (estimated)–2030 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-11-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2026-11-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2026-11-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] }, "end": { "value": { "date": "2030-01-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2030-01-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2030-01-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] } } } ] }, { "id": "therapyRoutes/eu-chu-nimes-phagopied", "name": "CHU Nîmes / PhagoPied multicenter study", "countries": [ "FR" ], "uuid": "a6ca51ab48b55f8cb6ca0f4f0f40d9ee", "permalink": "/items/chu-nimes-phagopied-multicenter-study-a6ca51ab48b55f8cb6ca0f4f0f40d9ee", "kind": "Network", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT02664740", "https://euclinicaltrials.eu/ctis-public/view/2022-500541-24-00?lang=en" ], "checked": "2026-10-03", "trialIds": [ "nct02664740" ], "location": "Nîmes / Le Grau-du-Roi coordinating sites; France", "accessMode": "trial-inquiry", "detail": "S. aureus phages for infected diabetic foot ulcers in a randomized study; French sites.", "searchTerms": [ "S. aureus phages for infected diabetic foot ulcers in a randomized study; French sites.", "Nîmes / Le Grau-du-Roi coordinating sites; France" ] }, { "id": "trial-site/2c0d774f364f015c", "name": "CHU Orléans — Orléans", "countries": [ "FR" ], "kind": "Trial site", "status": "Not yet recruiting (trial)", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07804082" ], "checked": "2026-10-03", "trialIds": [ "nct07804082" ], "location": "Orléans", "detail": "Recorded study locations: Ventilator Associated Bacterial Pneumonia; Pseudomonas Aeruginosa Infection. Not an offer of treatment.", "searchTerms": [ "CHU Orléans", "Orléans", "", "A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa", "Ventilator Associated Bacterial Pneumonia", "Pseudomonas Aeruginosa Infection", "NCT07804082" ], "studyYears": [ { "trialId": "nct07804082", "start": { "date": "2026-11-03", "kind": "estimated" }, "end": { "date": "2030-01-03", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "label": "2026 (estimated)–2030 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-11-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2026-11-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2026-11-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] }, "end": { "value": { "date": "2030-01-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2030-01-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2030-01-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] } } } ] }, { "id": "trial-site/4abcfe539644348b", "name": "Department of Infectious and Tropical Diseases of the Croix Rousse Hospital of the Civil Hospitals of Lyon — Lyon", "countries": [ "FR" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06185920" ], "checked": "2026-10-03", "trialIds": [ "nct06185920" ], "location": "Lyon", "detail": "Recorded study locations: Severe Infection. Not an offer of treatment.", "searchTerms": [ "Department of Infectious and Tropical Diseases of the Croix Rousse Hospital of the Civil Hospitals of Lyon", "Lyon", "", "PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.", "Severe Infection", "NCT06185920" ], "studyYears": [ { "trialId": "nct06185920", "start": { "date": "2023-02-01", "kind": "actual" }, "end": { "date": "2034-02-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06185920" ], "label": "2023–2034 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-02-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06185920" ], "candidates": [ { "date": "2023-02-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06185920" ] }, { "date": "2023-02-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06185920" ] } ] }, "end": { "value": { "date": "2034-02-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06185920" ], "candidates": [ { "date": "2034-02-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06185920" ] }, { "date": "2034-02-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06185920" ] } ] } } } ] }, { "id": "therapyRoutes/eu-eligo", "name": "Eligo Bioscience", "countries": [ "FR" ], "uuid": "3eccd2a42ba65cd7b5e865840e85349f", "permalink": "/items/eligo-bioscience-3eccd2a42ba65cd7b5e865840e85349f", "kind": "Company", "status": "Research/development", "activity": "research", "sources": [ "https://eligo.bio/", "https://eligo.bio/gsk-deal/" ], "checked": "2026-10-03", "location": "Paris; France", "detail": "Microbiome gene editing and genetic-circuit delivery using phage-derived particles, including antibacterial CRISPR approaches.", "searchTerms": [ "Microbiome gene editing and genetic-circuit delivery using phage-derived particles, including antibacterial CRISPR approaches.", "Paris; France" ] }, { "id": "trial-site/405f5925d6e9e7df", "name": "Hôpital Avicenne — Bobigny", "countries": [ "FR" ], "kind": "Trial site", "status": "Not yet recruiting (trial)", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07804082" ], "checked": "2026-10-03", "trialIds": [ "nct07804082" ], "location": "Bobigny", "detail": "Recorded study locations: Ventilator Associated Bacterial Pneumonia; Pseudomonas Aeruginosa Infection. Not an offer of treatment.", "searchTerms": [ "Hôpital Avicenne", "Bobigny", "", "A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa", "Ventilator Associated Bacterial Pneumonia", "Pseudomonas Aeruginosa Infection", "NCT07804082", "Hôpital Avicenne", "Bobigny", "", "A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa", "Ventilator Associated Bacterial Pneumonia", "Pseudomonas Aeruginosa Infection", "NCT07804082" ], "studyYears": [ { "trialId": "nct07804082", "start": { "date": "2026-11-03", "kind": "estimated" }, "end": { "date": "2030-01-03", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "label": "2026 (estimated)–2030 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-11-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2026-11-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2026-11-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] }, "end": { "value": { "date": "2030-01-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2030-01-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2030-01-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] } } } ] }, { "id": "trial-site/7ec3c67c0545cf63", "name": "Hôpital Bicêtre — Le Kremlin-Bicêtre", "countries": [ "FR" ], "kind": "Trial site", "status": "Not yet recruiting (trial)", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07804082" ], "checked": "2026-10-03", "trialIds": [ "nct07804082" ], "location": "Le Kremlin-Bicêtre", "detail": "Recorded study locations: Ventilator Associated Bacterial Pneumonia; Pseudomonas Aeruginosa Infection. Not an offer of treatment.", "searchTerms": [ "Hôpital Bicêtre", "Le Kremlin-Bicêtre", "", "A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa", "Ventilator Associated Bacterial Pneumonia", "Pseudomonas Aeruginosa Infection", "NCT07804082" ], "studyYears": [ { "trialId": "nct07804082", "start": { "date": "2026-11-03", "kind": "estimated" }, "end": { "date": "2030-01-03", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "label": "2026 (estimated)–2030 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-11-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2026-11-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2026-11-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] }, "end": { "value": { "date": "2030-01-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2030-01-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2030-01-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] } } } ] }, { "id": "trial-site/0494fd22aa7b4587", "name": "Hôpital d'instruction des armées Percy — Clamart", "countries": [ "FR" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT02116010" ], "checked": "2026-10-04", "trialIds": [ "nct02116010" ], "location": "Clamart", "detail": "Recorded study locations: Wound Infection. Not an offer of treatment.", "searchTerms": [ "Hôpital d'instruction des armées Percy", "Clamart", "", "Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients", "Wound Infection", "NCT02116010", "2014-000714-65" ], "studyYears": [ { "trialId": "nct02116010", "start": { "date": "2015-07-26", "kind": "actual" }, "end": { "date": "2017-01-16", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ], "label": "2015–2017", "dateEvidence": { "start": { "value": { "date": "2015-07-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ], "candidates": [ { "date": "2015-07-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] }, { "date": "2015-07", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02116010" ] }, { "date": "2015-07-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] } ] }, "end": { "value": { "date": "2017-01-16", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ], "candidates": [ { "date": "2017-01-16", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] }, { "date": "2017-01-16", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] }, { "date": "2017-01-16", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] } ] } } } ] }, { "id": "trial-site/dc5618dc50001e10", "name": "Hopital européen — Marseille", "countries": [ "FR" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT02664740" ], "checked": "2026-10-03", "trialIds": [ "nct02664740" ], "location": "Marseille", "detail": "Recorded study locations: Diabetic Foot; Staphylococcal Infections. Not an offer of treatment.", "searchTerms": [ "Hopital européen", "Marseille", "", "Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus", "Diabetic Foot", "Staphylococcal Infections", "NCT02664740", "2022-500541-24-00" ], "studyYears": [ { "trialId": "nct02664740", "start": { "date": "2026-09-01", "kind": "estimated" }, "end": { "date": "2028-11", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "label": "2026 (estimated)–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-09-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "candidates": [ { "date": "2026-09-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2026-09-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2024-07-02", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2022-500541-24-00?lang=en" ] } ] }, "end": { "value": { "date": "2028-11", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "candidates": [ { "date": "2028-11", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2028-11", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] } ] } } } ] }, { "id": "trial-site/1148c49d6f050abc", "name": "Hôpital Henri Mondor — Créteil", "countries": [ "FR" ], "kind": "Trial site", "status": "Not yet recruiting (trial)", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07804082" ], "checked": "2026-10-03", "trialIds": [ "nct07804082" ], "location": "Créteil", "detail": "Recorded study locations: Ventilator Associated Bacterial Pneumonia; Pseudomonas Aeruginosa Infection. Not an offer of treatment.", "searchTerms": [ "Hôpital Henri Mondor", "Créteil", "", "A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa", "Ventilator Associated Bacterial Pneumonia", "Pseudomonas Aeruginosa Infection", "NCT07804082" ], "studyYears": [ { "trialId": "nct07804082", "start": { "date": "2026-11-03", "kind": "estimated" }, "end": { "date": "2030-01-03", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "label": "2026 (estimated)–2030 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-11-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2026-11-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2026-11-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] }, "end": { "value": { "date": "2030-01-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2030-01-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2030-01-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] } } } ] }, { "id": "trial-site/3d6b55097eab6d31", "name": "Hôpital Louis Mourier — Colombes", "countries": [ "FR" ], "kind": "Trial site", "status": "Not yet recruiting (trial)", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07804082" ], "checked": "2026-10-03", "trialIds": [ "nct07804082" ], "location": "Colombes", "detail": "Recorded study locations: Ventilator Associated Bacterial Pneumonia; Pseudomonas Aeruginosa Infection. Not an offer of treatment.", "searchTerms": [ "Hôpital Louis Mourier", "Colombes", "", "A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa", "Ventilator Associated Bacterial Pneumonia", "Pseudomonas Aeruginosa Infection", "NCT07804082" ], "studyYears": [ { "trialId": "nct07804082", "start": { "date": "2026-11-03", "kind": "estimated" }, "end": { "date": "2030-01-03", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "label": "2026 (estimated)–2030 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-11-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2026-11-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2026-11-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] }, "end": { "value": { "date": "2030-01-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2030-01-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2030-01-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] } } } ] }, { "id": "trial-site/415d4e8ed6d6669c", "name": "Hôpital Pitié-Salpêtrière — Paris", "countries": [ "FR" ], "kind": "Trial site", "status": "Not yet recruiting (trial)", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07804082" ], "checked": "2026-10-03", "trialIds": [ "nct07804082" ], "location": "Paris", "detail": "Recorded study locations: Ventilator Associated Bacterial Pneumonia; Pseudomonas Aeruginosa Infection. Not an offer of treatment.", "searchTerms": [ "Hôpital Pitié-Salpêtrière", "Paris", "", "A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa", "Ventilator Associated Bacterial Pneumonia", "Pseudomonas Aeruginosa Infection", "NCT07804082", "Hôpital Pitié-Salpêtrière", "Paris", "", "A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa", "Ventilator Associated Bacterial Pneumonia", "Pseudomonas Aeruginosa Infection", "NCT07804082", "Hôpital Pitié-Salpêtrière", "Paris", "", "A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa", "Ventilator Associated Bacterial Pneumonia", "Pseudomonas Aeruginosa Infection", "NCT07804082", "Hôpital Pitié-Salpêtrière", "Paris", "", "A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa", "Ventilator Associated Bacterial Pneumonia", "Pseudomonas Aeruginosa Infection", "NCT07804082", "Hôpital Pitié-Salpêtrière", "Paris", "", "A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa", "Ventilator Associated Bacterial Pneumonia", "Pseudomonas Aeruginosa Infection", "NCT07804082" ], "studyYears": [ { "trialId": "nct07804082", "start": { "date": "2026-11-03", "kind": "estimated" }, "end": { "date": "2030-01-03", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "label": "2026 (estimated)–2030 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-11-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2026-11-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2026-11-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] }, "end": { "value": { "date": "2030-01-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2030-01-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2030-01-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] } } } ] }, { "id": "trial-site/463e0638c0f1af04", "name": "Hospices Civils de Lyon — Lyon", "countries": [ "FR" ], "kind": "Trial site", "status": "Mixed trial statuses", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT04650607", "https://clinicaltrials.gov/study/NCT04724603" ], "checked": "2026-10-03", "trialIds": [ "nct04650607", "nct04724603" ], "location": "Lyon", "detail": "Recorded study locations: Prosthetic Joint Infection; Severe Infection; Bone and Joint Infection. Not an offer of treatment.", "searchTerms": [ "Hospices Civils de Lyon", "Lyon", "", "Phage Safety Cohort Study", "Prosthetic Joint Infection", "Severe Infection", "NCT04650607", "Hospices Civils de Lyon", "Lyon", "", "Phage Safety Retrospective Cohort Study", "Bone and Joint Infection", "Prosthetic Joint Infection", "NCT04724603" ], "studyYears": [ { "trialId": "nct04650607", "start": { "date": "2022-05-09", "kind": "actual" }, "end": { "date": "2028-05-09", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04650607" ], "label": "2022–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-05-09", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04650607" ], "candidates": [ { "date": "2022-05-09", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04650607" ] }, { "date": "2022-05-09", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04650607" ] } ] }, "end": { "value": { "date": "2028-05-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04650607" ], "candidates": [ { "date": "2028-05-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04650607" ] }, { "date": "2028-05-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04650607" ] } ] } } }, { "trialId": "nct04724603", "start": { "date": "2021-02-01", "kind": "actual" }, "end": { "date": "2026-09-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04724603" ], "label": "2021–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2021-02-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04724603" ], "candidates": [ { "date": "2021-02-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04724603" ] }, { "date": "2021-02-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04724603" ] } ] }, "end": { "value": { "date": "2026-09-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04724603" ], "candidates": [ { "date": "2026-09-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04724603" ] }, { "date": "2026-09-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04724603" ] } ] } } } ] }, { "id": "therapyRoutes/eu-hcl-phageinlyon", "name": "Hospices Civils de Lyon / CRIOAc / PHAGEinLYON", "countries": [ "FR" ], "uuid": "1a790c707e8c53f6a8e7e431dba2c250", "permalink": "/items/hospices-civils-de-lyon-crioac-phageinlyon-1a790c707e8c53f6a8e7e431dba2c250", "kind": "Center", "status": "Official referral/inquiry route", "activity": "current", "sources": [ "https://www.chu-lyon.fr/phagotherapie-bacteriophage", "https://www.chu-lyon.fr/autorisation-production-phages-therapeutiques", "https://recherche.chu-lyon.fr/plateforme-des-phages-therapeutiques" ], "checked": "2026-10-04", "location": "Lyon; France", "detail": "Multidisciplinary evaluation for exceptional compassionate use, notably difficult bone/joint and implant infections with serious functional or vital risk; matching supply and authorization required. HCL’s PETRA platform supports phage selection, testing, preparation and quality control for compassionate care and trials.", "searchTerms": [ "Multidisciplinary evaluation for exceptional compassionate use, notably difficult bone/joint and implant infections with serious functional or vital risk; matching supply and authorization required. HCL’s PETRA platform supports phage selection, testing, preparation and quality control for compassionate care and trials.", "Lyon; France" ] }, { "uuid": "c543a266f0145770881a081c4164f64b", "permalink": "/items/phage-safety-cohort-study-c543a266f0145770881a081c4164f64b", "id": "trials/nct04650607", "name": "PHA-SA-CO (NCT04650607)", "countries": [ "FR" ], "kind": "Observational study", "status": "Recruiting", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT04650607" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct04650607", "start": { "date": "2022-05-09", "kind": "actual" }, "end": { "date": "2028-05-09", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04650607" ], "label": "2022–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-05-09", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04650607" ], "candidates": [ { "date": "2022-05-09", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04650607" ] }, { "date": "2022-05-09", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04650607" ] } ] }, "end": { "value": { "date": "2028-05-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04650607" ], "candidates": [ { "date": "2028-05-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04650607" ] }, { "date": "2028-05-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04650607" ] } ] } } } ], "detail": "Prosthetic Joint Infection; Severe Infection", "searchTerms": [ "Phage Safety Cohort Study", "Prosthetic Joint Infection", "Severe Infection", "NCT04650607", "Hospices Civils de Lyon", "Lyon", "", "France" ] }, { "uuid": "d7b7685136225d38b6fa3671679265de", "permalink": "/items/phageinlyon-clinic-cohort-study-a-descriptive-study-of-severe-infections-treated-with-phag-d7b7685136225d38b6fa3671679265de", "id": "trials/nct06185920", "name": "PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL. (NCT06185920)", "countries": [ "FR" ], "kind": "Observational study", "status": "Recruiting", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06185920" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct06185920", "start": { "date": "2023-02-01", "kind": "actual" }, "end": { "date": "2034-02-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06185920" ], "label": "2023–2034 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-02-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06185920" ], "candidates": [ { "date": "2023-02-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06185920" ] }, { "date": "2023-02-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06185920" ] } ] }, "end": { "value": { "date": "2034-02-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06185920" ], "candidates": [ { "date": "2034-02-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06185920" ] }, { "date": "2034-02-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06185920" ] } ] } } } ], "detail": "Severe Infection", "searchTerms": [ "PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.", "Severe Infection", "NCT06185920", "Department of Infectious and Tropical Diseases of the Croix Rousse Hospital of the Civil Hospitals of Lyon", "Lyon", "", "France" ] }, { "id": "therapyRoutes/eu-phagenix", "name": "PHAGENIX", "countries": [ "FR" ], "uuid": "48d318d6a1065d9b9e75d371a2288d79", "permalink": "/items/phagenix-48d318d6a1065d9b9e75d371a2288d79", "kind": "Company", "status": "Research/development", "activity": "research", "sources": [ "https://phagenix.com/en/mission-history/", "https://phagenix.com/en/contact-en/", "https://clinicaltrials.gov/study/NCT06605651", "https://euclinicaltrials.eu/ctis-public/view/2024-516555-40-00?lang=en", "https://euclinicaltrials.eu/ctis-public/view/2024-516207-17-00?lang=en" ], "checked": "2026-10-03", "trialIds": [ "nct05369104", "nct06605651" ], "location": "Lyon; France", "detail": "Site describes a specialty-pharmaceutical company established in 2025 with S. aureus, E. coli and P. aeruginosa phage portfolios.", "searchTerms": [ "Site describes a specialty-pharmaceutical company established in 2025 with S. aureus, E. coli and P. aeruginosa phage portfolios.", "Lyon; France" ] }, { "uuid": "2cfa70711cdd524fa06501fa6e8a864d", "permalink": "/items/phage-therapy-in-prosthetic-joint-infection-due-to-staphylococcus-aureus-treated-with-dair-2cfa70711cdd524fa06501fa6e8a864d", "id": "trials/nct05369104", "name": "PhagoDAIRI (NCT05369104)", "countries": [ "FR" ], "kind": "Trial", "status": "Ended", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05369104", "https://euclinicaltrials.eu/ctis-public/view/2024-516207-17-00?lang=en" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05369104", "start": { "date": "2022-06-15", "kind": "actual" }, "end": { "date": "2025-06-16", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05369104" ], "label": "2022–2025 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-06-15", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05369104" ], "candidates": [ { "date": "2022-06-15", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05369104" ] }, { "date": "2022-06-15", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05369104" ] }, { "date": "2022-06-15", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-516207-17-00?lang=en" ] } ] }, "end": { "value": { "date": "2025-06-16", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05369104" ], "candidates": [ { "date": "2025-06-16", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05369104" ] }, { "date": "2025-06-16", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05369104" ] }, { "date": "2025-04-08", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-516207-17-00?lang=en" ] } ] } } } ], "detail": "Infection of Total Hip Joint Prosthesis; Infection of Total Knee Joint Prosthesis", "searchTerms": [ "Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR.", "Infection of Total Hip Joint Prosthesis", "Infection of Total Knee Joint Prosthesis", "NCT05369104", "2024-516207-17-00", "Pr Tristan Ferry", "Lyon", "", "France" ] }, { "uuid": "97caac1775e7551e821f2388b79466b6", "permalink": "/items/standard-treatment-associated-with-phage-therapy-versus-placebo-for-diabetic-foot-ulcers-i-97caac1775e7551e821f2388b79466b6", "id": "trials/nct02664740", "name": "PhagoPied (NCT02664740)", "countries": [ "FR" ], "kind": "Trial", "status": "Conflicting status", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT02664740", "https://euclinicaltrials.eu/ctis-public/view/2022-500541-24-00?lang=en" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct02664740", "start": { "date": "2026-09-01", "kind": "estimated" }, "end": { "date": "2028-11", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "label": "2026 (estimated)–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-09-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "candidates": [ { "date": "2026-09-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2026-09-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2024-07-02", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2022-500541-24-00?lang=en" ] } ] }, "end": { "value": { "date": "2028-11", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ], "candidates": [ { "date": "2028-11", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] }, { "date": "2028-11", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02664740" ] } ] } } } ], "detail": "Diabetic Foot; Staphylococcal Infections", "searchTerms": [ "Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus", "Diabetic Foot", "Staphylococcal Infections", "NCT02664740", "2022-500541-24-00", "CHU de Bordeaux - Hôpital Pellegrin", "Bordeaux", "", "France", "CHRU de Nîmes - Hôpital Universitaire de Réadaptation du Grau du Roi", "Le Grau-du-Roi", "", "France", "Hopital européen", "Marseille", "", "France", "CHRU de Toulouse - Hôpital de Rangueil", "Toulouse", "", "France", "CH de Tourcoing", "Tourcoing", "", "France", "CH Intercommunal de Villeneuve-Saint-Georges", "Villeneuve-Saint-Georges", "", "France" ] }, { "uuid": "256c46ec866f53eaa7e211ff1013c835", "permalink": "/items/phage-safety-retrospective-cohort-study-256c46ec866f53eaa7e211ff1013c835", "id": "trials/nct04724603", "name": "PHASACO-retro (NCT04724603)", "countries": [ "FR" ], "kind": "Observational study", "status": "Status unconfirmed", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT04724603" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct04724603", "start": { "date": "2021-02-01", "kind": "actual" }, "end": { "date": "2026-09-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04724603" ], "label": "2021–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2021-02-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04724603" ], "candidates": [ { "date": "2021-02-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04724603" ] }, { "date": "2021-02-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04724603" ] } ] }, "end": { "value": { "date": "2026-09-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04724603" ], "candidates": [ { "date": "2026-09-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04724603" ] }, { "date": "2026-09-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04724603" ] } ] } } } ], "detail": "Bone and Joint Infection; Prosthetic Joint Infection", "searchTerms": [ "Phage Safety Retrospective Cohort Study", "Bone and Joint Infection", "Prosthetic Joint Infection", "NCT04724603", "Hospices Civils de Lyon", "Lyon", "", "France" ] }, { "id": "therapyRoutes/eu-phaxiam-pherecydes", "name": "PHAXIAM Therapeutics / former Pherecydes pipeline", "countries": [ "FR" ], "uuid": "02030a857d2d5a1987b3f078611e62e1", "permalink": "/items/phaxiam-therapeutics-former-pherecydes-pipeline-02030a857d2d5a1987b3f078611e62e1", "kind": "Company", "status": "Historical/inactive", "activity": "historical", "sources": [ "https://live.euronext.com/fr/products/equities/company-news/2025-06-12-phaxiam-therapeutics-annonce-sa-liquidation-judiciaire-et", "https://phagenix.com/en/phaxiam-therapeutics-announces-judicial-liquidation-and-delisting/", "https://cordis.europa.eu/project/id/601857" ], "checked": "2026-10-03", "trialIds": [ "nct02116010", "nct05369104", "nct06605651" ], "location": "Lyon / historical Nantes activity; France", "detail": "Historical S. aureus, E. coli and P. aeruginosa clinical phage development, including prosthetic joint infection and burn trials.", "searchTerms": [ "Historical S. aureus, E. coli and P. aeruginosa clinical phage development, including prosthetic joint infection and burn trials.", "Lyon / historical Nantes activity; France" ] }, { "id": "trial-site/3b9438aee306e85f", "name": "Pr Tristan Ferry — Lyon", "countries": [ "FR" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05369104" ], "checked": "2026-10-03", "trialIds": [ "nct05369104" ], "location": "Lyon", "detail": "Recorded study locations: Infection of Total Hip Joint Prosthesis; Infection of Total Knee Joint Prosthesis. Not an offer of treatment.", "searchTerms": [ "Pr Tristan Ferry", "Lyon", "", "Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR.", "Infection of Total Hip Joint Prosthesis", "Infection of Total Knee Joint Prosthesis", "NCT05369104", "2024-516207-17-00" ], "studyYears": [ { "trialId": "nct05369104", "start": { "date": "2022-06-15", "kind": "actual" }, "end": { "date": "2025-06-16", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05369104" ], "label": "2022–2025 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-06-15", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05369104" ], "candidates": [ { "date": "2022-06-15", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05369104" ] }, { "date": "2022-06-15", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05369104" ] }, { "date": "2022-06-15", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-516207-17-00?lang=en" ] } ] }, "end": { "value": { "date": "2025-06-16", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05369104" ], "candidates": [ { "date": "2025-06-16", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05369104" ] }, { "date": "2025-06-16", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05369104" ] }, { "date": "2025-04-08", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-516207-17-00?lang=en" ] } ] } } } ] }, { "uuid": "9fb9ae0a065a52689020e71b8979fae4", "permalink": "/items/a-double-blind-placebo-controlled-study-of-nebulized-bacteriophages-in-patients-with-venti-9fb9ae0a065a52689020e71b8979fae4", "id": "trials/nct07804082", "name": "PYOPHANEB (NCT07804082)", "countries": [ "FR" ], "kind": "Trial", "status": "Not yet recruiting", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07804082" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct07804082", "start": { "date": "2026-11-03", "kind": "estimated" }, "end": { "date": "2030-01-03", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "label": "2026 (estimated)–2030 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-11-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2026-11-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2026-11-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] }, "end": { "value": { "date": "2030-01-03", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ], "candidates": [ { "date": "2030-01-03", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] }, { "date": "2030-01-03", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07804082" ] } ] } } } ], "detail": "Ventilator Associated Bacterial Pneumonia; Pseudomonas Aeruginosa Infection", "searchTerms": [ "A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa", "Ventilator Associated Bacterial Pneumonia", "Pseudomonas Aeruginosa Infection", "NCT07804082", "CHU Amiens", "Amiens", "", "France", "CHU Amiens", "Amiens", "", "France", "CHU Angers", "Angers", "", "France", "Hôpital Avicenne", "Bobigny", "", "France", "Hôpital Avicenne", "Bobigny", "", "France", "CHU Clermont-Ferrand", "Clermont-Ferrand", "", "France", "Hôpital Louis Mourier", "Colombes", "", "France", "Hôpital Henri Mondor", "Créteil", "", "France", "Hôpital Bicêtre", "Le Kremlin-Bicêtre", "", "France", "CHU Nice", "Nice", "", "France", "CHU Orléans", "Orléans", "", "France", "Hôpital Pitié-Salpêtrière", "Paris", "", "France", "Hôpital Pitié-Salpêtrière", "Paris", "", "France", "Hôpital Pitié-Salpêtrière", "Paris", "", "France", "Hôpital Pitié-Salpêtrière", "Paris", "", "France", "Hôpital Pitié-Salpêtrière", "Paris", "", "France" ] }, { "uuid": "afae7557df685595a0a22281cb836f57", "permalink": "/items/phase-1-2a-to-assess-the-safety-and-tolerability-of-tp-122a-for-the-treatment-of-ventilato-afae7557df685595a0a22281cb836f57", "id": "trials/nct06370598", "name": "RECOVER (NCT06370598)", "countries": [ "FR" ], "kind": "Trial", "status": "Not authorised", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT06370598", "https://euclinicaltrials.eu/ctis-public/view/2023-508825-29-00?lang=en" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct06370598", "start": { "date": "2024-09", "kind": "estimated" }, "end": { "date": "2025-06", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06370598" ], "label": "2024 (estimated)–2025 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06370598" ], "candidates": [ { "date": "2024-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06370598" ] }, { "date": "2024-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06370598" ] } ] }, "end": { "value": { "date": "2025-06", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06370598" ], "candidates": [ { "date": "2025-06", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06370598" ] }, { "date": "2025-06", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06370598" ] } ] } } } ], "detail": "Pneumonia, Ventilator-Associated", "searchTerms": [ "Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia", "Pneumonia, Ventilator-Associated", "NCT06370598", "2023-508825-29-00", "CH Nantes", "Nantes", "", "France" ] }, { "uuid": "0e5331f1a7b0590e9843dc9afbc9b6b5", "permalink": "/items/bacteriophages-for-treating-urinary-tract-infections-in-patients-undergoing-transurethral-0e5331f1a7b0590e9843dc9afbc9b6b5", "id": "trials/nct03140085", "name": "Bacteriophages for Treating Urinary Tract Infections in Patients Undergoing Transurethral Resection of the Prostate (NCT03140085)", "countries": [ "GE" ], "kind": "Trial", "status": "Completed", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT03140085" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct03140085", "start": { "date": "2017-06-02", "kind": "actual" }, "end": { "date": "2018-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03140085" ], "label": "2017–2018", "dateEvidence": { "start": { "value": { "date": "2017-06-02", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03140085" ], "candidates": [ { "date": "2017-06-02", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03140085" ] }, { "date": "2017-06-02", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03140085" ] } ] }, "end": { "value": { "date": "2018-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03140085" ], "candidates": [ { "date": "2018-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03140085" ] }, { "date": "2018-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03140085" ] } ] } } } ], "detail": "Intravesical Bacteriophage Treatment for Urinary Tract Infections", "searchTerms": [ "Bacteriophages for Treating Urinary Tract Infections in Patients Undergoing Transurethral Resection of the Prostate", "Intravesical Bacteriophage Treatment for Urinary Tract Infections", "NCT03140085", "National Center of Urology", "Tbilisi", "", "Georgia" ] }, { "id": "therapyRoutes/eu-biochimpharm", "name": "BioChimPharm", "countries": [ "GE" ], "uuid": "15d1de369b355e0fb23f1ed4e6a20f30", "permalink": "/items/biochimpharm-15d1de369b355e0fb23f1ed4e6a20f30", "kind": "Supplier", "status": "Provider-listed inquiry route", "activity": "current", "sources": [ "https://biochimpharm.ge/en/", "https://biochimpharm.ge/en/news/biochimpharm-renovates-the-worlds-oldest-phage-factory/" ], "checked": "2026-10-03", "location": "Tbilisi; Georgia", "detail": "Human phage products targeting bacterial pathogens including staphylococci, E. coli, enterococci, Proteus, streptococci and P. aeruginosa.", "searchTerms": [ "Human phage products targeting bacterial pathogens including staphylococci, E. coli, enterococci, Proteus, streptococci and P. aeruginosa.", "Tbilisi; Georgia" ] }, { "id": "therapyRoutes/eu-eliava-biopreparations", "name": "Eliava BioPreparations", "countries": [ "GE" ], "uuid": "da7e9a6082b2584b83fd11b658b42f63", "permalink": "/items/eliava-biopreparations-da7e9a6082b2584b83fd11b658b42f63", "kind": "Supplier", "status": "Provider-listed inquiry route", "activity": "current", "sources": [ "https://phage.ge/en/about/1", "https://phage.ge/en/contact" ], "checked": "2026-10-03", "location": "Tbilisi; Georgia", "detail": "Company describes six marketed standard phage preparations and custom development for human, veterinary and environmental use.", "searchTerms": [ "Company describes six marketed standard phage preparations and custom development for human, veterinary and environmental use.", "Tbilisi; Georgia" ] }, { "id": "therapyRoutes/eu-eliava-eptc", "name": "Eliava Phage Therapy Center (EPTC)", "countries": [ "GE" ], "uuid": "ee64767f2ce65d3bad9942b23dce07c9", "permalink": "/items/eliava-phage-therapy-center-eptc-ee64767f2ce65d3bad9942b23dce07c9", "kind": "Center", "status": "Provider-listed inquiry route", "activity": "current", "sources": [ "https://eptc.ge/", "https://eptc.ge/contact/" ], "checked": "2026-10-05", "location": "Tbilisi; Georgia", "detail": "Bacterial infections evaluated by internal medicine, pediatrics, urology, gynecology and outpatient surgery specialists; isolate matching and individual assessment.", "searchTerms": [ "Bacterial infections evaluated by internal medicine, pediatrics, urology, gynecology and outpatient surgery specialists; isolate matching and individual assessment.", "Tbilisi; Georgia" ] }, { "id": "therapyRoutes/eu-eliava-institute", "name": "George Eliava Institute of Bacteriophages, Microbiology and Virology", "countries": [ "GE" ], "uuid": "731f51539c315b8c936b5bec2da3b361", "permalink": "/items/george-eliava-institute-of-bacteriophages-microbiology-and-virology-731f51539c315b8c936b5bec2da3b361", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://eliava-institute.org/en", "https://eliava-institute.org/en/about-us" ], "checked": "2026-10-03", "location": "Tbilisi; Georgia", "detail": "Phage research, collection, quality control and development; not listed as an additional patient intake clinic.", "searchTerms": [ "Phage research, collection, quality control and development; not listed as an additional patient intake clinic.", "Tbilisi; Georgia" ] }, { "id": "trial-site/8c9b437d1017037a", "name": "National Center of Urology — Tbilisi", "countries": [ "GE" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT03140085" ], "checked": "2026-10-03", "trialIds": [ "nct03140085" ], "location": "Tbilisi", "detail": "Recorded study locations: Intravesical Bacteriophage Treatment for Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "National Center of Urology", "Tbilisi", "", "Bacteriophages for Treating Urinary Tract Infections in Patients Undergoing Transurethral Resection of the Prostate", "Intravesical Bacteriophage Treatment for Urinary Tract Infections", "NCT03140085" ], "studyYears": [ { "trialId": "nct03140085", "start": { "date": "2017-06-02", "kind": "actual" }, "end": { "date": "2018-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03140085" ], "label": "2017–2018", "dateEvidence": { "start": { "value": { "date": "2017-06-02", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03140085" ], "candidates": [ { "date": "2017-06-02", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03140085" ] }, { "date": "2017-06-02", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03140085" ] } ] }, "end": { "value": { "date": "2018-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03140085" ], "candidates": [ { "date": "2018-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03140085" ] }, { "date": "2018-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03140085" ] } ] } } } ] }, { "id": "therapyRoutes/eu-phage-therapy-center-georgia", "name": "Phage Therapy Center LTD, Tbilisi", "countries": [ "GE" ], "uuid": "933789efb38555be9730d0563ad0b786", "permalink": "/items/phage-therapy-center-ltd-tbilisi-933789efb38555be9730d0563ad0b786", "kind": "Center", "status": "Provider-listed inquiry route", "activity": "current", "sources": [ "https://www.phagetherapycenter.com/pii/PatientServlet?command=responsive_medsvcs", "https://www.phagetherapycenter.com/pii/PatientServlet?command=responsive_treatoverview", "https://www.phagetherapycenter.com/pii/PatientServlet?command=responsive_ourhistory", "https://www.phagetherapycenter.com/pii/PatientServlet?command=responsive_home", "https://www.phagetherapycenter.com/pii/PatientServlet?command=responsive_contact", "https://www.phagetherapycenter.com/pii/PatientServlet?command=responsive_createuserid" ], "checked": "2026-10-05", "location": "Tbilisi; Georgia", "detail": "Separate from Eliava Phage Therapy Center (EPTC). The clinic describes individualized bacterial-infection assessment and outpatient phage treatment in Tbilisi; contact the clinic to confirm current availability.", "searchTerms": [ "Separate from Eliava Phage Therapy Center (EPTC). The clinic describes individualized bacterial-infection assessment and outpatient phage treatment in Tbilisi; contact the clinic to confirm current availability.", "Tbilisi; Georgia" ] }, { "id": "therapyRoutes/de-bergmannstrost-halle", "name": "BG Klinikum Bergmannstrost Halle / Institute for Phage Medicine", "countries": [ "DE" ], "uuid": "9de167d9ba9959fd905e9bc0d6ad5a17", "permalink": "/items/bg-klinikum-bergmannstrost-halle-institute-for-phage-medicine-9de167d9ba9959fd905e9bc0d6ad5a17", "kind": "Center", "status": "Case-by-case; Official referral/inquiry route", "activity": "current", "sources": [ "https://www.bg-kliniken.de/klinikum-bergmannstrost-halle/fachbereiche/detail/septische-und-rekonstruktive-chirurgie/", "https://www.bg-kliniken.de/mvz-bergmannstrost-halle/ueber-uns/klinikum-blaupause/aktuelles/pressemitteilungen/detail/bergmannstrost-gruendet-institut-fuer-phagenmedizin-neue-perspektiven-im-kampf-gegen-multiresistente-erreger/" ], "checked": "2026-10-04", "location": "Halle (Saale), Germany", "accessMode": "case-by-case", "detail": "Selected-case phage treatment for difficult bacterial infections, including bone and joint infections. The hospital announced its Institute for Phage Medicine on September 21, 2026.", "searchTerms": [ "Selected-case phage treatment for difficult bacterial infections, including bone and joint infections. The hospital announced its Institute for Phage Medicine on September 21, 2026.", "Halle (Saale), Germany" ] }, { "id": "therapyRoutes/eu-bundeswehr-berlin-phagoflow", "name": "Bundeswehr Hospital Berlin / PhagoFlow", "countries": [ "DE" ], "uuid": "477f62de610a5430bae562e0cd63a8ca", "permalink": "/items/bundeswehr-hospital-berlin-phagoflow-477f62de610a5430bae562e0cd63a8ca", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://innovationsfonds.g-ba.de/downloads/beschluss-dokumente/877/2025-06-20_PTmHBP.pdf" ], "checked": "2026-10-03", "location": "Berlin; Germany", "detail": "PhagoFlow produced P. aeruginosa phages and treated wound, urinary, ear and respiratory infections in individual attempts.", "searchTerms": [ "PhagoFlow produced P. aeruginosa phages and treated wound, urinary, ear and respiratory infections in individual attempts.", "Berlin; Germany" ] }, { "id": "therapyRoutes/eu-phage4cure", "name": "Charité / Phage4Cure consortium", "countries": [ "DE" ], "uuid": "f77bb9ffade95a84972e6d1f8106bfb5", "permalink": "/items/charite-phage4cure-consortium-f77bb9ffade95a84972e6d1f8106bfb5", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://phage4cure.de/en/news/", "https://phage4cure.de/de/projekt/" ], "checked": "2026-10-03", "location": "Berlin; Braunschweig; Hannover; Germany", "detail": "Inhaled phage development for P. aeruginosa; PHAGE4CURE-001 healthy-volunteer study completed September 2023 to May 2025.", "searchTerms": [ "Inhaled phage development for P. aeruginosa; PHAGE4CURE-001 healthy-volunteer study completed September 2023 to May 2025.", "Berlin; Braunschweig; Hannover; Germany" ] }, { "id": "trial-site/971521b637930da9", "name": "Department of Dermatology — Tübingen", "countries": [ "DE" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06290557" ], "checked": "2026-10-03", "trialIds": [ "nct06290557" ], "location": "Tübingen", "detail": "Recorded study locations: Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "Department of Dermatology", "Tübingen", "", "First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy ofHY-133", "Staphylococcus Aureus", "NCT06290557", "2023-507737-17-00" ], "studyYears": [ { "trialId": "nct06290557", "start": { "date": "2024-07-10", "kind": "actual" }, "end": { "date": "2026-07-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ], "label": "2024–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-07-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ], "candidates": [ { "date": "2024-07-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ] }, { "date": "2024-07-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ] }, { "date": "2024-07-10", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2023-507737-17-00?lang=en" ] } ] }, "end": { "value": { "date": "2026-07-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ], "candidates": [ { "date": "2026-07-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ] }, { "date": "2026-07-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ] } ] } } } ] }, { "id": "trial-site/7231b3d7c4d5ef57", "name": "Department of Dermatology, University Hospital Tuebingen — Tübingen", "countries": [ "DE" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06290557" ], "checked": "2026-10-03", "trialIds": [ "nct06290557" ], "location": "Tübingen", "detail": "Recorded study locations: Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "Department of Dermatology, University Hospital Tuebingen", "Tübingen", "", "First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy ofHY-133", "Staphylococcus Aureus", "NCT06290557", "2023-507737-17-00" ], "studyYears": [ { "trialId": "nct06290557", "start": { "date": "2024-07-10", "kind": "actual" }, "end": { "date": "2026-07-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ], "label": "2024–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-07-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ], "candidates": [ { "date": "2024-07-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ] }, { "date": "2024-07-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ] }, { "date": "2024-07-10", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2023-507737-17-00?lang=en" ] } ] }, "end": { "value": { "date": "2026-07-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ], "candidates": [ { "date": "2026-07-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ] }, { "date": "2026-07-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ] } ] } } } ] }, { "id": "therapyRoutes/eu-mhh-hannover", "name": "Hannover Medical School clinical phage program", "countries": [ "DE" ], "uuid": "87cc2eac1acb5b36b3cf85b25ebb4481", "permalink": "/items/hannover-medical-school-clinical-phage-program-87cc2eac1acb5b36b3cf85b25ebb4481", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.mhh.de/presse-news-detailansicht/die-guten-viren-was-bakteriophagen-leisten-koennen", "https://www.balgrist.ch/ueber-uns/medien/mit-viren-gegen-bakterien-eu-foerdert-phagentherapie-mit-15-millionen-euro-1011/" ], "checked": "2026-10-03", "location": "Hannover; Germany", "detail": "Heart/thorax/transplant/vascular surgery experience with difficult bacterial infections; REPhRAME research partnership now includes MHH.", "searchTerms": [ "Heart/thorax/transplant/vascular surgery experience with difficult bacterial infections; REPhRAME research partnership now includes MHH.", "Hannover; Germany" ] }, { "uuid": "df7243fd91555b2784b698d9bfa518c9", "permalink": "/items/first-in-man-single-dose-and-multiple-dose-study-to-evaluate-the-safety-tolerability-and-e-df7243fd91555b2784b698d9bfa518c9", "id": "trials/nct06290557", "name": "HY-133 (NCT06290557)", "countries": [ "DE" ], "kind": "Adjacent product trial", "status": "Recruiting", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06290557", "https://euclinicaltrials.eu/ctis-public/view/2023-507737-17-00?lang=en" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct06290557", "start": { "date": "2024-07-10", "kind": "actual" }, "end": { "date": "2026-07-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ], "label": "2024–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-07-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ], "candidates": [ { "date": "2024-07-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ] }, { "date": "2024-07-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ] }, { "date": "2024-07-10", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2023-507737-17-00?lang=en" ] } ] }, "end": { "value": { "date": "2026-07-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ], "candidates": [ { "date": "2026-07-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ] }, { "date": "2026-07-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06290557" ] } ] } } } ], "detail": "Staphylococcus Aureus", "searchTerms": [ "First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy ofHY-133", "Staphylococcus Aureus", "NCT06290557", "2023-507737-17-00", "Department of Dermatology, University Hospital Tuebingen", "Tübingen", "", "Germany", "Department of Dermatology", "Tübingen", "", "Germany" ] }, { "id": "therapyRoutes/eu-regensburg", "name": "Phage Center Regensburg / University Hospital Regensburg", "countries": [ "DE" ], "uuid": "d84b5894f64f5b1ca7e90bd1881bd9ae", "permalink": "/items/phage-center-regensburg-university-hospital-regensburg-d84b5894f64f5b1ca7e90bd1881bd9ae", "kind": "Center", "status": "Official referral/inquiry route", "activity": "current", "sources": [ "https://phagecenter-regensburg.de/service.html" ], "checked": "2026-10-03", "location": "Regensburg; Germany", "detail": "Severe or chronic resistant/biofilm/implant-related infections after alternatives are exhausted; matching, characterization and individual compassionate treatment.", "searchTerms": [ "Severe or chronic resistant/biofilm/implant-related infections after alternatives are exhausted; matching, characterization and individual compassionate treatment.", "Regensburg; Germany" ] }, { "id": "therapyRoutes/eu-phage-therapeutics-gmbh", "name": "Phage Therapeutics GmbH", "countries": [ "DE" ], "uuid": "2b3d291a7d2f59ceafa37117fae22d2c", "permalink": "/items/phage-therapeutics-gmbh-2b3d291a7d2f59ceafa37117fae22d2c", "kind": "Company", "status": "Research/development", "activity": "research", "sources": [ "https://www.phage-therapeutics.bio/en" ], "checked": "2026-10-03", "location": "Dortmund; Germany", "detail": "Phage development for respiratory/systemic S. aureus including MRSA/MSSA and other staphylococcal infections.", "searchTerms": [ "Phage development for respiratory/systemic S. aureus including MRSA/MSSA and other staphylococcal infections.", "Dortmund; Germany" ] }, { "uuid": "58516dd05a1255299b2d63daaf6a8a23", "permalink": "/items/phage4cure-001-58516dd05a1255299b2d63daaf6a8a23", "id": "trials/eu-2023-507203-55-00", "name": "Phage4Cure-001 (2023-507203-55-00)", "countries": [ "DE" ], "kind": "Trial", "status": "Ended", "activity": "historical", "sources": [ "https://euclinicaltrials.eu/ctis-public/view/2023-507203-55-00?lang=en", "https://euclinicaltrials.eu/ctis-public/view/2022-503145-22-00?lang=en" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "eu-2023-507203-55-00", "sourceUrls": [], "label": "Not listed", "dateEvidence": { "start": { "conflict": false, "sourceUrls": [], "candidates": [ { "date": "2023-08-21", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2023-507203-55-00?lang=en" ] } ] } } } ], "searchTerms": [ "Phage4Cure-001", "2023-507203-55-00", "2022-503145-22-00" ] }, { "id": "therapyRoutes/eu-frankfurt", "name": "Universitätsmedizin Frankfurt phage therapy program", "countries": [ "DE" ], "uuid": "204feb52d7435d3d9786571d8c3d46e6", "permalink": "/items/universitatsmedizin-frankfurt-phage-therapy-program-204feb52d7435d3d9786571d8c3d46e6", "kind": "Center", "status": "Official referral/inquiry route", "activity": "current", "sources": [ "https://www.unimedizin-ffm.de/einrichtungen/kliniken/zentrum-der-inneren-medizin/medizinische-klinik-2-haematologie-onkologie-haemostaseologie-rheumatologie-infektiologiehiv/infektiologie/forschung/bacteriophages" ], "checked": "2026-10-03", "location": "Frankfurt am Main; Germany", "detail": "Current inquiries limited by funding to infections involving Pseudomonas aeruginosa or Staphylococcus aureus.", "searchTerms": [ "Current inquiries limited by funding to infections involving Pseudomonas aeruginosa or Staphylococcus aureus.", "Frankfurt am Main; Germany" ] }, { "id": "therapyRoutes/eu-rephrame-consortium", "name": "REPhRAME research consortium", "countries": [ "DE", "CH", "NL", "HU", "SI", "DK", "GB", "LV" ], "uuid": "93010ddd7ac05ca980e0202ae475815a", "permalink": "/items/rephrame-research-consortium-93010ddd7ac05ca980e0202ae475815a", "kind": "Network", "status": "Research/development", "activity": "research", "sources": [ "https://www.rephrame-project.eu/" ], "checked": "2026-10-04", "location": "Coordinated in Frankfurt, Germany; European research consortium", "detail": "Research project on phage therapy and microbiome restoration for recurrent urinary tract infections. The project describes a Phase Ib/IIa randomized study.", "searchTerms": [ "Research project on phage therapy and microbiome restoration for recurrent urinary tract infections. The project describes a Phase Ib/IIa randomized study.", "Coordinated in Frankfurt, Germany; European research consortium" ] }, { "id": "therapyRoutes/in-aiims-new-delhi", "name": "All India Institute of Medical Sciences, New Delhi", "countries": [ "IN" ], "uuid": "a4354bba330b59268a287d5966350ada", "permalink": "/items/all-india-institute-of-medical-sciences-new-delhi-a4354bba330b59268a287d5966350ada", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://pmc.ncbi.nlm.nih.gov/articles/PMC10466484/" ], "checked": "2026-10-03", "location": "New Delhi; India", "detail": "In-vitro phage therapeutic/disinfectant research against MDR A. baumannii; clinical isolates are not human phage administration.", "searchTerms": [ "In-vitro phage therapeutic/disinfectant research against MDR A. baumannii; clinical isolates are not human phage administration.", "New Delhi; India" ] }, { "id": "trial-site/8362bd5f4cdb3790", "name": "Aman Hospital & Research Centre — Vadodara", "countries": [ "IN" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05948592" ], "checked": "2026-10-03", "trialIds": [ "nct05948592" ], "location": "Vadodara", "detail": "Recorded study locations: Diabetic Foot Infection. Not an offer of treatment.", "searchTerms": [ "Aman Hospital & Research Centre", "Vadodara", "", "Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection", "Diabetic Foot Infection", "NCT05948592", "2023-507716-13-00" ], "studyYears": [ { "trialId": "nct05948592", "start": { "date": "2023-11-08", "kind": "actual" }, "end": { "date": "2025-12-19", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "label": "2023–2025", "dateEvidence": { "start": { "value": { "date": "2023-11-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2023-11-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2023-11-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] } ] }, "end": { "value": { "date": "2025-12-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2025-12-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2023-507716-13-00?lang=en" ] } ] } } } ] }, { "id": "trial-site/56c6a858d5e32d84", "name": "Crescent Hospital & Heart Centre — Nagpur", "countries": [ "IN" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05948592" ], "checked": "2026-10-03", "trialIds": [ "nct05948592" ], "location": "Nagpur", "detail": "Recorded study locations: Diabetic Foot Infection. Not an offer of treatment.", "searchTerms": [ "Crescent Hospital & Heart Centre", "Nagpur", "", "Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection", "Diabetic Foot Infection", "NCT05948592", "2023-507716-13-00" ], "studyYears": [ { "trialId": "nct05948592", "start": { "date": "2023-11-08", "kind": "actual" }, "end": { "date": "2025-12-19", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "label": "2023–2025", "dateEvidence": { "start": { "value": { "date": "2023-11-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2023-11-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2023-11-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] } ] }, "end": { "value": { "date": "2025-12-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2025-12-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2023-507716-13-00?lang=en" ] } ] } } } ] }, { "id": "therapyRoutes/in-gangagen", "name": "GangaGen Biotechnologies", "countries": [ "IN" ], "uuid": "10824b7ff1e75ad78427d49ed0bc21aa", "permalink": "/items/gangagen-biotechnologies-10824b7ff1e75ad78427d49ed0bc21aa", "kind": "Company", "status": "Research/development", "activity": "research", "sources": [ "https://gangagen.com/about.html", "https://gangagen.com/Bacteriophages.html", "https://gangagen.com/locations.html" ], "checked": "2026-10-03", "location": "Bengaluru; India", "detail": "Human phage-derived protein/lysin antibacterials including P128; company states whole-bacteriophage applications shifted to nonhuman food, veterinary, environmental and agriculture markets in 2007.", "searchTerms": [ "Human phage-derived protein/lysin antibacterials including P128; company states whole-bacteriophage applications shifted to nonhuman food, veterinary, environmental and agriculture markets in 2007.", "Bengaluru; India" ] }, { "id": "trial-site/dcb9b3a248353766", "name": "GSVM Medical College — Kanpur", "countries": [ "IN" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05948592" ], "checked": "2026-10-03", "trialIds": [ "nct05948592" ], "location": "Kanpur", "detail": "Recorded study locations: Diabetic Foot Infection. Not an offer of treatment.", "searchTerms": [ "GSVM Medical College", "Kanpur", "", "Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection", "Diabetic Foot Infection", "NCT05948592", "2023-507716-13-00" ], "studyYears": [ { "trialId": "nct05948592", "start": { "date": "2023-11-08", "kind": "actual" }, "end": { "date": "2025-12-19", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "label": "2023–2025", "dateEvidence": { "start": { "value": { "date": "2023-11-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2023-11-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2023-11-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] } ] }, "end": { "value": { "date": "2025-12-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2025-12-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2023-507716-13-00?lang=en" ] } ] } } } ] }, { "id": "therapyRoutes/in-bhu-ims", "name": "Institute of Medical Sciences, Banaras Hindu University / Sir Sunderlal Hospital", "countries": [ "IN" ], "uuid": "5a047c60cf895371b490ed6a16b2156e", "permalink": "/items/institute-of-medical-sciences-banaras-hindu-university-sir-sunderlal-hospital-5a047c60cf895371b490ed6a16b2156e", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://pubmed.ncbi.nlm.nih.gov/42146989/", "https://www.bhu.ac.in/Images/files/Minimalist%20Fashion%20Style%20Brochure%20%283%29.pdf" ], "checked": "2026-10-03", "location": "Varanasi; India", "detail": "Customized topical phages for infected pressure ulcers in an ICU cohort; wider wound-infection clinical research leads remain separate from access.", "searchTerms": [ "Customized topical phages for infected pressure ulcers in an ICU cohort; wider wound-infection clinical research leads remain separate from access.", "Varanasi; India" ] }, { "id": "trial-site/36aa26443d1da429", "name": "Jupiter Hospital & Research Center — Vadodara", "countries": [ "IN" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05948592" ], "checked": "2026-10-03", "trialIds": [ "nct05948592" ], "location": "Vadodara", "detail": "Recorded study locations: Diabetic Foot Infection. Not an offer of treatment.", "searchTerms": [ "Jupiter Hospital & Research Center", "Vadodara", "", "Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection", "Diabetic Foot Infection", "NCT05948592", "2023-507716-13-00" ], "studyYears": [ { "trialId": "nct05948592", "start": { "date": "2023-11-08", "kind": "actual" }, "end": { "date": "2025-12-19", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "label": "2023–2025", "dateEvidence": { "start": { "value": { "date": "2023-11-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2023-11-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2023-11-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] } ] }, "end": { "value": { "date": "2025-12-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2025-12-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2023-507716-13-00?lang=en" ] } ] } } } ] }, { "id": "trial-site/c198307bae1aac07", "name": "MV Hospital for Diabetes Pvt. Ltd — Chennai", "countries": [ "IN" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05948592" ], "checked": "2026-10-03", "trialIds": [ "nct05948592" ], "location": "Chennai", "detail": "Recorded study locations: Diabetic Foot Infection. Not an offer of treatment.", "searchTerms": [ "MV Hospital for Diabetes Pvt. Ltd", "Chennai", "", "Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection", "Diabetic Foot Infection", "NCT05948592", "2023-507716-13-00" ], "studyYears": [ { "trialId": "nct05948592", "start": { "date": "2023-11-08", "kind": "actual" }, "end": { "date": "2025-12-19", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "label": "2023–2025", "dateEvidence": { "start": { "value": { "date": "2023-11-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2023-11-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2023-11-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] } ] }, "end": { "value": { "date": "2025-12-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2025-12-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2023-507716-13-00?lang=en" ] } ] } } } ] }, { "id": "trial-site/83367dff7c5501c5", "name": "Parikh Multispeciality Healthcare Pvt. Ltd — Vadodara", "countries": [ "IN" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05948592" ], "checked": "2026-10-03", "trialIds": [ "nct05948592" ], "location": "Vadodara", "detail": "Recorded study locations: Diabetic Foot Infection. Not an offer of treatment.", "searchTerms": [ "Parikh Multispeciality Healthcare Pvt. Ltd", "Vadodara", "", "Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection", "Diabetic Foot Infection", "NCT05948592", "2023-507716-13-00" ], "studyYears": [ { "trialId": "nct05948592", "start": { "date": "2023-11-08", "kind": "actual" }, "end": { "date": "2025-12-19", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "label": "2023–2025", "dateEvidence": { "start": { "value": { "date": "2023-11-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2023-11-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2023-11-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] } ] }, "end": { "value": { "date": "2025-12-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2025-12-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2023-507716-13-00?lang=en" ] } ] } } } ] }, { "id": "therapyRoutes/in-pgimer", "name": "Postgraduate Institute of Medical Education and Research", "countries": [ "IN" ], "uuid": "4ef0ba003c135ac787cfe011e007fc6a", "permalink": "/items/postgraduate-institute-of-medical-education-and-research-4ef0ba003c135ac787cfe011e007fc6a", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://pgimer.edu.in/PGIMER_PORTAL/PGIMERPORTAL/Department/Global/JSP/empview.jsp?id=548" ], "checked": "2026-10-03", "location": "Chandigarh; India", "detail": "E. coli/Vibrio phage research and bacterial-genome characterization.", "searchTerms": [ "E. coli/Vibrio phage research and bacterial-genome characterization.", "Chandigarh; India" ] }, { "id": "trial-site/b5e5a97f3c8ab3bd", "name": "Shree Siddhi Vinayak Hospital — Nashik", "countries": [ "IN" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05948592" ], "checked": "2026-10-03", "trialIds": [ "nct05948592" ], "location": "Nashik", "detail": "Recorded study locations: Diabetic Foot Infection. Not an offer of treatment.", "searchTerms": [ "Shree Siddhi Vinayak Hospital", "Nashik", "", "Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection", "Diabetic Foot Infection", "NCT05948592", "2023-507716-13-00" ], "studyYears": [ { "trialId": "nct05948592", "start": { "date": "2023-11-08", "kind": "actual" }, "end": { "date": "2025-12-19", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "label": "2023–2025", "dateEvidence": { "start": { "value": { "date": "2023-11-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2023-11-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2023-11-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] } ] }, "end": { "value": { "date": "2025-12-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2025-12-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2023-507716-13-00?lang=en" ] } ] } } } ] }, { "id": "therapyRoutes/in-swastha", "name": "Swastha Phage Solutions Pvt Ltd", "countries": [ "IN" ], "uuid": "2d0863b541b35832b51ae6081a86960d", "permalink": "/items/swastha-phage-solutions-pvt-ltd-2d0863b541b35832b51ae6081a86960d", "kind": "Company", "status": "Research/development", "activity": "research", "sources": [ "https://swastha-phage.com/" ], "checked": "2026-10-03", "location": "India", "detail": "Phage-based microbial therapeutic discovery and development; diagnostic/research services.", "searchTerms": [ "Phage-based microbial therapeutic discovery and development; diagnostic/research services.", "India" ] }, { "id": "therapyRoutes/in-vitalis", "name": "Vitalis Phage Therapy", "countries": [ "IN" ], "uuid": "3fee975eb36f52e5965e5102e23f44a1", "permalink": "/items/vitalis-phage-therapy-3fee975eb36f52e5965e5102e23f44a1", "kind": "Facilitator", "status": "Website active; facilitator", "activity": "current", "sources": [ "https://vitalisphagetherapy.com/", "https://vitalisphagetherapy.com/our-story/" ], "checked": "2026-10-03", "location": "India", "accessMode": "facilitation", "detail": "Facilitation for antibiotic-resistant bacterial infections; provider/treatment decisions belong to treating physicians and partner institutions.", "searchTerms": [ "Facilitation for antibiotic-resistant bacterial infections; provider/treatment decisions belong to treating physicians and partner institutions.", "India" ] }, { "id": "trial-site/af3a4b3aff259514", "name": "Yalamanchi Hospitals & Research Centers Pvt. Ltd — Vijayawada", "countries": [ "IN" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05948592" ], "checked": "2026-10-03", "trialIds": [ "nct05948592" ], "location": "Vijayawada", "detail": "Recorded study locations: Diabetic Foot Infection. Not an offer of treatment.", "searchTerms": [ "Yalamanchi Hospitals & Research Centers Pvt. Ltd", "Vijayawada", "", "Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection", "Diabetic Foot Infection", "NCT05948592", "2023-507716-13-00" ], "studyYears": [ { "trialId": "nct05948592", "start": { "date": "2023-11-08", "kind": "actual" }, "end": { "date": "2025-12-19", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "label": "2023–2025", "dateEvidence": { "start": { "value": { "date": "2023-11-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2023-11-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2023-11-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] } ] }, "end": { "value": { "date": "2025-12-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2025-12-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2023-507716-13-00?lang=en" ] } ] } } } ] }, { "uuid": "1c0cb24cbd715a459ee146337819d2a3", "permalink": "/items/bacteriophage-therapy-tp-102-in-patients-with-diabetic-foot-infection-1c0cb24cbd715a459ee146337819d2a3", "id": "trials/nct05948592", "name": "REVERSE2 (NCT05948592)", "countries": [ "IN", "PL", "US" ], "kind": "Trial", "status": "Completed", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05948592", "https://euclinicaltrials.eu/ctis-public/view/2023-507716-13-00?lang=en" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05948592", "start": { "date": "2023-11-08", "kind": "actual" }, "end": { "date": "2025-12-19", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "label": "2023–2025", "dateEvidence": { "start": { "value": { "date": "2023-11-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2023-11-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2023-11-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] } ] }, "end": { "value": { "date": "2025-12-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2025-12-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2023-507716-13-00?lang=en" ] } ] } } } ], "detail": "Diabetic Foot Infection", "searchTerms": [ "Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection", "Diabetic Foot Infection", "NCT05948592", "2023-507716-13-00", "Clemente Clinical Research", "Los Angeles", "California", "United States", "Tranquil Clinical Research", "Webster", "Texas", "United States", "MV Hospital for Diabetes Pvt. Ltd", "Chennai", "", "India", "GSVM Medical College", "Kanpur", "", "India", "Crescent Hospital & Heart Centre", "Nagpur", "", "India", "Shree Siddhi Vinayak Hospital", "Nashik", "", "India", "Jupiter Hospital & Research Center", "Vadodara", "", "India", "Parikh Multispeciality Healthcare Pvt. Ltd", "Vadodara", "", "India", "Aman Hospital & Research Centre", "Vadodara", "", "India", "Yalamanchi Hospitals & Research Centers Pvt. Ltd", "Vijayawada", "", "India" ] }, { "id": "therapyRoutes/ir-mazandaran", "name": "Mazandaran University of Medical Sciences hospital research teams", "countries": [ "IR" ], "uuid": "d22047e83e085a0a8100a3f99e4f1590", "permalink": "/items/mazandaran-university-of-medical-sciences-hospital-research-teams-d22047e83e085a0a8100a3f99e4f1590", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://pubmed.ncbi.nlm.nih.gov/37123173/", "https://pmc.ncbi.nlm.nih.gov/articles/PMC12467631/" ], "checked": "2026-10-03", "location": "Iran", "detail": "Adult COVID-19-associated secondary pneumonia and pediatric ventilator-associated pneumonia prevention studies; Razi hospital affiliation appears in adult study.", "searchTerms": [ "Adult COVID-19-associated secondary pneumonia and pediatric ventilator-associated pneumonia prevention studies; Razi hospital affiliation appears in adult study.", "Iran" ] }, { "id": "trial-site/c7c415da698e2347", "name": "Nooshin Dalili — Tehran", "countries": [ "IR" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05967130" ], "checked": "2026-10-03", "trialIds": [ "nct05967130" ], "location": "Tehran", "detail": "Recorded study locations: Urinary Tract Infections; Transplant-Related Disorder. Not an offer of treatment.", "searchTerms": [ "Nooshin Dalili", "Tehran", "", "Treatment Chronic UTI Post Kidney Transplant", "Urinary Tract Infections", "Transplant-Related Disorder", "NCT05967130" ], "studyYears": [ { "trialId": "nct05967130", "start": { "date": "2023-07-01", "kind": "actual" }, "end": { "date": "2024-07-01", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05967130" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-07-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05967130" ], "candidates": [ { "date": "2023-07-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05967130" ] }, { "date": "2023-07-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05967130" ] } ] }, "end": { "value": { "date": "2024-07-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05967130" ], "candidates": [ { "date": "2024-07-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05967130" ] }, { "date": "2024-07-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05967130" ] } ] } } } ] }, { "uuid": "ade14532d75d5889825bf2f084b43bb6", "permalink": "/items/treatment-chronic-uti-post-kidney-transplant-ade14532d75d5889825bf2f084b43bb6", "id": "trials/nct05967130", "name": "Treatment Chronic UTI Post Kidney Transplant (NCT05967130)", "countries": [ "IR" ], "kind": "Trial", "status": "Terminated", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05967130" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05967130", "start": { "date": "2023-07-01", "kind": "actual" }, "end": { "date": "2024-07-01", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05967130" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-07-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05967130" ], "candidates": [ { "date": "2023-07-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05967130" ] }, { "date": "2023-07-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05967130" ] } ] }, "end": { "value": { "date": "2024-07-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05967130" ], "candidates": [ { "date": "2024-07-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05967130" ] }, { "date": "2024-07-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05967130" ] } ] } } } ], "detail": "Urinary Tract Infections; Transplant-Related Disorder", "searchTerms": [ "Treatment Chronic UTI Post Kidney Transplant", "Urinary Tract Infections", "Transplant-Related Disorder", "NCT05967130", "Nooshin Dalili", "Tehran", "", "Iran" ] }, { "id": "trial-site/78c0518169d1de31", "name": "Carmel Medical Center — Haifa", "countries": [ "IL" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct05010577" ], "location": "Haifa", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Carmel Medical Center", "Haifa", "", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "id": "trial-site/d5e7a9f6f263816c", "name": "Hadassah Medical Center, Ein Kerem — Jerusalem", "countries": [ "IL" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04803708" ], "checked": "2026-10-03", "trialIds": [ "nct04803708" ], "location": "Jerusalem", "detail": "Recorded study locations: Diabetic Foot Ulcer; Pseudomonas Aeruginosa Infection; Staphylococcus Aureus Infection; Acinetobacter Infection. Not an offer of treatment.", "searchTerms": [ "Hadassah Medical Center, Ein Kerem", "Jerusalem", "", "Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers", "Diabetic Foot Ulcer", "Pseudomonas Aeruginosa Infection", "Staphylococcus Aureus Infection", "Acinetobacter Infection", "NCT04803708" ], "studyYears": [ { "trialId": "nct04803708", "start": { "date": "2021-03-22", "kind": "actual" }, "end": { "date": "2022-09-05", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ], "label": "2021–2022", "dateEvidence": { "start": { "value": { "date": "2021-03-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ], "candidates": [ { "date": "2021-03-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ] }, { "date": "2021-03-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ] } ] }, "end": { "value": { "date": "2022-09-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ], "candidates": [ { "date": "2022-09-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ] }, { "date": "2022-09-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ] } ] } } } ] }, { "id": "trial-site/54be37b15b40eea2", "name": "Hadassah University Medical Center — Jerusalem", "countries": [ "IL" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct05010577" ], "location": "Jerusalem", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Hadassah University Medical Center", "Jerusalem", "", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "id": "therapyRoutes/il-iptc", "name": "Israeli Phage Therapy Center — Hadassah Medical Center / Hebrew University", "countries": [ "IL" ], "uuid": "659b5d430058548ca1edff9f5fba6be5", "permalink": "/items/israeli-phage-therapy-center-hadassah-medical-center-hebrew-university-659b5d430058548ca1edff9f5fba6be5", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://international.huji.ac.il/news/huji-and-hadassah-join-%E2%82%AC15-million-euro-phage-uti-trial?ref_tid=20596", "https://he.hadassah.org.il/lab/the-israeli-center-for-the-treatment-of-phages/", "https://he.hadassah.org.il/medicine-specialization/specialization-in-clinical-microbiology-and-infectious-diseases/", "https://pmc.ncbi.nlm.nih.gov/articles/PMC10205549/" ], "checked": "2026-10-03", "location": "Jerusalem; Israel", "detail": "Personalized therapy for refractory/resistant infections; July 2026 Hebrew University announcement identifies current center leaders and planned P PEAKS UTI participation for recurrent E. coli infection.", "searchTerms": [ "Personalized therapy for refractory/resistant infections; July 2026 Hebrew University announcement identifies current center leaders and planned P PEAKS UTI participation for recurrent E. coli infection.", "Jerusalem; Israel" ] }, { "id": "trial-site/7e11fe9fde2fb651", "name": "Rambam Health Care Campus (RHCC) - Ruth Rappaport Children's Hospital — Haifa", "countries": [ "IL" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct05010577" ], "location": "Haifa", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Rambam Health Care Campus (RHCC) - Ruth Rappaport Children's Hospital", "Haifa", "", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "uuid": "d0f6c4cb92b35ba785498b69649c8e8c", "permalink": "/items/bacteriophage-therapy-tp-102-in-diabetic-foot-ulcers-d0f6c4cb92b35ba785498b69649c8e8c", "id": "trials/nct04803708", "name": "REVERSE (NCT04803708)", "countries": [ "IL" ], "kind": "Trial", "status": "Completed", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04803708" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct04803708", "start": { "date": "2021-03-22", "kind": "actual" }, "end": { "date": "2022-09-05", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ], "label": "2021–2022", "dateEvidence": { "start": { "value": { "date": "2021-03-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ], "candidates": [ { "date": "2021-03-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ] }, { "date": "2021-03-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ] } ] }, "end": { "value": { "date": "2022-09-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ], "candidates": [ { "date": "2022-09-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ] }, { "date": "2022-09-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ] } ] } } } ], "detail": "Diabetic Foot Ulcer; Pseudomonas Aeruginosa Infection; Staphylococcus Aureus Infection; Acinetobacter Infection", "searchTerms": [ "Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers", "Diabetic Foot Ulcer", "Pseudomonas Aeruginosa Infection", "Staphylococcus Aureus Infection", "Acinetobacter Infection", "NCT04803708", "Hadassah Medical Center, Ein Kerem", "Jerusalem", "", "Israel", "Tel Aviv Sourasky Medical Center", "Tel Aviv", "", "Israel" ] }, { "id": "trial-site/3925c70605a1a43c", "name": "Schneider Children's Medical Center of Israel — Petach Tikvah", "countries": [ "IL" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct05010577" ], "location": "Petach Tikvah", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Schneider Children's Medical Center of Israel", "Petach Tikvah", "", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "id": "trial-site/cf8daffdb0b2c84a", "name": "Tel Aviv Sourasky Medical Center — Tel Aviv", "countries": [ "IL" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04803708" ], "checked": "2026-10-03", "trialIds": [ "nct04803708" ], "location": "Tel Aviv", "detail": "Recorded study locations: Diabetic Foot Ulcer; Pseudomonas Aeruginosa Infection; Staphylococcus Aureus Infection; Acinetobacter Infection. Not an offer of treatment.", "searchTerms": [ "Tel Aviv Sourasky Medical Center", "Tel Aviv", "", "Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers", "Diabetic Foot Ulcer", "Pseudomonas Aeruginosa Infection", "Staphylococcus Aureus Infection", "Acinetobacter Infection", "NCT04803708" ], "studyYears": [ { "trialId": "nct04803708", "start": { "date": "2021-03-22", "kind": "actual" }, "end": { "date": "2022-09-05", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ], "label": "2021–2022", "dateEvidence": { "start": { "value": { "date": "2021-03-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ], "candidates": [ { "date": "2021-03-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ] }, { "date": "2021-03-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ] } ] }, "end": { "value": { "date": "2022-09-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ], "candidates": [ { "date": "2022-09-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ] }, { "date": "2022-09-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04803708" ] } ] } } } ] }, { "id": "trial-site/6ceae0775ee7db5f", "name": "The Chaim Sheba Medical Center — Ramat Gan", "countries": [ "IL" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct05010577" ], "location": "Ramat Gan", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "The Chaim Sheba Medical Center", "Ramat Gan", "", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "id": "therapyRoutes/biomx-apt-phagebank", "name": "BiomX / former Adaptive Phage Therapeutics (PhageBank)", "countries": [ "IL", "US" ], "uuid": "3cd4540af7035a76b49f7231d24cdeb6", "permalink": "/items/biomx-former-adaptive-phage-therapeutics-phagebank-3cd4540af7035a76b49f7231d24cdeb6", "kind": "Company", "status": "Historical/inactive", "activity": "historical", "sources": [ "https://www.sec.gov/Archives/edgar/data/1739174/000121390026078003/ea0298043-424b3_biomx.htm", "https://clinicaltrials.gov/study/NCT06998043", "https://clinicaltrials.gov/study/NCT05269134", "https://clinicaltrials.gov/study/NCT04787250" ], "checked": "2026-10-03", "trialIds": [ "nct04787250", "nct05269134", "nct06998043" ], "location": "Former APT operations: Gaithersburg, Maryland; United States / Israel", "detail": "BiomX's July 2026 SEC prospectus reports legacy phage operations substantially discontinued and a defense/security strategy pivot. BX004 phase 2b was discontinued December 8, 2025; former Israeli operating company entered insolvency, and APT facility lease ended December 31, 2025.", "searchTerms": [ "BiomX's July 2026 SEC prospectus reports legacy phage operations substantially discontinued and a defense/security strategy pivot. BX004 phase 2b was discontinued December 8, 2025; former Israeli operating company entered insolvency, and APT facility lease ended December 31, 2025.", "Former APT operations: Gaithersburg, Maryland; United States / Israel" ] }, { "id": "therapyRoutes/jp-jichi", "name": "Jichi Medical University, Bacteriology", "countries": [ "JP" ], "uuid": "8c0d1e4078ef51c7b484f9eb2f25b78b", "permalink": "/items/jichi-medical-university-bacteriology-8c0d1e4078ef51c7b484f9eb2f25b78b", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://www.jichi.ac.jp/bacteriology/en/research.html", "https://www.jichi.ac.jp/bacteriology/en/recruit_postdoc.html" ], "checked": "2026-10-03", "location": "Shimotsuke; Japan", "detail": "AMR-oriented phage drug discovery, bacterial surveillance and engineered phage/capsid approaches.", "searchTerms": [ "AMR-oriented phage drug discovery, bacterial surveillance and engineered phage/capsid approaches.", "Shimotsuke; Japan" ] }, { "id": "therapyRoutes/jp-osaka-metropolitan", "name": "Osaka Metropolitan University Hospital — acne phage trial", "countries": [ "JP" ], "uuid": "58f9688e8742560592eb0a9a7156e2f2", "permalink": "/items/osaka-metropolitan-university-hospital-acne-phage-trial-58f9688e8742560592eb0a9a7156e2f2", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://rctportal.mhlw.go.jp/en/detail?trial_id=jRCTs051230164" ], "checked": "2026-10-03", "trialIds": [ "jrcts051230164" ], "location": "Osaka; Japan", "detail": "Topical whole-bacteriophage gel for acne vulgaris twice daily for84days; target15, ages>=12. Native registry displays registration12/01/2024 and first enrollment03/07/2024 without resolving date-format ambiguity.", "searchTerms": [ "Topical whole-bacteriophage gel for acne vulgaris twice daily for84days; target15, ages>=12. Native registry displays registration12/01/2024 and first enrollment03/07/2024 without resolving date-format ambiguity.", "Osaka; Japan" ] }, { "uuid": "ff2d0e6cd4d85cc0ad38f18011d80f45", "permalink": "/items/topical-phage-gel-for-acne-vulgaris-ff2d0e6cd4d85cc0ad38f18011d80f45", "id": "trials/jrcts051230164", "name": "Topical phage gel for acne vulgaris (jRCTs051230164)", "countries": [ "JP" ], "kind": "Trial", "status": "Not recruiting", "activity": "historical", "sources": [ "https://rctportal.mhlw.go.jp/en/detail?trial_id=jRCTs051230164" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "jrcts051230164", "sourceUrls": [], "label": "Not listed", "dateEvidence": { "start": { "conflict": false, "sourceUrls": [], "candidates": [] } } } ], "searchTerms": [ "Topical phage gel for acne vulgaris", "jRCTs051230164" ] }, { "id": "therapyRoutes/jp-osaka-fujimoto", "name": "University of Osaka, RIMD Fujimoto Laboratory", "countries": [ "JP" ], "uuid": "54cc60059f1d56f8a900d3a2dcb13b7c", "permalink": "/items/university-of-osaka-rimd-fujimoto-laboratory-54cc60059f1d56f8a900d3a2dcb13b7c", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://www.biken.osaka-u.ac.jp/en/laboratories/detail/73", "https://rctportal.mhlw.go.jp/en/detail?trial_id=jRCTs051230164" ], "checked": "2026-10-03", "trialIds": [ "jrcts051230164" ], "location": "Suita; Japan", "detail": "Microbiome/pathobiont targeting, phage-derived lytic enzymes, clinical translation. jRCTs051230164 is hosted clinically at Osaka Metropolitan University Hospital.", "searchTerms": [ "Microbiome/pathobiont targeting, phage-derived lytic enzymes, clinical translation. jRCTs051230164 is hosted clinically at Osaka Metropolitan University Hospital.", "Suita; Japan" ] }, { "id": "therapyRoutes/jp-waseda", "name": "Waseda University Phage Therapy Institute", "countries": [ "JP" ], "uuid": "8e11c1ead43e5bf885b74dfb082b87af", "permalink": "/items/waseda-university-phage-therapy-institute-8e11c1ead43e5bf885b74dfb082b87af", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://www.waseda.jp/inst/cro/en/institutes-list/phage-therapy-institute/?lng=en" ], "checked": "2026-10-03", "location": "Tokyo; Japan", "detail": "Phage cocktail research and technical/ethical preparation for clinical implementation.", "searchTerms": [ "Phage cocktail research and technical/ethical preparation for clinical implementation.", "Tokyo; Japan" ] }, { "id": "therapyRoutes/ke-kipre", "name": "Kenya Institute of Primate Research", "countries": [ "KE" ], "uuid": "3372ed2159ea54f78d5613e60014b45d", "permalink": "/items/kenya-institute-of-primate-research-3372ed2159ea54f78d5613e60014b45d", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://www.health.go.ke/prioritizing-sustainable-health-solutions-universal-health-coverage" ], "checked": "2026-10-03", "location": "Kenya", "detail": "Preclinical/public-health phage research for AMR.", "searchTerms": [ "Preclinical/public-health phage research for AMR.", "Kenya" ] }, { "id": "therapyRoutes/ke-kemri", "name": "Kenya Medical Research Institute", "countries": [ "KE" ], "uuid": "7c1d6fb2275f54ac9c0885953bf87f24", "permalink": "/items/kenya-medical-research-institute-7c1d6fb2275f54ac9c0885953bf87f24", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://www.kemri.go.ke/bacteriophages-phages-to-complement-efforts-to-tackle-antimicrobial-resistance/", "https://www.kemri.go.ke/wp-content/uploads/2025/01/KEMRI-RESEARCHER-ISSUE-7-for-web-.pdf" ], "checked": "2026-10-03", "location": "Nairobi; Kenya", "detail": "Phage research intended to complement AMR control and future therapeutics.", "searchTerms": [ "Phage research intended to complement AMR control and future therapeutics.", "Nairobi; Kenya" ] }, { "uuid": "645704a771425cba921de8279f35bfc7", "permalink": "/items/a-randomized-controlled-trial-rct-of-yiqi-huoxue-jiedu-formula-combined-with-bacteriophage-645704a771425cba921de8279f35bfc7", "id": "trials/nct07338123", "name": "A Randomized Controlled Trial (RCT) of Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia Caused by Drug-resistant Gram-negative Bacilli (NCT07338123)", "countries": [], "kind": "Trial", "status": "Not yet recruiting", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07338123" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct07338123", "start": { "date": "2026-02-01", "kind": "estimated" }, "end": { "date": "2029-08-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07338123" ], "label": "2026 (estimated)–2029 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-02-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07338123" ], "candidates": [ { "date": "2026-02-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07338123" ] }, { "date": "2026-02-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07338123" ] } ] }, "end": { "value": { "date": "2029-08-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07338123" ], "candidates": [ { "date": "2029-08-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07338123" ] }, { "date": "2029-08-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07338123" ] } ] } } } ], "detail": "Pneumonia", "searchTerms": [ "A Randomized Controlled Trial (RCT) of Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia Caused by Drug-resistant Gram-negative Bacilli", "Pneumonia", "NCT07338123" ] }, { "uuid": "b2b5ad9bae66515099798b254ded6758", "permalink": "/items/a-study-of-topical-bx005-a-in-subjects-with-moderate-to-severe-atopic-dermatitis-b2b5ad9bae66515099798b254ded6758", "id": "trials/nct05240300", "name": "A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis (NCT05240300)", "countries": [], "kind": "Trial", "status": "Withdrawn", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05240300" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05240300", "start": { "date": "2022-05", "kind": "estimated" }, "end": { "date": "2023-06", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05240300" ], "label": "2022 (estimated)–2023 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-05", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05240300" ], "candidates": [ { "date": "2022-05", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05240300" ] }, { "date": "2022-05", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05240300" ] } ] }, "end": { "value": { "date": "2023-06", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05240300" ], "candidates": [ { "date": "2023-06", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05240300" ] }, { "date": "2023-06", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05240300" ] } ] } } } ], "detail": "Atopic Dermatitis", "searchTerms": [ "A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis", "Atopic Dermatitis", "NCT05240300" ] }, { "uuid": "009ed71b2d6c54958adf496aea0e9662", "permalink": "/items/bacteriophage-therapy-in-first-time-chronic-prosthetic-joint-infections-009ed71b2d6c54958adf496aea0e9662", "id": "trials/nct05269121", "name": "ACTIVE1 (NCT05269121)", "countries": [], "kind": "Trial", "status": "Withdrawn", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05269121" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05269121", "start": { "date": "2022-09", "kind": "estimated" }, "end": { "date": "2024-11", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269121" ], "label": "2022 (estimated)–2024 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269121" ], "candidates": [ { "date": "2022-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269121" ] }, { "date": "2022-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269121" ] } ] }, "end": { "value": { "date": "2024-11", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269121" ], "candidates": [ { "date": "2024-11", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269121" ] }, { "date": "2024-11", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269121" ] } ] } } } ], "detail": "Prosthetic Joint Infection; Bacterial Infections", "searchTerms": [ "Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections", "Prosthetic Joint Infection", "Bacterial Infections", "NCT05269121" ] }, { "uuid": "19aba276435c58b49abea6c135b44fd1", "permalink": "/items/bacteriophage-cocktail-therapy-for-multidrug-resistant-gram-negative-ventilator-associated-19aba276435c58b49abea6c135b44fd1", "id": "trials/nct07202234", "name": "Bacteriophage Cocktail Therapy for Multidrug-Resistant Gram-Negative Ventilator-Associated Pneumonia (NCT07202234)", "countries": [], "kind": "Trial", "status": "Not yet recruiting", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07202234" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct07202234", "start": { "date": "2025-11-01", "kind": "estimated" }, "end": { "date": "2028-05-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07202234" ], "label": "2025 (estimated)–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-11-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07202234" ], "candidates": [ { "date": "2025-11-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07202234" ] }, { "date": "2025-11-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07202234" ] } ] }, "end": { "value": { "date": "2028-05-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07202234" ], "candidates": [ { "date": "2028-05-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07202234" ] }, { "date": "2028-05-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07202234" ] } ] } } } ], "detail": "VAP - Ventilator Associated Pneumonia", "searchTerms": [ "Bacteriophage Cocktail Therapy for Multidrug-Resistant Gram-Negative Ventilator-Associated Pneumonia", "VAP - Ventilator Associated Pneumonia", "NCT07202234" ] }, { "uuid": "ee078d18a3b35540903a50bbb1e62d80", "permalink": "/items/bacteriophage-for-chronic-multidrug-resistant-mycobacterium-abscessus-subsp-abscessus-pulm-ee078d18a3b35540903a50bbb1e62d80", "id": "trials/nct07429162", "name": "Bacteriophage for Chronic Multidrug-Resistant Mycobacterium Abscessus Subsp. Abscessus Pulmonary Infection (NCT07429162)", "countries": [], "kind": "Individual-case protocol", "status": "Not yet recruiting", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07429162" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct07429162", "start": { "date": "2026-07-02", "kind": "estimated" }, "end": { "date": "2028-07-02", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07429162" ], "label": "2026 (estimated)–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-07-02", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07429162" ], "candidates": [ { "date": "2026-07-02", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07429162" ] }, { "date": "2026-07-02", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07429162" ] } ] }, "end": { "value": { "date": "2028-07-02", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07429162" ], "candidates": [ { "date": "2028-07-02", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07429162" ] }, { "date": "2028-07-02", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07429162" ] } ] } } } ], "detail": "Mycobacterium Abscessus Infection; Bacteriophage Therapy; Pulmonary Disease", "searchTerms": [ "Bacteriophage for Chronic Multidrug-Resistant Mycobacterium Abscessus Subsp. Abscessus Pulmonary Infection", "Mycobacterium Abscessus Infection", "Bacteriophage Therapy", "Pulmonary Disease", "NCT07429162" ] }, { "uuid": "1ab42c27eb0a55c7b0ca33f3273eb3a7", "permalink": "/items/bacteriophage-therapy-of-difficult-to-treat-infections-1ab42c27eb0a55c7b0ca33f3273eb3a7", "id": "trials/nct05498363", "name": "BT100 (NCT05498363)", "countries": [], "kind": "Observational study", "status": "Completed", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05498363" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05498363", "start": { "date": "2008-01-01", "kind": "actual" }, "end": { "date": "2021-12-31", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05498363" ], "label": "2008–2021", "dateEvidence": { "start": { "value": { "date": "2008-01-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05498363" ], "candidates": [ { "date": "2008-01-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05498363" ] }, { "date": "2008-01-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05498363" ] } ] }, "end": { "value": { "date": "2021-12-31", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05498363" ], "candidates": [ { "date": "2021-12-31", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05498363" ] }, { "date": "2021-12-31", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05498363" ] } ] } } } ], "detail": "Bacterial Infections", "searchTerms": [ "Bacteriophage Therapy of Difficult-to-treat Infections", "Bacterial Infections", "NCT05498363" ] }, { "uuid": "9b8b901b4ca052098383316ceb6c8d96", "permalink": "/items/effect-of-preforpro-on-urinary-and-vaginal-health-9b8b901b4ca052098383316ceb6c8d96", "id": "trials/nct05590195", "name": "Effect of PreforPro® on Urinary and Vaginal Health (NCT05590195)", "countries": [], "kind": "Adjacent product trial", "status": "Status unconfirmed", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT05590195" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05590195", "start": { "date": "2024-05-01", "kind": "estimated" }, "end": { "date": "2025-06-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05590195" ], "label": "2024 (estimated)–2025 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-05-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05590195" ], "candidates": [ { "date": "2024-05-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05590195" ] }, { "date": "2024-05-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05590195" ] } ] }, "end": { "value": { "date": "2025-06-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05590195" ], "candidates": [ { "date": "2025-06-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05590195" ] }, { "date": "2025-06-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05590195" ] } ] } } } ], "detail": "Bacterial Vaginosis; Bacterial Infections; Bacterial Vaginosis | Vaginal | Microbiology; Vaginal Infection", "searchTerms": [ "Effect of PreforPro® on Urinary and Vaginal Health", "Bacterial Vaginosis", "Bacterial Infections", "Bacterial Vaginosis | Vaginal | Microbiology", "Vaginal Infection", "NCT05590195" ] }, { "uuid": "a202d453c27d5cd295bee0489b879c81", "permalink": "/items/individual-patient-expanded-access-for-ab-pa01-an-investigational-anti-pseudomonas-aerugin-a202d453c27d5cd295bee0489b879c81", "id": "trials/nct03395743", "name": "Individual Patient Expanded Access for AB-PA01, an Investigational Anti-Pseudomonas Aeruginosa Bacteriophage Therapeutic (NCT03395743)", "countries": [], "kind": "Expanded access", "status": "Unavailable", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT03395743" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct03395743", "sourceUrls": [], "label": "Not listed", "dateEvidence": { "start": { "conflict": false, "sourceUrls": [], "candidates": [] } } } ], "detail": "", "searchTerms": [ "Individual Patient Expanded Access for AB-PA01, an Investigational Anti-Pseudomonas Aeruginosa Bacteriophage Therapeutic", "NCT03395743" ] }, { "uuid": "c3eba79c4d5e5be8a0f5cd97d16b2ba7", "permalink": "/items/individual-patient-expanded-access-for-ab-sa01-an-investigational-anti-staphylococcus-aure-c3eba79c4d5e5be8a0f5cd97d16b2ba7", "id": "trials/nct03395769", "name": "Individual Patient Expanded Access for AB-SA01, an Investigational Anti-Staphylococcus Aureus Bacteriophage Therapeutic (NCT03395769)", "countries": [], "kind": "Expanded access", "status": "Unavailable", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT03395769" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct03395769", "sourceUrls": [], "label": "Not listed", "dateEvidence": { "start": { "conflict": false, "sourceUrls": [], "candidates": [] } } } ], "detail": "", "searchTerms": [ "Individual Patient Expanded Access for AB-SA01, an Investigational Anti-Staphylococcus Aureus Bacteriophage Therapeutic", "NCT03395769" ] }, { "uuid": "ba78ae71afec5e2eb4e40dc70d29486f", "permalink": "/items/personalized-phage-treatment-in-covid-19-patients-with-bacterial-co-infections-microbials-ba78ae71afec5e2eb4e40dc70d29486f", "id": "trials/nct04636554", "name": "Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia (NCT04636554)", "countries": [], "kind": "Expanded access", "status": "Unavailable", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04636554" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct04636554", "sourceUrls": [], "label": "Not listed", "dateEvidence": { "start": { "conflict": false, "sourceUrls": [], "candidates": [] } } } ], "detail": "Covid19; Bacteremia; Septicemia; Acinetobacter Baumannii Infection; Pseudomonas Aeruginosa Infection; Staph Aureus Infection", "searchTerms": [ "Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia", "Covid19", "Bacteremia", "Septicemia", "Acinetobacter Baumannii Infection", "Pseudomonas Aeruginosa Infection", "Staph Aureus Infection", "NCT04636554" ] }, { "uuid": "f7ffd77d2993548ebddae9f9f4cf7c86", "permalink": "/items/phage-study-bacteriophages-as-novel-prebiotics-f7ffd77d2993548ebddae9f9f4cf7c86", "id": "trials/nct03269617", "name": "PHAGE Study: Bacteriophages as Novel Prebiotics (NCT03269617)", "countries": [], "kind": "Adjacent product trial", "status": "Completed", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT03269617" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct03269617", "start": { "date": "2016-10-01", "kind": "actual" }, "end": { "date": "2017-05-30", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03269617" ], "label": "2016–2017", "dateEvidence": { "start": { "value": { "date": "2016-10-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03269617" ], "candidates": [ { "date": "2016-10-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03269617" ] }, { "date": "2016-10-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03269617" ] } ] }, "end": { "value": { "date": "2017-05-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03269617" ], "candidates": [ { "date": "2017-05-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03269617" ] }, { "date": "2017-05-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03269617" ] } ] } } } ], "detail": "Gastrointestinal Disorder, Functional", "searchTerms": [ "PHAGE Study: Bacteriophages as Novel Prebiotics", "Gastrointestinal Disorder, Functional", "NCT03269617" ] }, { "uuid": "a108c5826c775356a8a5ba3a42409d43", "permalink": "/items/evaluation-of-safety-and-efficacy-of-phage-therapy-for-drug-resistant-bacterial-infections-a108c5826c775356a8a5ba3a42409d43", "id": "trials/nct07382271", "name": "Phage Therapy (NCT07382271)", "countries": [], "kind": "Trial", "status": "Not yet recruiting", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07382271" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct07382271", "start": { "date": "2026-02", "kind": "estimated" }, "end": { "date": "2026-08", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07382271" ], "label": "2026 (estimated)–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-02", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07382271" ], "candidates": [ { "date": "2026-02", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07382271" ] }, { "date": "2026-02", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07382271" ] } ] }, "end": { "value": { "date": "2026-08", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07382271" ], "candidates": [ { "date": "2026-08", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07382271" ] }, { "date": "2026-08", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07382271" ] } ] } } } ], "detail": "Urinary Tract Infections; Urinary Tract Infections Caused by Drug-resistant Bacteria", "searchTerms": [ "Evaluation of Safety and Efficacy of Phage Therapy for Drug-resistant Bacterial Infections: An Exploratory, Prospective Single-arm Study", "Urinary Tract Infections", "Urinary Tract Infections Caused by Drug-resistant Bacteria", "NCT07382271" ] }, { "uuid": "4850300983cf5aa2834b3369a1f62294", "permalink": "/items/phage-therapy-for-the-prevention-and-treatment-of-pressure-ulcers-4850300983cf5aa2834b3369a1f62294", "id": "trials/nct04815798", "name": "Phage Therapy for the Prevention and Treatment of Pressure Ulcers. (NCT04815798)", "countries": [], "kind": "Trial", "status": "Status unconfirmed", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT04815798" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct04815798", "start": { "date": "2022-01", "kind": "estimated" }, "end": { "date": "2023-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04815798" ], "label": "2022 (estimated)–2023 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04815798" ], "candidates": [ { "date": "2022-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04815798" ] }, { "date": "2022-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04815798" ] } ] }, "end": { "value": { "date": "2023-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04815798" ], "candidates": [ { "date": "2023-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04815798" ] }, { "date": "2023-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04815798" ] } ] } } } ], "detail": "Pressure Ulcer", "searchTerms": [ "Phage Therapy for the Prevention and Treatment of Pressure Ulcers.", "Pressure Ulcer", "NCT04815798" ] }, { "uuid": "543b5034f745523a97419ed35bc8bc0f", "permalink": "/items/phage-therapy-for-the-prevention-and-treatment-of-wound-infections-in-burned-patients-543b5034f745523a97419ed35bc8bc0f", "id": "trials/nct04323475", "name": "Phage Therapy for the Prevention and Treatment of Wound Infections in Burned Patients (NCT04323475)", "countries": [], "kind": "Trial", "status": "Status unconfirmed", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT04323475" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct04323475", "start": { "date": "2022-01", "kind": "estimated" }, "end": { "date": "2023-08", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04323475" ], "label": "2022 (estimated)–2023 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04323475" ], "candidates": [ { "date": "2022-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04323475" ] }, { "date": "2022-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04323475" ] } ] }, "end": { "value": { "date": "2023-08", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04323475" ], "candidates": [ { "date": "2023-08", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04323475" ] }, { "date": "2023-08", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04323475" ] } ] } } } ], "detail": "Wound Infection", "searchTerms": [ "Phage Therapy for the Prevention and Treatment of Wound Infections in Burned Patients", "Wound Infection", "NCT04323475" ] }, { "uuid": "ada2875fe80d5f059ca23c16d12c0650", "permalink": "/items/safety-of-combined-intravenous-antibiotic-and-bacteriophage-therapy-in-adults-with-cystic-ada2875fe80d5f059ca23c16d12c0650", "id": "trials/nct07280598", "name": "Safety of Combined Intravenous Antibiotic and Bacteriophage Therapy in Adults With Cystic Fibrosis and Antibiotic-Resistant Lung Infections (NCT07280598)", "countries": [], "kind": "Trial", "status": "Not yet recruiting", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07280598" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct07280598", "start": { "date": "2025-12-31", "kind": "estimated" }, "end": { "date": "2027-01-30", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07280598" ], "label": "2025 (estimated)–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07280598" ], "candidates": [ { "date": "2025-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07280598" ] }, { "date": "2025-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07280598" ] } ] }, "end": { "value": { "date": "2027-01-30", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07280598" ], "candidates": [ { "date": "2027-01-30", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07280598" ] }, { "date": "2027-01-30", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07280598" ] } ] } } } ], "detail": "CF - Cystic Fibrosis; Klebsiella Pneumoniae Infection; E Coli Infections; Staphylococcus Aureus Infection; Achromobacter; Stenotrophomonas Maltophilia Infection", "searchTerms": [ "Safety of Combined Intravenous Antibiotic and Bacteriophage Therapy in Adults With Cystic Fibrosis and Antibiotic-Resistant Lung Infections", "CF - Cystic Fibrosis", "Klebsiella Pneumoniae Infection", "E Coli Infections", "Staphylococcus Aureus Infection", "Achromobacter", "Stenotrophomonas Maltophilia Infection", "NCT07280598" ] }, { "id": "trial-site/930bd966f5d60d29", "name": "Amsterdam Medical Center — Amsterdam", "countries": [ "NL" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct05010577" ], "location": "Amsterdam", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Amsterdam Medical Center", "Amsterdam", "", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "id": "therapyRoutes/nl-umc-utrecht", "name": "UMC Utrecht personalized phage therapy program", "countries": [ "NL" ], "uuid": "287809c06ace5853a2180738c850b7d7", "permalink": "/items/umc-utrecht-personalized-phage-therapy-program-287809c06ace5853a2180738c850b7d7", "kind": "Center", "status": "Case-by-case; Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://research.umcutrecht.nl/news/first-experimental-therapy-at-umc-utrecht-with-personalized-bacteriophages/", "https://research.umcutrecht.nl/news/4-million-for-study-with-personalized-phage-therapy/", "https://www.umcutrecht.nl/nl/wetenschappelijk-onderzoek/chronisch-recidiverende-urineweginfecties" ], "checked": "2026-10-04", "location": "Utrecht, Netherlands", "accessMode": "case-by-case", "detail": "Personalized phage therapy research and reported clinical use; a planned study concerns recurrent urinary tract infections.", "searchTerms": [ "Personalized phage therapy research and reported clinical use; a planned study concerns recurrent urinary tract infections.", "Utrecht, Netherlands" ] }, { "id": "trial-site/ddc4975f044917b6", "name": "University Medical Center Utrecht — Utrecht", "countries": [ "NL" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct05010577" ], "location": "Utrecht", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "University Medical Center Utrecht", "Utrecht", "", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "uuid": "ea4dc8134d4a58589bbbc7e7599107f6", "permalink": "/items/tp-122-101a-ea4dc8134d4a58589bbbc7e7599107f6", "id": "trials/eu-2025-521533-85-00", "name": "TP-122_101A (2025-521533-85-00)", "countries": [ "NL", "PT" ], "kind": "Trial", "status": "Not yet recruiting", "activity": "planned", "sources": [ "https://euclinicaltrials.eu/ctis-public/view/2025-521533-85-00?lang=en" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "eu-2025-521533-85-00", "sourceUrls": [], "label": "Not listed", "dateEvidence": { "start": { "conflict": false, "sourceUrls": [], "candidates": [] } } } ], "searchTerms": [ "TP-122_101A", "2025-521533-85-00" ] }, { "id": "therapyRoutes/nz-otago", "name": "University of Otago phage research", "countries": [ "NZ" ], "uuid": "181d96b25ed65ca89d8918b650f980d9", "permalink": "/items/university-of-otago-phage-research-181d96b25ed65ca89d8918b650f980d9", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://www.otago.ac.nz/microbiology-and-immunology/our-people/peter-fineran", "https://www.hrc.govt.nz/resources/research-repository/genomics-led-approach-bacteriophage-therapies-infectious-disease" ], "checked": "2026-10-03", "location": "Dunedin; New Zealand", "detail": "Genomics-led phage development and microbial-defense research; clinical translation research rather than documented current patient service.", "searchTerms": [ "Genomics-led phage development and microbial-defense research; clinical translation research rather than documented current patient service.", "Dunedin; New Zealand" ] }, { "uuid": "5cb579a4601a5036a48fce65555bf013", "permalink": "/items/experimental-phage-therapy-of-bacterial-infections-5cb579a4601a5036a48fce65555bf013", "id": "trials/nct00945087", "name": "Experimental Phage Therapy of Bacterial Infections (NCT00945087)", "countries": [ "PL" ], "kind": "Trial", "status": "Status unconfirmed", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT00945087" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct00945087", "start": { "date": "2005-12", "kind": "reported" }, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00945087" ], "label": "Started 2005", "dateEvidence": { "start": { "value": { "date": "2005-12", "kind": "reported" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00945087" ], "candidates": [ { "date": "2005-12", "kind": "reported", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00945087" ] }, { "date": "2005-12", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00945087" ] } ] } } } ], "detail": "Bacterial Infections", "searchTerms": [ "Experimental Phage Therapy of Bacterial Infections", "Bacterial Infections", "NCT00945087", "Phage Therapy Unit at the Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences", "Wroclaw", "", "Poland" ] }, { "id": "therapyRoutes/eu-hirszfeld-ptu", "name": "Hirszfeld Institute Phage Therapy Unit", "countries": [ "PL" ], "uuid": "d806e48f3cbb55b0a3ae0eb4d7b57bc4", "permalink": "/items/hirszfeld-institute-phage-therapy-unit-d806e48f3cbb55b0a3ae0eb4d7b57bc4", "kind": "Center", "status": "Official referral/inquiry route", "activity": "current", "sources": [ "https://hirszfeld.pl/en/structure/iitd-pan-medical-center/phage-therapy-unit/" ], "checked": "2026-10-03", "location": "Wrocław; branches in Kraków and Częstochowa; Poland", "detail": "Outpatient experimental therapeutic protocol KB349/2005 for bacterial infections, including antibiotic-resistant infections.", "searchTerms": [ "Outpatient experimental therapeutic protocol KB349/2005 for bacterial infections, including antibiotic-resistant infections.", "Wrocław; branches in Kraków and Częstochowa; Poland" ] }, { "id": "trial-site/540277e84d44cbc8", "name": "Phage Therapy Unit at the Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences — Wroclaw", "countries": [ "PL" ], "kind": "Trial site", "status": "Status unconfirmed (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT00945087" ], "checked": "2026-10-03", "trialIds": [ "nct00945087" ], "location": "Wroclaw", "detail": "Recorded study locations: Bacterial Infections. Not an offer of treatment.", "searchTerms": [ "Phage Therapy Unit at the Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences", "Wroclaw", "", "Experimental Phage Therapy of Bacterial Infections", "Bacterial Infections", "NCT00945087" ], "studyYears": [ { "trialId": "nct00945087", "start": { "date": "2005-12", "kind": "reported" }, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00945087" ], "label": "Started 2005", "dateEvidence": { "start": { "value": { "date": "2005-12", "kind": "reported" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00945087" ], "candidates": [ { "date": "2005-12", "kind": "reported", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00945087" ] }, { "date": "2005-12", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00945087" ] } ] } } } ] }, { "id": "therapyRoutes/eu-technophage", "name": "TechnoPhage", "countries": [ "PT" ], "uuid": "84d05f26d1885786a85f3da1500e1d78", "permalink": "/items/technophage-84d05f26d1885786a85f3da1500e1d78", "kind": "Company", "status": "Provider-listed inquiry route", "activity": "current", "sources": [ "https://technophage.pt/expanded-access/", "https://technophage.pt/technophage-receives-regulatory-approval-to-initiate-phase-1-2a-tp-122-clinical-study-in-europe/", "https://clinicaltrials.gov/study/NCT05948592", "https://clinicaltrials.gov/study/NCT06370598", "https://euclinicaltrials.eu/ctis-public/view/2025-521533-85-00?lang=en" ], "checked": "2026-10-03", "trialIds": [ "eu-2025-521533-85-00", "nct04803708", "nct05948592", "nct06370598" ], "location": "Lisbon; Portugal", "detail": "TP-102 investigational topical phages for infected diabetic foot/nonhealing wounds involving S. aureus, P. aeruginosa or A. baumannii; separate TP-122 respiratory development.", "searchTerms": [ "TP-102 investigational topical phages for infected diabetic foot/nonhealing wounds involving S. aureus, P. aeruginosa or A. baumannii; separate TP-122 respiratory development.", "Lisbon; Portugal" ] }, { "id": "trial-site/614552453e8628ae", "name": "Budgetary Healthcare Institution of Arkhangelsk Region \"Severodvinsk City Clinical Emergency Hospital # 2\" — Severodvinsk, Arkhangelskaya oblast", "countries": [ "RU" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04325685" ], "checked": "2026-10-03", "trialIds": [ "nct04325685" ], "location": "Severodvinsk, Arkhangelskaya oblast", "detail": "Recorded study locations: Trauma Injury; Brain Injuries; Abdominal Sepsis; Pancreatitis; Meningitis; Encephalitis; Seizures; Acute Respiratory Distress Syndrome. Not an offer of treatment.", "searchTerms": [ "Budgetary Healthcare Institution of Arkhangelsk Region \"Severodvinsk City Clinical Emergency Hospital # 2\"", "Severodvinsk", "Arkhangelskaya oblast", "The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia", "Trauma Injury", "Brain Injuries", "Abdominal Sepsis", "Pancreatitis", "Meningitis", "Encephalitis", "Seizures", "Acute Respiratory Distress Syndrome", "NCT04325685" ], "studyYears": [ { "trialId": "nct04325685", "start": { "date": "2020-01-01", "kind": "actual" }, "end": { "date": "2023-11-07", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04325685" ], "label": "2020–2023", "dateEvidence": { "start": { "value": { "date": "2020-01-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04325685" ], "candidates": [ { "date": "2020-01-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04325685" ] }, { "date": "2020-01-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04325685" ] } ] }, "end": { "value": { "date": "2023-11-07", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04325685" ], "candidates": [ { "date": "2023-11-07", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04325685" ] }, { "date": "2023-11-07", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04325685" ] } ] } } } ] }, { "id": "therapyRoutes/eu-microgen", "name": "NPO Microgen", "countries": [ "RU" ], "uuid": "c7476cab764d5ca7820f0f0e5cd53015", "permalink": "/items/npo-microgen-c7476cab764d5ca7820f0f0e5cd53015", "kind": "Supplier", "status": "Provider-listed inquiry route", "activity": "current", "sources": [ "https://microgen.ru/products/" ], "checked": "2026-10-03", "location": "Moscow; manufacturing sites including Perm; Russia", "detail": "Commercial bacteriophage preparations including Sextaphag, Intestiphag, Piophag, Staphilophag and Klebsiphag.", "searchTerms": [ "Commercial bacteriophage preparations including Sextaphag, Intestiphag, Piophag, Staphilophag and Klebsiphag.", "Moscow; manufacturing sites including Perm; Russia" ] }, { "uuid": "167fa508207e531789516701a80db34b", "permalink": "/items/bacteriophages-in-addition-to-antibiotics-for-the-treatment-of-patients-with-infective-end-167fa508207e531789516701a80db34b", "id": "trials/nct06870409", "name": "PHARAOH (NCT06870409)", "countries": [ "RU" ], "kind": "Trial", "status": "Recruiting", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06870409" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct06870409", "start": { "date": "2025-02-05", "kind": "actual" }, "end": { "date": "2029-02-05", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06870409" ], "label": "2025–2029 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06870409" ], "candidates": [ { "date": "2025-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06870409" ] }, { "date": "2025-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06870409" ] } ] }, "end": { "value": { "date": "2029-02-05", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06870409" ], "candidates": [ { "date": "2029-02-05", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06870409" ] }, { "date": "2029-02-05", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06870409" ] } ] } } } ], "detail": "Endocarditis, Bacterial", "searchTerms": [ "Bacteriophages in Addition to Antibiotics for the Treatment of Patients With Infective Endocarditis", "Endocarditis, Bacterial", "NCT06870409", "University Clinical Hospital named after V.V.Vinogradov (branch) of the Peoples' Friendship University of Russia named after Patrice Lumumba", "Moscow", "", "Russia" ] }, { "id": "therapyRoutes/eu-micromir", "name": "Research and Production Center Micromir", "countries": [ "RU" ], "uuid": "8527d66d500e5633bcee2bca31e422eb", "permalink": "/items/research-and-production-center-micromir-8527d66d500e5633bcee2bca31e422eb", "kind": "Supplier", "status": "Provider-listed inquiry route", "activity": "current", "sources": [ "https://micromircorp.ru/en" ], "checked": "2026-10-03", "location": "Moscow; Russia", "detail": "Company describes a phage bank and registered pharmaceutical substances usable in magistral formulations; separately markets hygiene/cosmetic phage gels.", "searchTerms": [ "Company describes a phage bank and registered pharmaceutical substances usable in magistral formulations; separately markets hygiene/cosmetic phage gels.", "Moscow; Russia" ] }, { "id": "therapyRoutes/eu-rudn-pharaoh", "name": "RUDN / V.V. Vinogradov Clinical Hospital PHARAOH", "countries": [ "RU" ], "uuid": "5e94f35de23a5221a0e5ccf7fe4ba6d2", "permalink": "/items/rudn-v-v-vinogradov-clinical-hospital-pharaoh-5e94f35de23a5221a0e5ccf7fe4ba6d2", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT06870409" ], "checked": "2026-10-03", "trialIds": [ "nct06870409" ], "location": "Moscow; Russia", "accessMode": "trial-inquiry", "detail": "Randomized phage-plus-antibiotic treatment study for infective endocarditis; planned enrollment 30.", "searchTerms": [ "Randomized phage-plus-antibiotic treatment study for infective endocarditis; planned enrollment 30.", "Moscow; Russia" ] }, { "uuid": "23e27e858238501da0cc7079596ceede", "permalink": "/items/the-effect-of-supraglottic-and-oropharyngeal-decontamination-on-the-incidence-of-ventilato-23e27e858238501da0cc7079596ceede", "id": "trials/nct04325685", "name": "SGDC-VAP (NCT04325685)", "countries": [ "RU" ], "kind": "Trial", "status": "Completed", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04325685" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct04325685", "start": { "date": "2020-01-01", "kind": "actual" }, "end": { "date": "2023-11-07", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04325685" ], "label": "2020–2023", "dateEvidence": { "start": { "value": { "date": "2020-01-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04325685" ], "candidates": [ { "date": "2020-01-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04325685" ] }, { "date": "2020-01-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04325685" ] } ] }, "end": { "value": { "date": "2023-11-07", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04325685" ], "candidates": [ { "date": "2023-11-07", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04325685" ] }, { "date": "2023-11-07", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04325685" ] } ] } } } ], "detail": "Trauma Injury; Brain Injuries; Abdominal Sepsis; Pancreatitis; Meningitis; Encephalitis; Seizures; Acute Respiratory Distress Syndrome", "searchTerms": [ "The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia", "Trauma Injury", "Brain Injuries", "Abdominal Sepsis", "Pancreatitis", "Meningitis", "Encephalitis", "Seizures", "Acute Respiratory Distress Syndrome", "NCT04325685", "Budgetary Healthcare Institution of Arkhangelsk Region \"Severodvinsk City Clinical Emergency Hospital # 2\"", "Severodvinsk", "Arkhangelskaya oblast", "Russia" ] }, { "id": "trial-site/e1218de9548eaaab", "name": "University Clinical Hospital named after V.V.Vinogradov (branch) of the Peoples' Friendship University of Russia named after Patrice Lumumba — Moscow", "countries": [ "RU" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06870409" ], "checked": "2026-10-03", "trialIds": [ "nct06870409" ], "location": "Moscow", "detail": "Recorded study locations: Endocarditis, Bacterial. Not an offer of treatment.", "searchTerms": [ "University Clinical Hospital named after V.V.Vinogradov (branch) of the Peoples' Friendship University of Russia named after Patrice Lumumba", "Moscow", "", "Bacteriophages in Addition to Antibiotics for the Treatment of Patients With Infective Endocarditis", "Endocarditis, Bacterial", "NCT06870409" ], "studyYears": [ { "trialId": "nct06870409", "start": { "date": "2025-02-05", "kind": "actual" }, "end": { "date": "2029-02-05", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06870409" ], "label": "2025–2029 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06870409" ], "candidates": [ { "date": "2025-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06870409" ] }, { "date": "2025-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06870409" ] } ] }, "end": { "value": { "date": "2029-02-05", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06870409" ], "candidates": [ { "date": "2029-02-05", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06870409" ] }, { "date": "2029-02-05", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06870409" ] } ] } } } ] }, { "id": "therapyRoutes/sg-sgh", "name": "Singapore General Hospital", "countries": [ "SG" ], "uuid": "af839d8ff33b5ce9acd1c37303e108ff", "permalink": "/items/singapore-general-hospital-af839d8ff33b5ce9acd1c37303e108ff", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.sgh.com.sg/news/patient-care/century-old-therapy-used-to-treat-sgh-patient-with-antibiotic-re" ], "checked": "2026-10-03", "location": "Singapore; Singapore", "detail": "Personalized IV phages plus antibiotics for difficult implant-associated P. aeruginosa infection; local phage library and manufacture.", "searchTerms": [ "Personalized IV phages plus antibiotics for difficult implant-associated P. aeruginosa infection; local phage library and manufacture.", "Singapore; Singapore" ] }, { "id": "therapyRoutes/eu-jafral", "name": "JAFRAL", "countries": [ "SI" ], "uuid": "3cdb311567fb5105bb52c0a61a905f1b", "permalink": "/items/jafral-3cdb311567fb5105bb52c0a61a905f1b", "kind": "Supplier", "status": "Research/development", "activity": "research", "sources": [ "https://www.jafral.com/company" ], "checked": "2026-10-03", "location": "Ljubljana; Slovenia", "detail": "Phage process development and manufacturing for human therapeutics, with fill/finish and other biologic services.", "searchTerms": [ "Phage process development and manufacturing for human therapeutics, with fill/finish and other biologic services.", "Ljubljana; Slovenia" ] }, { "id": "therapyRoutes/za-task", "name": "TASK / Phages4TB consortium", "countries": [ "ZA" ], "uuid": "cd38f574583e5cb39ca19a145e5c660a", "permalink": "/items/task-phages4tb-consortium-cd38f574583e5cb39ca19a145e5c660a", "kind": "Company", "status": "Research/development", "activity": "research", "sources": [ "https://cordis.europa.eu/project/id/101063247/reporting", "https://taskclinical.com/about-us/" ], "checked": "2026-10-03", "location": "Cape Town; South Africa", "detail": "Mycobacteriophage discovery, ex-vivo sputum work and clinical trial preparation for pulmonary tuberculosis; planned adjunctive antibiotics.", "searchTerms": [ "Mycobacteriophage discovery, ex-vivo sputum work and clinical trial preparation for pulmonary tuberculosis; planned adjunctive antibiotics.", "Cape Town; South Africa" ] }, { "id": "therapyRoutes/kr-microbiotix", "name": "MicrobiotiX Co Ltd", "countries": [ "KR" ], "uuid": "c5835579838a548281ad5c028fc07288", "permalink": "/items/microbiotix-co-ltd-c5835579838a548281ad5c028fc07288", "kind": "Company", "status": "Research/development", "activity": "research", "sources": [ "https://www.microbiotix.net/introduce", "https://www.microbiotix.net/media/?bmode=view&idx=173474265&q=YToxOntzOjEyOiJrZXl3b3JkX3R5cGUiO3M6MzoiYWxsIjt9&t=board", "https://clinicaltrials.gov/study/NCT07492771" ], "checked": "2026-10-03", "trialIds": [ "nct07492771" ], "location": "Seoul; South Korea", "detail": "MP101 bacteriophage treatment for P. aeruginosa pneumonia. Official August 2026 release reports completion of the sentinel cohort in first-in-human phase1 trial.", "searchTerms": [ "MP101 bacteriophage treatment for P. aeruginosa pneumonia. Official August 2026 release reports completion of the sentinel cohort in first-in-human phase1 trial.", "Seoul; South Korea" ] }, { "uuid": "912bf10d155a573593cb4805d4cf642d", "permalink": "/items/mp101-in-adults-with-acute-pseudomonas-aeruginosa-pneumonia-912bf10d155a573593cb4805d4cf642d", "id": "trials/nct07492771", "name": "MP101-1001 (NCT07492771)", "countries": [ "KR" ], "kind": "Trial", "status": "Recruiting", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT07492771" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct07492771", "start": { "date": "2026-07-25", "kind": "actual" }, "end": { "date": "2026-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07492771" ], "label": "2026–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-07-25", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07492771" ], "candidates": [ { "date": "2026-07-25", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07492771" ] }, { "date": "2026-07-25", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07492771" ] } ] }, "end": { "value": { "date": "2026-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07492771" ], "candidates": [ { "date": "2026-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07492771" ] }, { "date": "2026-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07492771" ] } ] } } } ], "detail": "Pneumonia - Bacterial; Pseudomonas Aeruginosa Infection", "searchTerms": [ "MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia", "Pneumonia - Bacterial", "Pseudomonas Aeruginosa Infection", "NCT07492771", "Severance Hospital", "Seoul", "Seodaemun-gu", "South Korea" ] }, { "id": "therapyRoutes/kr-severance-mp101", "name": "Severance Hospital — MP101 pneumonia trial", "countries": [ "KR" ], "uuid": "d38939af5bb85063ad924cda874068b1", "permalink": "/items/severance-hospital-mp101-pneumonia-trial-d38939af5bb85063ad924cda874068b1", "kind": "Center", "status": "Official referral/inquiry route", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT07492771" ], "checked": "2026-10-03", "trialIds": [ "nct07492771" ], "location": "Seoul; South Korea", "accessMode": "trial-inquiry", "detail": "Phase1 adults with acute P. aeruginosa pneumonia; isolate must be susceptible to MP101 and not susceptible to current antibiotic therapy per protocol.", "searchTerms": [ "Phase1 adults with acute P. aeruginosa pneumonia; isolate must be susceptible to MP101 and not susceptible to current antibiotic therapy per protocol.", "Seoul; South Korea" ] }, { "id": "trial-site/c6bbfc7c37426588", "name": "Severance Hospital — Seoul, Seodaemun-gu", "countries": [ "KR" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT07492771" ], "checked": "2026-10-03", "trialIds": [ "nct07492771" ], "location": "Seoul, Seodaemun-gu", "detail": "Recorded study locations: Pneumonia - Bacterial; Pseudomonas Aeruginosa Infection. Not an offer of treatment.", "searchTerms": [ "Severance Hospital", "Seoul", "Seodaemun-gu", "MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia", "Pneumonia - Bacterial", "Pseudomonas Aeruginosa Infection", "NCT07492771" ], "studyYears": [ { "trialId": "nct07492771", "start": { "date": "2026-07-25", "kind": "actual" }, "end": { "date": "2026-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07492771" ], "label": "2026–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-07-25", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07492771" ], "candidates": [ { "date": "2026-07-25", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07492771" ] }, { "date": "2026-07-25", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07492771" ] } ] }, "end": { "value": { "date": "2026-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07492771" ], "candidates": [ { "date": "2026-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07492771" ] }, { "date": "2026-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07492771" ] } ] } } } ] }, { "id": "therapyRoutes/es-evolving-therapeutics", "name": "Evolving Therapeutics", "countries": [ "ES" ], "uuid": "3c04c4ffa44a5d9782ed825869c3d169", "permalink": "/items/evolving-therapeutics-3c04c4ffa44a5d9782ed825869c3d169", "kind": "Supplier", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://i2sysbio.es/communication/1338/", "https://www.evolvingtherapeutics.es/", "https://evolvingtherapeutics.es/contact/" ], "checked": "2026-10-04", "location": "Valencia, Spain", "accessMode": "clinician-support", "detail": "Phage production collaboration with the I2SysBio laboratory; this is a supplier record, not a treatment clinic.", "searchTerms": [ "Phage production collaboration with the I2SysBio laboratory; this is a supplier record, not a treatment clinic.", "Valencia, Spain" ] }, { "id": "trial-site/4c9e41c6d961ad9e", "name": "Hospital Clinico Universitario Virgen de la Arrixaca — El Palmar, Murcia", "countries": [ "ES" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct05010577" ], "location": "El Palmar, Murcia", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Hospital Clinico Universitario Virgen de la Arrixaca", "El Palmar", "Murcia", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "id": "therapyRoutes/es-i2sysbio", "name": "I2SysBio / University of Valencia-CSIC phage group", "countries": [ "ES" ], "uuid": "a521676fcdfc5562a6b95e55805a1e6d", "permalink": "/items/i2sysbio-university-of-valencia-csic-phage-group-a521676fcdfc5562a6b95e55805a1e6d", "kind": "Supplier", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://i2sysbio.es/communication/1338/", "https://www.uv.es/uvweb/uv-news/en/news/university-csic-obtain-first-clinical-results-viruses-destroy-multi-drug-resistant-bacteria-1285973304159/Novetat.html?id=1286389304279&idA=&plantilla=UV_Noticies%2FPage%2FTPGDetaillNews" ], "checked": "2026-10-04", "location": "Valencia, Spain", "accessMode": "clinician-support", "detail": "Institutional reports describe phage preparation for compassionate treatments, including respiratory infections in people with cystic fibrosis.", "searchTerms": [ "Institutional reports describe phage preparation for compassionate treatments, including respiratory infections in people with cystic fibrosis.", "Valencia, Spain" ] }, { "id": "therapyRoutes/es-inibic-microtm", "name": "INIBIC / CHUAC MicroTM phage research group", "countries": [ "ES" ], "uuid": "a1d4b92d7d17577aa7ae89ceca02d93c", "permalink": "/items/inibic-chuac-microtm-phage-research-group-a1d4b92d7d17577aa7ae89ceca02d93c", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://www.inibic.es/portfolio-items/grupo-de-microbiologia-traslacional-y-multidisciplinar-microtm/amp/" ], "checked": "2026-10-04", "location": "A Coruña, Spain", "detail": "Institutional research group studying phage therapy, phage-host interactions and approaches to antibiotic-resistant infections.", "searchTerms": [ "Institutional research group studying phage therapy, phage-host interactions and approaches to antibiotic-resistant infections.", "A Coruña, Spain" ] }, { "id": "therapyRoutes/es-hospital-la-fe", "name": "La Fe University Hospital phage therapy activity", "countries": [ "ES" ], "uuid": "17a828b9b44b5d148c9c71d73420ccb6", "permalink": "/items/la-fe-university-hospital-phage-therapy-activity-17a828b9b44b5d148c9c71d73420ccb6", "kind": "Center", "status": "Case-by-case; Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.uv.es/uvweb/uv-news/en/news/university-csic-obtain-first-clinical-results-viruses-destroy-multi-drug-resistant-bacteria-1285973304159/Novetat.html?id=1286389304279&idA=&plantilla=UV_Noticies%2FPage%2FTPGDetaillNews" ], "checked": "2026-10-04", "location": "Valencia, Spain", "accessMode": "case-by-case", "detail": "Reported nebulized phage treatment in a cystic fibrosis respiratory-infection case, in collaboration with I2SysBio and Yale.", "searchTerms": [ "Reported nebulized phage treatment in a cystic fibrosis respiratory-infection case, in collaboration with I2SysBio and Yale.", "Valencia, Spain" ] }, { "id": "trial-site/f923819b7530b452", "name": "Vall d'Hebron Barcelona Hospital Campus — Barcelona", "countries": [ "ES" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct05010577" ], "location": "Barcelona", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Vall d'Hebron Barcelona Hospital Campus", "Barcelona", "", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "id": "therapyRoutes/es-virgen-del-rocio", "name": "Virgen del Rocío Hospital phage therapy activity", "countries": [ "ES" ], "uuid": "68489458848357119e2b30fb6e7f10eb", "permalink": "/items/virgen-del-rocio-hospital-phage-therapy-activity-68489458848357119e2b30fb6e7f10eb", "kind": "Center", "status": "Case-by-case; Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.uv.es/uvweb/uv-news/en/news/university-csic-obtain-first-clinical-results-viruses-destroy-multi-drug-resistant-bacteria-1285973304159/Novetat.html?id=1286389304279&idA=&plantilla=UV_Noticies%2FPage%2FTPGDetaillNews" ], "checked": "2026-10-04", "location": "Seville, Spain", "accessMode": "case-by-case", "detail": "Reported nebulized phage treatment in a cystic fibrosis respiratory-infection case, in collaboration with I2SysBio and Yale.", "searchTerms": [ "Reported nebulized phage treatment in a cystic fibrosis respiratory-infection case, in collaboration with I2SysBio and Yale.", "Seville, Spain" ] }, { "uuid": "c33b13c18d7e5a0f93769435d0f086b6", "permalink": "/items/proof-of-concept-study-to-assess-safety-and-efficacy-of-phage-therapy-in-hip-or-knee-prost-c33b13c18d7e5a0f93769435d0f086b6", "id": "trials/nct06605651", "name": "GLORIA (NCT06605651)", "countries": [ "ES", "FR", "NL" ], "kind": "Trial", "status": "Not yet recruiting", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT06605651", "https://euclinicaltrials.eu/ctis-public/view/2024-516555-40-00?lang=en" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct06605651", "start": { "date": "2026-07", "kind": "estimated" }, "end": { "date": "2029-09", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06605651" ], "label": "2026 (estimated)–2029 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-07", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06605651" ], "candidates": [ { "date": "2026-07", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06605651" ] }, { "date": "2026-07", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06605651" ] } ] }, "end": { "value": { "date": "2029-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06605651" ], "candidates": [ { "date": "2029-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06605651" ] }, { "date": "2029-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06605651" ] } ] } } } ], "detail": "Hip Prosthesis Infection; Knee Prosthesis Infection", "searchTerms": [ "Proof of Concept Study to Assess Safety and Efficacy of Phage Therapy in Hip or Knee Prosthetic Joint Infections Due to Staphylococcus Aureus Treated by DAIR.", "Hip Prosthesis Infection", "Knee Prosthesis Infection", "NCT06605651", "2024-516555-40-00" ] }, { "id": "therapyRoutes/eu-karolinska", "name": "Karolinska University Hospital / Karolinska Institutet phage program", "countries": [ "SE" ], "uuid": "4be63316b5d85141b95170fc440b32ab", "permalink": "/items/karolinska-university-hospital-karolinska-institutet-phage-program-4be63316b5d85141b95170fc440b32ab", "kind": "Research", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.karolinska.se/om-oss/centrala-nyheter/2024/10/innovationsdagen-2024/" ], "checked": "2026-10-03", "location": "Stockholm; Sweden", "detail": "CF respiratory infection trial plans; clinical microbiology, Stockholm CF Center, infectious diseases and trauma/orthopedics collaboration.", "searchTerms": [ "CF respiratory infection trial plans; clinical microbiology, Stockholm CF Center, infectious diseases and trauma/orthopedics collaboration.", "Stockholm; Sweden" ] }, { "id": "therapyRoutes/eu-balgrist-rephrame", "name": "Balgrist Phage Therapy and Research / REPhRAME", "countries": [ "CH" ], "uuid": "5465b241a155534ebb0cf65493f59120", "permalink": "/items/balgrist-phage-therapy-and-research-rephrame-5465b241a155534ebb0cf65493f59120", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.balgrist.ch/ueber-uns/medien/mit-viren-gegen-bakterien-eu-foerdert-phagentherapie-mit-15-millionen-euro-1011/" ], "checked": "2026-10-03", "location": "Zurich; Switzerland", "detail": "Recurrent urinary tract infections; REPhRAME plans engineered E. coli phages followed by microbiota transfer.", "searchTerms": [ "Recurrent urinary tract infections; REPhRAME plans engineered E. coli phages followed by microbiota transfer.", "Zurich; Switzerland" ] }, { "id": "trial-site/9f2da827cb841c2a", "name": "Centre Hospitalier Universitaire Vaudois — Lausanne", "countries": [ "CH" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT02116010" ], "checked": "2026-10-04", "trialIds": [ "nct02116010" ], "location": "Lausanne", "detail": "Recorded study locations: Wound Infection. Not an offer of treatment.", "searchTerms": [ "Centre Hospitalier Universitaire Vaudois", "Lausanne", "", "Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients", "Wound Infection", "NCT02116010", "2014-000714-65" ], "studyYears": [ { "trialId": "nct02116010", "start": { "date": "2015-07-26", "kind": "actual" }, "end": { "date": "2017-01-16", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ], "label": "2015–2017", "dateEvidence": { "start": { "value": { "date": "2015-07-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ], "candidates": [ { "date": "2015-07-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] }, { "date": "2015-07", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02116010" ] }, { "date": "2015-07-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] } ] }, "end": { "value": { "date": "2017-01-16", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ], "candidates": [ { "date": "2017-01-16", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] }, { "date": "2017-01-16", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] }, { "date": "2017-01-16", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000714-65/results" ] } ] } } } ] }, { "id": "therapyRoutes/eu-chuv", "name": "CHUV bacteriophage and phagotherapy laboratory", "countries": [ "CH" ], "uuid": "75d54ad0674d5987ba4561d1ce964aa2", "permalink": "/items/chuv-bacteriophage-and-phagotherapy-laboratory-75d54ad0674d5987ba4561d1ce964aa2", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://www.chuv.ch/fr/crisp/therapies-innovantes-biologiques-et-cellulaires/laboratoire-des-bacteriophages-et-de-phagotherapie", "https://www.chuv.ch/fr/evenements/evenement/news_evt_783/forum-phagotherapie-debat-grand-public-avec-les-acteurs-concernes" ], "checked": "2026-10-03", "location": "Lausanne; Switzerland", "detail": "Phage and lysin research, experimental development and rare exceptional clinical use context.", "searchTerms": [ "Phage and lysin research, experimental development and rare exceptional clinical use context.", "Lausanne; Switzerland" ] }, { "id": "therapyRoutes/eu-hug-geneva", "name": "Geneva University Hospitals (HUG) clinical phage experience", "countries": [ "CH" ], "uuid": "f961d021685a53c7b8a101d49fde4776", "permalink": "/items/geneva-university-hospitals-hug-clinical-phage-experience-f961d021685a53c7b8a101d49fde4776", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://panorama.hug.ch/2023/un-patient-sauve-de-lantibioresistance-grace-aux-bacteriophages/", "https://www.hug.ch/sites/interhug/files/presse/2023.06.27-cp_bacteriophages_1.pdf" ], "checked": "2026-10-03", "location": "Geneva; Switzerland", "detail": "Documented difficult respiratory infection treatment, with additional pharmacy case experience.", "searchTerms": [ "Documented difficult respiratory infection treatment, with additional pharmacy case experience.", "Geneva; Switzerland" ] }, { "id": "therapyRoutes/eu-micreos", "name": "Micreos Pharmaceuticals AG / Micreos Group", "countries": [ "CH", "NL" ], "uuid": "1f922683c29b5a59bd3d1183ba0db345", "permalink": "/items/micreos-pharmaceuticals-ag-micreos-group-1f922683c29b5a59bd3d1183ba0db345", "kind": "Company", "status": "Research/development", "activity": "research", "sources": [ "https://micreos.com/", "https://micreosgroup.com/" ], "checked": "2026-10-03", "location": "Baar / Zurich; Bilthoven group activity; Switzerland; Netherlands", "detail": "Engineered endolysins, including MEndoB for S. aureus-associated atopic dermatitis; phage-derived enzymes rather than live therapeutic phage preparations.", "searchTerms": [ "Engineered endolysins, including MEndoB for S. aureus-associated atopic dermatitis; phage-derived enzymes rather than live therapeutic phage preparations.", "Baar / Zurich; Bilthoven group activity; Switzerland; Netherlands" ] }, { "id": "therapyRoutes/th-mahidol", "name": "Mahidol University / Siriraj phage research", "countries": [ "TH" ], "uuid": "b03d632e53515354b4f6d4dda9c9d564", "permalink": "/items/mahidol-university-siriraj-phage-research-b03d632e53515354b4f6d4dda9c9d564", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://www.si.mahidol.ac.th/Th/department/immunology/news_detail.asp?id=482&m=1&y=2566", "https://amric.mahidol.ac.th/research.html" ], "checked": "2026-10-03", "location": "Bangkok; Thailand", "detail": "Phage diagnostics and therapeutic discovery for AMR organisms, including biofilm/resistance laboratory studies.", "searchTerms": [ "Phage diagnostics and therapeutic discovery for AMR organisms, including biofilm/resistance laboratory studies.", "Bangkok; Thailand" ] }, { "id": "therapyRoutes/eu-primavac", "name": "PrimaVac / PRIMAFAG", "countries": [ "UA" ], "uuid": "2de27936263a5e2eb93e40726b592cf5", "permalink": "/items/primavac-primafag-2de27936263a5e2eb93e40726b592cf5", "kind": "Supplier", "status": "Provider-listed inquiry route", "activity": "current", "sources": [ "https://primavac.com.ua/" ], "checked": "2026-10-03", "location": "Ukraine", "detail": "Current site describes phage-containing dietary supplements for microbial balance and hygiene products, rather than an established clinical infection-treatment service.", "searchTerms": [ "Current site describes phage-containing dietary supplements for microbial balance and hygiene products, rather than an established clinical infection-treatment service.", "Ukraine" ] }, { "id": "therapyRoutes/historical-biocontrol", "name": "Biocontrol Ltd", "countries": [ "GB" ], "uuid": "17e2b9037eda56bba5167451c9bb6dbb", "permalink": "/items/biocontrol-ltd-17e2b9037eda56bba5167451c9bb6dbb", "kind": "Company", "status": "Acquired by AmpliPhi in 2011", "activity": "historical", "sources": [ "https://www.sec.gov/Archives/edgar/data/921114/000155837020002943/armp-20191231x10k.htm" ], "checked": "2026-10-03", "detail": "Historical phage-development company.", "searchTerms": [ "Historical phage-development company.", "" ] }, { "id": "therapyRoutes/eu-gosh", "name": "Great Ormond Street Hospital (GOSH)", "countries": [ "GB" ], "uuid": "e973dbc343ad5509bb28259561a13490", "permalink": "/items/great-ormond-street-hospital-gosh-e973dbc343ad5509bb28259561a13490", "kind": "Supplier", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.gosh.nhs.uk/wards-and-departments/departments/laboratory-medicine/laboratory-database/phage-reconstitution/", "https://www.gosh.nhs.uk/news/first-use-pioneering-phage-virus-therapy-treat-patient-cystic-fibrosis/" ], "checked": "2026-10-04", "location": "London; United Kingdom", "accessMode": "clinician-support", "detail": "Laboratory support for resistant infections; historical pediatric CF/transplant-associated Mycobacterium abscessus treatment.", "searchTerms": [ "Laboratory support for resistant infections; historical pediatric CF/transplant-associated Mycobacterium abscessus treatment.", "London; United Kingdom" ] }, { "id": "therapyRoutes/eu-nexabiome", "name": "NexaBiome (formerly Fixed Phage)", "countries": [ "GB" ], "uuid": "2e5c19e75b7455f8b9171bef6cfb3ee2", "permalink": "/items/nexabiome-formerly-fixed-phage-2e5c19e75b7455f8b9171bef6cfb3ee2", "kind": "Company", "status": "Research/development", "activity": "research", "sources": [ "https://nexabiome.com/", "https://gk.news/fixedphage/press-release/" ], "checked": "2026-10-03", "location": "Glasgow; United Kingdom", "detail": "Phage library, formulation/immobilization and human therapeutic development alongside other applications.", "searchTerms": [ "Phage library, formulation/immobilization and human therapeutic development alongside other applications.", "Glasgow; United Kingdom" ] }, { "id": "therapyRoutes/eu-nhs-tayside", "name": "NHS Tayside / Ninewells phage therapy program", "countries": [ "GB" ], "uuid": "7fe98a0443ba5086bcadbd4a340043d9", "permalink": "/items/nhs-tayside-ninewells-phage-therapy-program-7fe98a0443ba5086bcadbd4a340043d9", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://shtg.scot/our-advice/bacteriophage-therapy-for-patients-with-difficult-to-treat-bacterial-infections/", "https://discovery.dundee.ac.uk/ws/files/149452593/antibiotics-14-00114.pdf" ], "checked": "2026-10-03", "location": "Dundee; United Kingdom", "detail": "Unlicensed physician-led use for difficult infections, including when antibiotics or surgery fail or cannot be used.", "searchTerms": [ "Unlicensed physician-led use for difficult infections, including when antibiotics or surgery fail or cannot be used.", "Dundee; United Kingdom" ] }, { "uuid": "9aad11f9a086580aafa440554d0c7eef", "permalink": "/items/assessing-the-efficacy-of-anti-staphylococcal-phages-in-the-management-of-infected-foot-ul-9aad11f9a086580aafa440554d0c7eef", "id": "trials/nct04289948", "name": "PDFI (NCT04289948)", "countries": [ "GB" ], "kind": "Trial", "status": "Withdrawn", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04289948" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct04289948", "start": { "date": "2019-03-01", "kind": "estimated" }, "end": { "date": "2022-09-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04289948" ], "label": "2019 (estimated)–2022 (estimated)", "dateEvidence": { "start": { "value": { "date": "2019-03-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04289948" ], "candidates": [ { "date": "2019-03-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04289948" ] }, { "date": "2019-03-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04289948" ] } ] }, "end": { "value": { "date": "2022-09-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04289948" ], "candidates": [ { "date": "2022-09-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04289948" ] }, { "date": "2022-09-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04289948" ] } ] } } } ], "detail": "Diabetes; Diabetic Foot; Diabetic Foot Infection", "searchTerms": [ "Assessing the Efficacy of Anti-staphylococcal Phages in the Management of Infected Foot Ulcers in Diabetes", "Diabetes", "Diabetic Foot", "Diabetic Foot Infection", "NCT04289948", "University Hospitals Derby and Burton NHS Foundation Trust", "Derby", "Derbyshire", "United Kingdom" ] }, { "id": "therapyRoutes/eu-phage-uk", "name": "Phage UK", "countries": [ "GB" ], "uuid": "5df0a8e3dfee5fbbb92a72c3bbf1e56f", "permalink": "/items/phage-uk-5df0a8e3dfee5fbbb92a72c3bbf1e56f", "kind": "Facilitator", "status": "Status unconfirmed", "activity": "unconfirmed", "sources": [ "https://phageuk.org/general-enquiries", "https://committees.parliament.uk/writtenevidence/116523/pdf/" ], "checked": "2026-10-03", "location": "United Kingdom", "accessMode": "facilitation", "detail": "Nonprofit advocacy, clinician network and access support; no directly treating service established.", "searchTerms": [ "Nonprofit advocacy, clinician network and access support; no directly treating service established.", "United Kingdom" ] }, { "id": "therapyRoutes/eu-saspiphi-steps-cf", "name": "SASPiPhi Limited / STEPS-CF", "countries": [ "GB" ], "uuid": "787e468774775eaf85b1ff4f84526e6a", "permalink": "/items/saspiphi-limited-steps-cf-787e468774775eaf85b1ff4f84526e6a", "kind": "Company", "status": "Research/development", "activity": "research", "sources": [ "https://www.isrctn.com/ISRCTN57413769" ], "checked": "2026-10-03", "trialIds": [ "isrctn57413769" ], "location": "Cambridge (sponsor); Liverpool (planned trial); United Kingdom", "detail": "Phase 1b/2a IV engineered SASPject PT3.9 for adults aged 18–60 with CF-associated susceptible P. aeruginosa infection; projected first enrollment January 1, 2027.", "searchTerms": [ "Phase 1b/2a IV engineered SASPject PT3.9 for adults aged 18–60 with CF-associated susceptible P. aeruginosa infection; projected first enrollment January 1, 2027.", "Cambridge (sponsor); Liverpool (planned trial); United Kingdom" ] }, { "uuid": "555bc0b9fa5d504db2ec9ed33f70ca96", "permalink": "/items/steps-cf-saspject-pt3-9-555bc0b9fa5d504db2ec9ed33f70ca96", "id": "trials/isrctn57413769", "name": "STEPS-CF / SASPject PT3.9 (ISRCTN57413769)", "countries": [ "GB" ], "kind": "Trial", "status": "Not yet recruiting", "activity": "planned", "sources": [ "https://www.isrctn.com/ISRCTN57413769" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "isrctn57413769", "start": { "date": "2027-01-01", "kind": "estimated" }, "end": { "date": "2029-01-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://www.isrctn.com/ISRCTN57413769" ], "label": "2027 (estimated)–2029 (estimated)", "dateEvidence": { "start": { "value": { "date": "2027-01-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://www.isrctn.com/ISRCTN57413769" ], "candidates": [ { "date": "2027-01-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://www.isrctn.com/ISRCTN57413769" ] }, { "date": "2027-01-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://www.isrctn.com/ISRCTN57413769" ] } ] }, "end": { "value": { "date": "2029-01-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://www.isrctn.com/ISRCTN57413769" ], "candidates": [ { "date": "2029-01-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://www.isrctn.com/ISRCTN57413769" ] }, { "date": "2029-01-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://www.isrctn.com/ISRCTN57413769" ] } ] } } } ], "searchTerms": [ "STEPS-CF / SASPject PT3.9", "ISRCTN57413769" ] }, { "id": "therapyRoutes/eu-uk-phage-therapy", "name": "UK Phage Therapy", "countries": [ "GB" ], "uuid": "44c1282daf1f53579bdb951b8eb0c1ae", "permalink": "/items/uk-phage-therapy-44c1282daf1f53579bdb951b8eb0c1ae", "kind": "Facilitator", "status": "Status unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.ukphagetherapy.org/", "https://committees.parliament.uk/writtenevidence/116672/pdf/" ], "checked": "2026-10-03", "location": "United Kingdom", "accessMode": "facilitation", "detail": "Clinical support and manufacturing/access coordination; not itself confirmed as a treating clinic.", "searchTerms": [ "Clinical support and manufacturing/access coordination; not itself confirmed as a treating clinic.", "United Kingdom" ] }, { "id": "trial-site/ee0e20dcee73a52e", "name": "University Hospitals Derby and Burton NHS Foundation Trust — Derby, Derbyshire", "countries": [ "GB" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04289948" ], "checked": "2026-10-03", "trialIds": [ "nct04289948" ], "location": "Derby, Derbyshire", "detail": "Recorded study locations: Diabetes; Diabetic Foot; Diabetic Foot Infection. Not an offer of treatment.", "searchTerms": [ "University Hospitals Derby and Burton NHS Foundation Trust", "Derby", "Derbyshire", "Assessing the Efficacy of Anti-staphylococcal Phages in the Management of Infected Foot Ulcers in Diabetes", "Diabetes", "Diabetic Foot", "Diabetic Foot Infection", "NCT04289948" ], "studyYears": [ { "trialId": "nct04289948", "start": { "date": "2019-03-01", "kind": "estimated" }, "end": { "date": "2022-09-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04289948" ], "label": "2019 (estimated)–2022 (estimated)", "dateEvidence": { "start": { "value": { "date": "2019-03-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04289948" ], "candidates": [ { "date": "2019-03-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04289948" ] }, { "date": "2019-03-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04289948" ] } ] }, "end": { "value": { "date": "2022-09-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04289948" ], "candidates": [ { "date": "2022-09-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04289948" ] }, { "date": "2022-09-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04289948" ] } ] } } } ] }, { "id": "therapyRoutes/eu-exeter-phage-library", "name": "University of Exeter phage research / phage library", "countries": [ "GB" ], "uuid": "334f48b3b3c457919acf3f9750076788", "permalink": "/items/university-of-exeter-phage-research-phage-library-334f48b3b3c457919acf3f9750076788", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://www.exeter.ac.uk/research/amr/reducing-antibiotic-use/" ], "checked": "2026-10-03", "location": "Exeter / Penryn; United Kingdom", "detail": "Phage discovery, research supply and development, including collaborations relevant to difficult infections.", "searchTerms": [ "Phage discovery, research supply and development, including collaborations relevant to difficult infections.", "Exeter / Penryn; United Kingdom" ] }, { "uuid": "0b6d06a30e645c8d94f2fa3c49615df6", "permalink": "/items/a-phase-1b-2-trial-of-the-safety-and-microbiological-activity-of-bacteriophage-therapy-in-0b6d06a30e645c8d94f2fa3c49615df6", "id": "trials/nct05453578", "name": "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa (NCT05453578)", "countries": [ "US" ], "kind": "Trial", "status": "Completed", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05453578" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05453578", "start": { "date": "2022-10-03", "kind": "actual" }, "end": { "date": "2025-04-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-10-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2022-10-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2022-10-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] }, "end": { "value": { "date": "2025-04-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2025-04-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2025-04-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] } } } ], "detail": "Bacterial Disease Carrier; Cystic Fibrosis", "searchTerms": [ "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa", "Bacterial Disease Carrier", "Cystic Fibrosis", "NCT05453578", "The University of Arizona - Banner University Medical Center Tucson Campus - Tucson", "Tucson", "Arizona", "United States", "University of California, San Diego", "La Jolla", "California", "United States", "University of California, San Diego (UCSD) - Antiviral Research Center (AVRC)", "La Jolla", "California", "United States", "University of California Los Angeles Medical Center - Westwood Clinic", "Los Angeles", "California", "United States", "University of California Davis Health", "Sacramento", "California", "United States", "Stanford University", "Stanford", "California", "United States", "Yale North Haven Medical Center- Winchester Center for Lung Disease", "North Haven", "Connecticut", "United States", "University of South Florida/Tampa General Hospital", "Tampa", "Florida", "United States", "Emory University - Adult Cystic Fibrosis Program", "Atlanta", "Georgia", "United States", "Johns Hopkins University", "Baltimore", "Maryland", "United States", "Michigan Medicine", "Ann Arbor", "Michigan", "United States", "University of Minnesota Medical Center", "Minneapolis", "Minnesota", "United States", "Northwell Health", "New Hyde Park", "New York", "United States", "Duke University Medical Center", "Durham", "North Carolina", "United States", "Case Western Reserve University", "Cleveland", "Ohio", "United States", "Vanderbilt University Medical Center", "Nashville", "Tennessee", "United States", "University of Texas Southwestern Medical Center", "Dallas", "Texas", "United States", "Baylor College of Medicine", "Houston", "Texas", "United States", "University of Virginia", "Charlottesville", "Virginia", "United States" ] }, { "uuid": "6c867a88f4d45a81b8f6151116e5776f", "permalink": "/items/a-study-investigating-the-safety-recovery-and-pharmacodynamics-of-multiple-oral-administra-6c867a88f4d45a81b8f6151116e5776f", "id": "trials/nct05277350", "name": "A Study Investigating the Safety, Recovery, and Pharmacodynamics of Multiple Oral Administrations of SNIPR001 in Healthy Subjects (NCT05277350)", "countries": [ "US" ], "kind": "Trial", "status": "Completed", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05277350" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05277350", "start": { "date": "2022-03-24", "kind": "actual" }, "end": { "date": "2023-05-01", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05277350" ], "label": "2022–2023", "dateEvidence": { "start": { "value": { "date": "2022-03-24", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05277350" ], "candidates": [ { "date": "2022-03-24", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05277350" ] }, { "date": "2022-03-24", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05277350" ] } ] }, "end": { "value": { "date": "2023-05-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05277350" ], "candidates": [ { "date": "2023-05-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05277350" ] }, { "date": "2023-05-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05277350" ] } ] } } } ], "detail": "E.Coli Infections; Bloodstream Infection", "searchTerms": [ "A Study Investigating the Safety, Recovery, and Pharmacodynamics of Multiple Oral Administrations of SNIPR001 in Healthy Subjects", "E.Coli Infections", "Bloodstream Infection", "NCT05277350", "Medpace Clinical Pharmacology", "Cincinnati", "Ohio", "United States" ] }, { "uuid": "aa0b4be557ab5ebfbeccfeb7d8c3745f", "permalink": "/items/a-study-to-evaluate-the-safety-tolerability-and-fecal-pharmacokinetics-of-bx002-a-in-healt-aa0b4be557ab5ebfbeccfeb7d8c3745f", "id": "trials/nct04737876", "name": "A Study to Evaluate the Safety, Tolerability, and Fecal Pharmacokinetics of BX002-A in Healthy Adults (NCT04737876)", "countries": [ "US" ], "kind": "Trial", "status": "Completed", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04737876" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct04737876", "start": { "date": "2020-10-28", "kind": "actual" }, "end": { "date": "2020-12-21", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04737876" ], "label": "2020–2020", "dateEvidence": { "start": { "value": { "date": "2020-10-28", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04737876" ], "candidates": [ { "date": "2020-10-28", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04737876" ] }, { "date": "2020-10-28", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04737876" ] } ] }, "end": { "value": { "date": "2020-12-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04737876" ], "candidates": [ { "date": "2020-12-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04737876" ] }, { "date": "2020-12-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04737876" ] } ] } } } ], "detail": "Healthy Volunteers", "searchTerms": [ "A Study to Evaluate the Safety, Tolerability, and Fecal Pharmacokinetics of BX002-A in Healthy Adults", "Healthy Volunteers", "NCT04737876", "Medical Facility", "Cincinnati", "Ohio", "United States" ] }, { "uuid": "17097995b1105f178f95adf35085ba26", "permalink": "/items/bacteriophage-therapy-in-patients-with-prosthetic-joint-infections-pji-17097995b1105f178f95adf35085ba26", "id": "trials/nct05269134", "name": "ACTIVE2 (NCT05269134)", "countries": [ "US" ], "kind": "Trial", "status": "Withdrawn", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05269134" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05269134", "start": { "date": "2023-03-27", "kind": "actual" }, "end": { "date": "2027-07", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "label": "2023–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-03-27", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2023-03-27", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2023-03-27", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] }, "end": { "value": { "date": "2027-07", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2027-07", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2027-07", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] } } } ], "detail": "Prosthetic Joint Infection", "searchTerms": [ "Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)", "Prosthetic Joint Infection", "NCT05269134", "University of California San Diego Medical Center", "San Diego", "California", "United States", "Hartford Health Care Bone & Joint Insitute", "Hartford", "Connecticut", "United States", "Snake River Research", "Idaho Falls", "Idaho", "United States", "University of Maryland Medical Center", "Baltimore", "Maryland", "United States", "Sinai Hospital of Baltimore", "Baltimore", "Maryland", "United States", "Brigham & Women's Hospital", "Boston", "Massachusetts", "United States", "New England Baptist Hospital", "Boston", "Massachusetts", "United States", "William Beaumont Hospital", "Royal Oak", "Michigan", "United States", "Mayo Clinic", "Rochester", "Minnesota", "United States", "WVU Medicine JW Ruby Memorial Hospital", "Morgantown", "West Virginia", "United States" ] }, { "id": "trial-site/13dde5d8db945fb6", "name": "AdMed Research — Miami, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04287478" ], "checked": "2026-10-03", "trialIds": [ "nct04287478" ], "location": "Miami, Florida", "detail": "Recorded study locations: Urinary Tract Infection Bacterial. Not an offer of treatment.", "searchTerms": [ "AdMed Research", "Miami", "Florida", "Bacteriophage Therapy in Patients With Urinary Tract Infections", "Urinary Tract Infection Bacterial", "NCT04287478" ], "studyYears": [ { "trialId": "nct04287478", "start": { "date": "2020-12-09", "kind": "actual" }, "end": { "date": "2023-02-28", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "label": "2020–2023", "dateEvidence": { "start": { "value": { "date": "2020-12-09", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "candidates": [ { "date": "2020-12-09", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] }, { "date": "2020-12-09", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] } ] }, "end": { "value": { "date": "2023-02-28", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "candidates": [ { "date": "2023-02-28", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] }, { "date": "2023-02-28", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] } ] } } } ] }, { "id": "therapyRoutes/historical-ampliphi", "name": "AmpliPhi Biosciences", "countries": [ "US" ], "uuid": "05480b7ee3b1590098700fe4d78b762f", "permalink": "/items/ampliphi-biosciences-05480b7ee3b1590098700fe4d78b762f", "kind": "Company", "status": "Renamed Armata in 2019", "activity": "historical", "sources": [ "https://www.sec.gov/Archives/edgar/data/921114/000155837020002943/armp-20191231x10k.htm" ], "checked": "2026-10-03", "detail": "Historical phage-development company.", "searchTerms": [ "Historical phage-development company.", "" ] }, { "id": "trial-site/ff73d649038388e9", "name": "AMPM Research Clinic — Miami Gardens, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04191148", "https://clinicaltrials.gov/study/NCT04287478" ], "checked": "2026-10-03", "trialIds": [ "nct04191148", "nct04287478" ], "location": "Miami Gardens, Florida", "detail": "Recorded study locations: Urinary Tract Infections; Urinary Tract Infection Bacterial. Not an offer of treatment.", "searchTerms": [ "AMPM Research Clinic", "Miami Gardens", "Florida", "Safety, Tolerability, and PK of LBP-EC01 in Patients With Lower Urinary Tract Colonization Caused by E. Coli", "Urinary Tract Infections", "NCT04191148", "AMPM Research Clinic", "Miami Gardens", "Florida", "Bacteriophage Therapy in Patients With Urinary Tract Infections", "Urinary Tract Infection Bacterial", "NCT04287478" ], "studyYears": [ { "trialId": "nct04191148", "start": { "date": "2019-12-30", "kind": "actual" }, "end": { "date": "2020-11-19", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "label": "2019–2020", "dateEvidence": { "start": { "value": { "date": "2019-12-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "candidates": [ { "date": "2019-12-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] }, { "date": "2019-12-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] } ] }, "end": { "value": { "date": "2020-11-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "candidates": [ { "date": "2020-11-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] }, { "date": "2020-11-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] } ] } } }, { "trialId": "nct04287478", "start": { "date": "2020-12-09", "kind": "actual" }, "end": { "date": "2023-02-28", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "label": "2020–2023", "dateEvidence": { "start": { "value": { "date": "2020-12-09", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "candidates": [ { "date": "2020-12-09", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] }, { "date": "2020-12-09", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] } ] }, "end": { "value": { "date": "2023-02-28", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "candidates": [ { "date": "2023-02-28", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] }, { "date": "2023-02-28", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] } ] } } } ] }, { "id": "therapyRoutes/armata", "name": "Armata Pharmaceuticals", "countries": [ "US" ], "uuid": "b51d2132a0c352da891b974e30dddd09", "permalink": "/items/armata-pharmaceuticals-b51d2132a0c352da891b974e30dddd09", "kind": "Company", "status": "Research/development", "activity": "research", "sources": [ "https://www.armatapharma.com/pipeline/ap-sa02/", "https://www.armatapharma.com/pipeline/pipeline-overview/", "https://www.armatapharma.com/contact-us/", "https://clinicaltrials.gov/study/NCT05184764", "https://clinicaltrials.gov/study/NCT05616221", "https://clinicaltrials.gov/study/NCT03395743", "https://clinicaltrials.gov/study/NCT03395769" ], "checked": "2026-10-03", "trialIds": [ "nct03395743", "nct03395769", "nct04596319", "nct05184764", "nct05616221" ], "location": "Los Angeles, California; United States", "detail": "AP-SA02 S. aureus complicated bacteremia; AP-PA02 CF/non-CF bronchiectasis. Prior trials completed. Legacy AB-PA01/AB-SA01 expanded access no longer available.", "searchTerms": [ "AP-SA02 S. aureus complicated bacteremia; AP-PA02 CF/non-CF bronchiectasis. Prior trials completed. Legacy AB-PA01/AB-SA01 expanded access no longer available.", "Los Angeles, California; United States" ] }, { "uuid": "196b826dfc885300a38fba74145153a1", "permalink": "/items/ascending-dose-study-of-the-safety-of-ab-sa01-when-topically-applied-to-intact-skin-of-hea-196b826dfc885300a38fba74145153a1", "id": "trials/nct02757755", "name": "Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults (NCT02757755)", "countries": [ "US" ], "kind": "Trial", "status": "Completed", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT02757755" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct02757755", "start": { "date": "2016-05", "kind": "reported" }, "end": { "date": "2016-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02757755" ], "label": "2016–2016", "dateEvidence": { "start": { "value": { "date": "2016-05", "kind": "reported" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02757755" ], "candidates": [ { "date": "2016-05", "kind": "reported", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02757755" ] }, { "date": "2016-05", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02757755" ] } ] }, "end": { "value": { "date": "2016-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02757755" ], "candidates": [ { "date": "2016-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02757755" ] }, { "date": "2016-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02757755" ] } ] } } } ], "detail": "Healthy Volunteers", "searchTerms": [ "Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults", "Healthy Volunteers", "NCT02757755", "Clinical Trials Center, WRAIR", "Silver Spring", "Maryland", "United States" ] }, { "id": "trial-site/3e73e1290bb6f38e", "name": "Avanza Medical Center — Pensacola, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT06998043" ], "checked": "2026-10-03", "trialIds": [ "nct06998043" ], "location": "Pensacola, Florida", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis (CF). Not an offer of treatment.", "searchTerms": [ "Avanza Medical Center", "Pensacola", "Florida", "Study With Phage for CF Subjects With Pseudomonas Lung Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis (CF)", "NCT06998043", "2024-519856-94-00" ], "studyYears": [ { "trialId": "nct06998043", "start": { "date": "2025-07-02", "kind": "actual" }, "end": { "date": "2026-09", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-07-02", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2025-07-02", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-07-02", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-08-18", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] }, "end": { "value": { "date": "2026-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2026-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2026-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-12-08", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] } } } ] }, { "uuid": "727277c967475b7d95a26d7457fef85f", "permalink": "/items/bacteriophage-therapy-in-patients-with-prosthetic-joint-infections-727277c967475b7d95a26d7457fef85f", "id": "trials/nct04787250", "name": "Bacteriophage Therapy in Patients With Prosthetic Joint Infections (NCT04787250)", "countries": [ "US" ], "kind": "Trial", "status": "Withdrawn", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04787250" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct04787250", "start": { "date": "2022-10", "kind": "estimated" }, "end": { "date": "2024-05", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04787250" ], "label": "2022 (estimated)–2024 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-10", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04787250" ], "candidates": [ { "date": "2022-10", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04787250" ] }, { "date": "2022-10", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04787250" ] } ] }, "end": { "value": { "date": "2024-05", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04787250" ], "candidates": [ { "date": "2024-05", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04787250" ] }, { "date": "2024-05", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04787250" ] } ] } } } ], "detail": "Prosthetic Joint Infection", "searchTerms": [ "Bacteriophage Therapy in Patients With Prosthetic Joint Infections", "Prosthetic Joint Infection", "NCT04787250", "Mayo Clinic", "Rochester", "Minnesota", "United States" ] }, { "uuid": "4ba9d50c45235ddcbce7e435e9f17d25", "permalink": "/items/bacteriophage-therapy-in-patients-with-urinary-tract-infections-4ba9d50c45235ddcbce7e435e9f17d25", "id": "trials/nct04287478", "name": "Bacteriophage Therapy in Patients With Urinary Tract Infections (NCT04287478)", "countries": [ "US" ], "kind": "Trial", "status": "Terminated", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04287478" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct04287478", "start": { "date": "2020-12-09", "kind": "actual" }, "end": { "date": "2023-02-28", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "label": "2020–2023", "dateEvidence": { "start": { "value": { "date": "2020-12-09", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "candidates": [ { "date": "2020-12-09", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] }, { "date": "2020-12-09", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] } ] }, "end": { "value": { "date": "2023-02-28", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "candidates": [ { "date": "2023-02-28", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] }, { "date": "2023-02-28", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] } ] } } } ], "detail": "Urinary Tract Infection Bacterial", "searchTerms": [ "Bacteriophage Therapy in Patients With Urinary Tract Infections", "Urinary Tract Infection Bacterial", "NCT04287478", "Universal Axon Clinical Research", "Doral", "Florida", "United States", "AdMed Research", "Miami", "Florida", "United States", "AMPM Research Clinic", "Miami Gardens", "Florida", "United States", "Innovation Medical Research Center, Inc", "Palmetto Bay", "Florida", "United States", "Henry Ford Hospital", "Detroit", "Michigan", "United States", "James J. Peters VA Medical Center", "The Bronx", "New York", "United States", "University of Texas Southwestern Medical Center", "Dallas", "Texas", "United States", "DHR Health Institute for Research and Development", "Edinburg", "Texas", "United States" ] }, { "uuid": "601fc44da2d95a09bea0ff1e9f500f54", "permalink": "/items/bacteriophages-for-adults-with-cystic-fibrosis-and-chronic-achromobacter-lung-infection-601fc44da2d95a09bea0ff1e9f500f54", "id": "trials/nct07275905", "name": "Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection (NCT07275905)", "countries": [ "US" ], "kind": "Trial", "status": "Recruiting", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT07275905" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct07275905", "start": { "date": "2026-08-01", "kind": "estimated" }, "end": { "date": "2028-02", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ], "label": "2026 (estimated)–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-08-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ], "candidates": [ { "date": "2026-08-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ] }, { "date": "2026-08-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ] } ] }, "end": { "value": { "date": "2028-02", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ], "candidates": [ { "date": "2028-02", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ] }, { "date": "2028-02", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ] } ] } } } ], "detail": "Cystic Fibrosis (CF); Achromobacter Infection", "searchTerms": [ "Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection", "Cystic Fibrosis (CF)", "Achromobacter Infection", "NCT07275905", "University of California San Diego (UCSD)", "San Diego", "California", "United States", "University of Pittsburgh", "Pittsburgh", "Pennsylvania", "United States" ] }, { "id": "trial-site/6fe0aa0a3a290e37", "name": "Banner University Medical Center — Tucson, Arizona", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Tucson, Arizona", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "Banner University Medical Center", "Tucson", "Arizona", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "trial-site/2f568ae9391b9cfd", "name": "Baylor College of Medicine — Houston, Texas", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05453578" ], "checked": "2026-10-03", "trialIds": [ "nct05453578" ], "location": "Houston, Texas", "detail": "Recorded study locations: Bacterial Disease Carrier; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Baylor College of Medicine", "Houston", "Texas", "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa", "Bacterial Disease Carrier", "Cystic Fibrosis", "NCT05453578" ], "studyYears": [ { "trialId": "nct05453578", "start": { "date": "2022-10-03", "kind": "actual" }, "end": { "date": "2025-04-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-10-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2022-10-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2022-10-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] }, "end": { "value": { "date": "2025-04-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2025-04-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2025-04-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] } } } ] }, { "id": "therapyRoutes/baylor-tailor", "name": "Baylor College of Medicine TAILOR", "countries": [ "US" ], "uuid": "481ea596ee5f516791a74d3f40b44248", "permalink": "/items/baylor-college-of-medicine-tailor-481ea596ee5f516791a74d3f40b44248", "kind": "Supplier", "status": "Case-by-case; Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.bcm.edu/research/research-centers/tailor" ], "checked": "2026-10-03", "location": "Houston, Texas; United States", "accessMode": "case-by-case", "detail": "Phage discovery, characterization and personalized preparation supporting treating clinicians; also non-clinical applications.", "searchTerms": [ "Phage discovery, characterization and personalized preparation supporting treating clinicians; also non-clinical applications.", "Houston, Texas; United States" ] }, { "id": "trial-site/b495ae2464d3555c", "name": "Baylor College of Medicine, Texas Children Clinic — Houston, Texas", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct05010577" ], "location": "Houston, Texas", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Baylor College of Medicine, Texas Children Clinic", "Houston", "Texas", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "id": "trial-site/8cba83ab3be89935", "name": "Bio X Cell Research LLC — San Antonio, Texas", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05177107" ], "checked": "2026-10-03", "trialIds": [ "nct05177107" ], "location": "San Antonio, Texas", "detail": "Recorded study locations: Osteomyelitis; Diabetic Foot Osteomyelitis. Not an offer of treatment.", "searchTerms": [ "Bio X Cell Research LLC", "San Antonio", "Texas", "Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis", "Osteomyelitis", "Diabetic Foot Osteomyelitis", "NCT05177107" ], "studyYears": [ { "trialId": "nct05177107", "start": { "date": "2021-11-24", "kind": "actual" }, "end": { "date": "2025-05-30", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "label": "2021–2025", "dateEvidence": { "start": { "value": { "date": "2021-11-24", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2021-11-24", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2021-11-24", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] }, "end": { "value": { "date": "2025-05-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2025-05-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2025-05-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] } } } ] }, { "uuid": "2f17bfe1938f518ea844f2be4c31fc12", "permalink": "/items/biomarkers-of-phage-treatment-response-in-ntm-and-other-infections-2f17bfe1938f518ea844f2be4c31fc12", "id": "trials/nct07076238", "name": "Biomarkers of Phage Treatment Response in NTM and Other Infections (NCT07076238)", "countries": [ "US" ], "kind": "Observational study", "status": "Recruiting", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT07076238" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct07076238", "start": { "date": "2025-06-25", "kind": "actual" }, "end": { "date": "2032-06-25", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07076238" ], "label": "2025–2032 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-06-25", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07076238" ], "candidates": [ { "date": "2025-06-25", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07076238" ] }, { "date": "2025-06-25", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07076238" ] } ] }, "end": { "value": { "date": "2032-06-25", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07076238" ], "candidates": [ { "date": "2032-06-25", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07076238" ] }, { "date": "2032-06-25", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07076238" ] } ] } } } ], "detail": "Nontuberculous Mycobacterial Lung Disease", "searchTerms": [ "Biomarkers of Phage Treatment Response in NTM and Other Infections", "Nontuberculous Mycobacterial Lung Disease", "NCT07076238", "NYU Langone Health", "New York", "New York", "United States" ] }, { "id": "trial-site/bf5b5e80ec52b06a", "name": "Boston Children's Hospital — Boston, Massachusetts", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04596319", "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct04596319", "nct05010577" ], "location": "Boston, Massachusetts", "detail": "Recorded study locations: Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal; Chronic Pseudomonas Aeruginosa Infection. Not an offer of treatment.", "searchTerms": [ "Boston Children's Hospital", "Boston", "Massachusetts", "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319", "Boston Children's Hospital", "Boston", "Massachusetts", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } }, { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "id": "trial-site/71d47c680d6a3096", "name": "Boston Childrens Hospital — Boston, Massachusetts", "countries": [ "US" ], "kind": "Trial site", "status": "Invitation only (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06262282" ], "checked": "2026-10-03", "trialIds": [ "nct06262282" ], "location": "Boston, Massachusetts", "detail": "Recorded study locations: Cystic Fibrosis; Nontuberculous Mycobacterial Lung Disease; Nontuberculous Mycobacterium Infection; Mycobacterium Infections; Mycobacterium; Pulmonary. Not an offer of treatment.", "searchTerms": [ "Boston Childrens Hospital", "Boston", "Massachusetts", "Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria", "Cystic Fibrosis", "Nontuberculous Mycobacterial Lung Disease", "Nontuberculous Mycobacterium Infection", "Mycobacterium Infections", "Mycobacterium; Pulmonary", "NCT06262282" ], "studyYears": [ { "trialId": "nct06262282", "start": { "date": "2024-02-05", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "label": "2024–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2024-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2024-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] } } } ] }, { "id": "trial-site/2ac1aa5864805f0a", "name": "Brigham & Women's Hospital — Boston, Massachusetts", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05269134" ], "checked": "2026-10-03", "trialIds": [ "nct05269134" ], "location": "Boston, Massachusetts", "detail": "Recorded study locations: Prosthetic Joint Infection. Not an offer of treatment.", "searchTerms": [ "Brigham & Women's Hospital", "Boston", "Massachusetts", "Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)", "Prosthetic Joint Infection", "NCT05269134" ], "studyYears": [ { "trialId": "nct05269134", "start": { "date": "2023-03-27", "kind": "actual" }, "end": { "date": "2027-07", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "label": "2023–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-03-27", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2023-03-27", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2023-03-27", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] }, "end": { "value": { "date": "2027-07", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2027-07", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2027-07", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] } } } ] }, { "id": "therapyRoutes/historical-c3j", "name": "C3J Therapeutics", "countries": [ "US" ], "uuid": "19a9292d1422551dbae94f41fb68d691", "permalink": "/items/c3j-therapeutics-19a9292d1422551dbae94f41fb68d691", "kind": "Company", "status": "Merged into Armata 2019", "activity": "historical", "sources": [ "https://www.sec.gov/Archives/edgar/data/921114/000155837020002943/armp-20191231x10k.htm" ], "checked": "2026-10-03", "detail": "Historical Armata predecessor company.", "searchTerms": [ "Historical Armata predecessor company.", "" ] }, { "id": "trial-site/1a13e2549c7d7f97", "name": "Case Western Reserve University — Cleveland, Ohio", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05453578" ], "checked": "2026-10-03", "trialIds": [ "nct05453578" ], "location": "Cleveland, Ohio", "detail": "Recorded study locations: Bacterial Disease Carrier; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Case Western Reserve University", "Cleveland", "Ohio", "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa", "Bacterial Disease Carrier", "Cystic Fibrosis", "NCT05453578" ], "studyYears": [ { "trialId": "nct05453578", "start": { "date": "2022-10-03", "kind": "actual" }, "end": { "date": "2025-04-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-10-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2022-10-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2022-10-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] }, "end": { "value": { "date": "2025-04-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2025-04-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2025-04-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] } } } ] }, { "id": "trial-site/8d10aa1ccfea5f24", "name": "Central Florida Pulmonary Group — Orlando, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT05010577", "https://clinicaltrials.gov/study/NCT06998043" ], "checked": "2026-10-03", "trialIds": [ "nct05010577", "nct06998043" ], "location": "Orlando, Florida", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis; Cystic Fibrosis (CF). Not an offer of treatment.", "searchTerms": [ "Central Florida Pulmonary Group", "Orlando", "Florida", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577", "Central Florida Pulmonary Group", "Orlando", "Florida", "Study With Phage for CF Subjects With Pseudomonas Lung Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis (CF)", "NCT06998043", "2024-519856-94-00" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } }, { "trialId": "nct06998043", "start": { "date": "2025-07-02", "kind": "actual" }, "end": { "date": "2026-09", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-07-02", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2025-07-02", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-07-02", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-08-18", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] }, "end": { "value": { "date": "2026-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2026-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2026-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-12-08", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] } } } ] }, { "id": "trial-site/129e87865f99efe0", "name": "Children's Hospital Los Angeles — Los Angeles, California", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04596319" ], "checked": "2026-10-03", "trialIds": [ "nct04596319" ], "location": "Los Angeles, California", "detail": "Recorded study locations: Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal. Not an offer of treatment.", "searchTerms": [ "Children's Hospital Los Angeles", "Los Angeles", "California", "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319" ], "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } } ] }, { "id": "trial-site/5d21318b1fc55f77", "name": "Children's Hospital of Los Angeles — Los Angeles, California", "countries": [ "US" ], "kind": "Trial site", "status": "Invitation only (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06262282" ], "checked": "2026-10-03", "trialIds": [ "nct06262282" ], "location": "Los Angeles, California", "detail": "Recorded study locations: Cystic Fibrosis; Nontuberculous Mycobacterial Lung Disease; Nontuberculous Mycobacterium Infection; Mycobacterium Infections; Mycobacterium; Pulmonary. Not an offer of treatment.", "searchTerms": [ "Children's Hospital of Los Angeles", "Los Angeles", "California", "Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria", "Cystic Fibrosis", "Nontuberculous Mycobacterial Lung Disease", "Nontuberculous Mycobacterium Infection", "Mycobacterium Infections", "Mycobacterium; Pulmonary", "NCT06262282" ], "studyYears": [ { "trialId": "nct06262282", "start": { "date": "2024-02-05", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "label": "2024–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2024-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2024-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] } } } ] }, { "id": "trial-site/235b404bda78788a", "name": "Children's National Medical Center — Washington D.C., District of Columbia", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct05010577" ], "location": "Washington D.C., District of Columbia", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Children's National Medical Center", "Washington D.C.", "District of Columbia", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "id": "trial-site/c33718cef351f3fc", "name": "Childrens Hospital Colorado — Denver, Colorado", "countries": [ "US" ], "kind": "Trial site", "status": "Invitation only (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06262282" ], "checked": "2026-10-03", "trialIds": [ "nct06262282" ], "location": "Denver, Colorado", "detail": "Recorded study locations: Cystic Fibrosis; Nontuberculous Mycobacterial Lung Disease; Nontuberculous Mycobacterium Infection; Mycobacterium Infections; Mycobacterium; Pulmonary. Not an offer of treatment.", "searchTerms": [ "Childrens Hospital Colorado", "Denver", "Colorado", "Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria", "Cystic Fibrosis", "Nontuberculous Mycobacterial Lung Disease", "Nontuberculous Mycobacterium Infection", "Mycobacterium Infections", "Mycobacterium; Pulmonary", "NCT06262282" ], "studyYears": [ { "trialId": "nct06262282", "start": { "date": "2024-02-05", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "label": "2024–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2024-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2024-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] } } } ] }, { "id": "trial-site/f33d6b044c1939ab", "name": "Cincinnati Children's Hospital — Cincinnati, Ohio", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct05010577" ], "location": "Cincinnati, Ohio", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Cincinnati Children's Hospital", "Cincinnati", "Ohio", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "id": "trial-site/6b67c4cd77f70c8f", "name": "City of Hope — Duarte, California", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06938867" ], "checked": "2026-10-03", "trialIds": [ "nct06938867" ], "location": "Duarte, California", "detail": "Recorded study locations: E Coli Infections; Allogenic Transplant Patients. Not an offer of treatment.", "searchTerms": [ "City of Hope", "Duarte", "California", "Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant", "E Coli Infections", "Allogenic Transplant Patients", "NCT06938867" ], "studyYears": [ { "trialId": "nct06938867", "start": { "date": "2025-02-25", "kind": "actual" }, "end": { "date": "2026-04-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-02-25", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "candidates": [ { "date": "2025-02-25", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] }, { "date": "2025-02-25", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] } ] }, "end": { "value": { "date": "2026-04-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "candidates": [ { "date": "2026-04-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] }, { "date": "2026-04-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] } ] } } } ] }, { "id": "trial-site/031a07424d49ab69", "name": "Clemente Clinical Research — Los Angeles, California", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05948592" ], "checked": "2026-10-03", "trialIds": [ "nct05948592" ], "location": "Los Angeles, California", "detail": "Recorded study locations: Diabetic Foot Infection. Not an offer of treatment.", "searchTerms": [ "Clemente Clinical Research", "Los Angeles", "California", "Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection", "Diabetic Foot Infection", "NCT05948592", "2023-507716-13-00" ], "studyYears": [ { "trialId": "nct05948592", "start": { "date": "2023-11-08", "kind": "actual" }, "end": { "date": "2025-12-19", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "label": "2023–2025", "dateEvidence": { "start": { "value": { "date": "2023-11-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2023-11-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2023-11-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] } ] }, "end": { "value": { "date": "2025-12-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2025-12-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2023-507716-13-00?lang=en" ] } ] } } } ] }, { "id": "trial-site/24d2e50700c2e205", "name": "Clinical Trials Center, WRAIR — Silver Spring, Maryland", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT02757755" ], "checked": "2026-10-03", "trialIds": [ "nct02757755" ], "location": "Silver Spring, Maryland", "detail": "Recorded study locations: Healthy Volunteers. Not an offer of treatment.", "searchTerms": [ "Clinical Trials Center, WRAIR", "Silver Spring", "Maryland", "Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults", "Healthy Volunteers", "NCT02757755" ], "studyYears": [ { "trialId": "nct02757755", "start": { "date": "2016-05", "kind": "reported" }, "end": { "date": "2016-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02757755" ], "label": "2016–2016", "dateEvidence": { "start": { "value": { "date": "2016-05", "kind": "reported" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02757755" ], "candidates": [ { "date": "2016-05", "kind": "reported", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02757755" ] }, { "date": "2016-05", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02757755" ] } ] }, "end": { "value": { "date": "2016-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02757755" ], "candidates": [ { "date": "2016-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02757755" ] }, { "date": "2016-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT02757755" ] } ] } } } ] }, { "id": "trial-site/1057eaf19492441d", "name": "Colorado State University — Fort Collins, Colorado", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT04511221", "https://clinicaltrials.gov/study/NCT07816809" ], "checked": "2026-10-03", "trialIds": [ "nct04511221", "nct07816809" ], "location": "Fort Collins, Colorado", "detail": "Recorded study locations: Mild Gastrointestinal Symptoms in Healthy Adults; Gastrointestinal Symptoms; Skin Quality. Not an offer of treatment.", "searchTerms": [ "Colorado State University", "Fort Collins", "Colorado", "BacterioPHAGE for Gastrointestinal Health 2 Study", "Mild Gastrointestinal Symptoms in Healthy Adults", "NCT04511221", "Colorado State University", "Fort Collins", "Colorado", "Phage-based Control and Limitation of Pathobionts for Microbiome Equilibrium and Resilience", "Gastrointestinal Symptoms", "Skin Quality", "NCT07816809" ], "studyYears": [ { "trialId": "nct04511221", "start": { "date": "2018-10-01", "kind": "actual" }, "end": { "date": "2020-03-31", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04511221" ], "label": "2018–2020", "dateEvidence": { "start": { "value": { "date": "2018-10-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04511221" ], "candidates": [ { "date": "2018-10-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04511221" ] }, { "date": "2018-10-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04511221" ] } ] }, "end": { "value": { "date": "2020-03-31", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04511221" ], "candidates": [ { "date": "2020-03-31", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04511221" ] }, { "date": "2020-03-31", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04511221" ] } ] } } }, { "trialId": "nct07816809", "start": { "date": "2026-09-14", "kind": "estimated" }, "end": { "date": "2028-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07816809" ], "label": "2026 (estimated)–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-09-14", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07816809" ], "candidates": [ { "date": "2026-09-14", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07816809" ] }, { "date": "2026-09-14", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07816809" ] } ] }, "end": { "value": { "date": "2028-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07816809" ], "candidates": [ { "date": "2028-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07816809" ] }, { "date": "2028-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07816809" ] } ] } } } ] }, { "id": "trial-site/fa627d5e8883ccb5", "name": "Columbia University — New York, New York", "countries": [ "US" ], "kind": "Trial site", "status": "Invitation only (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06262282" ], "checked": "2026-10-03", "trialIds": [ "nct06262282" ], "location": "New York, New York", "detail": "Recorded study locations: Cystic Fibrosis; Nontuberculous Mycobacterial Lung Disease; Nontuberculous Mycobacterium Infection; Mycobacterium Infections; Mycobacterium; Pulmonary. Not an offer of treatment.", "searchTerms": [ "Columbia University", "New York", "New York", "Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria", "Cystic Fibrosis", "Nontuberculous Mycobacterial Lung Disease", "Nontuberculous Mycobacterium Infection", "Mycobacterium Infections", "Mycobacterium; Pulmonary", "NCT06262282" ], "studyYears": [ { "trialId": "nct06262282", "start": { "date": "2024-02-05", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "label": "2024–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2024-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2024-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] } } } ] }, { "id": "trial-site/390d390f5db5c2d3", "name": "CurAlta Foot and Ankle — Westwood, New Jersey", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05177107" ], "checked": "2026-10-03", "trialIds": [ "nct05177107" ], "location": "Westwood, New Jersey", "detail": "Recorded study locations: Osteomyelitis; Diabetic Foot Osteomyelitis. Not an offer of treatment.", "searchTerms": [ "CurAlta Foot and Ankle", "Westwood", "New Jersey", "Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis", "Osteomyelitis", "Diabetic Foot Osteomyelitis", "NCT05177107" ], "studyYears": [ { "trialId": "nct05177107", "start": { "date": "2021-11-24", "kind": "actual" }, "end": { "date": "2025-05-30", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "label": "2021–2025", "dateEvidence": { "start": { "value": { "date": "2021-11-24", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2021-11-24", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2021-11-24", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] }, "end": { "value": { "date": "2025-05-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2025-05-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2025-05-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] } } } ] }, { "uuid": "33d5ef5219c757598dd5d49ce8dce195", "permalink": "/items/cystic-fibrosis-bacteriophage-study-at-yale-cyphy-33d5ef5219c757598dd5d49ce8dce195", "id": "trials/nct04684641", "name": "CYstic Fibrosis bacterioPHage Study at Yale (CYPHY) (NCT04684641)", "countries": [ "US" ], "kind": "Trial", "status": "Completed", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04684641" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct04684641", "start": { "date": "2021-03-29", "kind": "actual" }, "end": { "date": "2023-06-22", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04684641" ], "label": "2021–2023", "dateEvidence": { "start": { "value": { "date": "2021-03-29", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04684641" ], "candidates": [ { "date": "2021-03-29", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04684641" ] }, { "date": "2021-03-29", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04684641" ] } ] }, "end": { "value": { "date": "2023-06-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04684641" ], "candidates": [ { "date": "2023-06-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04684641" ] }, { "date": "2023-06-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04684641" ] } ] } } } ], "detail": "Cystic Fibrosis", "searchTerms": [ "CYstic Fibrosis bacterioPHage Study at Yale (CYPHY)", "Cystic Fibrosis", "NCT04684641", "Yale New Haven Hospital", "New Haven", "Connecticut", "United States" ] }, { "uuid": "3ef0119d874b58b7b9288d6b0bb92eb5", "permalink": "/items/bacteriophage-therapy-in-patients-with-diabetic-foot-osteomyelitis-3ef0119d874b58b7b9288d6b0bb92eb5", "id": "trials/nct05177107", "name": "DANCE (NCT05177107)", "countries": [ "US" ], "kind": "Trial", "status": "Terminated", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05177107" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05177107", "start": { "date": "2021-11-24", "kind": "actual" }, "end": { "date": "2025-05-30", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "label": "2021–2025", "dateEvidence": { "start": { "value": { "date": "2021-11-24", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2021-11-24", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2021-11-24", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] }, "end": { "value": { "date": "2025-05-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2025-05-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2025-05-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] } } } ], "detail": "Osteomyelitis; Diabetic Foot Osteomyelitis", "searchTerms": [ "Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis", "Osteomyelitis", "Diabetic Foot Osteomyelitis", "NCT05177107", "Southern Arizona VA Health Care System", "Tuscon", "Arizona", "United States", "NorthBay Healthcare", "Fairfield", "California", "United States", "Harbor Hospital / UCLA", "Torrance", "California", "United States", "Rocky Mountain VA", "Aurora", "Colorado", "United States", "Holy Cross Health", "Fort Lauderdale", "Florida", "United States", "Infectious Disease Consultants od the Treasure Coast", "Sebastian", "Florida", "United States", "Podiatry 1st / Gateway Clinical Trials", "O'Fallon", "Illinois", "United States", "Foot & Ankle Center of Illinois", "Springfield", "Illinois", "United States", "Henry Ford Health", "Detroit", "Michigan", "United States", "Holy Name Medical Center", "Teaneck", "New Jersey", "United States", "CurAlta Foot and Ankle", "Westwood", "New Jersey", "United States", "Futuro Clinical Trials, LLC", "McAllen", "Texas", "United States", "Bio X Cell Research LLC", "San Antonio", "Texas", "United States", "Foot and Ankle Specialists of the Mid-Atlantic", "Salem", "Virginia", "United States", "Salem VA", "Salem", "Virginia", "United States" ] }, { "id": "trial-site/f8331d0852c3f31d", "name": "Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire", "countries": [ "US" ], "kind": "Trial site", "status": "Invitation only (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06262282" ], "checked": "2026-10-03", "trialIds": [ "nct06262282" ], "location": "Lebanon, New Hampshire", "detail": "Recorded study locations: Cystic Fibrosis; Nontuberculous Mycobacterial Lung Disease; Nontuberculous Mycobacterium Infection; Mycobacterium Infections; Mycobacterium; Pulmonary. Not an offer of treatment.", "searchTerms": [ "Dartmouth Hitchcock Medical Center", "Lebanon", "New Hampshire", "Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria", "Cystic Fibrosis", "Nontuberculous Mycobacterial Lung Disease", "Nontuberculous Mycobacterium Infection", "Mycobacterium Infections", "Mycobacterium; Pulmonary", "NCT06262282" ], "studyYears": [ { "trialId": "nct06262282", "start": { "date": "2024-02-05", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "label": "2024–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2024-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2024-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] } } } ] }, { "id": "trial-site/65289e873681a32b", "name": "DHR Health Institute for Research and Development — Edinburg, Texas", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04287478" ], "checked": "2026-10-03", "trialIds": [ "nct04287478" ], "location": "Edinburg, Texas", "detail": "Recorded study locations: Urinary Tract Infection Bacterial. Not an offer of treatment.", "searchTerms": [ "DHR Health Institute for Research and Development", "Edinburg", "Texas", "Bacteriophage Therapy in Patients With Urinary Tract Infections", "Urinary Tract Infection Bacterial", "NCT04287478" ], "studyYears": [ { "trialId": "nct04287478", "start": { "date": "2020-12-09", "kind": "actual" }, "end": { "date": "2023-02-28", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "label": "2020–2023", "dateEvidence": { "start": { "value": { "date": "2020-12-09", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "candidates": [ { "date": "2020-12-09", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] }, { "date": "2020-12-09", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] } ] }, "end": { "value": { "date": "2023-02-28", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "candidates": [ { "date": "2023-02-28", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] }, { "date": "2023-02-28", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] } ] } } } ] }, { "id": "trial-site/084007565b750e2d", "name": "doTERRA International — Pleasant Grove, Utah", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT06931977" ], "checked": "2026-10-03", "trialIds": [ "nct06931977" ], "location": "Pleasant Grove, Utah", "detail": "Recorded study locations: Healthy. Not an offer of treatment.", "searchTerms": [ "doTERRA International", "Pleasant Grove", "Utah", "Natural Product System and Lifestyle Modification", "Healthy", "NCT06931977" ], "studyYears": [ { "trialId": "nct06931977", "start": { "date": "2025-04-29", "kind": "actual" }, "end": { "date": "2025-09-03", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06931977" ], "label": "2025–2025", "dateEvidence": { "start": { "value": { "date": "2025-04-29", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06931977" ], "candidates": [ { "date": "2025-04-29", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06931977" ] }, { "date": "2025-04-29", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06931977" ] } ] }, "end": { "value": { "date": "2025-09-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06931977" ], "candidates": [ { "date": "2025-09-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06931977" ] }, { "date": "2025-09-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06931977" ] } ] } } } ] }, { "id": "trial-site/c9ea8f3357f83d40", "name": "Duke University Medical Center — Durham, North Carolina", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05453578" ], "checked": "2026-10-03", "trialIds": [ "nct05453578" ], "location": "Durham, North Carolina", "detail": "Recorded study locations: Bacterial Disease Carrier; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Duke University Medical Center", "Durham", "North Carolina", "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa", "Bacterial Disease Carrier", "Cystic Fibrosis", "NCT05453578" ], "studyYears": [ { "trialId": "nct05453578", "start": { "date": "2022-10-03", "kind": "actual" }, "end": { "date": "2025-04-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-10-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2022-10-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2022-10-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] }, "end": { "value": { "date": "2025-04-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2025-04-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2025-04-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] } } } ] }, { "uuid": "092ecdb4ac515d96a5fdca5d1f9d4cc7", "permalink": "/items/a-study-of-lbp-ec01-in-the-treatment-of-acute-uncomplicated-uti-caused-by-drug-resistant-e-092ecdb4ac515d96a5fdca5d1f9d4cc7", "id": "trials/nct05488340", "name": "ELIMINATE (NCT05488340)", "countries": [ "US" ], "kind": "Trial", "status": "Recruiting", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05488340" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05488340", "start": { "date": "2022-07-13", "kind": "actual" }, "end": { "date": "2027-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-07-13", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2022-07-13", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2022-07-13", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] }, "end": { "value": { "date": "2027-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2027-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2027-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] } } } ], "detail": "Urinary Tract Infections", "searchTerms": [ "A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)", "Urinary Tract Infections", "NCT05488340", "Research Site 138", "Fresno", "California", "United States", "Research Site 131", "Lancaster", "California", "United States", "Research Site 123", "Los Angeles", "California", "United States", "Research Site 125", "Montebello", "California", "United States", "Research Site 152", "Murrieta", "California", "United States", "Research Site 137", "San Diego", "California", "United States", "Research Site 126", "Tustin", "California", "United States", "Research Site 102", "Doral", "Florida", "United States", "Research Site 151", "Hialeah", "Florida", "United States", "Research Site 140", "Jensen Beach", "Florida", "United States", "Research Site 103", "Miami", "Florida", "United States", "Research Site 149", "Miami", "Florida", "United States", "Research Site 153", "Ocala", "Florida", "United States", "Research Site 120", "Boston", "Massachusetts", "United States", "Research Site 154", "St Louis", "Missouri", "United States", "Research Site 145", "Raleigh", "North Carolina", "United States", "Research Site 118", "Winston-Salem", "North Carolina", "United States" ] }, { "id": "trial-site/15e8e82a21668715", "name": "Emory University - Adult Cystic Fibrosis Program — Atlanta, Georgia", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05453578" ], "checked": "2026-10-03", "trialIds": [ "nct05453578" ], "location": "Atlanta, Georgia", "detail": "Recorded study locations: Bacterial Disease Carrier; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Emory University - Adult Cystic Fibrosis Program", "Atlanta", "Georgia", "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa", "Bacterial Disease Carrier", "Cystic Fibrosis", "NCT05453578" ], "studyYears": [ { "trialId": "nct05453578", "start": { "date": "2022-10-03", "kind": "actual" }, "end": { "date": "2025-04-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-10-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2022-10-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2022-10-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] }, "end": { "value": { "date": "2025-04-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2025-04-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2025-04-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] } } } ] }, { "id": "trial-site/a3788a17c157a359", "name": "Emory University Hospital Midtown — Atlanta, Georgia", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Atlanta, Georgia", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "Emory University Hospital Midtown", "Atlanta", "Georgia", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "trial-site/92983636b70d70b4", "name": "Food and Nutrition Clinical Research Lab(FNCRL), Colorado State University — Fort Collins, Colorado", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05750433" ], "checked": "2026-10-03", "trialIds": [ "nct05750433" ], "location": "Fort Collins, Colorado", "detail": "Recorded study locations: Gastrointestinal Dysfunction. Not an offer of treatment.", "searchTerms": [ "Food and Nutrition Clinical Research Lab(FNCRL), Colorado State University", "Fort Collins", "Colorado", "Phage 3Determination of Phage/Probiotic Synergistic Effects on Gastrointestinal Health", "Gastrointestinal Dysfunction", "NCT05750433" ], "studyYears": [ { "trialId": "nct05750433", "start": { "date": "2021-10-01", "kind": "actual" }, "end": { "date": "2024-03-31", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05750433" ], "label": "2021–2024", "dateEvidence": { "start": { "value": { "date": "2021-10-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05750433" ], "candidates": [ { "date": "2021-10-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05750433" ] }, { "date": "2021-10-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05750433" ] } ] }, "end": { "value": { "date": "2024-03-31", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05750433" ], "candidates": [ { "date": "2024-03-31", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05750433" ] }, { "date": "2024-03-31", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05750433" ] } ] } } } ] }, { "id": "trial-site/8ae63fd5d57a8e51", "name": "Foot & Ankle Center of Illinois — Springfield, Illinois", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05177107" ], "checked": "2026-10-03", "trialIds": [ "nct05177107" ], "location": "Springfield, Illinois", "detail": "Recorded study locations: Osteomyelitis; Diabetic Foot Osteomyelitis. Not an offer of treatment.", "searchTerms": [ "Foot & Ankle Center of Illinois", "Springfield", "Illinois", "Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis", "Osteomyelitis", "Diabetic Foot Osteomyelitis", "NCT05177107" ], "studyYears": [ { "trialId": "nct05177107", "start": { "date": "2021-11-24", "kind": "actual" }, "end": { "date": "2025-05-30", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "label": "2021–2025", "dateEvidence": { "start": { "value": { "date": "2021-11-24", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2021-11-24", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2021-11-24", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] }, "end": { "value": { "date": "2025-05-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2025-05-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2025-05-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] } } } ] }, { "id": "trial-site/19b8878bcdfc4482", "name": "Foot and Ankle Specialists of the Mid-Atlantic — Salem, Virginia", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05177107" ], "checked": "2026-10-03", "trialIds": [ "nct05177107" ], "location": "Salem, Virginia", "detail": "Recorded study locations: Osteomyelitis; Diabetic Foot Osteomyelitis. Not an offer of treatment.", "searchTerms": [ "Foot and Ankle Specialists of the Mid-Atlantic", "Salem", "Virginia", "Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis", "Osteomyelitis", "Diabetic Foot Osteomyelitis", "NCT05177107" ], "studyYears": [ { "trialId": "nct05177107", "start": { "date": "2021-11-24", "kind": "actual" }, "end": { "date": "2025-05-30", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "label": "2021–2025", "dateEvidence": { "start": { "value": { "date": "2021-11-24", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2021-11-24", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2021-11-24", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] }, "end": { "value": { "date": "2025-05-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2025-05-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2025-05-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] } } } ] }, { "id": "trial-site/12576cb93f764854", "name": "Fred Hutchinson Cancer Center — Seattle, Washington", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06938867" ], "checked": "2026-10-03", "trialIds": [ "nct06938867" ], "location": "Seattle, Washington", "detail": "Recorded study locations: E Coli Infections; Allogenic Transplant Patients. Not an offer of treatment.", "searchTerms": [ "Fred Hutchinson Cancer Center", "Seattle", "Washington", "Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant", "E Coli Infections", "Allogenic Transplant Patients", "NCT06938867" ], "studyYears": [ { "trialId": "nct06938867", "start": { "date": "2025-02-25", "kind": "actual" }, "end": { "date": "2026-04-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-02-25", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "candidates": [ { "date": "2025-02-25", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] }, { "date": "2025-02-25", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] } ] }, "end": { "value": { "date": "2026-04-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "candidates": [ { "date": "2026-04-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] }, { "date": "2026-04-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] } ] } } } ] }, { "id": "trial-site/1d7c2f6a4591a484", "name": "Froedtert Hospital and the Medical College of Wisconsin — Milwaukee, Wisconsin", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Milwaukee, Wisconsin", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "Froedtert Hospital and the Medical College of Wisconsin", "Milwaukee", "Wisconsin", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "trial-site/ef5c2b7d426e3bd1", "name": "Futuro Clinical Trials, LLC — McAllen, Texas", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05177107" ], "checked": "2026-10-03", "trialIds": [ "nct05177107" ], "location": "McAllen, Texas", "detail": "Recorded study locations: Osteomyelitis; Diabetic Foot Osteomyelitis. Not an offer of treatment.", "searchTerms": [ "Futuro Clinical Trials, LLC", "McAllen", "Texas", "Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis", "Osteomyelitis", "Diabetic Foot Osteomyelitis", "NCT05177107" ], "studyYears": [ { "trialId": "nct05177107", "start": { "date": "2021-11-24", "kind": "actual" }, "end": { "date": "2025-05-30", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "label": "2021–2025", "dateEvidence": { "start": { "value": { "date": "2021-11-24", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2021-11-24", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2021-11-24", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] }, "end": { "value": { "date": "2025-05-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2025-05-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2025-05-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] } } } ] }, { "id": "trial-site/fa28fdb7f5d7f09a", "name": "Georgetown University Hospital / Pulmonary Critical Care and Sleep Medicine — Washington D.C., District of Columbia", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct05616221" ], "location": "Washington D.C., District of Columbia", "detail": "Recorded study locations: Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection. Not an offer of treatment.", "searchTerms": [ "Georgetown University Hospital / Pulmonary Critical Care and Sleep Medicine", "Washington D.C.", "District of Columbia", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "id": "therapyRoutes/gladstone-phaige", "name": "Gladstone Center for PhAIge Therapy", "countries": [ "US" ], "uuid": "db60b288ea00536298ed2c90c147e53e", "permalink": "/items/gladstone-center-for-phaige-therapy-db60b288ea00536298ed2c90c147e53e", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://gladstone.org/science/centers/center-for-phaige-therapy/" ], "checked": "2026-10-03", "location": "San Francisco, California; United States", "detail": "2026 research center using phage engineering, computational tools, susceptibility prediction and preclinical infection models.", "searchTerms": [ "2026 research center using phage engineering, computational tools, susceptibility prediction and preclinical infection models.", "San Francisco, California; United States" ] }, { "id": "trial-site/2dc1ec0be53966b9", "name": "Harbor Hospital / UCLA — Torrance, California", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05177107" ], "checked": "2026-10-03", "trialIds": [ "nct05177107" ], "location": "Torrance, California", "detail": "Recorded study locations: Osteomyelitis; Diabetic Foot Osteomyelitis. Not an offer of treatment.", "searchTerms": [ "Harbor Hospital / UCLA", "Torrance", "California", "Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis", "Osteomyelitis", "Diabetic Foot Osteomyelitis", "NCT05177107" ], "studyYears": [ { "trialId": "nct05177107", "start": { "date": "2021-11-24", "kind": "actual" }, "end": { "date": "2025-05-30", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "label": "2021–2025", "dateEvidence": { "start": { "value": { "date": "2021-11-24", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2021-11-24", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2021-11-24", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] }, "end": { "value": { "date": "2025-05-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2025-05-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2025-05-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] } } } ] }, { "id": "trial-site/19446573fd7db12f", "name": "Harper University Hospital — Detroit, Michigan", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04596319" ], "checked": "2026-10-03", "trialIds": [ "nct04596319" ], "location": "Detroit, Michigan", "detail": "Recorded study locations: Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal. Not an offer of treatment.", "searchTerms": [ "Harper University Hospital", "Detroit", "Michigan", "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319" ], "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } } ] }, { "id": "trial-site/96f1f110987fd95c", "name": "Hartford Health Care Bone & Joint Insitute — Hartford, Connecticut", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05269134" ], "checked": "2026-10-03", "trialIds": [ "nct05269134" ], "location": "Hartford, Connecticut", "detail": "Recorded study locations: Prosthetic Joint Infection. Not an offer of treatment.", "searchTerms": [ "Hartford Health Care Bone & Joint Insitute", "Hartford", "Connecticut", "Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)", "Prosthetic Joint Infection", "NCT05269134" ], "studyYears": [ { "trialId": "nct05269134", "start": { "date": "2023-03-27", "kind": "actual" }, "end": { "date": "2027-07", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "label": "2023–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-03-27", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2023-03-27", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2023-03-27", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] }, "end": { "value": { "date": "2027-07", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2027-07", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2027-07", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] } } } ] }, { "id": "trial-site/cc09c03be896c09f", "name": "Henry Ford Health — Detroit, Michigan", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05177107" ], "checked": "2026-10-03", "trialIds": [ "nct05177107" ], "location": "Detroit, Michigan", "detail": "Recorded study locations: Osteomyelitis; Diabetic Foot Osteomyelitis. Not an offer of treatment.", "searchTerms": [ "Henry Ford Health", "Detroit", "Michigan", "Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis", "Osteomyelitis", "Diabetic Foot Osteomyelitis", "NCT05177107" ], "studyYears": [ { "trialId": "nct05177107", "start": { "date": "2021-11-24", "kind": "actual" }, "end": { "date": "2025-05-30", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "label": "2021–2025", "dateEvidence": { "start": { "value": { "date": "2021-11-24", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2021-11-24", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2021-11-24", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] }, "end": { "value": { "date": "2025-05-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2025-05-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2025-05-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] } } } ] }, { "id": "trial-site/0c7dac77c49dc771", "name": "Henry Ford Health System — Detroit, Michigan", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Detroit, Michigan", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "Henry Ford Health System", "Detroit", "Michigan", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "trial-site/2ad6df6739b8a4b5", "name": "Henry Ford Hospital — Detroit, Michigan", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04287478" ], "checked": "2026-10-03", "trialIds": [ "nct04287478" ], "location": "Detroit, Michigan", "detail": "Recorded study locations: Urinary Tract Infection Bacterial. Not an offer of treatment.", "searchTerms": [ "Henry Ford Hospital", "Detroit", "Michigan", "Bacteriophage Therapy in Patients With Urinary Tract Infections", "Urinary Tract Infection Bacterial", "NCT04287478" ], "studyYears": [ { "trialId": "nct04287478", "start": { "date": "2020-12-09", "kind": "actual" }, "end": { "date": "2023-02-28", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "label": "2020–2023", "dateEvidence": { "start": { "value": { "date": "2020-12-09", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "candidates": [ { "date": "2020-12-09", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] }, { "date": "2020-12-09", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] } ] }, "end": { "value": { "date": "2023-02-28", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "candidates": [ { "date": "2023-02-28", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] }, { "date": "2023-02-28", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] } ] } } } ] }, { "id": "trial-site/9c4483f4cf448536", "name": "Holy Cross Health — Fort Lauderdale, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05177107" ], "checked": "2026-10-03", "trialIds": [ "nct05177107" ], "location": "Fort Lauderdale, Florida", "detail": "Recorded study locations: Osteomyelitis; Diabetic Foot Osteomyelitis. Not an offer of treatment.", "searchTerms": [ "Holy Cross Health", "Fort Lauderdale", "Florida", "Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis", "Osteomyelitis", "Diabetic Foot Osteomyelitis", "NCT05177107" ], "studyYears": [ { "trialId": "nct05177107", "start": { "date": "2021-11-24", "kind": "actual" }, "end": { "date": "2025-05-30", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "label": "2021–2025", "dateEvidence": { "start": { "value": { "date": "2021-11-24", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2021-11-24", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2021-11-24", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] }, "end": { "value": { "date": "2025-05-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2025-05-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2025-05-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] } } } ] }, { "id": "trial-site/1a797adcef7c87c2", "name": "Holy Name Medical Center — Teaneck, New Jersey", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05177107" ], "checked": "2026-10-03", "trialIds": [ "nct05177107" ], "location": "Teaneck, New Jersey", "detail": "Recorded study locations: Osteomyelitis; Diabetic Foot Osteomyelitis. Not an offer of treatment.", "searchTerms": [ "Holy Name Medical Center", "Teaneck", "New Jersey", "Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis", "Osteomyelitis", "Diabetic Foot Osteomyelitis", "NCT05177107" ], "studyYears": [ { "trialId": "nct05177107", "start": { "date": "2021-11-24", "kind": "actual" }, "end": { "date": "2025-05-30", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "label": "2021–2025", "dateEvidence": { "start": { "value": { "date": "2021-11-24", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2021-11-24", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2021-11-24", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] }, "end": { "value": { "date": "2025-05-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2025-05-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2025-05-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] } } } ] }, { "id": "trial-site/bc39fd11516dc0a6", "name": "Icahn School of Medicine at Mount Sinai — New York, New York", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "New York, New York", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "Icahn School of Medicine at Mount Sinai", "New York", "New York", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "trial-site/75ef53c973ff4eae", "name": "Icahn School of Medicine at Mount Sinai Hospital — New York, New York", "countries": [ "US" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT03808103" ], "checked": "2026-10-03", "trialIds": [ "nct03808103" ], "location": "New York, New York", "detail": "Recorded study locations: Crohn Disease. Not an offer of treatment.", "searchTerms": [ "Icahn School of Medicine at Mount Sinai Hospital", "New York", "New York", "Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease", "Crohn Disease", "NCT03808103" ], "studyYears": [ { "trialId": "nct03808103", "start": { "date": "2019-05-01", "kind": "actual" }, "end": { "date": "2026-06-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ], "label": "2019–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2019-05-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ], "candidates": [ { "date": "2019-05-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ] }, { "date": "2019-05-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ] } ] }, "end": { "value": { "date": "2026-06-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ], "candidates": [ { "date": "2026-06-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ] }, { "date": "2026-06-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ] } ] } } } ] }, { "id": "trial-site/bf3a83c810d6eba3", "name": "Infectious Disease Consultants od the Treasure Coast — Sebastian, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05177107" ], "checked": "2026-10-03", "trialIds": [ "nct05177107" ], "location": "Sebastian, Florida", "detail": "Recorded study locations: Osteomyelitis; Diabetic Foot Osteomyelitis. Not an offer of treatment.", "searchTerms": [ "Infectious Disease Consultants od the Treasure Coast", "Sebastian", "Florida", "Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis", "Osteomyelitis", "Diabetic Foot Osteomyelitis", "NCT05177107" ], "studyYears": [ { "trialId": "nct05177107", "start": { "date": "2021-11-24", "kind": "actual" }, "end": { "date": "2025-05-30", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "label": "2021–2025", "dateEvidence": { "start": { "value": { "date": "2021-11-24", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2021-11-24", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2021-11-24", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] }, "end": { "value": { "date": "2025-05-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2025-05-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2025-05-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] } } } ] }, { "id": "trial-site/6c479b93c62e7147", "name": "Innovation Medical Research Center — Palmetto Bay, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04191148" ], "checked": "2026-10-03", "trialIds": [ "nct04191148" ], "location": "Palmetto Bay, Florida", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Innovation Medical Research Center", "Palmetto Bay", "Florida", "Safety, Tolerability, and PK of LBP-EC01 in Patients With Lower Urinary Tract Colonization Caused by E. Coli", "Urinary Tract Infections", "NCT04191148" ], "studyYears": [ { "trialId": "nct04191148", "start": { "date": "2019-12-30", "kind": "actual" }, "end": { "date": "2020-11-19", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "label": "2019–2020", "dateEvidence": { "start": { "value": { "date": "2019-12-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "candidates": [ { "date": "2019-12-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] }, { "date": "2019-12-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] } ] }, "end": { "value": { "date": "2020-11-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "candidates": [ { "date": "2020-11-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] }, { "date": "2020-11-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] } ] } } } ] }, { "id": "trial-site/e3741f5261bc90f7", "name": "Innovation Medical Research Center, Inc — Palmetto Bay, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04287478" ], "checked": "2026-10-03", "trialIds": [ "nct04287478" ], "location": "Palmetto Bay, Florida", "detail": "Recorded study locations: Urinary Tract Infection Bacterial. Not an offer of treatment.", "searchTerms": [ "Innovation Medical Research Center, Inc", "Palmetto Bay", "Florida", "Bacteriophage Therapy in Patients With Urinary Tract Infections", "Urinary Tract Infection Bacterial", "NCT04287478" ], "studyYears": [ { "trialId": "nct04287478", "start": { "date": "2020-12-09", "kind": "actual" }, "end": { "date": "2023-02-28", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "label": "2020–2023", "dateEvidence": { "start": { "value": { "date": "2020-12-09", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "candidates": [ { "date": "2020-12-09", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] }, { "date": "2020-12-09", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] } ] }, "end": { "value": { "date": "2023-02-28", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "candidates": [ { "date": "2023-02-28", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] }, { "date": "2023-02-28", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] } ] } } } ] }, { "id": "therapyRoutes/intralytix", "name": "Intralytix", "countries": [ "US" ], "uuid": "a5131fe71a835d2fbf02e4ac488b09bc", "permalink": "/items/intralytix-a5131fe71a835d2fbf02e4ac488b09bc", "kind": "Supplier", "status": "Official referral/inquiry route", "activity": "current", "sources": [ "https://www.intralytix.com/expanded-access", "https://www.intralytix.com/clinical-trials", "https://clinicaltrials.gov/study/NCT03808103", "https://clinicaltrials.gov/study/NCT05182749", "https://clinicaltrials.gov/study/NCT05715619" ], "checked": "2026-10-03", "trialIds": [ "nct03808103", "nct05182749", "nct05715619" ], "location": "Columbia, Maryland; United States", "detail": "Supplier expanded access plus EcoActive, ShigActive and VRELysin clinical development; fixed indications and product availability limit access.", "searchTerms": [ "Supplier expanded access plus EcoActive, ShigActive and VRELysin clinical development; fixed indications and product availability limit access.", "Columbia, Maryland; United States" ] }, { "id": "trial-site/c992b9c00dd7ebac", "name": "James J. Peters VA Medical Center — The Bronx, New York", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04287478" ], "checked": "2026-10-03", "trialIds": [ "nct04287478" ], "location": "The Bronx, New York", "detail": "Recorded study locations: Urinary Tract Infection Bacterial. Not an offer of treatment.", "searchTerms": [ "James J. Peters VA Medical Center", "The Bronx", "New York", "Bacteriophage Therapy in Patients With Urinary Tract Infections", "Urinary Tract Infection Bacterial", "NCT04287478" ], "studyYears": [ { "trialId": "nct04287478", "start": { "date": "2020-12-09", "kind": "actual" }, "end": { "date": "2023-02-28", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "label": "2020–2023", "dateEvidence": { "start": { "value": { "date": "2020-12-09", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "candidates": [ { "date": "2020-12-09", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] }, { "date": "2020-12-09", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] } ] }, "end": { "value": { "date": "2023-02-28", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "candidates": [ { "date": "2023-02-28", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] }, { "date": "2023-02-28", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] } ] } } } ] }, { "id": "trial-site/d50e3ca239b44fcc", "name": "Joe DiMaggio Children's Health — Hollywood, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT06998043" ], "checked": "2026-10-03", "trialIds": [ "nct06998043" ], "location": "Hollywood, Florida", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis (CF). Not an offer of treatment.", "searchTerms": [ "Joe DiMaggio Children's Health", "Hollywood", "Florida", "Study With Phage for CF Subjects With Pseudomonas Lung Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis (CF)", "NCT06998043", "2024-519856-94-00" ], "studyYears": [ { "trialId": "nct06998043", "start": { "date": "2025-07-02", "kind": "actual" }, "end": { "date": "2026-09", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-07-02", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2025-07-02", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-07-02", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-08-18", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] }, "end": { "value": { "date": "2026-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2026-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2026-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-12-08", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] } } } ] }, { "id": "trial-site/43ea24428d43e842", "name": "Joe DiMaggio Children's Hospital — Hollywood, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct05010577" ], "location": "Hollywood, Florida", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Joe DiMaggio Children's Hospital", "Hollywood", "Florida", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "id": "trial-site/f5bc786850c20341", "name": "John Hopkins University — Baltimore, Maryland", "countries": [ "US" ], "kind": "Trial site", "status": "Mixed trial statuses", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06262282", "https://clinicaltrials.gov/study/NCT06938867" ], "checked": "2026-10-03", "trialIds": [ "nct06262282", "nct06938867" ], "location": "Baltimore, Maryland", "detail": "Recorded study locations: Cystic Fibrosis; Nontuberculous Mycobacterial Lung Disease; Nontuberculous Mycobacterium Infection; Mycobacterium Infections; Mycobacterium; Pulmonary; E Coli Infections; Allogenic Transplant Patients. Not an offer of treatment.", "searchTerms": [ "John Hopkins University", "Baltimore", "Maryland", "Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria", "Cystic Fibrosis", "Nontuberculous Mycobacterial Lung Disease", "Nontuberculous Mycobacterium Infection", "Mycobacterium Infections", "Mycobacterium; Pulmonary", "NCT06262282", "John Hopkins University", "Baltimore", "Maryland", "Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant", "E Coli Infections", "Allogenic Transplant Patients", "NCT06938867" ], "studyYears": [ { "trialId": "nct06262282", "start": { "date": "2024-02-05", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "label": "2024–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2024-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2024-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] } } }, { "trialId": "nct06938867", "start": { "date": "2025-02-25", "kind": "actual" }, "end": { "date": "2026-04-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-02-25", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "candidates": [ { "date": "2025-02-25", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] }, { "date": "2025-02-25", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] } ] }, "end": { "value": { "date": "2026-04-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "candidates": [ { "date": "2026-04-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] }, { "date": "2026-04-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] } ] } } } ] }, { "id": "therapyRoutes/johns-hopkins-ecoactive", "name": "Johns Hopkins — EcoActive Crohn's research site", "countries": [ "US" ], "uuid": "803bc17c77d75c408fcf6b0196ee8d28", "permalink": "/items/johns-hopkins-ecoactive-crohn-s-research-site-803bc17c77d75c408fcf6b0196ee8d28", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.intralytix.com/clinical-trial/5", "https://clinicaltrials.gov/study/NCT03808103" ], "checked": "2026-10-03", "trialIds": [ "nct03808103" ], "location": "Baltimore, Maryland; United States", "detail": "EcoActive oral E. coli phage preparation for adults with inactive Crohn's and intestinal adherent-invasive E. coli.", "searchTerms": [ "EcoActive oral E. coli phage preparation for adults with inactive Crohn's and intestinal adherent-invasive E. coli.", "Baltimore, Maryland; United States" ] }, { "id": "trial-site/58439d79a5f8207c", "name": "Johns Hopkins Green Spring Station — Lutherville, Maryland", "countries": [ "US" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT03808103" ], "checked": "2026-10-03", "trialIds": [ "nct03808103" ], "location": "Lutherville, Maryland", "detail": "Recorded study locations: Crohn Disease. Not an offer of treatment.", "searchTerms": [ "Johns Hopkins Green Spring Station", "Lutherville", "Maryland", "Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease", "Crohn Disease", "NCT03808103" ], "studyYears": [ { "trialId": "nct03808103", "start": { "date": "2019-05-01", "kind": "actual" }, "end": { "date": "2026-06-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ], "label": "2019–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2019-05-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ], "candidates": [ { "date": "2019-05-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ] }, { "date": "2019-05-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ] } ] }, "end": { "value": { "date": "2026-06-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ], "candidates": [ { "date": "2026-06-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ] }, { "date": "2026-06-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ] } ] } } } ] }, { "id": "trial-site/a72e232f4dce3892", "name": "Johns Hopkins University — Baltimore, Maryland", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04596319", "https://clinicaltrials.gov/study/NCT05184764", "https://clinicaltrials.gov/study/NCT05453578" ], "checked": "2026-10-03", "trialIds": [ "nct04596319", "nct05184764", "nct05453578" ], "location": "Baltimore, Maryland", "detail": "Recorded study locations: Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal; Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus; Bacterial Disease Carrier. Not an offer of treatment.", "searchTerms": [ "Johns Hopkins University", "Baltimore", "Maryland", "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319", "Johns Hopkins University", "Baltimore", "Maryland", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764", "Johns Hopkins University", "Baltimore", "Maryland", "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa", "Bacterial Disease Carrier", "Cystic Fibrosis", "NCT05453578" ], "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } }, { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } }, { "trialId": "nct05453578", "start": { "date": "2022-10-03", "kind": "actual" }, "end": { "date": "2025-04-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-10-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2022-10-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2022-10-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] }, "end": { "value": { "date": "2025-04-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2025-04-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2025-04-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] } } } ] }, { "id": "trial-site/395a7b7117dd9377", "name": "Johns Hopkins University School of Medicine — Baltimore, Maryland", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct05616221" ], "location": "Baltimore, Maryland", "detail": "Recorded study locations: Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection. Not an offer of treatment.", "searchTerms": [ "Johns Hopkins University School of Medicine", "Baltimore", "Maryland", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "id": "therapyRoutes/locus", "name": "Locus Biosciences", "countries": [ "US" ], "uuid": "27fabc4274d156d681d07d8ec0e1aace", "permalink": "/items/locus-biosciences-27fabc4274d156d681d07d8ec0e1aace", "kind": "Company", "status": "Official referral/inquiry route", "activity": "current", "sources": [ "https://www.locus-bio.com/pipeline/", "https://clinicaltrials.gov/study/NCT05488340" ], "checked": "2026-10-03", "trialIds": [ "nct05488340" ], "location": "Research Triangle Park, North Carolina; United States", "detail": "LBP-EC01 engineered CRISPR-Cas3 E. coli phage therapy for drug-resistant acute uncomplicated UTI; other pipeline programs are separate development work.", "searchTerms": [ "LBP-EC01 engineered CRISPR-Cas3 E. coli phage therapy for drug-resistant acute uncomplicated UTI; other pipeline programs are separate development work.", "Research Triangle Park, North Carolina; United States" ] }, { "id": "trial-site/194d5d36a4d64510", "name": "Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center — Torrance, California", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Torrance, California", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center", "Torrance", "California", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "trial-site/9cc88f58a567ea02", "name": "Massachusetts General Hospital — Boston, Massachusetts", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04596319" ], "checked": "2026-10-03", "trialIds": [ "nct04596319" ], "location": "Boston, Massachusetts", "detail": "Recorded study locations: Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal. Not an offer of treatment.", "searchTerms": [ "Massachusetts General Hospital", "Boston", "Massachusetts", "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319" ], "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } } ] }, { "id": "trial-site/747d69b7091a7970", "name": "Mayo Clinic — Rochester, Minnesota", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04787250", "https://clinicaltrials.gov/study/NCT05269134", "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct04787250", "nct05269134", "nct05616221" ], "location": "Rochester, Minnesota", "detail": "Recorded study locations: Prosthetic Joint Infection; Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection. Not an offer of treatment.", "searchTerms": [ "Mayo Clinic", "Rochester", "Minnesota", "Bacteriophage Therapy in Patients With Prosthetic Joint Infections", "Prosthetic Joint Infection", "NCT04787250", "Mayo Clinic", "Rochester", "Minnesota", "Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)", "Prosthetic Joint Infection", "NCT05269134", "Mayo Clinic", "Rochester", "Minnesota", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct04787250", "start": { "date": "2022-10", "kind": "estimated" }, "end": { "date": "2024-05", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04787250" ], "label": "2022 (estimated)–2024 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-10", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04787250" ], "candidates": [ { "date": "2022-10", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04787250" ] }, { "date": "2022-10", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04787250" ] } ] }, "end": { "value": { "date": "2024-05", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04787250" ], "candidates": [ { "date": "2024-05", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04787250" ] }, { "date": "2024-05", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04787250" ] } ] } } }, { "trialId": "nct05269134", "start": { "date": "2023-03-27", "kind": "actual" }, "end": { "date": "2027-07", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "label": "2023–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-03-27", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2023-03-27", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2023-03-27", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] }, "end": { "value": { "date": "2027-07", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2027-07", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2027-07", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] } } }, { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "uuid": "e4fc08cbad11504897bf38fee937bbf5", "permalink": "/items/mayo-clinic-phage-program-biobank-e4fc08cbad11504897bf38fee937bbf5", "id": "trials/nct05314426", "name": "Mayo Clinic Phage Program Biobank (NCT05314426)", "countries": [ "US" ], "kind": "Observational study", "status": "Invitation only", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05314426" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05314426", "start": { "date": "2022-04-19", "kind": "actual" }, "end": { "date": "2027-04", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05314426" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-04-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05314426" ], "candidates": [ { "date": "2022-04-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05314426" ] }, { "date": "2022-04-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05314426" ] } ] }, "end": { "value": { "date": "2027-04", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05314426" ], "candidates": [ { "date": "2027-04", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05314426" ] }, { "date": "2027-04", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05314426" ] } ] } } } ], "detail": "Bacteriophage Therapy", "searchTerms": [ "Mayo Clinic Phage Program Biobank", "Bacteriophage Therapy", "NCT05314426", "Mayo Clinic Rochester", "Rochester", "Minnesota", "United States" ] }, { "id": "therapyRoutes/mayo-phage", "name": "Mayo Clinic Phage Therapy Program", "countries": [ "US" ], "uuid": "ab1c2c01adb55b17b9c2d1b87d99dcea", "permalink": "/items/mayo-clinic-phage-therapy-program-ab1c2c01adb55b17b9c2d1b87d99dcea", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.mayoclinic.org/biographies/suh-gina-a-m-d/bio-20462452", "https://www.mayo.edu/research/clinical-trials/cls-20531162", "https://newsnetwork.mayoclinic.org/discussion/in-a-first-mayo-clinic-treats-cardiology-patient-with-phage-therapy/", "https://clinicaltrials.gov/study/NCT05314426", "https://clinicaltrials.gov/study/NCT04787250" ], "checked": "2026-10-03", "trialIds": [ "nct04787250", "nct05314426" ], "location": "Rochester, Minnesota; United States", "detail": "Clinical program with musculoskeletal and device-associated infection experience; published LVAD case. Observational phage biobank is enrolling by invitation.", "searchTerms": [ "Clinical program with musculoskeletal and device-associated infection experience; published LVAD case. Observational phage biobank is enrolling by invitation.", "Rochester, Minnesota; United States" ] }, { "id": "trial-site/cd66b4d89e4491ec", "name": "Mayo Clinic Rochester — Rochester, Minnesota", "countries": [ "US" ], "kind": "Trial site", "status": "Invitation only (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05314426" ], "checked": "2026-10-03", "trialIds": [ "nct05314426" ], "location": "Rochester, Minnesota", "detail": "Recorded study locations: Bacteriophage Therapy. Not an offer of treatment.", "searchTerms": [ "Mayo Clinic Rochester", "Rochester", "Minnesota", "Mayo Clinic Phage Program Biobank", "Bacteriophage Therapy", "NCT05314426" ], "studyYears": [ { "trialId": "nct05314426", "start": { "date": "2022-04-19", "kind": "actual" }, "end": { "date": "2027-04", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05314426" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-04-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05314426" ], "candidates": [ { "date": "2022-04-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05314426" ] }, { "date": "2022-04-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05314426" ] } ] }, "end": { "value": { "date": "2027-04", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05314426" ], "candidates": [ { "date": "2027-04", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05314426" ] }, { "date": "2027-04", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05314426" ] } ] } } } ] }, { "id": "trial-site/c9426b52fef81903", "name": "Mayo Clinic/Pulmonary, Critical Care, and Sleep Medicine — Jacksonville, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct05616221" ], "location": "Jacksonville, Florida", "detail": "Recorded study locations: Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection. Not an offer of treatment.", "searchTerms": [ "Mayo Clinic/Pulmonary, Critical Care, and Sleep Medicine", "Jacksonville", "Florida", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "id": "trial-site/79222d4d6ab792a5", "name": "Medical Facility — Cincinnati, Ohio", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04737876" ], "checked": "2026-10-03", "trialIds": [ "nct04737876" ], "location": "Cincinnati, Ohio", "detail": "Recorded study locations: Healthy Volunteers. Not an offer of treatment.", "searchTerms": [ "Medical Facility", "Cincinnati", "Ohio", "A Study to Evaluate the Safety, Tolerability, and Fecal Pharmacokinetics of BX002-A in Healthy Adults", "Healthy Volunteers", "NCT04737876" ], "studyYears": [ { "trialId": "nct04737876", "start": { "date": "2020-10-28", "kind": "actual" }, "end": { "date": "2020-12-21", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04737876" ], "label": "2020–2020", "dateEvidence": { "start": { "value": { "date": "2020-10-28", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04737876" ], "candidates": [ { "date": "2020-10-28", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04737876" ] }, { "date": "2020-10-28", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04737876" ] } ] }, "end": { "value": { "date": "2020-12-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04737876" ], "candidates": [ { "date": "2020-12-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04737876" ] }, { "date": "2020-12-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04737876" ] } ] } } } ] }, { "id": "trial-site/4bd71dc6e2978657", "name": "Medical University of South Carolina — Charleston, South Carolina", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04596319", "https://clinicaltrials.gov/study/NCT05010577", "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct04596319", "nct05010577", "nct05616221" ], "location": "Charleston, South Carolina", "detail": "Recorded study locations: Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal; Chronic Pseudomonas Aeruginosa Infection; Non-cystic Fibrosis Bronchiectasis. Not an offer of treatment.", "searchTerms": [ "Medical University of South Carolina", "Charleston", "South Carolina", "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319", "Medical University of South Carolina", "Charleston", "South Carolina", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577", "Medical University of South Carolina", "Charleston", "South Carolina", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } }, { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } }, { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "id": "trial-site/1979d14df1a77d59", "name": "Medpace Clinical Pharmacology — Cincinnati, Ohio", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05277350" ], "checked": "2026-10-03", "trialIds": [ "nct05277350" ], "location": "Cincinnati, Ohio", "detail": "Recorded study locations: E.Coli Infections; Bloodstream Infection. Not an offer of treatment.", "searchTerms": [ "Medpace Clinical Pharmacology", "Cincinnati", "Ohio", "A Study Investigating the Safety, Recovery, and Pharmacodynamics of Multiple Oral Administrations of SNIPR001 in Healthy Subjects", "E.Coli Infections", "Bloodstream Infection", "NCT05277350" ], "studyYears": [ { "trialId": "nct05277350", "start": { "date": "2022-03-24", "kind": "actual" }, "end": { "date": "2023-05-01", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05277350" ], "label": "2022–2023", "dateEvidence": { "start": { "value": { "date": "2022-03-24", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05277350" ], "candidates": [ { "date": "2022-03-24", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05277350" ] }, { "date": "2022-03-24", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05277350" ] } ] }, "end": { "value": { "date": "2023-05-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05277350" ], "candidates": [ { "date": "2023-05-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05277350" ] }, { "date": "2023-05-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05277350" ] } ] } } } ] }, { "id": "trial-site/9a741205cfbd16a5", "name": "Methodist Hospital Research Institute - Houston — Houston, Texas", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Houston, Texas", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "Methodist Hospital Research Institute - Houston", "Houston", "Texas", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "trial-site/ab30356e25d2e069", "name": "Michael E. DeBakey VA Medical Center — Houston, Texas", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06559618" ], "checked": "2026-10-03", "trialIds": [ "nct06559618" ], "location": "Houston, Texas", "detail": "Recorded study locations: Bacteriuria; Spinal Cord Injuries; Asymptomatic Bacteriuria; Escherichia Coli. Not an offer of treatment.", "searchTerms": [ "Michael E. DeBakey VA Medical Center", "Houston", "Texas", "Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria", "Bacteriuria", "Spinal Cord Injuries", "Asymptomatic Bacteriuria", "Escherichia Coli", "NCT06559618" ], "studyYears": [ { "trialId": "nct06559618", "start": { "date": "2025-02-03", "kind": "actual" }, "end": { "date": "2028-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ], "label": "2025–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-02-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ], "candidates": [ { "date": "2025-02-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ] }, { "date": "2025-02-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ] } ] }, "end": { "value": { "date": "2028-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ], "candidates": [ { "date": "2028-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ] }, { "date": "2028-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ] } ] } } } ] }, { "id": "therapyRoutes/houston-va-sci", "name": "Michael E. DeBakey VA Medical Center — SCI bacteriuria trial", "countries": [ "US" ], "uuid": "4eaf6e7377885c1f898666c41ccb506a", "permalink": "/items/michael-e-debakey-va-medical-center-sci-bacteriuria-trial-4eaf6e7377885c1f898666c41ccb506a", "kind": "Center", "status": "Official referral/inquiry route", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06559618" ], "checked": "2026-10-03", "trialIds": [ "nct06559618" ], "location": "Houston, Texas; United States", "accessMode": "trial-inquiry", "detail": "Spinal cord injury E. coli bacteriuria; personalized intravesical phage/placebo research.", "searchTerms": [ "Spinal cord injury E. coli bacteriuria; personalized intravesical phage/placebo research.", "Houston, Texas; United States" ] }, { "id": "trial-site/ddf851661df7eb3c", "name": "Michigan Medicine — Ann Arbor, Michigan", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05453578" ], "checked": "2026-10-03", "trialIds": [ "nct05453578" ], "location": "Ann Arbor, Michigan", "detail": "Recorded study locations: Bacterial Disease Carrier; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Michigan Medicine", "Ann Arbor", "Michigan", "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa", "Bacterial Disease Carrier", "Cystic Fibrosis", "NCT05453578" ], "studyYears": [ { "trialId": "nct05453578", "start": { "date": "2022-10-03", "kind": "actual" }, "end": { "date": "2025-04-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-10-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2022-10-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2022-10-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] }, "end": { "value": { "date": "2025-04-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2025-04-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2025-04-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] } } } ] }, { "id": "trial-site/c4a3dfa9e7e8364d", "name": "Montefiore Medical Center — The Bronx, New York", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "The Bronx, New York", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "Montefiore Medical Center", "The Bronx", "New York", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "therapyRoutes/mount-sinai-ecoactive", "name": "Mount Sinai — EcoActive Crohn's research site", "countries": [ "US" ], "uuid": "fc10d87895c85559ad97e6e0ab6fe1dd", "permalink": "/items/mount-sinai-ecoactive-crohn-s-research-site-fc10d87895c85559ad97e6e0ab6fe1dd", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.intralytix.com/clinical-trial/5", "https://www.mountsinai.org/clinical-trials/safety-efficacy-of-ecoactive-on-intestinal-adherent-invasive-e-coli-in-patients-with-inactive-crohns-disease", "https://clinicaltrials.gov/study/NCT03808103" ], "checked": "2026-10-03", "trialIds": [ "nct03808103" ], "location": "New York, New York; United States", "detail": "EcoActive in inactive Crohn's with intestinal adherent-invasive E. coli.", "searchTerms": [ "EcoActive in inactive Crohn's with intestinal adherent-invasive E. coli.", "New York, New York; United States" ] }, { "id": "trial-site/a4d4bdbdcf17b800", "name": "National Jewish Health — Denver, Colorado", "countries": [ "US" ], "kind": "Trial site", "status": "Mixed trial statuses", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06262282", "https://clinicaltrials.gov/study/NCT06998043" ], "checked": "2026-10-03", "trialIds": [ "nct06262282", "nct06998043" ], "location": "Denver, Colorado", "detail": "Recorded study locations: Cystic Fibrosis; Nontuberculous Mycobacterial Lung Disease; Nontuberculous Mycobacterium Infection; Mycobacterium Infections; Mycobacterium; Pulmonary; Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis (CF). Not an offer of treatment.", "searchTerms": [ "National Jewish Health", "Denver", "Colorado", "Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria", "Cystic Fibrosis", "Nontuberculous Mycobacterial Lung Disease", "Nontuberculous Mycobacterium Infection", "Mycobacterium Infections", "Mycobacterium; Pulmonary", "NCT06262282", "National Jewish Health", "Denver", "Colorado", "Study With Phage for CF Subjects With Pseudomonas Lung Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis (CF)", "NCT06998043", "2024-519856-94-00" ], "studyYears": [ { "trialId": "nct06262282", "start": { "date": "2024-02-05", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "label": "2024–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2024-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2024-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] } } }, { "trialId": "nct06998043", "start": { "date": "2025-07-02", "kind": "actual" }, "end": { "date": "2026-09", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-07-02", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2025-07-02", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-07-02", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-08-18", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] }, "end": { "value": { "date": "2026-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2026-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2026-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-12-08", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] } } } ] }, { "id": "therapyRoutes/national-jewish", "name": "National Jewish Health / POSTSTAMP", "countries": [ "US" ], "uuid": "6a8459e6d74c5ba29b09362c64bdbc16", "permalink": "/items/national-jewish-health-poststamp-6a8459e6d74c5ba29b09362c64bdbc16", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT06262282", "https://www.nationaljewish.org/about-us/news/press-releases/2022-news/researchers-use-virus-to-fight-bacterial-infection%2C-clearing-way-for-life-saving-lung-transplant" ], "checked": "2026-10-04", "trialIds": [ "nct06262282" ], "location": "Denver, Colorado; United States", "detail": "Invitation-only observational cohort for persistent NTM infection after at least 12 months of guideline-based therapy in people with cystic fibrosis; usual antibiotics continue. Earlier institutional evidence describes a 2022 Mycobacterium abscessus case.", "searchTerms": [ "Invitation-only observational cohort for persistent NTM infection after at least 12 months of guideline-based therapy in people with cystic fibrosis; usual antibiotics continue. Earlier institutional evidence describes a 2022 Mycobacterium abscessus case.", "Denver, Colorado; United States" ] }, { "id": "trial-site/265d44362933e8e7", "name": "Nationwide Children's Hospital — Columbus, Ohio", "countries": [ "US" ], "kind": "Trial site", "status": "Invitation only (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT04596319", "https://clinicaltrials.gov/study/NCT05010577", "https://clinicaltrials.gov/study/NCT06262282" ], "checked": "2026-10-03", "trialIds": [ "nct04596319", "nct05010577", "nct06262282" ], "location": "Columbus, Ohio", "detail": "Recorded study locations: Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal; Chronic Pseudomonas Aeruginosa Infection; Nontuberculous Mycobacterial Lung Disease; Nontuberculous Mycobacterium Infection; Mycobacterium Infections; Mycobacterium; Pulmonary. Not an offer of treatment.", "searchTerms": [ "Nationwide Children's Hospital", "Columbus", "Ohio", "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319", "Nationwide Children's Hospital", "Columbus", "Ohio", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577", "Nationwide Children's Hospital", "Columbus", "Ohio", "Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria", "Cystic Fibrosis", "Nontuberculous Mycobacterial Lung Disease", "Nontuberculous Mycobacterium Infection", "Mycobacterium Infections", "Mycobacterium; Pulmonary", "NCT06262282" ], "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } }, { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } }, { "trialId": "nct06262282", "start": { "date": "2024-02-05", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "label": "2024–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2024-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2024-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] } } } ] }, { "uuid": "78814b62e90e55a58da36cb9468ba40d", "permalink": "/items/natural-product-system-and-lifestyle-modification-78814b62e90e55a58da36cb9468ba40d", "id": "trials/nct06931977", "name": "Natural Product System and Lifestyle Modification (NCT06931977)", "countries": [ "US" ], "kind": "Adjacent product trial", "status": "Completed", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT06931977" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct06931977", "start": { "date": "2025-04-29", "kind": "actual" }, "end": { "date": "2025-09-03", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06931977" ], "label": "2025–2025", "dateEvidence": { "start": { "value": { "date": "2025-04-29", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06931977" ], "candidates": [ { "date": "2025-04-29", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06931977" ] }, { "date": "2025-04-29", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06931977" ] } ] }, "end": { "value": { "date": "2025-09-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06931977" ], "candidates": [ { "date": "2025-09-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06931977" ] }, { "date": "2025-09-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06931977" ] } ] } } } ], "detail": "Healthy", "searchTerms": [ "Natural Product System and Lifestyle Modification", "Healthy", "NCT06931977", "doTERRA International", "Pleasant Grove", "Utah", "United States" ] }, { "id": "trial-site/0ace091be318426d", "name": "New England Baptist Hospital — Boston, Massachusetts", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05269134" ], "checked": "2026-10-03", "trialIds": [ "nct05269134" ], "location": "Boston, Massachusetts", "detail": "Recorded study locations: Prosthetic Joint Infection. Not an offer of treatment.", "searchTerms": [ "New England Baptist Hospital", "Boston", "Massachusetts", "Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)", "Prosthetic Joint Infection", "NCT05269134" ], "studyYears": [ { "trialId": "nct05269134", "start": { "date": "2023-03-27", "kind": "actual" }, "end": { "date": "2027-07", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "label": "2023–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-03-27", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2023-03-27", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2023-03-27", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] }, "end": { "value": { "date": "2027-07", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2027-07", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2027-07", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] } } } ] }, { "id": "trial-site/910e4b12ce9bc16a", "name": "New York Medical College — Hawthorne, New York", "countries": [ "US" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT05616221", "https://clinicaltrials.gov/study/NCT06998043" ], "checked": "2026-10-03", "trialIds": [ "nct05616221", "nct06998043" ], "location": "Hawthorne, New York", "detail": "Recorded study locations: Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection; Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis (CF). Not an offer of treatment.", "searchTerms": [ "New York Medical College", "Hawthorne", "New York", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221", "New York Medical College", "Hawthorne", "New York", "Study With Phage for CF Subjects With Pseudomonas Lung Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis (CF)", "NCT06998043", "2024-519856-94-00" ], "studyYears": [ { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } }, { "trialId": "nct06998043", "start": { "date": "2025-07-02", "kind": "actual" }, "end": { "date": "2026-09", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-07-02", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2025-07-02", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-07-02", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-08-18", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] }, "end": { "value": { "date": "2026-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2026-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2026-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-12-08", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] } } } ] }, { "id": "trial-site/4c86a5109e35bdf1", "name": "New York Medical College — Valhalla, New York", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04596319", "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct04596319", "nct05010577" ], "location": "Valhalla, New York", "detail": "Recorded study locations: Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal; Chronic Pseudomonas Aeruginosa Infection. Not an offer of treatment.", "searchTerms": [ "New York Medical College", "Valhalla", "New York", "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319", "New York Medical College", "Valhalla", "New York", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } }, { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "id": "trial-site/c05c60b989caab5e", "name": "NorthBay Healthcare — Fairfield, California", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05177107" ], "checked": "2026-10-03", "trialIds": [ "nct05177107" ], "location": "Fairfield, California", "detail": "Recorded study locations: Osteomyelitis; Diabetic Foot Osteomyelitis. Not an offer of treatment.", "searchTerms": [ "NorthBay Healthcare", "Fairfield", "California", "Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis", "Osteomyelitis", "Diabetic Foot Osteomyelitis", "NCT05177107" ], "studyYears": [ { "trialId": "nct05177107", "start": { "date": "2021-11-24", "kind": "actual" }, "end": { "date": "2025-05-30", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "label": "2021–2025", "dateEvidence": { "start": { "value": { "date": "2021-11-24", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2021-11-24", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2021-11-24", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] }, "end": { "value": { "date": "2025-05-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2025-05-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2025-05-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] } } } ] }, { "id": "trial-site/b5f61eeb7405b97f", "name": "Northwell Health — New Hyde Park, New York", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05453578" ], "checked": "2026-10-03", "trialIds": [ "nct05453578" ], "location": "New Hyde Park, New York", "detail": "Recorded study locations: Bacterial Disease Carrier; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Northwell Health", "New Hyde Park", "New York", "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa", "Bacterial Disease Carrier", "Cystic Fibrosis", "NCT05453578" ], "studyYears": [ { "trialId": "nct05453578", "start": { "date": "2022-10-03", "kind": "actual" }, "end": { "date": "2025-04-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-10-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2022-10-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2022-10-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] }, "end": { "value": { "date": "2025-04-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2025-04-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2025-04-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] } } } ] }, { "id": "trial-site/1b567989dc1c0872", "name": "Northwell Health — New York, New York", "countries": [ "US" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT06998043" ], "checked": "2026-10-03", "trialIds": [ "nct06998043" ], "location": "New York, New York", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis (CF). Not an offer of treatment.", "searchTerms": [ "Northwell Health", "New York", "New York", "Study With Phage for CF Subjects With Pseudomonas Lung Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis (CF)", "NCT06998043", "2024-519856-94-00" ], "studyYears": [ { "trialId": "nct06998043", "start": { "date": "2025-07-02", "kind": "actual" }, "end": { "date": "2026-09", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-07-02", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2025-07-02", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-07-02", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-08-18", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] }, "end": { "value": { "date": "2026-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2026-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2026-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-12-08", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] } } } ] }, { "id": "trial-site/f39f6fac3eb76852", "name": "Northwestern University — Chicago, Illinois", "countries": [ "US" ], "kind": "Trial site", "status": "Invitation only (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT04596319", "https://clinicaltrials.gov/study/NCT06262282" ], "checked": "2026-10-03", "trialIds": [ "nct04596319", "nct06262282" ], "location": "Chicago, Illinois", "detail": "Recorded study locations: Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal; Nontuberculous Mycobacterial Lung Disease; Nontuberculous Mycobacterium Infection; Mycobacterium Infections; Mycobacterium; Pulmonary. Not an offer of treatment.", "searchTerms": [ "Northwestern University", "Chicago", "Illinois", "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319", "Northwestern University", "Chicago", "Illinois", "Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria", "Cystic Fibrosis", "Nontuberculous Mycobacterial Lung Disease", "Nontuberculous Mycobacterium Infection", "Mycobacterium Infections", "Mycobacterium; Pulmonary", "NCT06262282" ], "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } }, { "trialId": "nct06262282", "start": { "date": "2024-02-05", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "label": "2024–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2024-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2024-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] } } } ] }, { "id": "trial-site/c11190c7c8601286", "name": "NYU Langone Health — New York, New York", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT07076238" ], "checked": "2026-10-03", "trialIds": [ "nct07076238" ], "location": "New York, New York", "detail": "Recorded study locations: Nontuberculous Mycobacterial Lung Disease. Not an offer of treatment.", "searchTerms": [ "NYU Langone Health", "New York", "New York", "Biomarkers of Phage Treatment Response in NTM and Other Infections", "Nontuberculous Mycobacterial Lung Disease", "NCT07076238" ], "studyYears": [ { "trialId": "nct07076238", "start": { "date": "2025-06-25", "kind": "actual" }, "end": { "date": "2032-06-25", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07076238" ], "label": "2025–2032 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-06-25", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07076238" ], "candidates": [ { "date": "2025-06-25", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07076238" ] }, { "date": "2025-06-25", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07076238" ] } ] }, "end": { "value": { "date": "2032-06-25", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07076238" ], "candidates": [ { "date": "2032-06-25", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07076238" ] }, { "date": "2032-06-25", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07076238" ] } ] } } } ] }, { "id": "therapyRoutes/nyu-phage", "name": "NYU Langone NTM/bronchiectasis phage program", "countries": [ "US" ], "uuid": "b343e3c105ec519ba7032a0c512648d1", "permalink": "/items/nyu-langone-ntm-bronchiectasis-phage-program-b343e3c105ec519ba7032a0c512648d1", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://physicianfocus.nyulangone.org/advancing-phage-therapy-for-nontuberculosis-mycobacteria-infection-and-bronchiectasis/", "https://clinicaltrials.gov/study/NCT07076238" ], "checked": "2026-10-03", "trialIds": [ "nct07076238" ], "location": "New York, New York; United States", "detail": "Selected severe NTM infection with bronchiectasis treated under individualized IND; collaboration with Pittsburgh for matching. Biomarker study also covers other infections.", "searchTerms": [ "Selected severe NTM infection with bronchiectasis treated under individualized IND; collaboration with Pittsburgh for matching. Biomarker study also covers other infections.", "New York, New York; United States" ] }, { "id": "trial-site/7e19ab8fcfdd2203", "name": "Oregon Health & Science University — Portland, Oregon", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct05616221" ], "location": "Portland, Oregon", "detail": "Recorded study locations: Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection. Not an offer of treatment.", "searchTerms": [ "Oregon Health & Science University", "Portland", "Oregon", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "id": "trial-site/c086580fa2dfa8f6", "name": "Penn State Health Milton S. Hershey Medical Center — Hershey, Pennsylvania", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct05010577" ], "location": "Hershey, Pennsylvania", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Penn State Health Milton S. Hershey Medical Center", "Hershey", "Pennsylvania", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "uuid": "045f44bd2ea7553997115c801f8a3357", "permalink": "/items/bacteriophage-therapy-in-spinal-cord-injury-patients-with-bacteriuria-045f44bd2ea7553997115c801f8a3357", "id": "trials/nct06559618", "name": "Phage (NCT06559618)", "countries": [ "US" ], "kind": "Trial", "status": "Recruiting", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06559618" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct06559618", "start": { "date": "2025-02-03", "kind": "actual" }, "end": { "date": "2028-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ], "label": "2025–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-02-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ], "candidates": [ { "date": "2025-02-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ] }, { "date": "2025-02-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ] } ] }, "end": { "value": { "date": "2028-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ], "candidates": [ { "date": "2028-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ] }, { "date": "2028-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ] } ] } } } ], "detail": "Bacteriuria; Spinal Cord Injuries; Asymptomatic Bacteriuria; Escherichia Coli", "searchTerms": [ "Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria", "Bacteriuria", "Spinal Cord Injuries", "Asymptomatic Bacteriuria", "Escherichia Coli", "NCT06559618", "Washington University in St Louis", "St Louis", "Missouri", "United States", "Michael E. DeBakey VA Medical Center", "Houston", "Texas", "United States" ] }, { "uuid": "324ca77ecae35e9a8689c062af9c720a", "permalink": "/items/phage-3determination-of-phage-probiotic-synergistic-effects-on-gastrointestinal-health-324ca77ecae35e9a8689c062af9c720a", "id": "trials/nct05750433", "name": "Phage 3Determination of Phage/Probiotic Synergistic Effects on Gastrointestinal Health (NCT05750433)", "countries": [ "US" ], "kind": "Adjacent product trial", "status": "Completed", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05750433" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05750433", "start": { "date": "2021-10-01", "kind": "actual" }, "end": { "date": "2024-03-31", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05750433" ], "label": "2021–2024", "dateEvidence": { "start": { "value": { "date": "2021-10-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05750433" ], "candidates": [ { "date": "2021-10-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05750433" ] }, { "date": "2021-10-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05750433" ] } ] }, "end": { "value": { "date": "2024-03-31", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05750433" ], "candidates": [ { "date": "2024-03-31", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05750433" ] }, { "date": "2024-03-31", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05750433" ] } ] } } } ], "detail": "Gastrointestinal Dysfunction", "searchTerms": [ "Phage 3Determination of Phage/Probiotic Synergistic Effects on Gastrointestinal Health", "Gastrointestinal Dysfunction", "NCT05750433", "Food and Nutrition Clinical Research Lab(FNCRL), Colorado State University", "Fort Collins", "Colorado", "United States" ] }, { "id": "therapyRoutes/historical-phage-international", "name": "Phage International Inc.", "countries": [ "US" ], "uuid": "47a2aee6e6b05760be7fd43356c20955", "permalink": "/items/phage-international-inc-47a2aee6e6b05760be7fd43356c20955", "kind": "Company", "status": "Ceased operations 2023", "activity": "historical", "sources": [ "https://www.phagetherapycenter.com/pii/PatientServlet?command=responsive_ourhistory" ], "checked": "2026-10-03", "detail": "Former US parent of Phage Therapy Center LTD, Georgia.", "searchTerms": [ "Former US parent of Phage Therapy Center LTD, Georgia.", "" ] }, { "uuid": "8ac608a3710b57069555aee5915369fe", "permalink": "/items/phage-therapy-for-recurrent-utis-in-kidney-transplant-recipients-8ac608a3710b57069555aee5915369fe", "id": "trials/nct06409819", "name": "Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients (NCT06409819)", "countries": [ "US" ], "kind": "Trial", "status": "Recruiting", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06409819" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct06409819", "start": { "date": "2025-06-15", "kind": "actual" }, "end": { "date": "2027-03-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06409819" ], "label": "2025–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-06-15", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06409819" ], "candidates": [ { "date": "2025-06-15", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06409819" ] }, { "date": "2025-06-15", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06409819" ] } ] }, "end": { "value": { "date": "2027-03-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06409819" ], "candidates": [ { "date": "2027-03-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06409819" ] }, { "date": "2027-03-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06409819" ] } ] } } } ], "detail": "Urinary Tract Infection, Recurrent", "searchTerms": [ "Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients", "Urinary Tract Infection, Recurrent", "NCT06409819", "University of California, San Diego", "La Jolla", "California", "United States" ] }, { "uuid": "5583c646df12557da18ffc591a3146d0", "permalink": "/items/phage-based-control-and-limitation-of-pathobionts-for-microbiome-equilibrium-and-resilienc-5583c646df12557da18ffc591a3146d0", "id": "trials/nct07816809", "name": "Phage-CLEAR (NCT07816809)", "countries": [ "US" ], "kind": "Adjacent product trial", "status": "Recruiting", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT07816809" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct07816809", "start": { "date": "2026-09-14", "kind": "estimated" }, "end": { "date": "2028-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07816809" ], "label": "2026 (estimated)–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-09-14", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07816809" ], "candidates": [ { "date": "2026-09-14", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07816809" ] }, { "date": "2026-09-14", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07816809" ] } ] }, "end": { "value": { "date": "2028-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07816809" ], "candidates": [ { "date": "2028-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07816809" ] }, { "date": "2028-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07816809" ] } ] } } } ], "detail": "Gastrointestinal Symptoms; Skin Quality", "searchTerms": [ "Phage-based Control and Limitation of Pathobionts for Microbiome Equilibrium and Resilience", "Gastrointestinal Symptoms", "Skin Quality", "NCT07816809", "Colorado State University", "Fort Collins", "Colorado", "United States" ] }, { "uuid": "895becacc4c4531cad7984533aaddf8c", "permalink": "/items/bacteriophage-for-gastrointestinal-health-2-study-895becacc4c4531cad7984533aaddf8c", "id": "trials/nct04511221", "name": "PHAGE2 (NCT04511221)", "countries": [ "US" ], "kind": "Adjacent product trial", "status": "Completed", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04511221" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct04511221", "start": { "date": "2018-10-01", "kind": "actual" }, "end": { "date": "2020-03-31", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04511221" ], "label": "2018–2020", "dateEvidence": { "start": { "value": { "date": "2018-10-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04511221" ], "candidates": [ { "date": "2018-10-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04511221" ] }, { "date": "2018-10-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04511221" ] } ] }, "end": { "value": { "date": "2020-03-31", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04511221" ], "candidates": [ { "date": "2020-03-31", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04511221" ] }, { "date": "2020-03-31", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04511221" ] } ] } } } ], "detail": "Mild Gastrointestinal Symptoms in Healthy Adults", "searchTerms": [ "BacterioPHAGE for Gastrointestinal Health 2 Study", "Mild Gastrointestinal Symptoms in Healthy Adults", "NCT04511221", "Colorado State University", "Fort Collins", "Colorado", "United States" ] }, { "id": "therapyRoutes/phagepro", "name": "PhagePro", "countries": [ "US" ], "uuid": "147643890e9359a59b3c479a5a5714b4", "permalink": "/items/phagepro-147643890e9359a59b3c479a5a5714b4", "kind": "Company", "status": "Research/development", "activity": "research", "sources": [ "https://www.phageproinc.com/who-we-are" ], "checked": "2026-10-03", "location": "Boston, Massachusetts; United States", "detail": "Company explicitly describes itself as preclinical; ProphaLytic-Vc cholera-prevention development.", "searchTerms": [ "Company explicitly describes itself as preclinical; ProphaLytic-Vc cholera-prevention development.", "Boston, Massachusetts; United States" ] }, { "uuid": "64c957f6dbd95d459f29072a55037ff8", "permalink": "/items/phase-1b-2a-randomized-double-blind-study-to-investigate-safety-tolerability-pk-pd-prelimi-64c957f6dbd95d459f29072a55037ff8", "id": "trials/nct06938867", "name": "Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant (NCT06938867)", "countries": [ "US" ], "kind": "Trial", "status": "Recruiting", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06938867", "https://www.sniprbiome.com/" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct06938867", "start": { "date": "2025-02-25", "kind": "actual" }, "end": { "date": "2026-04-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-02-25", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "candidates": [ { "date": "2025-02-25", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] }, { "date": "2025-02-25", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] } ] }, "end": { "value": { "date": "2026-04-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "candidates": [ { "date": "2026-04-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] }, { "date": "2026-04-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] } ] } } } ], "detail": "E Coli Infections; Allogenic Transplant Patients", "searchTerms": [ "Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant", "E Coli Infections", "Allogenic Transplant Patients", "NCT06938867", "City of Hope", "Duarte", "California", "United States", "University of California, San Francisco", "San Francisco", "California", "United States", "John Hopkins University", "Baltimore", "Maryland", "United States", "University of Minnesota", "Minneapolis", "Minnesota", "United States", "Weill Cornell Medicine", "New York", "New York", "United States", "UPMC", "Pittsburgh", "Pennsylvania", "United States", "University of Texas MD Anderson Cancer Center", "Houston", "Texas", "United States", "Fred Hutchinson Cancer Center", "Seattle", "Washington", "United States" ] }, { "id": "therapyRoutes/phiogen", "name": "Phiogen", "countries": [ "US" ], "uuid": "4d5f339c599b5bc7ac979c5915708b7a", "permalink": "/items/phiogen-4d5f339c599b5bc7ac979c5915708b7a", "kind": "Company", "status": "Research/development", "activity": "research", "sources": [ "https://www.phiogenpharma.com/" ], "checked": "2026-10-03", "location": "Houston, Texas; United States", "detail": "Developing evolved phages for drug-resistant pathogens; company reports historical emergency clinical use.", "searchTerms": [ "Developing evolved phages for drug-resistant pathogens; company reports historical emergency clinical use.", "Houston, Texas; United States" ] }, { "uuid": "d039305f6e9d5d10a08773787967aa9d", "permalink": "/items/safety-and-tolerability-of-ntr-101-in-patients-with-acute-alcohol-associated-hepatitis-d039305f6e9d5d10a08773787967aa9d", "id": "trials/nct06750588", "name": "PhoenixAH (NCT06750588)", "countries": [ "US" ], "kind": "Trial", "status": "Not yet recruiting", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT06750588" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct06750588", "start": { "date": "2025-11-05", "kind": "estimated" }, "end": { "date": "2026-06", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06750588" ], "label": "2025 (estimated)–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-11-05", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06750588" ], "candidates": [ { "date": "2025-11-05", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06750588" ] }, { "date": "2025-11-05", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06750588" ] } ] }, "end": { "value": { "date": "2026-06", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06750588" ], "candidates": [ { "date": "2026-06", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06750588" ] }, { "date": "2026-06", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06750588" ] } ] } } } ], "detail": "Alcohol-Associated Hepatitis", "searchTerms": [ "Safety and Tolerability of NTR-101 in Patients With Acute Alcohol-Associated Hepatitis", "Alcohol-Associated Hepatitis", "NCT06750588", "Southern California Research Center, inc", "Coronado", "California", "United States" ] }, { "id": "trial-site/7b7d330bd8bcbddb", "name": "Pinnacle Research Group — Anniston, Alabama", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04191148" ], "checked": "2026-10-03", "trialIds": [ "nct04191148" ], "location": "Anniston, Alabama", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Pinnacle Research Group", "Anniston", "Alabama", "Safety, Tolerability, and PK of LBP-EC01 in Patients With Lower Urinary Tract Colonization Caused by E. Coli", "Urinary Tract Infections", "NCT04191148" ], "studyYears": [ { "trialId": "nct04191148", "start": { "date": "2019-12-30", "kind": "actual" }, "end": { "date": "2020-11-19", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "label": "2019–2020", "dateEvidence": { "start": { "value": { "date": "2019-12-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "candidates": [ { "date": "2019-12-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] }, { "date": "2019-12-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] } ] }, "end": { "value": { "date": "2020-11-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "candidates": [ { "date": "2020-11-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] }, { "date": "2020-11-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] } ] } } } ] }, { "id": "therapyRoutes/pitt-p3", "name": "Pittsburgh Phage Program (P3), University of Pittsburgh/UPMC", "countries": [ "US" ], "uuid": "42d651272043584791a4e3010dd22c37", "permalink": "/items/pittsburgh-phage-program-p3-university-of-pittsburgh-upmc-42d651272043584791a4e3010dd22c37", "kind": "Center", "status": "Case-by-case; Official referral/inquiry route", "activity": "current", "sources": [ "https://dom.pitt.edu/id/research/phage/", "https://clinicaltrials.gov/study/NCT07275905" ], "checked": "2026-10-03", "trialIds": [ "nct07275905" ], "location": "Pittsburgh, Pennsylvania; United States", "accessMode": "case-by-case", "detail": "Multidisciplinary compassionate use, phage discovery/manufacturing and clinical trials; AchromoPhage adults with CF and chronic Achromobacter infection is recruiting at Pittsburgh.", "searchTerms": [ "Multidisciplinary compassionate use, phage discovery/manufacturing and clinical trials; AchromoPhage adults with CF and chronic Achromobacter infection is recruiting at Pittsburgh.", "Pittsburgh, Pennsylvania; United States" ] }, { "id": "trial-site/84f0aa93ff30ef6e", "name": "Podiatry 1st / Gateway Clinical Trials — O'Fallon, Illinois", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05177107" ], "checked": "2026-10-03", "trialIds": [ "nct05177107" ], "location": "O'Fallon, Illinois", "detail": "Recorded study locations: Osteomyelitis; Diabetic Foot Osteomyelitis. Not an offer of treatment.", "searchTerms": [ "Podiatry 1st / Gateway Clinical Trials", "O'Fallon", "Illinois", "Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis", "Osteomyelitis", "Diabetic Foot Osteomyelitis", "NCT05177107" ], "studyYears": [ { "trialId": "nct05177107", "start": { "date": "2021-11-24", "kind": "actual" }, "end": { "date": "2025-05-30", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "label": "2021–2025", "dateEvidence": { "start": { "value": { "date": "2021-11-24", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2021-11-24", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2021-11-24", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] }, "end": { "value": { "date": "2025-05-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2025-05-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2025-05-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] } } } ] }, { "uuid": "2c3eba0c61d35bdabae61bfbc22de974", "permalink": "/items/mycobacteriophage-treatment-of-non-tuberculosis-mycobacteria-2c3eba0c61d35bdabae61bfbc22de974", "id": "trials/nct06262282", "name": "POSTSTAMP (NCT06262282)", "countries": [ "US" ], "kind": "Observational study", "status": "Invitation only", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06262282" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct06262282", "start": { "date": "2024-02-05", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "label": "2024–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2024-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2024-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] } } } ], "detail": "Cystic Fibrosis; Nontuberculous Mycobacterial Lung Disease; Nontuberculous Mycobacterium Infection; Mycobacterium Infections; Mycobacterium; Pulmonary", "searchTerms": [ "Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria", "Cystic Fibrosis", "Nontuberculous Mycobacterial Lung Disease", "Nontuberculous Mycobacterium Infection", "Mycobacterium Infections", "Mycobacterium; Pulmonary", "NCT06262282", "University of Alabama", "Birmingham", "Alabama", "United States", "Children's Hospital of Los Angeles", "Los Angeles", "California", "United States", "University of California", "San Diego", "California", "United States", "Childrens Hospital Colorado", "Denver", "Colorado", "United States", "National Jewish Health", "Denver", "Colorado", "United States", "University of Florida", "Gainesville", "Florida", "United States", "Northwestern University", "Chicago", "Illinois", "United States", "John Hopkins University", "Baltimore", "Maryland", "United States", "Boston Childrens Hospital", "Boston", "Massachusetts", "United States", "University of Michigan", "Ann Arbor", "Michigan", "United States", "Dartmouth Hitchcock Medical Center", "Lebanon", "New Hampshire", "United States", "Columbia University", "New York", "New York", "United States", "University of North Carolina at Chapel Hill", "Chapel Hill", "North Carolina", "United States", "Nationwide Children's Hospital", "Columbus", "Ohio", "United States", "University of Pittsburgh Medical Center", "Pittsburgh", "Pennsylvania", "United States", "Southwestern Medical Center at Dallas", "Dallas", "Texas", "United States", "University of Vermont", "Burlington", "Vermont", "United States", "University of Washington", "Seattle", "Washington", "United States" ] }, { "id": "trial-site/22d52b656438de5e", "name": "Providence Alaska Medical Center — Anchorage, Alaska", "countries": [ "US" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT05010577", "https://clinicaltrials.gov/study/NCT06998043" ], "checked": "2026-10-03", "trialIds": [ "nct05010577", "nct06998043" ], "location": "Anchorage, Alaska", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis; Cystic Fibrosis (CF). Not an offer of treatment.", "searchTerms": [ "Providence Alaska Medical Center", "Anchorage", "Alaska", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577", "Providence Alaska Medical Center", "Anchorage", "Alaska", "Study With Phage for CF Subjects With Pseudomonas Lung Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis (CF)", "NCT06998043", "2024-519856-94-00" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } }, { "trialId": "nct06998043", "start": { "date": "2025-07-02", "kind": "actual" }, "end": { "date": "2026-09", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-07-02", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2025-07-02", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-07-02", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-08-18", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] }, "end": { "value": { "date": "2026-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2026-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2026-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-12-08", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] } } } ] }, { "id": "trial-site/b936448154a769a1", "name": "Ralph H. Johnson VA Medical Center — Charleston, South Carolina", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04191148" ], "checked": "2026-10-03", "trialIds": [ "nct04191148" ], "location": "Charleston, South Carolina", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Ralph H. Johnson VA Medical Center", "Charleston", "South Carolina", "Safety, Tolerability, and PK of LBP-EC01 in Patients With Lower Urinary Tract Colonization Caused by E. Coli", "Urinary Tract Infections", "NCT04191148" ], "studyYears": [ { "trialId": "nct04191148", "start": { "date": "2019-12-30", "kind": "actual" }, "end": { "date": "2020-11-19", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "label": "2019–2020", "dateEvidence": { "start": { "value": { "date": "2019-12-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "candidates": [ { "date": "2019-12-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] }, { "date": "2019-12-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] } ] }, "end": { "value": { "date": "2020-11-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "candidates": [ { "date": "2020-11-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] }, { "date": "2020-11-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] } ] } } } ] }, { "id": "trial-site/4870ce6c2966a209", "name": "Regional One Healthcare — Memphis, Tennessee", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Memphis, Tennessee", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "Regional One Healthcare", "Memphis", "Tennessee", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "trial-site/e83be6a66f42544a", "name": "Research Site 102 — Doral, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05488340" ], "checked": "2026-10-03", "trialIds": [ "nct05488340" ], "location": "Doral, Florida", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Research Site 102", "Doral", "Florida", "A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)", "Urinary Tract Infections", "NCT05488340" ], "studyYears": [ { "trialId": "nct05488340", "start": { "date": "2022-07-13", "kind": "actual" }, "end": { "date": "2027-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-07-13", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2022-07-13", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2022-07-13", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] }, "end": { "value": { "date": "2027-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2027-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2027-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] } } } ] }, { "id": "trial-site/d32c1e293566b163", "name": "Research Site 103 — Miami, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05488340" ], "checked": "2026-10-03", "trialIds": [ "nct05488340" ], "location": "Miami, Florida", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Research Site 103", "Miami", "Florida", "A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)", "Urinary Tract Infections", "NCT05488340" ], "studyYears": [ { "trialId": "nct05488340", "start": { "date": "2022-07-13", "kind": "actual" }, "end": { "date": "2027-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-07-13", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2022-07-13", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2022-07-13", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] }, "end": { "value": { "date": "2027-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2027-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2027-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] } } } ] }, { "id": "trial-site/75e4ee408305b21b", "name": "Research Site 118 — Winston-Salem, North Carolina", "countries": [ "US" ], "kind": "Trial site", "status": "Completed (trial)", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05488340" ], "checked": "2026-10-03", "trialIds": [ "nct05488340" ], "location": "Winston-Salem, North Carolina", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Research Site 118", "Winston-Salem", "North Carolina", "A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)", "Urinary Tract Infections", "NCT05488340" ], "studyYears": [ { "trialId": "nct05488340", "start": { "date": "2022-07-13", "kind": "actual" }, "end": { "date": "2027-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-07-13", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2022-07-13", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2022-07-13", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] }, "end": { "value": { "date": "2027-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2027-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2027-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] } } } ] }, { "id": "trial-site/438490d8d698fe86", "name": "Research Site 120 — Boston, Massachusetts", "countries": [ "US" ], "kind": "Trial site", "status": "Completed (trial)", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05488340" ], "checked": "2026-10-03", "trialIds": [ "nct05488340" ], "location": "Boston, Massachusetts", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Research Site 120", "Boston", "Massachusetts", "A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)", "Urinary Tract Infections", "NCT05488340" ], "studyYears": [ { "trialId": "nct05488340", "start": { "date": "2022-07-13", "kind": "actual" }, "end": { "date": "2027-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-07-13", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2022-07-13", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2022-07-13", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] }, "end": { "value": { "date": "2027-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2027-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2027-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] } } } ] }, { "id": "trial-site/46f95d84e7f7ce0d", "name": "Research Site 123 — Los Angeles, California", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05488340" ], "checked": "2026-10-03", "trialIds": [ "nct05488340" ], "location": "Los Angeles, California", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Research Site 123", "Los Angeles", "California", "A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)", "Urinary Tract Infections", "NCT05488340" ], "studyYears": [ { "trialId": "nct05488340", "start": { "date": "2022-07-13", "kind": "actual" }, "end": { "date": "2027-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-07-13", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2022-07-13", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2022-07-13", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] }, "end": { "value": { "date": "2027-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2027-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2027-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] } } } ] }, { "id": "trial-site/e9bfc93893309daa", "name": "Research Site 125 — Montebello, California", "countries": [ "US" ], "kind": "Trial site", "status": "Completed (trial)", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05488340" ], "checked": "2026-10-03", "trialIds": [ "nct05488340" ], "location": "Montebello, California", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Research Site 125", "Montebello", "California", "A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)", "Urinary Tract Infections", "NCT05488340" ], "studyYears": [ { "trialId": "nct05488340", "start": { "date": "2022-07-13", "kind": "actual" }, "end": { "date": "2027-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-07-13", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2022-07-13", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2022-07-13", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] }, "end": { "value": { "date": "2027-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2027-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2027-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] } } } ] }, { "id": "trial-site/23cdf793e9bdf145", "name": "Research Site 126 — Tustin, California", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05488340" ], "checked": "2026-10-03", "trialIds": [ "nct05488340" ], "location": "Tustin, California", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Research Site 126", "Tustin", "California", "A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)", "Urinary Tract Infections", "NCT05488340" ], "studyYears": [ { "trialId": "nct05488340", "start": { "date": "2022-07-13", "kind": "actual" }, "end": { "date": "2027-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-07-13", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2022-07-13", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2022-07-13", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] }, "end": { "value": { "date": "2027-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2027-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2027-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] } } } ] }, { "id": "trial-site/3ceb333fc2c0b234", "name": "Research Site 131 — Lancaster, California", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05488340" ], "checked": "2026-10-03", "trialIds": [ "nct05488340" ], "location": "Lancaster, California", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Research Site 131", "Lancaster", "California", "A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)", "Urinary Tract Infections", "NCT05488340" ], "studyYears": [ { "trialId": "nct05488340", "start": { "date": "2022-07-13", "kind": "actual" }, "end": { "date": "2027-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-07-13", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2022-07-13", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2022-07-13", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] }, "end": { "value": { "date": "2027-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2027-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2027-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] } } } ] }, { "id": "trial-site/112a5e8735ea9a8f", "name": "Research Site 137 — San Diego, California", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05488340" ], "checked": "2026-10-03", "trialIds": [ "nct05488340" ], "location": "San Diego, California", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Research Site 137", "San Diego", "California", "A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)", "Urinary Tract Infections", "NCT05488340" ], "studyYears": [ { "trialId": "nct05488340", "start": { "date": "2022-07-13", "kind": "actual" }, "end": { "date": "2027-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-07-13", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2022-07-13", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2022-07-13", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] }, "end": { "value": { "date": "2027-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2027-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2027-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] } } } ] }, { "id": "trial-site/f3915331fc337a4f", "name": "Research Site 138 — Fresno, California", "countries": [ "US" ], "kind": "Trial site", "status": "Completed (trial)", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05488340" ], "checked": "2026-10-03", "trialIds": [ "nct05488340" ], "location": "Fresno, California", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Research Site 138", "Fresno", "California", "A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)", "Urinary Tract Infections", "NCT05488340" ], "studyYears": [ { "trialId": "nct05488340", "start": { "date": "2022-07-13", "kind": "actual" }, "end": { "date": "2027-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-07-13", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2022-07-13", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2022-07-13", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] }, "end": { "value": { "date": "2027-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2027-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2027-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] } } } ] }, { "id": "trial-site/a1fad481199b9d99", "name": "Research Site 140 — Jensen Beach, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Completed (trial)", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05488340" ], "checked": "2026-10-03", "trialIds": [ "nct05488340" ], "location": "Jensen Beach, Florida", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Research Site 140", "Jensen Beach", "Florida", "A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)", "Urinary Tract Infections", "NCT05488340" ], "studyYears": [ { "trialId": "nct05488340", "start": { "date": "2022-07-13", "kind": "actual" }, "end": { "date": "2027-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-07-13", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2022-07-13", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2022-07-13", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] }, "end": { "value": { "date": "2027-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2027-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2027-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] } } } ] }, { "id": "trial-site/ab72e38ce081b664", "name": "Research Site 145 — Raleigh, North Carolina", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05488340" ], "checked": "2026-10-03", "trialIds": [ "nct05488340" ], "location": "Raleigh, North Carolina", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Research Site 145", "Raleigh", "North Carolina", "A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)", "Urinary Tract Infections", "NCT05488340" ], "studyYears": [ { "trialId": "nct05488340", "start": { "date": "2022-07-13", "kind": "actual" }, "end": { "date": "2027-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-07-13", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2022-07-13", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2022-07-13", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] }, "end": { "value": { "date": "2027-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2027-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2027-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] } } } ] }, { "id": "trial-site/cda6c6631c0ace0e", "name": "Research Site 149 — Miami, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05488340" ], "checked": "2026-10-03", "trialIds": [ "nct05488340" ], "location": "Miami, Florida", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Research Site 149", "Miami", "Florida", "A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)", "Urinary Tract Infections", "NCT05488340" ], "studyYears": [ { "trialId": "nct05488340", "start": { "date": "2022-07-13", "kind": "actual" }, "end": { "date": "2027-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-07-13", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2022-07-13", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2022-07-13", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] }, "end": { "value": { "date": "2027-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2027-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2027-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] } } } ] }, { "id": "trial-site/179df8eead0df816", "name": "Research Site 151 — Hialeah, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05488340" ], "checked": "2026-10-03", "trialIds": [ "nct05488340" ], "location": "Hialeah, Florida", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Research Site 151", "Hialeah", "Florida", "A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)", "Urinary Tract Infections", "NCT05488340" ], "studyYears": [ { "trialId": "nct05488340", "start": { "date": "2022-07-13", "kind": "actual" }, "end": { "date": "2027-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-07-13", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2022-07-13", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2022-07-13", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] }, "end": { "value": { "date": "2027-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2027-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2027-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] } } } ] }, { "id": "trial-site/c4c84dbec3a62e24", "name": "Research Site 152 — Murrieta, California", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05488340" ], "checked": "2026-10-03", "trialIds": [ "nct05488340" ], "location": "Murrieta, California", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Research Site 152", "Murrieta", "California", "A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)", "Urinary Tract Infections", "NCT05488340" ], "studyYears": [ { "trialId": "nct05488340", "start": { "date": "2022-07-13", "kind": "actual" }, "end": { "date": "2027-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-07-13", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2022-07-13", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2022-07-13", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] }, "end": { "value": { "date": "2027-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2027-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2027-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] } } } ] }, { "id": "trial-site/5108a785525ab616", "name": "Research Site 153 — Ocala, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05488340" ], "checked": "2026-10-03", "trialIds": [ "nct05488340" ], "location": "Ocala, Florida", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Research Site 153", "Ocala", "Florida", "A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)", "Urinary Tract Infections", "NCT05488340" ], "studyYears": [ { "trialId": "nct05488340", "start": { "date": "2022-07-13", "kind": "actual" }, "end": { "date": "2027-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-07-13", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2022-07-13", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2022-07-13", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] }, "end": { "value": { "date": "2027-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2027-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2027-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] } } } ] }, { "id": "trial-site/931cff2d3749149b", "name": "Research Site 154 — St Louis, Missouri", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05488340" ], "checked": "2026-10-03", "trialIds": [ "nct05488340" ], "location": "St Louis, Missouri", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Research Site 154", "St Louis", "Missouri", "A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)", "Urinary Tract Infections", "NCT05488340" ], "studyYears": [ { "trialId": "nct05488340", "start": { "date": "2022-07-13", "kind": "actual" }, "end": { "date": "2027-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "label": "2022–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2022-07-13", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2022-07-13", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2022-07-13", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] }, "end": { "value": { "date": "2027-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ], "candidates": [ { "date": "2027-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] }, { "date": "2027-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05488340" ] } ] } } } ] }, { "id": "trial-site/b99ea1a8bf6c14b3", "name": "Rhode Island Hospital — Providence, Rhode Island", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Providence, Rhode Island", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "Rhode Island Hospital", "Providence", "Rhode Island", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "trial-site/ec461e222379024a", "name": "Rocky Mountain Regional VA Medical Center — Aurora, Colorado", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Aurora, Colorado", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "Rocky Mountain Regional VA Medical Center", "Aurora", "Colorado", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "trial-site/181b1f2fd89d21b8", "name": "Rocky Mountain VA — Aurora, Colorado", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05177107" ], "checked": "2026-10-03", "trialIds": [ "nct05177107" ], "location": "Aurora, Colorado", "detail": "Recorded study locations: Osteomyelitis; Diabetic Foot Osteomyelitis. Not an offer of treatment.", "searchTerms": [ "Rocky Mountain VA", "Aurora", "Colorado", "Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis", "Osteomyelitis", "Diabetic Foot Osteomyelitis", "NCT05177107" ], "studyYears": [ { "trialId": "nct05177107", "start": { "date": "2021-11-24", "kind": "actual" }, "end": { "date": "2025-05-30", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "label": "2021–2025", "dateEvidence": { "start": { "value": { "date": "2021-11-24", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2021-11-24", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2021-11-24", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] }, "end": { "value": { "date": "2025-05-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2025-05-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2025-05-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] } } } ] }, { "id": "trial-site/2045e0bcf8757e38", "name": "Rutgers Robert Wood Johnson Medical School — New Brunswick, New Jersey", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04596319", "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct04596319", "nct05616221" ], "location": "New Brunswick, New Jersey", "detail": "Recorded study locations: Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal; Non-cystic Fibrosis Bronchiectasis. Not an offer of treatment.", "searchTerms": [ "Rutgers Robert Wood Johnson Medical School", "New Brunswick", "New Jersey", "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319", "Rutgers Robert Wood Johnson Medical School", "New Brunswick", "New Jersey", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } }, { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "id": "trial-site/863f306b232bf966", "name": "Rutgers, Robert Wood Johnson Medical School — New Brunswick, New Jersey", "countries": [ "US" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT06998043" ], "checked": "2026-10-03", "trialIds": [ "nct06998043" ], "location": "New Brunswick, New Jersey", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis (CF). Not an offer of treatment.", "searchTerms": [ "Rutgers, Robert Wood Johnson Medical School", "New Brunswick", "New Jersey", "Study With Phage for CF Subjects With Pseudomonas Lung Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis (CF)", "NCT06998043", "2024-519856-94-00" ], "studyYears": [ { "trialId": "nct06998043", "start": { "date": "2025-07-02", "kind": "actual" }, "end": { "date": "2026-09", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-07-02", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2025-07-02", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-07-02", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-08-18", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] }, "end": { "value": { "date": "2026-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2026-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2026-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-12-08", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] } } } ] }, { "uuid": "c2756f0a31b05efa8baa48c7cc23d926", "permalink": "/items/safety-and-efficacy-of-ecoactive-on-intestinal-adherent-invasive-e-coli-in-patients-with-i-c2756f0a31b05efa8baa48c7cc23d926", "id": "trials/nct03808103", "name": "Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease (NCT03808103)", "countries": [ "US" ], "kind": "Trial", "status": "Conflicting status", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT03808103", "https://www.intralytix.com/clinical-trial/5" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct03808103", "start": { "date": "2019-05-01", "kind": "actual" }, "end": { "date": "2026-06-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ], "label": "2019–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2019-05-01", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ], "candidates": [ { "date": "2019-05-01", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ] }, { "date": "2019-05-01", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ] } ] }, "end": { "value": { "date": "2026-06-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ], "candidates": [ { "date": "2026-06-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ] }, { "date": "2026-06-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT03808103" ] } ] } } } ], "detail": "Crohn Disease", "searchTerms": [ "Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease", "Crohn Disease", "NCT03808103", "Johns Hopkins Green Spring Station", "Lutherville", "Maryland", "United States", "Icahn School of Medicine at Mount Sinai Hospital", "New York", "New York", "United States" ] }, { "uuid": "0ea3354d342a597b92f801058674ee00", "permalink": "/items/safety-and-efficacy-of-oral-administration-of-the-phage-cocktail-vrelysintm-in-healthy-and-0ea3354d342a597b92f801058674ee00", "id": "trials/nct05715619", "name": "Safety and Efficacy of Oral Administration of the Phage Cocktail, VRELysin™, In Healthy and VRE-Colonized Subjects (NCT05715619)", "countries": [ "US" ], "kind": "Trial", "status": "Suspended", "activity": "paused", "sources": [ "https://clinicaltrials.gov/study/NCT05715619" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05715619", "start": { "date": "2023-10-25", "kind": "actual" }, "end": { "date": "2026-10-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05715619" ], "label": "2023–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-10-25", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05715619" ], "candidates": [ { "date": "2023-10-25", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05715619" ] }, { "date": "2023-10-25", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05715619" ] } ] }, "end": { "value": { "date": "2026-10-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05715619" ], "candidates": [ { "date": "2026-10-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05715619" ] }, { "date": "2026-10-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05715619" ] } ] } } } ], "detail": "Vancomycin-Resistant Enterococcal Colonization", "searchTerms": [ "Safety and Efficacy of Oral Administration of the Phage Cocktail, VRELysin™, In Healthy and VRE-Colonized Subjects", "Vancomycin-Resistant Enterococcal Colonization", "NCT05715619", "UPMC Presbyterian", "Pittsburgh", "Pennsylvania", "United States" ] }, { "uuid": "661a9fcf56aa5e9db6ed536d857d3a11", "permalink": "/items/safety-and-efficacy-of-the-bacteriophage-preparation-shigactivetm-in-a-human-experimental-661a9fcf56aa5e9db6ed536d857d3a11", "id": "trials/nct05182749", "name": "Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of Shigellosis (NCT05182749)", "countries": [ "US" ], "kind": "Trial", "status": "Active, not recruiting", "activity": "ongoing", "sources": [ "https://clinicaltrials.gov/study/NCT05182749" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05182749", "start": { "date": "2023-02-23", "kind": "actual" }, "end": { "date": "2025-09-30", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05182749" ], "label": "2023–2025 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-02-23", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05182749" ], "candidates": [ { "date": "2023-02-23", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05182749" ] }, { "date": "2023-02-23", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05182749" ] } ] }, "end": { "value": { "date": "2025-09-30", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05182749" ], "candidates": [ { "date": "2025-09-30", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05182749" ] }, { "date": "2025-09-30", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05182749" ] } ] } } } ], "detail": "Shigellosis", "searchTerms": [ "Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of Shigellosis", "Shigellosis", "NCT05182749", "University of Maryland, Baltimore, University of Maryland School of Medicine, Center for Vaccine Development and Global Health", "Baltimore", "Maryland", "United States" ] }, { "uuid": "834d7dc5077c573fa1b915c72e5421e8", "permalink": "/items/safety-tolerability-and-pk-of-lbp-ec01-in-patients-with-lower-urinary-tract-colonization-c-834d7dc5077c573fa1b915c72e5421e8", "id": "trials/nct04191148", "name": "Safety, Tolerability, and PK of LBP-EC01 in Patients With Lower Urinary Tract Colonization Caused by E. Coli (NCT04191148)", "countries": [ "US" ], "kind": "Trial", "status": "Completed", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04191148" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct04191148", "start": { "date": "2019-12-30", "kind": "actual" }, "end": { "date": "2020-11-19", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "label": "2019–2020", "dateEvidence": { "start": { "value": { "date": "2019-12-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "candidates": [ { "date": "2019-12-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] }, { "date": "2019-12-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] } ] }, "end": { "value": { "date": "2020-11-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "candidates": [ { "date": "2020-11-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] }, { "date": "2020-11-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] } ] } } } ], "detail": "Urinary Tract Infections", "searchTerms": [ "Safety, Tolerability, and PK of LBP-EC01 in Patients With Lower Urinary Tract Colonization Caused by E. Coli", "Urinary Tract Infections", "NCT04191148", "Pinnacle Research Group", "Anniston", "Alabama", "United States", "Tilda Research", "Irvine", "California", "United States", "Universal Axon Clinical Research", "Doral", "Florida", "United States", "Universal Axon - Homestead, LL", "Homestead", "Florida", "United States", "AMPM Research Clinic", "Miami Gardens", "Florida", "United States", "Innovation Medical Research Center", "Palmetto Bay", "Florida", "United States", "Ralph H. Johnson VA Medical Center", "Charleston", "South Carolina", "United States" ] }, { "id": "trial-site/d36253f6d7787f6f", "name": "Salem VA — Salem, Virginia", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05177107" ], "checked": "2026-10-03", "trialIds": [ "nct05177107" ], "location": "Salem, Virginia", "detail": "Recorded study locations: Osteomyelitis; Diabetic Foot Osteomyelitis. Not an offer of treatment.", "searchTerms": [ "Salem VA", "Salem", "Virginia", "Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis", "Osteomyelitis", "Diabetic Foot Osteomyelitis", "NCT05177107" ], "studyYears": [ { "trialId": "nct05177107", "start": { "date": "2021-11-24", "kind": "actual" }, "end": { "date": "2025-05-30", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "label": "2021–2025", "dateEvidence": { "start": { "value": { "date": "2021-11-24", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2021-11-24", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2021-11-24", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] }, "end": { "value": { "date": "2025-05-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2025-05-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2025-05-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] } } } ] }, { "id": "trial-site/7f6cd86f3460cada", "name": "Seattle Children's Hospital — Seattle, Washington", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct05010577" ], "location": "Seattle, Washington", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Seattle Children's Hospital", "Seattle", "Washington", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "id": "trial-site/87294eced081b962", "name": "Sinai Hospital of Baltimore — Baltimore, Maryland", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05269134" ], "checked": "2026-10-03", "trialIds": [ "nct05269134" ], "location": "Baltimore, Maryland", "detail": "Recorded study locations: Prosthetic Joint Infection. Not an offer of treatment.", "searchTerms": [ "Sinai Hospital of Baltimore", "Baltimore", "Maryland", "Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)", "Prosthetic Joint Infection", "NCT05269134" ], "studyYears": [ { "trialId": "nct05269134", "start": { "date": "2023-03-27", "kind": "actual" }, "end": { "date": "2027-07", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "label": "2023–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-03-27", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2023-03-27", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2023-03-27", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] }, "end": { "value": { "date": "2027-07", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2027-07", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2027-07", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] } } } ] }, { "id": "trial-site/675d703fc357f6ee", "name": "Snake River Research — Idaho Falls, Idaho", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05269134" ], "checked": "2026-10-03", "trialIds": [ "nct05269134" ], "location": "Idaho Falls, Idaho", "detail": "Recorded study locations: Prosthetic Joint Infection. Not an offer of treatment.", "searchTerms": [ "Snake River Research", "Idaho Falls", "Idaho", "Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)", "Prosthetic Joint Infection", "NCT05269134" ], "studyYears": [ { "trialId": "nct05269134", "start": { "date": "2023-03-27", "kind": "actual" }, "end": { "date": "2027-07", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "label": "2023–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-03-27", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2023-03-27", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2023-03-27", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] }, "end": { "value": { "date": "2027-07", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2027-07", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2027-07", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] } } } ] }, { "id": "trial-site/c830ed49a88081dd", "name": "Southern Arizona VA Health Care System — Tuscon, Arizona", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05177107" ], "checked": "2026-10-03", "trialIds": [ "nct05177107" ], "location": "Tuscon, Arizona", "detail": "Recorded study locations: Osteomyelitis; Diabetic Foot Osteomyelitis. Not an offer of treatment.", "searchTerms": [ "Southern Arizona VA Health Care System", "Tuscon", "Arizona", "Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis", "Osteomyelitis", "Diabetic Foot Osteomyelitis", "NCT05177107" ], "studyYears": [ { "trialId": "nct05177107", "start": { "date": "2021-11-24", "kind": "actual" }, "end": { "date": "2025-05-30", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "label": "2021–2025", "dateEvidence": { "start": { "value": { "date": "2021-11-24", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2021-11-24", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2021-11-24", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] }, "end": { "value": { "date": "2025-05-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ], "candidates": [ { "date": "2025-05-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] }, { "date": "2025-05-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05177107" ] } ] } } } ] }, { "id": "trial-site/e527c9333e6d445f", "name": "Southern California Institute for Respiratory Diseases Cedars-Sinai West Tower — Los Angeles, California", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct05616221" ], "location": "Los Angeles, California", "detail": "Recorded study locations: Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection. Not an offer of treatment.", "searchTerms": [ "Southern California Institute for Respiratory Diseases Cedars-Sinai West Tower", "Los Angeles", "California", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "id": "trial-site/41fcb64f846c9b2a", "name": "Southern California Research Center, inc — Coronado, California", "countries": [ "US" ], "kind": "Trial site", "status": "Not yet recruiting (trial)", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT06750588" ], "checked": "2026-10-03", "trialIds": [ "nct06750588" ], "location": "Coronado, California", "detail": "Recorded study locations: Alcohol-Associated Hepatitis. Not an offer of treatment.", "searchTerms": [ "Southern California Research Center, inc", "Coronado", "California", "Safety and Tolerability of NTR-101 in Patients With Acute Alcohol-Associated Hepatitis", "Alcohol-Associated Hepatitis", "NCT06750588" ], "studyYears": [ { "trialId": "nct06750588", "start": { "date": "2025-11-05", "kind": "estimated" }, "end": { "date": "2026-06", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06750588" ], "label": "2025 (estimated)–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-11-05", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06750588" ], "candidates": [ { "date": "2025-11-05", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06750588" ] }, { "date": "2025-11-05", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06750588" ] } ] }, "end": { "value": { "date": "2026-06", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06750588" ], "candidates": [ { "date": "2026-06", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06750588" ] }, { "date": "2026-06", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06750588" ] } ] } } } ] }, { "id": "trial-site/6c9e39ef8179f150", "name": "Southweast Regional Wound Care Center — Lubbock, Texas", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT00663091" ], "checked": "2026-10-03", "trialIds": [ "nct00663091" ], "location": "Lubbock, Texas", "detail": "Recorded study locations: Venous Leg Ulcers. Not an offer of treatment.", "searchTerms": [ "Southweast Regional Wound Care Center", "Lubbock", "Texas", "A Prospective, Randomized, Double-Blind Controlled Study of WPP-201 for the Safety and Efficacy of Treatment of Venous Leg Ulcers", "Venous Leg Ulcers", "NCT00663091" ], "studyYears": [ { "trialId": "nct00663091", "start": { "date": "2006-09", "kind": "reported" }, "end": { "date": "2008-05", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00663091" ], "label": "2006–2008", "dateEvidence": { "start": { "value": { "date": "2006-09", "kind": "reported" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00663091" ], "candidates": [ { "date": "2006-09", "kind": "reported", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00663091" ] }, { "date": "2006-09", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00663091" ] } ] }, "end": { "value": { "date": "2008-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00663091" ], "candidates": [ { "date": "2008-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00663091" ] }, { "date": "2008-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00663091" ] } ] } } } ] }, { "id": "trial-site/12e6c93a461f1e2f", "name": "Southwest General Healthcare Center — Fort Myers, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct05616221" ], "location": "Fort Myers, Florida", "detail": "Recorded study locations: Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection. Not an offer of treatment.", "searchTerms": [ "Southwest General Healthcare Center", "Fort Myers", "Florida", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "id": "trial-site/b9a822b7a6d36fd6", "name": "Southwestern Medical Center at Dallas — Dallas, Texas", "countries": [ "US" ], "kind": "Trial site", "status": "Invitation only (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06262282" ], "checked": "2026-10-03", "trialIds": [ "nct06262282" ], "location": "Dallas, Texas", "detail": "Recorded study locations: Cystic Fibrosis; Nontuberculous Mycobacterial Lung Disease; Nontuberculous Mycobacterium Infection; Mycobacterium Infections; Mycobacterium; Pulmonary. Not an offer of treatment.", "searchTerms": [ "Southwestern Medical Center at Dallas", "Dallas", "Texas", "Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria", "Cystic Fibrosis", "Nontuberculous Mycobacterial Lung Disease", "Nontuberculous Mycobacterium Infection", "Mycobacterium Infections", "Mycobacterium; Pulmonary", "NCT06262282" ], "studyYears": [ { "trialId": "nct06262282", "start": { "date": "2024-02-05", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "label": "2024–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2024-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2024-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] } } } ] }, { "id": "trial-site/03ebc18f6e4a91f2", "name": "St. Luke's Cystic Fibrosis Center of Idaho — Boise, Idaho", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04596319" ], "checked": "2026-10-03", "trialIds": [ "nct04596319" ], "location": "Boise, Idaho", "detail": "Recorded study locations: Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal. Not an offer of treatment.", "searchTerms": [ "St. Luke's Cystic Fibrosis Center of Idaho", "Boise", "Idaho", "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319" ], "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } } ] }, { "id": "trial-site/cee584d9ef606690", "name": "St. Lukes Hospital — Boise, Idaho", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct05616221" ], "location": "Boise, Idaho", "detail": "Recorded study locations: Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection. Not an offer of treatment.", "searchTerms": [ "St. Lukes Hospital", "Boise", "Idaho", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "id": "therapyRoutes/stanford-phage", "name": "Stanford Center for Phage Pharmaceuticals", "countries": [ "US" ], "uuid": "2a04ef586fb5529c8ba02512c71d7537", "permalink": "/items/stanford-center-for-phage-pharmaceuticals-2a04ef586fb5529c8ba02512c71d7537", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://med.stanford.edu/news/all-news/2026/06/bollyky-niaid-grant.html" ], "checked": "2026-10-03", "location": "Stanford, California; United States", "detail": "2026 NIAID-supported translational program led by Paul Bollyky; initial focus on developing lung-delivery phages for Pseudomonas infection in CF.", "searchTerms": [ "2026 NIAID-supported translational program led by Paul Bollyky; initial focus on developing lung-delivery phages for Pseudomonas infection in CF.", "Stanford, California; United States" ] }, { "id": "trial-site/4d55a81ae868a13d", "name": "Stanford University — Palo Alto, California", "countries": [ "US" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT06998043" ], "checked": "2026-10-03", "trialIds": [ "nct06998043" ], "location": "Palo Alto, California", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis (CF). Not an offer of treatment.", "searchTerms": [ "Stanford University", "Palo Alto", "California", "Study With Phage for CF Subjects With Pseudomonas Lung Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis (CF)", "NCT06998043", "2024-519856-94-00" ], "studyYears": [ { "trialId": "nct06998043", "start": { "date": "2025-07-02", "kind": "actual" }, "end": { "date": "2026-09", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-07-02", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2025-07-02", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-07-02", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-08-18", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] }, "end": { "value": { "date": "2026-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2026-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2026-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-12-08", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] } } } ] }, { "id": "trial-site/4f6e6101d33ca38d", "name": "Stanford University — Stanford, California", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05453578" ], "checked": "2026-10-03", "trialIds": [ "nct05453578" ], "location": "Stanford, California", "detail": "Recorded study locations: Bacterial Disease Carrier; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Stanford University", "Stanford", "California", "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa", "Bacterial Disease Carrier", "Cystic Fibrosis", "NCT05453578" ], "studyYears": [ { "trialId": "nct05453578", "start": { "date": "2022-10-03", "kind": "actual" }, "end": { "date": "2025-04-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-10-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2022-10-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2022-10-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] }, "end": { "value": { "date": "2025-04-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2025-04-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2025-04-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] } } } ] }, { "uuid": "0d3910c4ec4b5f39bfd57f3bbc97f7ab", "permalink": "/items/ph-1-2-study-evaluating-safety-and-tolerability-of-inhaled-ap-pa02-in-subjects-with-chroni-0d3910c4ec4b5f39bfd57f3bbc97f7ab", "id": "trials/nct04596319", "name": "SWARM-Pa (NCT04596319)", "countries": [ "US" ], "kind": "Trial", "status": "Completed", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04596319" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } } ], "detail": "Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal", "searchTerms": [ "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319", "Children's Hospital Los Angeles", "Los Angeles", "California", "United States", "University of South Florida", "Tampa", "Florida", "United States", "St. Luke's Cystic Fibrosis Center of Idaho", "Boise", "Idaho", "United States", "Northwestern University", "Chicago", "Illinois", "United States", "University of Iowa", "Iowa City", "Iowa", "United States", "The University of Kansas Medical Center", "Kansas City", "Kansas", "United States", "Johns Hopkins University", "Baltimore", "Maryland", "United States", "Massachusetts General Hospital", "Boston", "Massachusetts", "United States", "Boston Children's Hospital", "Boston", "Massachusetts", "United States", "Harper University Hospital", "Detroit", "Michigan", "United States", "Rutgers Robert Wood Johnson Medical School", "New Brunswick", "New Jersey", "United States", "New York Medical College", "Valhalla", "New York", "United States", "University Hospitals Cleveland Medical Center", "Cleveland", "Ohio", "United States", "Nationwide Children's Hospital", "Columbus", "Ohio", "United States", "The Hospital of the University of Pennsylvania", "Philadelphia", "Pennsylvania", "United States", "Medical University of South Carolina", "Charleston", "South Carolina", "United States", "Vanderbilt University Medical Center", "Nashville", "Tennessee", "United States", "University of Texas Southwestern", "Dallas", "Texas", "United States", "University of Washington", "Seattle", "Washington", "United States", "University of Wisconsin", "Madison", "Wisconsin", "United States" ] }, { "id": "therapyRoutes/tabula", "name": "Tabula Bioscience", "countries": [ "US" ], "uuid": "132714488f675100bfcb001edeb54b4f", "permalink": "/items/tabula-bioscience-132714488f675100bfcb001edeb54b4f", "kind": "Company", "status": "Official referral/inquiry route", "activity": "current", "sources": [ "https://www.tabulabio.com/expanded-access", "https://www.tabulabio.com/" ], "checked": "2026-10-03", "location": "San Francisco, California / Madison, Wisconsin (listed work sites); United States", "detail": "Investigational individualized phage therapies; serious bacterial infections without satisfactory alternatives and infeasible trial participation; isolate matching, manufacturing capacity and regulatory/ethical requirements determine supply.", "searchTerms": [ "Investigational individualized phage therapies; serious bacterial infections without satisfactory alternatives and infeasible trial participation; isolate matching, manufacturing capacity and regulatory/ethical requirements determine supply.", "San Francisco, California / Madison, Wisconsin (listed work sites); United States" ] }, { "uuid": "7424f9cd19985d3fa59fd580d9f43d9f", "permalink": "/items/study-to-evaluate-the-safety-phage-kinetics-and-efficacy-of-inhaled-ap-pa02-in-subjects-wi-7424f9cd19985d3fa59fd580d9f43d9f", "id": "trials/nct05616221", "name": "Tailwind (NCT05616221)", "countries": [ "US" ], "kind": "Trial", "status": "Completed", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ], "detail": "Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection", "searchTerms": [ "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221", "Velocity Clinical Research", "Mobile", "Alabama", "United States", "Southern California Institute for Respiratory Diseases Cedars-Sinai West Tower", "Los Angeles", "California", "United States", "UCONN Health", "Farmington", "Connecticut", "United States", "Georgetown University Hospital / Pulmonary Critical Care and Sleep Medicine", "Washington D.C.", "District of Columbia", "United States", "Southwest General Healthcare Center", "Fort Myers", "Florida", "United States", "TecTum Medical Research, Inc.", "Hollywood", "Florida", "United States", "Mayo Clinic/Pulmonary, Critical Care, and Sleep Medicine", "Jacksonville", "Florida", "United States", "University of Miami", "Miami", "Florida", "United States", "St. Lukes Hospital", "Boise", "Idaho", "United States", "The University of Kansas Medical Center / Dept of Medicine", "Kansas City", "Kansas", "United States", "Johns Hopkins University School of Medicine", "Baltimore", "Maryland", "United States", "Mayo Clinic", "Rochester", "Minnesota", "United States", "Rutgers Robert Wood Johnson Medical School", "New Brunswick", "New Jersey", "United States", "New York Medical College", "Hawthorne", "New York", "United States", "University of Cincinnati - College of Medicine", "Cincinnati", "Ohio", "United States", "University Hospitals of Cleveland Medical Center", "Cleveland", "Ohio", "United States", "Oregon Health & Science University", "Portland", "Oregon", "United States", "University of Pennslyvania", "Philadelphia", "Pennsylvania", "United States", "Medical University of South Carolina", "Charleston", "South Carolina", "United States", "Vanderbilt University Medical Center", "Nashville", "Tennessee", "United States", "University of Texas Health Science Center at Tyler", "Tyler", "Texas", "United States", "Virginia Commonwealth University (VCU)", "Richmond", "Virginia", "United States", "University of Washington Medical Center", "Seattle", "Washington", "United States" ] }, { "id": "trial-site/8addb0ac5aca29e8", "name": "TecTum Medical Research, Inc. — Hollywood, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct05616221" ], "location": "Hollywood, Florida", "detail": "Recorded study locations: Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection. Not an offer of treatment.", "searchTerms": [ "TecTum Medical Research, Inc.", "Hollywood", "Florida", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "id": "therapyRoutes/texas-am-cpt", "name": "Texas A&M Center for Phage Technology", "countries": [ "US" ], "uuid": "293121a347f75ec084333ae1eff41be2", "permalink": "/items/texas-a-m-center-for-phage-technology-293121a347f75ec084333ae1eff41be2", "kind": "Supplier", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://cpt.tamu.edu/phage-therapy/", "https://cpt.tamu.edu/phage-therapy-projects/" ], "checked": "2026-10-03", "location": "College Station, Texas; United States", "accessMode": "clinician-support", "detail": "Clinical-support phage sourcing plus bacterial/phage engineering and other preclinical projects.", "searchTerms": [ "Clinical-support phage sourcing plus bacterial/phage engineering and other preclinical projects.", "College Station, Texas; United States" ] }, { "id": "trial-site/9584952b73d8101c", "name": "The Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04596319" ], "checked": "2026-10-03", "trialIds": [ "nct04596319" ], "location": "Philadelphia, Pennsylvania", "detail": "Recorded study locations: Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal. Not an offer of treatment.", "searchTerms": [ "The Hospital of the University of Pennsylvania", "Philadelphia", "Pennsylvania", "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319" ], "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } } ] }, { "id": "trial-site/5dfb32f4a143e907", "name": "The Jamaica Hospital Medical Center — Jamaica, New York", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Jamaica, New York", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "The Jamaica Hospital Medical Center", "Jamaica", "New York", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "trial-site/947f271423267e57", "name": "The University of Alabama at Birmingham — Birmingham, Alabama", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct05010577" ], "location": "Birmingham, Alabama", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "The University of Alabama at Birmingham", "Birmingham", "Alabama", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "id": "trial-site/006120ff314c1003", "name": "The University of Arizona - Banner University Medical Center Tucson Campus - Tucson — Tucson, Arizona", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05453578" ], "checked": "2026-10-03", "trialIds": [ "nct05453578" ], "location": "Tucson, Arizona", "detail": "Recorded study locations: Bacterial Disease Carrier; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "The University of Arizona - Banner University Medical Center Tucson Campus - Tucson", "Tucson", "Arizona", "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa", "Bacterial Disease Carrier", "Cystic Fibrosis", "NCT05453578" ], "studyYears": [ { "trialId": "nct05453578", "start": { "date": "2022-10-03", "kind": "actual" }, "end": { "date": "2025-04-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-10-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2022-10-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2022-10-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] }, "end": { "value": { "date": "2025-04-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2025-04-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2025-04-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] } } } ] }, { "id": "trial-site/52d9b6fb403f46d0", "name": "The University of Kansas Medical Center — Kansas City, Kansas", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04596319" ], "checked": "2026-10-03", "trialIds": [ "nct04596319" ], "location": "Kansas City, Kansas", "detail": "Recorded study locations: Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal. Not an offer of treatment.", "searchTerms": [ "The University of Kansas Medical Center", "Kansas City", "Kansas", "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319" ], "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } } ] }, { "id": "trial-site/5867258bd0897f99", "name": "The University of Kansas Medical Center / Dept of Medicine — Kansas City, Kansas", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct05616221" ], "location": "Kansas City, Kansas", "detail": "Recorded study locations: Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection. Not an offer of treatment.", "searchTerms": [ "The University of Kansas Medical Center / Dept of Medicine", "Kansas City", "Kansas", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "id": "trial-site/8e348fe550f2ac00", "name": "Tilda Research — Irvine, California", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04191148" ], "checked": "2026-10-03", "trialIds": [ "nct04191148" ], "location": "Irvine, California", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Tilda Research", "Irvine", "California", "Safety, Tolerability, and PK of LBP-EC01 in Patients With Lower Urinary Tract Colonization Caused by E. Coli", "Urinary Tract Infections", "NCT04191148" ], "studyYears": [ { "trialId": "nct04191148", "start": { "date": "2019-12-30", "kind": "actual" }, "end": { "date": "2020-11-19", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "label": "2019–2020", "dateEvidence": { "start": { "value": { "date": "2019-12-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "candidates": [ { "date": "2019-12-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] }, { "date": "2019-12-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] } ] }, "end": { "value": { "date": "2020-11-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "candidates": [ { "date": "2020-11-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] }, { "date": "2020-11-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] } ] } } } ] }, { "id": "therapyRoutes/tolka", "name": "Tolka AI Therapeutics", "countries": [ "US" ], "uuid": "d949d531b00d5fc4baaabbdb9deea416", "permalink": "/items/tolka-ai-therapeutics-d949d531b00d5fc4baaabbdb9deea416", "kind": "Company", "status": "Provider-listed inquiry route", "activity": "current", "sources": [ "https://tolka.ai/work/expandedaccess/", "https://tolka.ai/contact/" ], "checked": "2026-10-05", "location": "Miami, Florida, United States (company office)", "detail": "Personalized phages for NTM lung disease, initially Mycobacterium abscessus complex; serious/life-threatening disease without viable options, trial ineligibility, favorable assessment, supply and local regulatory/ethical permission.", "searchTerms": [ "Personalized phages for NTM lung disease, initially Mycobacterium abscessus complex; serious/life-threatening disease without viable options, trial ineligibility, favorable assessment, supply and local regulatory/ethical permission.", "Miami, Florida, United States (company office)" ] }, { "id": "trial-site/35b436254a722966", "name": "Tranquil Clinical Research — Webster, Texas", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05948592" ], "checked": "2026-10-03", "trialIds": [ "nct05948592" ], "location": "Webster, Texas", "detail": "Recorded study locations: Diabetic Foot Infection. Not an offer of treatment.", "searchTerms": [ "Tranquil Clinical Research", "Webster", "Texas", "Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection", "Diabetic Foot Infection", "NCT05948592", "2023-507716-13-00" ], "studyYears": [ { "trialId": "nct05948592", "start": { "date": "2023-11-08", "kind": "actual" }, "end": { "date": "2025-12-19", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "label": "2023–2025", "dateEvidence": { "start": { "value": { "date": "2023-11-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2023-11-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2023-11-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] } ] }, "end": { "value": { "date": "2025-12-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ], "candidates": [ { "date": "2025-12-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05948592" ] }, { "date": "2025-12-19", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2023-507716-13-00?lang=en" ] } ] } } } ] }, { "id": "trial-site/4cc8f230f3457839", "name": "Tufts Medical Center — Boston, Massachusetts", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Boston, Massachusetts", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "Tufts Medical Center", "Boston", "Massachusetts", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "therapyRoutes/ucsd-ipath", "name": "UC San Diego IPATH", "countries": [ "US" ], "uuid": "22a8c8655ddb5e8587a68da2308819b1", "permalink": "/items/uc-san-diego-ipath-22a8c8655ddb5e8587a68da2308819b1", "kind": "Center", "status": "Case-by-case; Official referral/inquiry route", "activity": "current", "sources": [ "https://idgph.ucsd.edu/research/center-innovative-phage-applications-and-therapeutics/clinical-trial/faq-phage-therapy.html", "https://idgph.ucsd.edu/research/center-innovative-phage-applications-and-therapeutics/about/contact.html", "https://clinicaltrials.gov/study/NCT06409819", "https://clinicaltrials.gov/study/NCT07275905", "https://clinicaltrials.gov/study/NCT07280598", "https://idgph.ucsd.edu/research/center-innovative-phage-applications-and-therapeutics/_files/ucsd-authorization-to-release-health-information.pdf" ], "checked": "2026-10-03", "trialIds": [ "nct06409819", "nct07275905", "nct07280598" ], "location": "La Jolla, California; United States", "accessMode": "case-by-case", "detail": "Compassionate-use support for serious resistant or device-associated bacterial infections; prioritizes life/limb-threatening cases, complicated UTIs, transplant and implant-associated infections. Matching, clinical review, supply and regulatory authorization remain necessary.", "searchTerms": [ "Compassionate-use support for serious resistant or device-associated bacterial infections; prioritizes life/limb-threatening cases, complicated UTIs, transplant and implant-associated infections. Matching, clinical review, supply and regulatory authorization remain necessary.", "La Jolla, California; United States" ] }, { "id": "trial-site/0c44363de1da65b1", "name": "UCONN Health — Farmington, Connecticut", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct05616221" ], "location": "Farmington, Connecticut", "detail": "Recorded study locations: Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection. Not an offer of treatment.", "searchTerms": [ "UCONN Health", "Farmington", "Connecticut", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "id": "therapyRoutes/ucsf-bx004", "name": "UCSF — former BX004 phage trial site", "countries": [ "US" ], "uuid": "6fcc554c953350f392997d3467dea7e6", "permalink": "/items/ucsf-former-bx004-phage-trial-site-6fcc554c953350f392997d3467dea7e6", "kind": "Center", "status": "Historical/inactive", "activity": "historical", "sources": [ "https://clinicaltrials.ucsf.edu/trial/NCT06998043", "https://www.sec.gov/Archives/edgar/data/1739174/000121390026078003/ea0298043-424b3_biomx.htm" ], "checked": "2026-10-03", "trialIds": [ "nct06998043" ], "location": "San Francisco, California; United States", "detail": "Former phase 2b inhaled BX004 research for adults with CF and chronic Pseudomonas lung infection.", "searchTerms": [ "Former phase 2b inhaled BX004 research for adults with CF and chronic Pseudomonas lung infection.", "San Francisco, California; United States" ] }, { "id": "trial-site/73bd561a0ccd2779", "name": "Universal Axon - Homestead, LL — Homestead, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04191148" ], "checked": "2026-10-03", "trialIds": [ "nct04191148" ], "location": "Homestead, Florida", "detail": "Recorded study locations: Urinary Tract Infections. Not an offer of treatment.", "searchTerms": [ "Universal Axon - Homestead, LL", "Homestead", "Florida", "Safety, Tolerability, and PK of LBP-EC01 in Patients With Lower Urinary Tract Colonization Caused by E. Coli", "Urinary Tract Infections", "NCT04191148" ], "studyYears": [ { "trialId": "nct04191148", "start": { "date": "2019-12-30", "kind": "actual" }, "end": { "date": "2020-11-19", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "label": "2019–2020", "dateEvidence": { "start": { "value": { "date": "2019-12-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "candidates": [ { "date": "2019-12-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] }, { "date": "2019-12-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] } ] }, "end": { "value": { "date": "2020-11-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "candidates": [ { "date": "2020-11-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] }, { "date": "2020-11-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] } ] } } } ] }, { "id": "trial-site/829190df3608ae92", "name": "Universal Axon Clinical Research — Doral, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04191148", "https://clinicaltrials.gov/study/NCT04287478" ], "checked": "2026-10-03", "trialIds": [ "nct04191148", "nct04287478" ], "location": "Doral, Florida", "detail": "Recorded study locations: Urinary Tract Infections; Urinary Tract Infection Bacterial. Not an offer of treatment.", "searchTerms": [ "Universal Axon Clinical Research", "Doral", "Florida", "Safety, Tolerability, and PK of LBP-EC01 in Patients With Lower Urinary Tract Colonization Caused by E. Coli", "Urinary Tract Infections", "NCT04191148", "Universal Axon Clinical Research", "Doral", "Florida", "Bacteriophage Therapy in Patients With Urinary Tract Infections", "Urinary Tract Infection Bacterial", "NCT04287478" ], "studyYears": [ { "trialId": "nct04191148", "start": { "date": "2019-12-30", "kind": "actual" }, "end": { "date": "2020-11-19", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "label": "2019–2020", "dateEvidence": { "start": { "value": { "date": "2019-12-30", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "candidates": [ { "date": "2019-12-30", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] }, { "date": "2019-12-30", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] } ] }, "end": { "value": { "date": "2020-11-19", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ], "candidates": [ { "date": "2020-11-19", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] }, { "date": "2020-11-19", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04191148" ] } ] } } }, { "trialId": "nct04287478", "start": { "date": "2020-12-09", "kind": "actual" }, "end": { "date": "2023-02-28", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "label": "2020–2023", "dateEvidence": { "start": { "value": { "date": "2020-12-09", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "candidates": [ { "date": "2020-12-09", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] }, { "date": "2020-12-09", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] } ] }, "end": { "value": { "date": "2023-02-28", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "candidates": [ { "date": "2023-02-28", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] }, { "date": "2023-02-28", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] } ] } } } ] }, { "id": "trial-site/2cc69408bdf25e8d", "name": "University Hospitals Cleveland Medical Center — Cleveland, Ohio", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04596319" ], "checked": "2026-10-03", "trialIds": [ "nct04596319" ], "location": "Cleveland, Ohio", "detail": "Recorded study locations: Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal. Not an offer of treatment.", "searchTerms": [ "University Hospitals Cleveland Medical Center", "Cleveland", "Ohio", "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319" ], "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } } ] }, { "id": "trial-site/6a36dec3fda3d1db", "name": "University Hospitals of Cleveland Medical Center — Cleveland, Ohio", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct05616221" ], "location": "Cleveland, Ohio", "detail": "Recorded study locations: Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection. Not an offer of treatment.", "searchTerms": [ "University Hospitals of Cleveland Medical Center", "Cleveland", "Ohio", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "id": "trial-site/d156ad7569b5f3c8", "name": "University Hospitals Rainbow Babies and Children's Hospital — Cleveland, Ohio", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct05010577" ], "location": "Cleveland, Ohio", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "University Hospitals Rainbow Babies and Children's Hospital", "Cleveland", "Ohio", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "id": "trial-site/1ed49df4f23359d7", "name": "University of Alabama — Birmingham, Alabama", "countries": [ "US" ], "kind": "Trial site", "status": "Invitation only (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06262282" ], "checked": "2026-10-03", "trialIds": [ "nct06262282" ], "location": "Birmingham, Alabama", "detail": "Recorded study locations: Cystic Fibrosis; Nontuberculous Mycobacterial Lung Disease; Nontuberculous Mycobacterium Infection; Mycobacterium Infections; Mycobacterium; Pulmonary. Not an offer of treatment.", "searchTerms": [ "University of Alabama", "Birmingham", "Alabama", "Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria", "Cystic Fibrosis", "Nontuberculous Mycobacterial Lung Disease", "Nontuberculous Mycobacterium Infection", "Mycobacterium Infections", "Mycobacterium; Pulmonary", "NCT06262282" ], "studyYears": [ { "trialId": "nct06262282", "start": { "date": "2024-02-05", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "label": "2024–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2024-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2024-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] } } } ] }, { "id": "trial-site/5d4e05fd8c62cd3a", "name": "University of Alabama at Birmingham — Birmingham, Alabama", "countries": [ "US" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT06998043" ], "checked": "2026-10-03", "trialIds": [ "nct06998043" ], "location": "Birmingham, Alabama", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis (CF). Not an offer of treatment.", "searchTerms": [ "University of Alabama at Birmingham", "Birmingham", "Alabama", "Study With Phage for CF Subjects With Pseudomonas Lung Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis (CF)", "NCT06998043", "2024-519856-94-00" ], "studyYears": [ { "trialId": "nct06998043", "start": { "date": "2025-07-02", "kind": "actual" }, "end": { "date": "2026-09", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-07-02", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2025-07-02", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-07-02", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-08-18", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] }, "end": { "value": { "date": "2026-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2026-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2026-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-12-08", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] } } } ] }, { "id": "trial-site/94fd112a967da2f6", "name": "University of Arkansas for Medical Sciences — Little Rock, Arkansas", "countries": [ "US" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT05010577", "https://clinicaltrials.gov/study/NCT06998043" ], "checked": "2026-10-03", "trialIds": [ "nct05010577", "nct06998043" ], "location": "Little Rock, Arkansas", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis; Cystic Fibrosis (CF). Not an offer of treatment.", "searchTerms": [ "University of Arkansas for Medical Sciences", "Little Rock", "Arkansas", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577", "University of Arkansas for Medical Sciences", "Little Rock", "Arkansas", "Study With Phage for CF Subjects With Pseudomonas Lung Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis (CF)", "NCT06998043", "2024-519856-94-00" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } }, { "trialId": "nct06998043", "start": { "date": "2025-07-02", "kind": "actual" }, "end": { "date": "2026-09", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-07-02", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2025-07-02", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-07-02", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-08-18", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] }, "end": { "value": { "date": "2026-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2026-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2026-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-12-08", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] } } } ] }, { "id": "trial-site/98a8507c69cb7ac9", "name": "University of California — San Diego, California", "countries": [ "US" ], "kind": "Trial site", "status": "Invitation only (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06262282" ], "checked": "2026-10-03", "trialIds": [ "nct06262282" ], "location": "San Diego, California", "detail": "Recorded study locations: Cystic Fibrosis; Nontuberculous Mycobacterial Lung Disease; Nontuberculous Mycobacterium Infection; Mycobacterium Infections; Mycobacterium; Pulmonary. Not an offer of treatment.", "searchTerms": [ "University of California", "San Diego", "California", "Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria", "Cystic Fibrosis", "Nontuberculous Mycobacterial Lung Disease", "Nontuberculous Mycobacterium Infection", "Mycobacterium Infections", "Mycobacterium; Pulmonary", "NCT06262282" ], "studyYears": [ { "trialId": "nct06262282", "start": { "date": "2024-02-05", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "label": "2024–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2024-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2024-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] } } } ] }, { "id": "trial-site/53cd69fac2934e33", "name": "University of California Davis Health — Sacramento, California", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05453578" ], "checked": "2026-10-03", "trialIds": [ "nct05453578" ], "location": "Sacramento, California", "detail": "Recorded study locations: Bacterial Disease Carrier; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "University of California Davis Health", "Sacramento", "California", "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa", "Bacterial Disease Carrier", "Cystic Fibrosis", "NCT05453578" ], "studyYears": [ { "trialId": "nct05453578", "start": { "date": "2022-10-03", "kind": "actual" }, "end": { "date": "2025-04-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-10-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2022-10-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2022-10-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] }, "end": { "value": { "date": "2025-04-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2025-04-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2025-04-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] } } } ] }, { "id": "trial-site/c5ac7dda31b67427", "name": "University of California Los Angeles Medical Center - Westwood Clinic — Los Angeles, California", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05453578" ], "checked": "2026-10-03", "trialIds": [ "nct05453578" ], "location": "Los Angeles, California", "detail": "Recorded study locations: Bacterial Disease Carrier; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "University of California Los Angeles Medical Center - Westwood Clinic", "Los Angeles", "California", "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa", "Bacterial Disease Carrier", "Cystic Fibrosis", "NCT05453578" ], "studyYears": [ { "trialId": "nct05453578", "start": { "date": "2022-10-03", "kind": "actual" }, "end": { "date": "2025-04-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-10-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2022-10-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2022-10-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] }, "end": { "value": { "date": "2025-04-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2025-04-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2025-04-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] } } } ] }, { "id": "trial-site/b331b07f00b2f477", "name": "University of California San Diego (UCSD) — San Diego, California", "countries": [ "US" ], "kind": "Trial site", "status": "Not yet recruiting (trial)", "activity": "planned", "sources": [ "https://clinicaltrials.gov/study/NCT07275905" ], "checked": "2026-10-03", "trialIds": [ "nct07275905" ], "location": "San Diego, California", "detail": "Recorded study locations: Cystic Fibrosis (CF); Achromobacter Infection. Not an offer of treatment.", "searchTerms": [ "University of California San Diego (UCSD)", "San Diego", "California", "Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection", "Cystic Fibrosis (CF)", "Achromobacter Infection", "NCT07275905" ], "studyYears": [ { "trialId": "nct07275905", "start": { "date": "2026-08-01", "kind": "estimated" }, "end": { "date": "2028-02", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ], "label": "2026 (estimated)–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-08-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ], "candidates": [ { "date": "2026-08-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ] }, { "date": "2026-08-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ] } ] }, "end": { "value": { "date": "2028-02", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ], "candidates": [ { "date": "2028-02", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ] }, { "date": "2028-02", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ] } ] } } } ] }, { "id": "trial-site/eaaa8d56a863070d", "name": "University of California San Diego Medical Center — San Diego, California", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05269134" ], "checked": "2026-10-03", "trialIds": [ "nct05269134" ], "location": "San Diego, California", "detail": "Recorded study locations: Prosthetic Joint Infection. Not an offer of treatment.", "searchTerms": [ "University of California San Diego Medical Center", "San Diego", "California", "Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)", "Prosthetic Joint Infection", "NCT05269134" ], "studyYears": [ { "trialId": "nct05269134", "start": { "date": "2023-03-27", "kind": "actual" }, "end": { "date": "2027-07", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "label": "2023–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-03-27", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2023-03-27", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2023-03-27", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] }, "end": { "value": { "date": "2027-07", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2027-07", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2027-07", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] } } } ] }, { "id": "trial-site/46f5fec92586bda1", "name": "University of California San Francisco — San Francisco, California", "countries": [ "US" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT06998043" ], "checked": "2026-10-03", "trialIds": [ "nct06998043" ], "location": "San Francisco, California", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis (CF). Not an offer of treatment.", "searchTerms": [ "University of California San Francisco", "San Francisco", "California", "Study With Phage for CF Subjects With Pseudomonas Lung Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis (CF)", "NCT06998043", "2024-519856-94-00" ], "studyYears": [ { "trialId": "nct06998043", "start": { "date": "2025-07-02", "kind": "actual" }, "end": { "date": "2026-09", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-07-02", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2025-07-02", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-07-02", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-08-18", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] }, "end": { "value": { "date": "2026-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2026-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2026-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-12-08", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] } } } ] }, { "id": "trial-site/c036a421522fd4b9", "name": "University of California, Los Angeles (UCLA) - Medical Center — Los Angeles, California", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Los Angeles, California", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "University of California, Los Angeles (UCLA) - Medical Center", "Los Angeles", "California", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "trial-site/9b56664b77ebfbd4", "name": "University of California, San Diego — La Jolla, California", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05453578", "https://clinicaltrials.gov/study/NCT06409819" ], "checked": "2026-10-03", "trialIds": [ "nct05453578", "nct06409819" ], "location": "La Jolla, California", "detail": "Recorded study locations: Bacterial Disease Carrier; Cystic Fibrosis; Urinary Tract Infection, Recurrent. Not an offer of treatment.", "searchTerms": [ "University of California, San Diego", "La Jolla", "California", "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa", "Bacterial Disease Carrier", "Cystic Fibrosis", "NCT05453578", "University of California, San Diego", "La Jolla", "California", "Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients", "Urinary Tract Infection, Recurrent", "NCT06409819" ], "studyYears": [ { "trialId": "nct05453578", "start": { "date": "2022-10-03", "kind": "actual" }, "end": { "date": "2025-04-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-10-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2022-10-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2022-10-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] }, "end": { "value": { "date": "2025-04-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2025-04-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2025-04-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] } } }, { "trialId": "nct06409819", "start": { "date": "2025-06-15", "kind": "actual" }, "end": { "date": "2027-03-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06409819" ], "label": "2025–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-06-15", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06409819" ], "candidates": [ { "date": "2025-06-15", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06409819" ] }, { "date": "2025-06-15", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06409819" ] } ] }, "end": { "value": { "date": "2027-03-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06409819" ], "candidates": [ { "date": "2027-03-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06409819" ] }, { "date": "2027-03-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06409819" ] } ] } } } ] }, { "id": "trial-site/f4b0f918326bf569", "name": "University of California, San Diego (UCSD) - Antiviral Research Center (AVRC) — La Jolla, California", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05453578" ], "checked": "2026-10-03", "trialIds": [ "nct05453578" ], "location": "La Jolla, California", "detail": "Recorded study locations: Bacterial Disease Carrier; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "University of California, San Diego (UCSD) - Antiviral Research Center (AVRC)", "La Jolla", "California", "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa", "Bacterial Disease Carrier", "Cystic Fibrosis", "NCT05453578" ], "studyYears": [ { "trialId": "nct05453578", "start": { "date": "2022-10-03", "kind": "actual" }, "end": { "date": "2025-04-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-10-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2022-10-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2022-10-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] }, "end": { "value": { "date": "2025-04-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2025-04-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2025-04-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] } } } ] }, { "id": "trial-site/727668430c629f55", "name": "University of California, San Diego (UCSD) - Medical Center — La Jolla, California", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "La Jolla, California", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "University of California, San Diego (UCSD) - Medical Center", "La Jolla", "California", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "trial-site/b5800f628211c94c", "name": "University of California, San Francisco — San Francisco, California", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06938867" ], "checked": "2026-10-03", "trialIds": [ "nct06938867" ], "location": "San Francisco, California", "detail": "Recorded study locations: E Coli Infections; Allogenic Transplant Patients. Not an offer of treatment.", "searchTerms": [ "University of California, San Francisco", "San Francisco", "California", "Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant", "E Coli Infections", "Allogenic Transplant Patients", "NCT06938867" ], "studyYears": [ { "trialId": "nct06938867", "start": { "date": "2025-02-25", "kind": "actual" }, "end": { "date": "2026-04-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-02-25", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "candidates": [ { "date": "2025-02-25", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] }, { "date": "2025-02-25", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] } ] }, "end": { "value": { "date": "2026-04-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "candidates": [ { "date": "2026-04-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] }, { "date": "2026-04-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] } ] } } } ] }, { "id": "trial-site/0ac563105fe04589", "name": "University of Cincinnati - College of Medicine — Cincinnati, Ohio", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct05616221" ], "location": "Cincinnati, Ohio", "detail": "Recorded study locations: Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection. Not an offer of treatment.", "searchTerms": [ "University of Cincinnati - College of Medicine", "Cincinnati", "Ohio", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "id": "trial-site/1a93cdc0553d3742", "name": "University of Florida - Jacksonville — Jacksonville, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Jacksonville, Florida", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "University of Florida - Jacksonville", "Jacksonville", "Florida", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "trial-site/ad1044a73a64803f", "name": "University of Florida — Gainesville, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Invitation only (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05010577", "https://clinicaltrials.gov/study/NCT06262282" ], "checked": "2026-10-03", "trialIds": [ "nct05010577", "nct06262282" ], "location": "Gainesville, Florida", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis; Nontuberculous Mycobacterial Lung Disease; Nontuberculous Mycobacterium Infection; Mycobacterium Infections; Mycobacterium; Pulmonary. Not an offer of treatment.", "searchTerms": [ "University of Florida", "Gainesville", "Florida", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577", "University of Florida", "Gainesville", "Florida", "Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria", "Cystic Fibrosis", "Nontuberculous Mycobacterial Lung Disease", "Nontuberculous Mycobacterium Infection", "Mycobacterium Infections", "Mycobacterium; Pulmonary", "NCT06262282" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } }, { "trialId": "nct06262282", "start": { "date": "2024-02-05", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "label": "2024–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2024-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2024-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] } } } ] }, { "id": "trial-site/3aa9d8d13f342127", "name": "University of Florida (UF) - Division of Infectious Disease — Gainesville, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Gainesville, Florida", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "University of Florida (UF) - Division of Infectious Disease", "Gainesville", "Florida", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "trial-site/66f22acc0d318b4c", "name": "University of Iowa — Iowa City, Iowa", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04596319" ], "checked": "2026-10-03", "trialIds": [ "nct04596319" ], "location": "Iowa City, Iowa", "detail": "Recorded study locations: Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal. Not an offer of treatment.", "searchTerms": [ "University of Iowa", "Iowa City", "Iowa", "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319" ], "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } } ] }, { "id": "trial-site/c14dae7adf776ec9", "name": "University of Maryland Medical Center — Baltimore, Maryland", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05269134" ], "checked": "2026-10-03", "trialIds": [ "nct05269134" ], "location": "Baltimore, Maryland", "detail": "Recorded study locations: Prosthetic Joint Infection. Not an offer of treatment.", "searchTerms": [ "University of Maryland Medical Center", "Baltimore", "Maryland", "Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)", "Prosthetic Joint Infection", "NCT05269134" ], "studyYears": [ { "trialId": "nct05269134", "start": { "date": "2023-03-27", "kind": "actual" }, "end": { "date": "2027-07", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "label": "2023–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-03-27", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2023-03-27", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2023-03-27", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] }, "end": { "value": { "date": "2027-07", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2027-07", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2027-07", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] } } } ] }, { "id": "therapyRoutes/maryland-doub", "name": "University of Maryland School of Medicine — James Doub clinical research", "countries": [ "US" ], "uuid": "cd3a48c88b34552e857747fd9ea7a50e", "permalink": "/items/university-of-maryland-school-of-medicine-james-doub-clinical-research-cd3a48c88b34552e857747fd9ea7a50e", "kind": "Center", "status": "Intake unconfirmed", "activity": "unconfirmed", "sources": [ "https://www.medschool.umaryland.edu/profiles/doub-james/", "https://clinicaltrials.gov/study/NCT05269134" ], "checked": "2026-10-03", "trialIds": [ "nct05269134" ], "location": "Baltimore, Maryland; United States", "detail": "Clinical/translational musculoskeletal infection program and phage research; profile reports treatment protocols and research funding.", "searchTerms": [ "Clinical/translational musculoskeletal infection program and phage research; profile reports treatment protocols and research funding.", "Baltimore, Maryland; United States" ] }, { "id": "trial-site/84c941d16baeefd7", "name": "University of Maryland, Baltimore, University of Maryland School of Medicine, Center for Vaccine Development and Global Health — Baltimore, Maryland", "countries": [ "US" ], "kind": "Trial site", "status": "Active, not recruiting (trial)", "activity": "ongoing", "sources": [ "https://clinicaltrials.gov/study/NCT05182749" ], "checked": "2026-10-03", "trialIds": [ "nct05182749" ], "location": "Baltimore, Maryland", "detail": "Recorded study locations: Shigellosis. Not an offer of treatment.", "searchTerms": [ "University of Maryland, Baltimore, University of Maryland School of Medicine, Center for Vaccine Development and Global Health", "Baltimore", "Maryland", "Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of Shigellosis", "Shigellosis", "NCT05182749" ], "studyYears": [ { "trialId": "nct05182749", "start": { "date": "2023-02-23", "kind": "actual" }, "end": { "date": "2025-09-30", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05182749" ], "label": "2023–2025 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-02-23", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05182749" ], "candidates": [ { "date": "2023-02-23", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05182749" ] }, { "date": "2023-02-23", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05182749" ] } ] }, "end": { "value": { "date": "2025-09-30", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05182749" ], "candidates": [ { "date": "2025-09-30", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05182749" ] }, { "date": "2025-09-30", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05182749" ] } ] } } } ] }, { "id": "trial-site/caacaec6d636a899", "name": "University of Miami — Miami, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct05616221" ], "location": "Miami, Florida", "detail": "Recorded study locations: Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection. Not an offer of treatment.", "searchTerms": [ "University of Miami", "Miami", "Florida", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "id": "trial-site/d7779b121b58c446", "name": "University of Michigan — Ann Arbor, Michigan", "countries": [ "US" ], "kind": "Trial site", "status": "Invitation only (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT05184764", "https://clinicaltrials.gov/study/NCT06262282" ], "checked": "2026-10-03", "trialIds": [ "nct05184764", "nct06262282" ], "location": "Ann Arbor, Michigan", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus; Cystic Fibrosis; Nontuberculous Mycobacterial Lung Disease; Nontuberculous Mycobacterium Infection; Mycobacterium Infections; Mycobacterium; Pulmonary. Not an offer of treatment.", "searchTerms": [ "University of Michigan", "Ann Arbor", "Michigan", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764", "University of Michigan", "Ann Arbor", "Michigan", "Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria", "Cystic Fibrosis", "Nontuberculous Mycobacterial Lung Disease", "Nontuberculous Mycobacterium Infection", "Mycobacterium Infections", "Mycobacterium; Pulmonary", "NCT06262282" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } }, { "trialId": "nct06262282", "start": { "date": "2024-02-05", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "label": "2024–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2024-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2024-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] } } } ] }, { "id": "trial-site/455e5097e7245318", "name": "University of Minnesota — Minneapolis, Minnesota", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06938867" ], "checked": "2026-10-03", "trialIds": [ "nct06938867" ], "location": "Minneapolis, Minnesota", "detail": "Recorded study locations: E Coli Infections; Allogenic Transplant Patients. Not an offer of treatment.", "searchTerms": [ "University of Minnesota", "Minneapolis", "Minnesota", "Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant", "E Coli Infections", "Allogenic Transplant Patients", "NCT06938867" ], "studyYears": [ { "trialId": "nct06938867", "start": { "date": "2025-02-25", "kind": "actual" }, "end": { "date": "2026-04-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-02-25", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "candidates": [ { "date": "2025-02-25", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] }, { "date": "2025-02-25", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] } ] }, "end": { "value": { "date": "2026-04-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "candidates": [ { "date": "2026-04-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] }, { "date": "2026-04-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] } ] } } } ] }, { "id": "trial-site/968d6c43adc29776", "name": "University of Minnesota Medical Center — Minneapolis, Minnesota", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05453578" ], "checked": "2026-10-03", "trialIds": [ "nct05453578" ], "location": "Minneapolis, Minnesota", "detail": "Recorded study locations: Bacterial Disease Carrier; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "University of Minnesota Medical Center", "Minneapolis", "Minnesota", "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa", "Bacterial Disease Carrier", "Cystic Fibrosis", "NCT05453578" ], "studyYears": [ { "trialId": "nct05453578", "start": { "date": "2022-10-03", "kind": "actual" }, "end": { "date": "2025-04-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-10-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2022-10-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2022-10-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] }, "end": { "value": { "date": "2025-04-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2025-04-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2025-04-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] } } } ] }, { "id": "trial-site/bc093186d347b665", "name": "University of North Carolina - Chapel Hill School of Medicine — Chapel Hill, North Carolina", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Chapel Hill, North Carolina", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "University of North Carolina - Chapel Hill School of Medicine", "Chapel Hill", "North Carolina", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "trial-site/2e36311059c502d3", "name": "University of North Carolina at Chapel Hill — Chapel Hill, North Carolina", "countries": [ "US" ], "kind": "Trial site", "status": "Invitation only (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06262282" ], "checked": "2026-10-03", "trialIds": [ "nct06262282" ], "location": "Chapel Hill, North Carolina", "detail": "Recorded study locations: Cystic Fibrosis; Nontuberculous Mycobacterial Lung Disease; Nontuberculous Mycobacterium Infection; Mycobacterium Infections; Mycobacterium; Pulmonary. Not an offer of treatment.", "searchTerms": [ "University of North Carolina at Chapel Hill", "Chapel Hill", "North Carolina", "Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria", "Cystic Fibrosis", "Nontuberculous Mycobacterial Lung Disease", "Nontuberculous Mycobacterium Infection", "Mycobacterium Infections", "Mycobacterium; Pulmonary", "NCT06262282" ], "studyYears": [ { "trialId": "nct06262282", "start": { "date": "2024-02-05", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "label": "2024–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2024-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2024-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] } } } ] }, { "id": "trial-site/4a55b69217fac75d", "name": "University of Pennslyvania — Philadelphia, Pennsylvania", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct05616221" ], "location": "Philadelphia, Pennsylvania", "detail": "Recorded study locations: Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection. Not an offer of treatment.", "searchTerms": [ "University of Pennslyvania", "Philadelphia", "Pennsylvania", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "id": "trial-site/3575b8d6fe0d0772", "name": "University of Pittsburgh — Pittsburgh, Pennsylvania", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT07275905" ], "checked": "2026-10-03", "trialIds": [ "nct07275905" ], "location": "Pittsburgh, Pennsylvania", "detail": "Recorded study locations: Cystic Fibrosis (CF); Achromobacter Infection. Not an offer of treatment.", "searchTerms": [ "University of Pittsburgh", "Pittsburgh", "Pennsylvania", "Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection", "Cystic Fibrosis (CF)", "Achromobacter Infection", "NCT07275905" ], "studyYears": [ { "trialId": "nct07275905", "start": { "date": "2026-08-01", "kind": "estimated" }, "end": { "date": "2028-02", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ], "label": "2026 (estimated)–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2026-08-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ], "candidates": [ { "date": "2026-08-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ] }, { "date": "2026-08-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ] } ] }, "end": { "value": { "date": "2028-02", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ], "candidates": [ { "date": "2028-02", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ] }, { "date": "2028-02", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07275905" ] } ] } } } ] }, { "id": "trial-site/4e411e41a76f1daa", "name": "University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania", "countries": [ "US" ], "kind": "Trial site", "status": "Invitation only (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06262282" ], "checked": "2026-10-03", "trialIds": [ "nct06262282" ], "location": "Pittsburgh, Pennsylvania", "detail": "Recorded study locations: Cystic Fibrosis; Nontuberculous Mycobacterial Lung Disease; Nontuberculous Mycobacterium Infection; Mycobacterium Infections; Mycobacterium; Pulmonary. Not an offer of treatment.", "searchTerms": [ "University of Pittsburgh Medical Center", "Pittsburgh", "Pennsylvania", "Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria", "Cystic Fibrosis", "Nontuberculous Mycobacterial Lung Disease", "Nontuberculous Mycobacterium Infection", "Mycobacterium Infections", "Mycobacterium; Pulmonary", "NCT06262282" ], "studyYears": [ { "trialId": "nct06262282", "start": { "date": "2024-02-05", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "label": "2024–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2024-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2024-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] } } } ] }, { "id": "trial-site/e5000989962b9979", "name": "University of South Florida — Tampa, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04596319", "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct04596319", "nct05184764" ], "location": "Tampa, Florida", "detail": "Recorded study locations: Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal; Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "University of South Florida", "Tampa", "Florida", "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319", "University of South Florida", "Tampa", "Florida", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } }, { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "trial-site/efe60551d5260a06", "name": "University of South Florida/Tampa General Hospital — Tampa, Florida", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05453578" ], "checked": "2026-10-03", "trialIds": [ "nct05453578" ], "location": "Tampa, Florida", "detail": "Recorded study locations: Bacterial Disease Carrier; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "University of South Florida/Tampa General Hospital", "Tampa", "Florida", "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa", "Bacterial Disease Carrier", "Cystic Fibrosis", "NCT05453578" ], "studyYears": [ { "trialId": "nct05453578", "start": { "date": "2022-10-03", "kind": "actual" }, "end": { "date": "2025-04-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-10-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2022-10-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2022-10-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] }, "end": { "value": { "date": "2025-04-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2025-04-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2025-04-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] } } } ] }, { "id": "trial-site/47751c644d2b0902", "name": "University of Southern California Keck School of Medicine — Los Angeles, California", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Los Angeles, California", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "University of Southern California Keck School of Medicine", "Los Angeles", "California", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "trial-site/98a323fcd60c82d9", "name": "University of Texas Health Science Center at Tyler — Tyler, Texas", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct05616221" ], "location": "Tyler, Texas", "detail": "Recorded study locations: Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection. Not an offer of treatment.", "searchTerms": [ "University of Texas Health Science Center at Tyler", "Tyler", "Texas", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "id": "trial-site/f305eb5c7cf43758", "name": "University of Texas MD Anderson Cancer Center — Houston, Texas", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06938867" ], "checked": "2026-10-03", "trialIds": [ "nct06938867" ], "location": "Houston, Texas", "detail": "Recorded study locations: E Coli Infections; Allogenic Transplant Patients. Not an offer of treatment.", "searchTerms": [ "University of Texas MD Anderson Cancer Center", "Houston", "Texas", "Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant", "E Coli Infections", "Allogenic Transplant Patients", "NCT06938867" ], "studyYears": [ { "trialId": "nct06938867", "start": { "date": "2025-02-25", "kind": "actual" }, "end": { "date": "2026-04-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-02-25", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "candidates": [ { "date": "2025-02-25", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] }, { "date": "2025-02-25", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] } ] }, "end": { "value": { "date": "2026-04-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "candidates": [ { "date": "2026-04-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] }, { "date": "2026-04-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] } ] } } } ] }, { "id": "trial-site/3d79e72b129b6c69", "name": "University of Texas Southwestern — Dallas, Texas", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04596319" ], "checked": "2026-10-03", "trialIds": [ "nct04596319" ], "location": "Dallas, Texas", "detail": "Recorded study locations: Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal. Not an offer of treatment.", "searchTerms": [ "University of Texas Southwestern", "Dallas", "Texas", "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319" ], "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } } ] }, { "id": "trial-site/f3c6fa0cdcf47746", "name": "University of Texas Southwestern Medical Center — Dallas, Texas", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04287478", "https://clinicaltrials.gov/study/NCT05453578" ], "checked": "2026-10-03", "trialIds": [ "nct04287478", "nct05453578" ], "location": "Dallas, Texas", "detail": "Recorded study locations: Urinary Tract Infection Bacterial; Bacterial Disease Carrier; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "University of Texas Southwestern Medical Center", "Dallas", "Texas", "Bacteriophage Therapy in Patients With Urinary Tract Infections", "Urinary Tract Infection Bacterial", "NCT04287478", "University of Texas Southwestern Medical Center", "Dallas", "Texas", "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa", "Bacterial Disease Carrier", "Cystic Fibrosis", "NCT05453578" ], "studyYears": [ { "trialId": "nct04287478", "start": { "date": "2020-12-09", "kind": "actual" }, "end": { "date": "2023-02-28", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "label": "2020–2023", "dateEvidence": { "start": { "value": { "date": "2020-12-09", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "candidates": [ { "date": "2020-12-09", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] }, { "date": "2020-12-09", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] } ] }, "end": { "value": { "date": "2023-02-28", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ], "candidates": [ { "date": "2023-02-28", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] }, { "date": "2023-02-28", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04287478" ] } ] } } }, { "trialId": "nct05453578", "start": { "date": "2022-10-03", "kind": "actual" }, "end": { "date": "2025-04-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-10-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2022-10-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2022-10-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] }, "end": { "value": { "date": "2025-04-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2025-04-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2025-04-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] } } } ] }, { "id": "trial-site/d8735785837faa2b", "name": "University of Utah — Salt Lake City, Utah", "countries": [ "US" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT05010577", "https://clinicaltrials.gov/study/NCT06998043" ], "checked": "2026-10-03", "trialIds": [ "nct05010577", "nct06998043" ], "location": "Salt Lake City, Utah", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis; Cystic Fibrosis (CF). Not an offer of treatment.", "searchTerms": [ "University of Utah", "Salt Lake City", "Utah", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577", "University of Utah", "Salt Lake City", "Utah", "Study With Phage for CF Subjects With Pseudomonas Lung Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis (CF)", "NCT06998043", "2024-519856-94-00" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } }, { "trialId": "nct06998043", "start": { "date": "2025-07-02", "kind": "actual" }, "end": { "date": "2026-09", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-07-02", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2025-07-02", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-07-02", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-08-18", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] }, "end": { "value": { "date": "2026-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2026-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2026-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-12-08", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] } } } ] }, { "id": "trial-site/49f76071399e97d9", "name": "University of Vermont — Burlington, Vermont", "countries": [ "US" ], "kind": "Trial site", "status": "Invitation only (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06262282" ], "checked": "2026-10-03", "trialIds": [ "nct06262282" ], "location": "Burlington, Vermont", "detail": "Recorded study locations: Cystic Fibrosis; Nontuberculous Mycobacterial Lung Disease; Nontuberculous Mycobacterium Infection; Mycobacterium Infections; Mycobacterium; Pulmonary. Not an offer of treatment.", "searchTerms": [ "University of Vermont", "Burlington", "Vermont", "Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria", "Cystic Fibrosis", "Nontuberculous Mycobacterial Lung Disease", "Nontuberculous Mycobacterium Infection", "Mycobacterium Infections", "Mycobacterium; Pulmonary", "NCT06262282" ], "studyYears": [ { "trialId": "nct06262282", "start": { "date": "2024-02-05", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "label": "2024–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2024-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2024-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] } } } ] }, { "id": "trial-site/c0277bce61748d87", "name": "University of Virginia — Charlottesville, Virginia", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05453578" ], "checked": "2026-10-03", "trialIds": [ "nct05453578" ], "location": "Charlottesville, Virginia", "detail": "Recorded study locations: Bacterial Disease Carrier; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "University of Virginia", "Charlottesville", "Virginia", "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa", "Bacterial Disease Carrier", "Cystic Fibrosis", "NCT05453578" ], "studyYears": [ { "trialId": "nct05453578", "start": { "date": "2022-10-03", "kind": "actual" }, "end": { "date": "2025-04-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-10-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2022-10-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2022-10-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] }, "end": { "value": { "date": "2025-04-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2025-04-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2025-04-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] } } } ] }, { "id": "trial-site/8c3c648e0208f475", "name": "University of Washington — Seattle, Washington", "countries": [ "US" ], "kind": "Trial site", "status": "Invitation only (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT04596319", "https://clinicaltrials.gov/study/NCT06262282" ], "checked": "2026-10-03", "trialIds": [ "nct04596319", "nct06262282" ], "location": "Seattle, Washington", "detail": "Recorded study locations: Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal; Nontuberculous Mycobacterial Lung Disease; Nontuberculous Mycobacterium Infection; Mycobacterium Infections; Mycobacterium; Pulmonary. Not an offer of treatment.", "searchTerms": [ "University of Washington", "Seattle", "Washington", "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319", "University of Washington", "Seattle", "Washington", "Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria", "Cystic Fibrosis", "Nontuberculous Mycobacterial Lung Disease", "Nontuberculous Mycobacterium Infection", "Mycobacterium Infections", "Mycobacterium; Pulmonary", "NCT06262282" ], "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } }, { "trialId": "nct06262282", "start": { "date": "2024-02-05", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "label": "2024–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2024-02-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2024-02-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2024-02-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06262282" ] } ] } } } ] }, { "id": "trial-site/0d238dab4bd77ba5", "name": "University of Washington Medical Center — Seattle, Washington", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct05616221" ], "location": "Seattle, Washington", "detail": "Recorded study locations: Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection. Not an offer of treatment.", "searchTerms": [ "University of Washington Medical Center", "Seattle", "Washington", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "id": "trial-site/673f408dd5559f7b", "name": "University of Wisconsin — Madison, Wisconsin", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04596319" ], "checked": "2026-10-03", "trialIds": [ "nct04596319" ], "location": "Madison, Wisconsin", "detail": "Recorded study locations: Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal. Not an offer of treatment.", "searchTerms": [ "University of Wisconsin", "Madison", "Wisconsin", "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319" ], "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } } ] }, { "id": "trial-site/dbef5797f31d365a", "name": "UPMC — Pittsburgh, Pennsylvania", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06938867" ], "checked": "2026-10-03", "trialIds": [ "nct06938867" ], "location": "Pittsburgh, Pennsylvania", "detail": "Recorded study locations: E Coli Infections; Allogenic Transplant Patients. Not an offer of treatment.", "searchTerms": [ "UPMC", "Pittsburgh", "Pennsylvania", "Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant", "E Coli Infections", "Allogenic Transplant Patients", "NCT06938867" ], "studyYears": [ { "trialId": "nct06938867", "start": { "date": "2025-02-25", "kind": "actual" }, "end": { "date": "2026-04-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-02-25", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "candidates": [ { "date": "2025-02-25", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] }, { "date": "2025-02-25", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] } ] }, "end": { "value": { "date": "2026-04-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "candidates": [ { "date": "2026-04-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] }, { "date": "2026-04-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] } ] } } } ] }, { "id": "trial-site/b7b48b03e43c8282", "name": "UPMC Presbyterian — Pittsburgh, Pennsylvania", "countries": [ "US" ], "kind": "Trial site", "status": "Suspended (trial)", "activity": "paused", "sources": [ "https://clinicaltrials.gov/study/NCT05715619" ], "checked": "2026-10-03", "trialIds": [ "nct05715619" ], "location": "Pittsburgh, Pennsylvania", "detail": "Recorded study locations: Vancomycin-Resistant Enterococcal Colonization. Not an offer of treatment.", "searchTerms": [ "UPMC Presbyterian", "Pittsburgh", "Pennsylvania", "Safety and Efficacy of Oral Administration of the Phage Cocktail, VRELysin™, In Healthy and VRE-Colonized Subjects", "Vancomycin-Resistant Enterococcal Colonization", "NCT05715619" ], "studyYears": [ { "trialId": "nct05715619", "start": { "date": "2023-10-25", "kind": "actual" }, "end": { "date": "2026-10-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05715619" ], "label": "2023–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-10-25", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05715619" ], "candidates": [ { "date": "2023-10-25", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05715619" ] }, { "date": "2023-10-25", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05715619" ] } ] }, "end": { "value": { "date": "2026-10-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05715619" ], "candidates": [ { "date": "2026-10-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05715619" ] }, { "date": "2026-10-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05715619" ] } ] } } } ] }, { "id": "therapyRoutes/san-antonio-phage", "name": "UT Health San Antonio phage research collaboration", "countries": [ "US" ], "uuid": "8644a1aeb85b501b810823a0f22496e3", "permalink": "/items/ut-health-san-antonio-phage-research-collaboration-8644a1aeb85b501b810823a0f22496e3", "kind": "Research", "status": "Research/development", "activity": "research", "sources": [ "https://news.uthscsa.edu/local-grant-boosts-ut-health-san-antonio-scientists-mission-to-advance-phage-therapy/" ], "checked": "2026-10-03", "location": "San Antonio, Texas; United States", "detail": "Exploratory phage persistence and production research with UTSA, Texas Biomedical and Brooke Army Medical Center; Phage Refinery commercialization link.", "searchTerms": [ "Exploratory phage persistence and production research with UTSA, Texas Biomedical and Brooke Army Medical Center; Phage Refinery commercialization link.", "San Antonio, Texas; United States" ] }, { "id": "trial-site/902496e4297058e4", "name": "Vanderbilt University Medical Center — Nashville, Tennessee", "countries": [ "US" ], "kind": "Trial site", "status": "Conflicting status (trial)", "activity": "unconfirmed", "sources": [ "https://clinicaltrials.gov/study/NCT04596319", "https://clinicaltrials.gov/study/NCT05453578", "https://clinicaltrials.gov/study/NCT05616221", "https://clinicaltrials.gov/study/NCT06998043" ], "checked": "2026-10-03", "trialIds": [ "nct04596319", "nct05453578", "nct05616221", "nct06998043" ], "location": "Nashville, Tennessee", "detail": "Recorded study locations: Cystic Fibrosis; Pseudomonas Aeruginosa; Pseudomonas; Lung Infection; Lung Infection Pseudomonal; Bacterial Disease Carrier; Non-cystic Fibrosis Bronchiectasis; Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis (CF). Not an offer of treatment.", "searchTerms": [ "Vanderbilt University Medical Center", "Nashville", "Tennessee", "Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis", "Cystic Fibrosis", "Pseudomonas Aeruginosa", "Pseudomonas", "Lung Infection", "Lung Infection Pseudomonal", "NCT04596319", "Vanderbilt University Medical Center", "Nashville", "Tennessee", "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa", "Bacterial Disease Carrier", "Cystic Fibrosis", "NCT05453578", "Vanderbilt University Medical Center", "Nashville", "Tennessee", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221", "Vanderbilt University Medical Center", "Nashville", "Tennessee", "Study With Phage for CF Subjects With Pseudomonas Lung Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis (CF)", "NCT06998043", "2024-519856-94-00" ], "studyYears": [ { "trialId": "nct04596319", "start": { "date": "2020-12-22", "kind": "actual" }, "end": { "date": "2022-12-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "label": "2020–2022", "dateEvidence": { "start": { "value": { "date": "2020-12-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2020-12-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2020-12-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] }, "end": { "value": { "date": "2022-12-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ], "candidates": [ { "date": "2022-12-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] }, { "date": "2022-12-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04596319" ] } ] } } }, { "trialId": "nct05453578", "start": { "date": "2022-10-03", "kind": "actual" }, "end": { "date": "2025-04-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-10-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2022-10-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2022-10-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] }, "end": { "value": { "date": "2025-04-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2025-04-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2025-04-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] } } }, { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } }, { "trialId": "nct06998043", "start": { "date": "2025-07-02", "kind": "actual" }, "end": { "date": "2026-09", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-07-02", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2025-07-02", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-07-02", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-08-18", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] }, "end": { "value": { "date": "2026-09", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ], "candidates": [ { "date": "2026-09", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2026-09", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06998043" ] }, { "date": "2025-12-08", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://euclinicaltrials.eu/ctis-public/view/2024-519856-94-00?lang=en" ] } ] } } } ] }, { "id": "trial-site/70d48e485d6a1800", "name": "Velocity Clinical Research — Mobile, Alabama", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct05616221" ], "location": "Mobile, Alabama", "detail": "Recorded study locations: Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection. Not an offer of treatment.", "searchTerms": [ "Velocity Clinical Research", "Mobile", "Alabama", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "id": "trial-site/c3337c37b5fd824c", "name": "Virginia Commonwealth University (VCU) — Richmond, Virginia", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05616221" ], "checked": "2026-10-03", "trialIds": [ "nct05616221" ], "location": "Richmond, Virginia", "detail": "Recorded study locations: Non-cystic Fibrosis Bronchiectasis; Pseudomonas Aeruginosa; Lung Infection. Not an offer of treatment.", "searchTerms": [ "Virginia Commonwealth University (VCU)", "Richmond", "Virginia", "Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection", "Non-cystic Fibrosis Bronchiectasis", "Pseudomonas Aeruginosa", "Lung Infection", "NCT05616221" ], "studyYears": [ { "trialId": "nct05616221", "start": { "date": "2023-01-10", "kind": "actual" }, "end": { "date": "2024-08-08", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "label": "2023–2024", "dateEvidence": { "start": { "value": { "date": "2023-01-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2023-01-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2023-01-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] }, "end": { "value": { "date": "2024-08-08", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ], "candidates": [ { "date": "2024-08-08", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] }, { "date": "2024-08-08", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05616221" ] } ] } } } ] }, { "id": "trial-site/cf5bc1569f241158", "name": "Wake Forest University Health Sciences — Winston-Salem, North Carolina", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05184764" ], "checked": "2026-10-03", "trialIds": [ "nct05184764" ], "location": "Winston-Salem, North Carolina", "detail": "Recorded study locations: Bacteremia; Staphylococcus Aureus; Staphylococcus Aureus Bacteremia; Bacteremia Staph; Bacteremia Due to Staphylococcus Aureus. Not an offer of treatment.", "searchTerms": [ "Wake Forest University Health Sciences", "Winston-Salem", "North Carolina", "Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia", "Bacteremia", "Staphylococcus Aureus", "Staphylococcus Aureus Bacteremia", "Bacteremia Staph", "Bacteremia Due to Staphylococcus Aureus", "NCT05184764" ], "studyYears": [ { "trialId": "nct05184764", "start": { "date": "2022-04-26", "kind": "actual" }, "end": { "date": "2025-01-14", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-04-26", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2022-04-26", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2022-04-26", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] }, "end": { "value": { "date": "2025-01-14", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ], "candidates": [ { "date": "2025-01-14", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] }, { "date": "2025-01-14", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05184764" ] } ] } } } ] }, { "id": "trial-site/9cedf0061452a79e", "name": "Washington University in St Louis — St Louis, Missouri", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06559618" ], "checked": "2026-10-03", "trialIds": [ "nct06559618" ], "location": "St Louis, Missouri", "detail": "Recorded study locations: Bacteriuria; Spinal Cord Injuries; Asymptomatic Bacteriuria; Escherichia Coli. Not an offer of treatment.", "searchTerms": [ "Washington University in St Louis", "St Louis", "Missouri", "Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria", "Bacteriuria", "Spinal Cord Injuries", "Asymptomatic Bacteriuria", "Escherichia Coli", "NCT06559618" ], "studyYears": [ { "trialId": "nct06559618", "start": { "date": "2025-02-03", "kind": "actual" }, "end": { "date": "2028-12", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ], "label": "2025–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-02-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ], "candidates": [ { "date": "2025-02-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ] }, { "date": "2025-02-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ] } ] }, "end": { "value": { "date": "2028-12", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ], "candidates": [ { "date": "2028-12", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ] }, { "date": "2028-12", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06559618" ] } ] } } } ] }, { "id": "therapyRoutes/wustl-sci", "name": "Washington University School of Medicine — SCI bacteriuria trial", "countries": [ "US" ], "uuid": "8d97021ab4ca5477b4edf58201954927", "permalink": "/items/washington-university-school-of-medicine-sci-bacteriuria-trial-8d97021ab4ca5477b4edf58201954927", "kind": "Center", "status": "Official referral/inquiry route", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06559618" ], "checked": "2026-10-03", "trialIds": [ "nct06559618" ], "location": "St. Louis, Missouri; United States", "accessMode": "trial-inquiry", "detail": "Randomized intravesical matched phage/placebo trial in adults with spinal cord injury and E. coli bacteriuria.", "searchTerms": [ "Randomized intravesical matched phage/placebo trial in adults with spinal cord injury and E. coli bacteriuria.", "St. Louis, Missouri; United States" ] }, { "id": "trial-site/c00f0a1dba08f8d4", "name": "Weill Cornell Medicine — New York, New York", "countries": [ "US" ], "kind": "Trial site", "status": "Recruiting (trial)", "activity": "current", "sources": [ "https://clinicaltrials.gov/study/NCT06938867" ], "checked": "2026-10-03", "trialIds": [ "nct06938867" ], "location": "New York, New York", "detail": "Recorded study locations: E Coli Infections; Allogenic Transplant Patients. Not an offer of treatment.", "searchTerms": [ "Weill Cornell Medicine", "New York", "New York", "Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant", "E Coli Infections", "Allogenic Transplant Patients", "NCT06938867" ], "studyYears": [ { "trialId": "nct06938867", "start": { "date": "2025-02-25", "kind": "actual" }, "end": { "date": "2026-04-01", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "label": "2025–2026 (estimated)", "dateEvidence": { "start": { "value": { "date": "2025-02-25", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "candidates": [ { "date": "2025-02-25", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] }, { "date": "2025-02-25", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] } ] }, "end": { "value": { "date": "2026-04-01", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ], "candidates": [ { "date": "2026-04-01", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] }, { "date": "2026-04-01", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT06938867" ] } ] } } } ] }, { "id": "trial-site/acaddd015ffc651e", "name": "William Beaumont Hospital — Royal Oak, Michigan", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05269134" ], "checked": "2026-10-03", "trialIds": [ "nct05269134" ], "location": "Royal Oak, Michigan", "detail": "Recorded study locations: Prosthetic Joint Infection. Not an offer of treatment.", "searchTerms": [ "William Beaumont Hospital", "Royal Oak", "Michigan", "Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)", "Prosthetic Joint Infection", "NCT05269134" ], "studyYears": [ { "trialId": "nct05269134", "start": { "date": "2023-03-27", "kind": "actual" }, "end": { "date": "2027-07", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "label": "2023–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-03-27", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2023-03-27", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2023-03-27", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] }, "end": { "value": { "date": "2027-07", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2027-07", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2027-07", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] } } } ] }, { "uuid": "04af88763fe55bf68e78fba222f27646", "permalink": "/items/a-prospective-randomized-double-blind-controlled-study-of-wpp-201-for-the-safety-and-effic-04af88763fe55bf68e78fba222f27646", "id": "trials/nct00663091", "name": "WPP-201 (NCT00663091)", "countries": [ "US" ], "kind": "Trial", "status": "Completed", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT00663091" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct00663091", "start": { "date": "2006-09", "kind": "reported" }, "end": { "date": "2008-05", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00663091" ], "label": "2006–2008", "dateEvidence": { "start": { "value": { "date": "2006-09", "kind": "reported" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00663091" ], "candidates": [ { "date": "2006-09", "kind": "reported", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00663091" ] }, { "date": "2006-09", "kind": "reported", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00663091" ] } ] }, "end": { "value": { "date": "2008-05", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00663091" ], "candidates": [ { "date": "2008-05", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00663091" ] }, { "date": "2008-05", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT00663091" ] } ] } } } ], "detail": "Venous Leg Ulcers", "searchTerms": [ "A Prospective, Randomized, Double-Blind Controlled Study of WPP-201 for the Safety and Efficacy of Treatment of Venous Leg Ulcers", "Venous Leg Ulcers", "NCT00663091", "Southweast Regional Wound Care Center", "Lubbock", "Texas", "United States" ] }, { "id": "trial-site/c4c060cbc024703f", "name": "WVU Medicine JW Ruby Memorial Hospital — Morgantown, West Virginia", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05269134" ], "checked": "2026-10-03", "trialIds": [ "nct05269134" ], "location": "Morgantown, West Virginia", "detail": "Recorded study locations: Prosthetic Joint Infection. Not an offer of treatment.", "searchTerms": [ "WVU Medicine JW Ruby Memorial Hospital", "Morgantown", "West Virginia", "Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)", "Prosthetic Joint Infection", "NCT05269134" ], "studyYears": [ { "trialId": "nct05269134", "start": { "date": "2023-03-27", "kind": "actual" }, "end": { "date": "2027-07", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "label": "2023–2027 (estimated)", "dateEvidence": { "start": { "value": { "date": "2023-03-27", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2023-03-27", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2023-03-27", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] }, "end": { "value": { "date": "2027-07", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ], "candidates": [ { "date": "2027-07", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] }, { "date": "2027-07", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05269134" ] } ] } } } ] }, { "id": "trial-site/9adbe2b23cd454c8", "name": "Yale New Haven Hospital — New Haven, Connecticut", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT04684641" ], "checked": "2026-10-03", "trialIds": [ "nct04684641" ], "location": "New Haven, Connecticut", "detail": "Recorded study locations: Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Yale New Haven Hospital", "New Haven", "Connecticut", "CYstic Fibrosis bacterioPHage Study at Yale (CYPHY)", "Cystic Fibrosis", "NCT04684641" ], "studyYears": [ { "trialId": "nct04684641", "start": { "date": "2021-03-29", "kind": "actual" }, "end": { "date": "2023-06-22", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04684641" ], "label": "2021–2023", "dateEvidence": { "start": { "value": { "date": "2021-03-29", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04684641" ], "candidates": [ { "date": "2021-03-29", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04684641" ] }, { "date": "2021-03-29", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04684641" ] } ] }, "end": { "value": { "date": "2023-06-22", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04684641" ], "candidates": [ { "date": "2023-06-22", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04684641" ] }, { "date": "2023-06-22", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04684641" ] } ] } } } ] }, { "id": "trial-site/62fcc57704431e5f", "name": "Yale North Haven Medical Center- Winchester Center for Lung Disease — North Haven, Connecticut", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05453578" ], "checked": "2026-10-03", "trialIds": [ "nct05453578" ], "location": "North Haven, Connecticut", "detail": "Recorded study locations: Bacterial Disease Carrier; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Yale North Haven Medical Center- Winchester Center for Lung Disease", "North Haven", "Connecticut", "A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa", "Bacterial Disease Carrier", "Cystic Fibrosis", "NCT05453578" ], "studyYears": [ { "trialId": "nct05453578", "start": { "date": "2022-10-03", "kind": "actual" }, "end": { "date": "2025-04-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "label": "2022–2025", "dateEvidence": { "start": { "value": { "date": "2022-10-03", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2022-10-03", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2022-10-03", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] }, "end": { "value": { "date": "2025-04-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ], "candidates": [ { "date": "2025-04-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] }, { "date": "2025-04-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05453578" ] } ] } } } ] }, { "id": "therapyRoutes/yale-phage", "name": "Yale Phage Therapy Program", "countries": [ "US" ], "uuid": "cb12c9f5d1955a75ad1272ea4a0f35ff", "permalink": "/items/yale-phage-therapy-program-cb12c9f5d1955a75ad1272ea4a0f35ff", "kind": "Center", "status": "Case-by-case; Official referral/inquiry route", "activity": "current", "sources": [ "https://phage.yale.edu/faqs", "https://phage.yale.edu/therapy", "https://clinicaltrials.gov/study/NCT04684641" ], "checked": "2026-10-03", "trialIds": [ "nct04684641" ], "location": "New Haven, Connecticut; United States", "accessMode": "case-by-case", "detail": "Clinical phage therapy at Yale and collaborating clinics for antibiotic-resistant bacterial infection; individualized compassionate-use eligibility.", "searchTerms": [ "Clinical phage therapy at Yale and collaborating clinics for antibiotic-resistant bacterial infection; individualized compassionate-use eligibility.", "New Haven, Connecticut; United States" ] }, { "id": "trial-site/c72331ddd926cfcc", "name": "Yale University — New Haven, Connecticut", "countries": [ "US" ], "kind": "Trial site", "status": "Historical trial site", "activity": "historical", "sources": [ "https://clinicaltrials.gov/study/NCT05010577" ], "checked": "2026-10-03", "trialIds": [ "nct05010577" ], "location": "New Haven, Connecticut", "detail": "Recorded study locations: Chronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis. Not an offer of treatment.", "searchTerms": [ "Yale University", "New Haven", "Connecticut", "Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection", "Chronic Pseudomonas Aeruginosa Infection", "Cystic Fibrosis", "NCT05010577" ], "studyYears": [ { "trialId": "nct05010577", "start": { "date": "2022-06-21", "kind": "actual" }, "end": { "date": "2024-03-10", "kind": "actual" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "label": "2022–2024", "dateEvidence": { "start": { "value": { "date": "2022-06-21", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2022-06-21", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2022-06-21", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] }, "end": { "value": { "date": "2024-03-10", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ], "candidates": [ { "date": "2024-03-10", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] }, { "date": "2024-03-10", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT05010577" ] } ] } } } ] }, { "id": "therapyRoutes/kinzbio", "name": "Kinzbio personalized phage supply", "countries": [ "UY" ], "uuid": "473aeb03804c5ca0bf54936eec84650b", "permalink": "/items/kinzbio-personalized-phage-supply-473aeb03804c5ca0bf54936eec84650b", "kind": "Supplier", "status": "Official referral/inquiry route", "activity": "current", "sources": [ "https://www.gub.uy/ministerio-salud-publica/institucional/normativa/ordenanza-n-1162024-autorizacion-para-practica-terapia-personalizada", "https://www.gub.uy/ministerio-salud-publica/sites/ministerio-salud-publica/files/2025-05/Ord_1162_2024.pdf", "https://www.kinzbio.com/" ], "checked": "2026-10-03", "location": "Montevideo; Uruguay", "detail": "Individualized treatment/prevention of multidrug-resistant bacterial infection; clinician/institution-mediated supply rather than a verified independent destination clinic.", "searchTerms": [ "Individualized treatment/prevention of multidrug-resistant bacterial infection; clinician/institution-mediated supply rather than a verified independent destination clinic.", "Montevideo; Uruguay" ] }, { "uuid": "5d8c6f3294ad54ba80fdab800c0c567d", "permalink": "/items/bacteriophage-therapy-in-tonsillitis-5d8c6f3294ad54ba80fdab800c0c567d", "id": "trials/nct04682964", "name": "Bacteriophage Therapy in Tonsillitis (NCT04682964)", "countries": [ "UZ" ], "kind": "Trial", "status": "Active, not recruiting", "activity": "ongoing", "sources": [ "https://clinicaltrials.gov/study/NCT04682964" ], "checked": "2026-10-03", "studyYears": [ { "trialId": "nct04682964", "start": { "date": "2020-10-02", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04682964" ], "label": "2020–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2020-10-02", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04682964" ], "candidates": [ { "date": "2020-10-02", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04682964" ] }, { "date": "2020-10-02", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04682964" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04682964" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04682964" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04682964" ] } ] } } } ], "detail": "Acute Tonsillitis", "searchTerms": [ "Bacteriophage Therapy in Tonsillitis", "Acute Tonsillitis", "NCT04682964", "Tashkent Pediatric Medical Institute", "Tashkent", "", "Uzbekistan" ] }, { "id": "trial-site/2d454e2e1c95a1de", "name": "Tashkent Pediatric Medical Institute — Tashkent", "countries": [ "UZ" ], "kind": "Trial site", "status": "Active, not recruiting (trial)", "activity": "ongoing", "sources": [ "https://clinicaltrials.gov/study/NCT04682964" ], "checked": "2026-10-03", "trialIds": [ "nct04682964" ], "location": "Tashkent", "detail": "Recorded study locations: Acute Tonsillitis. Not an offer of treatment.", "searchTerms": [ "Tashkent Pediatric Medical Institute", "Tashkent", "", "Bacteriophage Therapy in Tonsillitis", "Acute Tonsillitis", "NCT04682964" ], "studyYears": [ { "trialId": "nct04682964", "start": { "date": "2020-10-02", "kind": "actual" }, "end": { "date": "2028-12-31", "kind": "estimated" }, "endEvent": "completion", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04682964" ], "label": "2020–2028 (estimated)", "dateEvidence": { "start": { "value": { "date": "2020-10-02", "kind": "actual" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04682964" ], "candidates": [ { "date": "2020-10-02", "kind": "actual", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04682964" ] }, { "date": "2020-10-02", "kind": "actual", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04682964" ] } ] }, "end": { "value": { "date": "2028-12-31", "kind": "estimated" }, "conflict": false, "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04682964" ], "candidates": [ { "date": "2028-12-31", "kind": "estimated", "origin": "canonical", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04682964" ] }, { "date": "2028-12-31", "kind": "estimated", "origin": "registry", "sourceUrls": [ "https://clinicaltrials.gov/study/NCT04682964" ] } ] } } } ] } ], "summary": { "rows": 508, "trials": 96, "routes": 139, "trialSiteGroups": 273, "siteObservations": 312, "historicalSiteGroups": 162, "historicalSitesWithStudyYears": 162 } }